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Summary 
The drive to increase interprofessional teamwork in the healthcare environment has gained 
significant traction in recent years. This has partly been as a consequence of UK inquiries 
that have cited breakdowns in communication and teamwork as contributory factors 
leading to poor patient outcomes. One method to prepare practitioners for 
interprofessional teamworking is interprofessional education (IPE).  The General 
Pharmaceutical Council specifies that IPE must be embedded within UK Master of Pharmacy 
(MPharm) programmes. However, there is a paucity of literature examining IPE related to 
pharmacy and limited knowledge of pharmacists’ interprofessional interactions with 
healthcare professionals (HCPs). This makes it challenging for pharmacy educators to 
design IPE sessions that are reflective of practice. To address this, a mapping process was 
undertaken to identify IPE sessions that are delivered in UK MPharm programmes (17/29 
schools responded). This identified significant variation in IPE sessions delivered in terms 
of learning outcomes addressed, topics covered, and the range of student HCPs involved. A 
mixed method study was then undertaken to explore pharmacists’ interprofessional 
interactions in practice. A questionnaire was disseminated to pharmacists in Wales via 
community pharmacies (61.9% response) and hospital pharmacy departments (estimated 
59.1% response). Analysis of returned questionnaires identified that although the extent of 
interprofessional collaboration varied pharmacists in both sectors most frequently interact 
with doctors and nurses. Semi-structured interviews were undertaken with pharmacists 
from both the community (n=14) and hospital (n=15) sectors to explore the nature of 
interactions. Using deductive and inductive thematic analysis, the nature of pharmacists’ 
interactions with HCPs was elucidated, facilitators and barriers to interactions were 
determined and suggestions for IPE developed. Findings from these studies resulted in a 
series of recommendations for pharmacy educators and policy makers to facilitate 
pharmacists’ interprofessional collaboration in practice and aid the development of 
relevant IPE that is of value to learners.  
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1.1. About this study 
In recent years the World Health Organisation (2010) and the UK Department of Health 
(2013c) have recognised the need to improve interprofessional collaboration in order to 
provide patient-centred care. This desire was further increased following the publication of 
a number of UK inquiries (including those by Francis (2013), Andrews and Butler (2014), 
Kirkup (2015) and Carter (2016)) that cited breakdowns in communication and teamwork 
as contributory factors leading to poor patient outcomes. One method which aims to 
enhance interprofessional collaboration and teamworking in the healthcare environment is 
the provision of interprofessional education (IPE) through undergraduate and 
postgraduate studies (World Health Organisation, 2013). Although IPE is now a required 
element of the undergraduate UK pharmacy curriculum (General Pharmaceutical Council, 
2011), there is still a paucity of published guidance and literature about IPE involving 
pharmacists or pharmacy students and similarly, a limited knowledge of pharmacists’ 
interprofessional practice. This makes the design of IPE sessions that are meaningful, 
relevant and reflective of practice challenging for pharmacy educators. This study aimed to 
bridge these gaps. To do this an initial mapping process was conducted to determine the 
provision of IPE across UK schools of pharmacy. An online questionnaire was disseminated 
to IPE educators across all UK schools of pharmacy. This was followed by a mixed method 
study to identify and explore pharmacists’ interprofessional interactions in practice. As this 
thesis was conducted within Wales (at Cardiff University) there was a specific focus on the 
experiences of pharmacists based within NHS Wales, which although devolved from other 
UK NHS organisations (i.e. NHS England) is still guided by procedures and policies produced 
by the Department of Health. This study initially utilised a self-complete questionnaire to 
determine both community and hospital pharmacists’ perceived frequency of interactions 
with other healthcare professionals and wider healthcare team members (jointly termed 
HCTMs). Semi-structured interviews were subsequently undertaken with a range of 
pharmacists from both sectors to further explore these interactions, determining the nature 
of specific interactions with healthcare professionals (HCPs) pharmacists frequently 
interacted with (including the topic of interactions and the mode in which they took place), 
any facilitators and barriers to these interactions and suggestions for IPE. The ultimate aim 
of this thesis was to produce a series of recommendations for pharmacy educators and 
policy makers to facilitate pharmacists’ interprofessional collaboration in practice and aid 
the development of relevant IPE that is of value to and supports learners. Whilst the Welsh 
NHS has some autonomy in its delivery its practice is primarily governed by the Department 
of Health and therefore it is likely that data gathered from these pharmacists based within 
Chapter 1 
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Wales may reflect that of pharmacists based within other UK principalities such as England, 
Scotland and Northern Ireland. 
1.2. Organisation of the thesis 
Background literature informing the development and conduct of this study is presented in 
chapter 2. The chapter: outlines recent policy and practice changes that have resulted in a 
need for greater interprofessional collaboration across healthcare, with a particular 
reference to that between pharmacists and other healthcare professionals; examines 
existing literature related to pharmacist-HCP relationships, identifying gaps in knowledge; 
discusses the evidence surrounding why interprofessional collaboration is not currently the 
norm across healthcare environments; and explores the methods that have been used to try 
and improve interprofessional collaboration, with specific reference to the use of 
interprofessional education in the field of pharmacy. The chapter concludes by presenting 
the aims and specific objectives of the study.  
 
Chapter 3 determines the current landscape of interprofessional education in schools of 
pharmacy across the UK. An exploration in undertaken of the types of sessions taking place 
in universities; who these sessions were conducted with; the timing of sessions and the 
topic explored; and methods used in assessing sessions or student progress. 
 
Chapter 4 is the first of three chapters which explores pharmacists’ interprofessional 
interactions in practice. This chapter focuses on the study design and methods used. It 
provides detail on the mixed method approach used within the studies (quantitative 
questionnaire and qualitative interviews); methods of sampling and selection; design and 
piloting of the research instruments; data collection strategies and recruitment; and the 
handling and analysis of data.  
 
Chapter 5 presents the findings from a mixed method analysis exploring community 
pharmacists’ interactions with other HCPs. An examination is made of the data gathered 
from a quantitative questionnaire to determine the HCPs that pharmacists most frequently 
interact with and explores the factors that influence such interactions, for example 
demographic and geographical characteristics. The chapter also details an analysis of data 
gathered from a series of interviews with community pharmacists. Here deductive and 
inductive thematic analysis identified the reasons community pharmacists interact with 
HCPs; the benefits these interactions can have for patients and the HCPs themselves; any 
barriers to, and solutions for, working interprofessionally with other HCPs; and the mode 
with which interactions take place. 
Chapter 1 
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Chapter 6 presents the findings from the mixed method analysis exploring hospital 
pharmacists’ interactions with other HCPs. The same areas as chapter 5 were explored, 
however with the focus on hospital pharmacists’ interactions with HCPs.   
 
Chapter 7 concludes the thesis, providing an overview of the findings across the studies and 
discusses the similarities and differences between community and hospital pharmacists’ 
interprofessional interactions. This chapter also, discusses implications for practice, 
education and further research, provides a series of recommendations for educators and 
policy makers that may serve to improve interprofessional collaboration and education, and 
describes how this thesis has directly impacted the authors own professional practice.  
Chapter 2 
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2.1. Chapter overview 
Working as part of a team is an essential element of modern life in a number of domains. 
From an early stage in life we are encouraged to integrate into a variety of teams including 
for example in sports teams, communities of learning in schools and as we embark on our 
careers in the workplace. The overarching philosophy of the team is for individuals to work 
together, utilising each individual’s skills to achieve a common purpose (Reeves et al., 
2010a). This shared responsibility across the team to effectively achieve desired outcomes 
is synergistic producing further reach than when individuals act alone (Reeves et al., 
2010b). Ultimately, a team’s successes and failures allow for collective reflection and 
improvements in teamworking and outcomes (Jelphs et al., 2016).  
 
In the healthcare setting, a range of professions work in concert to deliver patient care. In 
general, patients do not see the inner workings of such teams and arguably this is not an 
issue as long as their health needs have been met. However, when effective teamwork 
breaks down, the consequence may be that patient related outcomes are negatively 
impacted. 
 
Within the United Kingdom (UK) healthcare is predominantly delivered through the 
National Health Service (NHS), a free at the point of use service that provides treatment for 
patients related to all aspects of their health and social care (Department of Health, 2010). 
In total the NHS employs 1.7 million people, which range from health and social care 
professionals to administrative and support staff, making it the world’s fifth largest 
employer (Nuffield Trust, 2017). With such a range of professions working within the NHS 
to deliver a common mission, it is recognised that interprofessional teams must work 
together efficiently and effectively in order to optimise patient outcomes across the 
multitude of services delivered (Department of Health, 2013c; Carter, 2016). Effective 
interprofessional teamwork in this context maximises the utilisation of a range of HCPs 
(both generalists and specialists) working together to find solutions to simple and complex 
patient problems. However, coordination of interprofessional teams on such a large scale 
provides a challenge for the NHS because of a range of factors including the ingrained 
separation of HCPs in location, specialism, professional identity and values, and educational 
experiences (see section 2.4). Ultimately, the effective operation of teams in the healthcare 
environment can have significant consequences on patient morbidity and mortality. Indeed, 
a number of recent enquiries including those by Francis (2013), Andrews and Butler (2014), 
Kirkup (2015) and Carter (2016) have demonstrated negative consequences on patient 
outcomes directly related to ineffective teamwork (see section 2.3).    
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In this introductory chapter, an overview of interprofessional collaboration is provided, 
highlighting benefits to practice, barriers and facilitators to collaboration across a range of 
healthcare settings and the potential role of interprofessional education (IPE) in developing 
interprofessional practitioners. As the thesis will primarily address the role of the 
pharmacist in interprofessional teams, the introduction will include a focus on this area.  
Literature cited in this chapter was identified through a review process outlined in 
Appendix A. 
2.2. Overview of key terminology 
Before exploring the concepts of interprofessional collaboration and education it is 
important to acknowledge the terminology referred to throughout this thesis. In recent 
years there has been an expansion in research on interprofessional teamworking and 
education in the field of healthcare. As a consequence, there has been a proliferation of 
terms related to these concepts without a clear consensus on their use. Indeed, many 
studies use a range of terms to describe the same concept or conversely use the same terms 
to describe different concepts, something that has been highlighted in a number of review 
articles (Hall and Weaver, 2001; D'Amour et al., 2005; Reeves et al., 2010b; Jelphs et al., 
2016). This thesis uses a common set of definitions, highlighted in Table 2.1, that have been 
defined by Barr et al. (2005), Jelphs et al. (2016) and Reeves et al. (2010a) and reflect those 
used in the Journal of Interprofessional Care. 
 
Whilst there are a range of terms used throughout the literature this thesis primarily 
focuses on the interprofessional collaboration and teamworking that take place between 
health and social care professionals (HCPs) (rather than academic disciplines) in order to 
understand the ways pharmacists’ work towards a common goal. The difference between 
interprofessional teamworking and collaboration is based on the level of integration of 
HCPs, whereby teamworking implies this occurs in a fully integrated manner, something 
which is in contrast absent in collaborative working. Whilst ‘teamworking’ may be desired 
(see section 2.3) limited research and varied terminology use makes the differentiation 
between the two (teamworking and collaboration) often difficult to determine, resulting in 
the terms often being used interchangeably to highlight professions working in partnership 
to achieve a common goal. The term interprofessional interaction (IPI) is also used within 
this thesis to highlight there is some element of engagement between HCPs however it does 
not reference the extent of this engagement. ‘Interaction’ therefore could range between 
teamworking (where HCPs have worked together, sharing knowledge and skills to solve 
issues in an integrated manner) to information transfer (where HCPs have communicated 
information however did not directly work together during this exchange). 
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Table 2.1. A glossary of the definitions used throughout this thesis identified within Barr et al. (2005), Reeves et al. (2010a) and Jelphs et al. (2016) 
Term  Definition (* = definition adapted for use within this thesis) 
Healthcare 
professional (HCP) 
*Occupational professional groups who in general provide health and social services to others, such as pharmacists or social workers. It can be 
used as a term of self-ascription to avoid the need to apply regulatory criteria which differ between groups 
Healthcare team 
member (HCTM) 
*All professional and non-professional groups (i.e. administrative staff such as GP receptionists) who are associated with the delivery of healthcare, 
inclusive of all healthcare professionals 
Discipline Comprises of different academic disciplines (psychology, sociology, mathematics) rather than from different professions such as pharmacists, 
doctors, social workers etc. 
Collaboration  An active and on-going partnership, often between people from diverse backgrounds, who work together to solve problems or provide services 
Teamwork An active and on-going partnership, often between people from diverse backgrounds, who share a team identity and work closely together in an 
integrated and interdependent manner to solve problems and deliver services. 
Interaction Any activity that involves direct engagement/communication with another person irrespective of the topic, frequency or nature (i.e. 
collaboration/teamwork) 
Information 
transfer 
*This is where an interaction has occurred (see above) however is purely focused on the transfer of information, with no direct collaborative 
working undertaken to jointly solve problems or provide services 
Interprofessional A term which describes any activity undertaken where there is a strong propensity for team members to interact across boundaries to actively 
work towards jointly solving a problem 
Multiprofessional Similar to ‘interprofessional’ but implies lower levels of cross boundary interactions, lower levels of collaboration and more ‘side by side’ working 
Transprofessional Similar to ‘interprofessional’ but implies complete integration of professionals across sectors utilising the same conceptual and methodological 
approaches thus promoting generic working: a process whereby the activities of one professional group are undertaken by members of another 
Intraprofessional  Any activity which is undertaken by individuals within the same profession 
Uniprofessional Any activity undertaken by one profession alone 
Interprofessional 
collaboration  
A type of interprofessional work which involves different health and social care professions who regularly come together to solve problems or 
provide services. 
Interprofessional 
teamwork  
A type of interprofessional work which involves different health and/or social professions who share a team identity and work closely together in 
an integrated and interdependent manner to solve problems and deliver services. 
Interprofessional 
education  
An educational tool used where members (or students) of two or more health and/or social care professions engage in learning with, from and 
about each other to improve collaboration and the delivery of care 
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2.3. The need for interprofessional collaboration within UK healthcare practice 
Since its foundation in 1948, the NHS has been the centerpiece of health and social care in 
the UK. At its heart is the provision of a comprehensive service that is based on clinical need, 
available to all and free at the point of use (Department of Health, 2010). Across the UK the 
NHS is devolved and managed by each of the four independent countries: NHS Wales, NHS 
England, NHS Scotland and the affiliated Health and Social Care (HSC) in Northern 
Ireland. Whilst each of these nations have responsibility for the specific delivery of patient 
care the Department of Health (DoH) has a strong influence over the final policies across all 
four nations. Therefore, although this project primarily focuses on pharmacists who work 
within NHS Wales and thus references specific Welsh policy documents, NHS Wales often 
adopts the DoH guidance aligning them with the other three UK nations.  
 
The NHS constitution published by the Department of Health (2009) states, among other 
principles, that it aspires to maintain the highest standards of excellence and 
professionalism by working in partnership across professions in the interests of patient 
care. However, in recent years a number of reviews have identified that the NHS is failing in 
some instances to reach these high standards and such reviews have frequently cited a 
failure in interprofessional teamworking as a contributory factor leading to poor patient 
care (Francis, 2013; Andrews and Butler, 2014; Kirkup, 2015). 
 
The earliest of these reviews was conducted by Francis who investigated the Mid-
Staffordshire NHS Foundation Trust between 2005 to 2008 over serious failings that led to 
the “appalling suffering of many patients” that included patients left in excrement, lack of 
privacy and dignity (even in death), patients denied requests for help, and food and water 
left out of reach (Francis, 2013). One key factor identified within the report which was 
paramount to the trusts  failure to provide adequate patient care was the lack of effective 
interprofessional teamwork.  A failure in communication between care sectors and HCPs 
was highlighted as preventing the active sharing of vital patient related information. Of note, 
there was an underlying assumption by many HCPs that monitoring, performance 
management and interventions were the responsibility of someone else due to a lack of 
understanding of roles and responsibilities. This was found to have significantly 
contributed to poor patient care. Furthermore, a fundamental lack of openness and 
transparency between HCPs was identified which ultimately limited sharing and 
communicating of information. This led Francis to recommend that “there needs to be 
effective teamwork between all the different disciplines” (pg.110).  
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Following publication of the Francis report, the Department of Health (2013c) responded 
with the publication of the ‘Patients First and Foremost’ document that underlined the 
importance of ensuring that the values and behaviours of HCPs were not siloed but rather 
they ensure a culture of open and effective teamwork. This was the first DoH publication to 
directly highlight the need for improved interprofessional teamworking across healthcare 
settings and was a clear priority with the then government health minister outlining a 
number of “Statements of Common Purpose” within the report that HCPs, alongside other 
care givers, must be committed to in order to improve UK healthcare delivery; the first 
statement of common purpose was “working together for patients” (pg. 9). The key feature 
underpinning these statements is that by getting HCPs to interact and collaborate in an 
interprofessional manner on behalf of the patients, individual strengths will be combined, 
professional knowledge shared, and healthcare teams will harbor a collective responsibility 
for the provision of quality patient care. This was reinforced in a supplementary document 
entitled ‘Integrated Care and Support: Our Shared Commitment’ also published by the 
Department of Health (2013a). The document stated that interprofessional teamworking 
needed to occur across all healthcare boundaries and settings to create a culture of 
cooperation and coordination between health, social care, public health and other local 
services. Similarly, the document stated that there must be an end to the institutional divide 
between physical and mental health services, and primary and secondary care. The desire 
to remove professional silos and better integrate interprofessional teams was neatly 
summarised; “too often, we don’t communicate properly with each other, don’t work 
together as a team or don’t treat people as whole individuals. As a result, care and support 
is often fragmented, delayed or duplicated, which can result in missed opportunities to 
prevent needs from escalating and intervening early. This leads to poorer outcomes and 
experiences for the people who use our services” (pg. 6) (Department of Health, 2013a). 
The drive to integrate professions throughout health, education and social care and across 
both primary and secondary care was also highlighted in the ‘Health and Social Care Act 
2012’ released by the Department of Health (2012) the year prior to the ‘Integrated Care 
and Support’ document, further cementing the DoH’s desire to enhance collaboration across 
all aspects of care.   
 
In 2014 attention was once again drawn to failings in interprofessional teamworking in a 
report published by Andrews and Butler (2014) that detailed an independent review of two 
hospitals within the Abertawe Bro Morgannwg University (ABMU) Health Board in Wales. 
This was a consequence of concerns that were raised relating to patient safety. Andrews 
and Butler found that there was (amongst other areas) poor professional behavior, lack of 
suitably qualified and educated staff, a disconnection between front-line staff and 
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managers, and confusion over leadership responsibilities and accountabilities. The report 
once again made a series of recommendations that reiterated the need for more cohesive 
interprofessional collaboration and greater levels of shared patient responsibility and 
accountability at all levels of patient care, with one recommendation specifically stating the 
need to make sure that “professional staff operate in cohesive clinical teams” (pg. 12). The 
ABMU board were also recommended to “develop more cohesive multidisciplinary team 
practice in the medical wards at the two hospitals, built around shared responsibility and 
accountability for patient care and standards of professional behaviour” (pg. 13) (Andrews 
and Butler, 2014). 
 
In 2015, a review was published by Kirkup that detailed failings in the provision of care at 
the maternity and neonatal services within the University Hospitals of Morecambe Bay NHS 
Foundation Trust between 2004 and 2013. This review identified a number of serious 
failings within the trust which resulted in the unnecessary deaths of mothers and babies 
including (amongst other areas): substandard clinical competence; extremely poor working 
relationships, particularly between different staff groups, such as obstetricians, 
paediatricians and midwives; and failures of risk assessment and care planning that 
resulted in inappropriate and unsafe care. Kirkup also indicated that there was a culture of 
poor working relationships between HCPs that meant they were unable to work together 
effectively leading to repeated instances where HCPs failed to communicate important 
clinical information about individual patients to one another. He also cited a toxic “them and 
us culture” (pg. 13) as having a detrimental effect on team dynamics, and subsequently 
concluded that the breakdown in interprofessional collaboration was a key factor in 
unwarranted patient deaths. 
 
Following these independent enquiries, the DoH published a further response entitled 
‘Learning not blaming: The government response to Freedom to Speak Up, the Public 
Administration Select Committee report on clinical incidents, and the Morecambe Bay 
Investigation’ (Department of Health, 2015). Here they specifically noted the need to 
identify and develop measures that will promote effective interprofessional team working, 
believing that the removal of “inflexible demarcations between professional groups” (pg. 
98) could help improve interprofessional care. This was reinforced in a review of the 
operational productivity of 136 NHS England acute hospitals conducted by Carter (2016) 
which found unwarranted variation in a range of key resource areas such as: clinical staff, 
pharmacy and medicines; diagnostics and imaging; procurement; back-office functions; and 
estates and facilities. One key finding Carter identified across trusts was the challenges 
related to delayed transfer of care and barriers to greater collaboration and cooperation, 
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which he found could “inhibit trusts’ ability to improve performance and result in sub-
optimal clinical quality and efficiency across the local health economy” (pg. 8) (Carter, 
2016).  
 
Against a backdrop of these failings where interprofessional teamwork has not be effective, 
the potential benefits of interprofessional collaboration in the healthcare setting have been 
reported. For example, O'Leary et al. (2012) produced a general review article summarising 
the interprofessional working undertaken across hospitals, highlighting that teamworking 
across professions was critically important in the provision of safe, effective hospital care. 
They further surmised that hospitals with high teamwork ratings experienced higher 
patient satisfaction, lower hospital costs and higher staff retention, findings reiterated in 
the  seminal ‘Working in Teams’ book by Jelphs et al. (2016). Of note, interprofessional 
interactions have been shown to have positive impacts in a number of domains including 
affording HCPs: (i) the opportunities to learn from one another (Freeth et al., 2008), (ii) 
recognise respective roles and responsibilities (Barrett et al., 2005; Freeth et al., 2008; 
Jacobsen et al., 2009) and (iii) build social relationships which make the work environment 
more pleasurable (Reeves et al., 2010b; Jelphs et al., 2016). 
 
It is not just in the UK where the need for interprofessional working has gained traction. A 
number of recent publications by the World Health Organisation (WHO) have stressed the 
need for efficient and effective interprofessional collaboration across healthcare sectors in 
order to improve the delivery of patient care (World Health Organisation, 2010; World 
Health Organisation, 2013). The WHO stated in its ‘Framework for Action on 
Interprofessional Education & Collaborative Practice’ that having a strong, flexible and 
collaborative health workforce is one of the best ways to confront highly complex health 
challenges. Here it stated that interprofessional collaboration could benefit: family and 
community health; HIV/AIDS tuberculosis, and malaria; health action in crisis (i.e. in a 
provision of care in a humanitarian crisis); health security (i.e. responding to epidemics and 
pandemics); non-communicable diseases and mental health (i.e. working collaboratively to 
prevent and manage complex chronic conditions such as dementia, malnutrition and 
asthma); healthcare systems and services (i.e. through maximising the strengths and skills 
of HCPs, enabling them to function at the highest capacity, helping manage the strains 
placed on healthcare as a consequence of a shortage of healthcare workers)(World Health 
Organisation, 2010). The report highlighted that interprofessional collaborative practice 
can improve: access to and coordination of health-services; appropriate use of specialist 
clinical resources; health outcomes for people with chronic diseases; and patient care and 
safety, as well as decrease: total patient complications; length of hospital stay; tension and 
Chapter 2 
 29 
conflict among caregivers; staff turnover; hospital admissions; clinical error rates; and 
mortality rates. 
 
Collectively then, there is a national and international mandate for HCPs to build 
interprofessional healthcare teams in order to most appropriately utilise the skills and 
knowledge of a range of individuals to provide healthcare that meets the demanding needs 
of patients. 
2.4. How do pharmacists fit within the interprofessional team? 
One profession that has experienced a significant shift in roles and responsibilities over 
recent years is the pharmacy profession. Pharmacists, representing the third largest 
healthcare profession in the UK (General Pharmaceutical Council, 2018d), primarily 
practise within the community or hospital setting although there are specialist roles for 
example in the pharmaceutical industry or in academia and roles within the primary care 
sector which have seen significant growth in recent years (NHS England, 2014b; Welsh 
Assembly Government, 2015; General Pharmaceutical Council, 2018b). Pharmacists occupy 
a unique role as experts in medicines (NHS Health Education England, 2018) ensuring their 
safe supply from the dispensary setting and advising patients and HCPs on their safe and 
effective use (General Pharmaceutical Council, 2018d). Significantly, the independent 
report for the DoH conducted by Carter (2016) highlighted the need for greater 
incorporation of pharmacists within interprofessional teams in order to better utilise their 
clinical skills and improve patient care through their unique insight into medicines.  
 
The General Pharmaceutical Council (GPhC) is responsible for regulating pharmacists, 
pharmacy technicians and pharmacies across the UK to assure and improve standards of 
care for people using pharmacy services. Therefore, although the NHS is devolved into the 
four independent UK nations (NHS England, NHS Wales, NHS Scotland and the 
affiliated Health and Social Care (HSC) in Northern) minimum standards must be met 
by pharmacists and pharmacies across the UK.  This said, the drive to enhance the 
interprofessional integration of pharmacists has had a number of consequences for the role 
of the pharmacist in Wales including the development of new community pharmacy led 
services such as: discharge medication reviews (DMRs), smoking cessation services and flu 
vaccinations amongst others (Community Pharmacy Wales, 2018); greater access to patient 
care records (NHS Wales, 2018c); new hospital roles for example increased numbers of 
pharmacist prescribers and more time spent on patient facing medicines optimisation 
activities (as recommended by the Hospital Pharmacy Transformation Programme detailed 
by Carter (2016)); and integration of pharmacists in GP practices where they undertake 
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patient consultations to monitor and rationalise patients repeat prescriptions, improve 
medication adherence and conduct specialist reviews (particularly if they are prescribers) 
to optimise patients medications in a variety of clinical areas (i.e. anticoagulation, diabetes, 
etc.) (Primary Care Workforce Commission, 2015; Welsh Assembly Government, 2015). 
Although this has enabled pharmacists to expand their roles and responsibilities there has 
been a concomitant challenge for both pharmacists and other HCPs in understanding the 
position of the pharmacist within the interprofessional team. This lack of understanding of 
roles can be a significant barrier to interprofessional collaboration as HCPs are unaware of 
the ways pharmacists can benefit the interprofessional team (see section 2.4) (Hughes and 
McCann, 2003).   
 
The apparent ambiguity of the pharmacists’ role in both the public and professional 
conscious is not a new phenomenon. In a study conducted by Elvey et al. (2013), UK 
pharmacists (n=43) based within community, hospital and primary care settings were 
interviewed and found to have varied perceptions of their roles. The authors identified nine 
separate pharmacist identities: (i) the scientist; (ii) the medicines adviser; (iii) the clinical 
practitioner; (iv) the social carer; (v) the medicines maker; (vi) the medicines supplier; (vii) 
the manager; (viii) the business person; and (ix) unremarkable character. Elvey concluded 
as a result that pharmacists’ have a lack of clear direction and ownership of what makes 
them unique as a health profession. Elvey also suggested that these varying perceptions also 
showed flexibility in pharmacists’ view of their professional role. A similar finding was 
demonstrated by Schindel et al. (2017) using a mixed method approach (a survey (n=416) 
with Canadian community and hospital pharmacists and focus groups/interviews with a 
total of 75 participants including community and hospital pharmacists, pharmacy 
technicians, other HCPs and members of the public) which identified that: participants 
perceived that the pharmacist’s role was transitioning to focus more on patient care; the 
varying consistency in pharmacists’ uptake of more developed professional roles was 
reflected in the range of beliefs and expectations voiced by the general public; and 
pharmacists with expanded scopes of practice were assuming greater responsibility. 
Schindel also found that pharmacists viewed interprofessional collaboration and the 
development of strong relationships with other HCPs as essential for practice.  
 
Although the role of the pharmacist in interprofessional practice is generally 
underexplored, there has been some attention on the interactions between community 
pharmacists and GPs. These include a UK study employing social network analysis to 
determine practitioner perceptions of interactions through interviews with both 
community pharmacists and GPs by Bradley (2012); mailed questionnaires determining 
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community pharmacists’ attitudes towards becoming more active members of the 
interprofessional team in Canada by Dobson et al. (2006); a mixed methods study (small 
numbers of interviews and questionnaires) with community pharmacists and GP pairs to 
describe and identify the extent of the collaborative working taking place in the USA by 
Snyder et al. (2010); semi-structured interviews conducted in Australia with both 
community pharmacists and GPs to determine the extent of interactions and the impact 
pharmacy services have on these interactions by Van et al. (2011); uniprofessional focus 
groups with community pharmacists and GPs within Northern Ireland to explore the 
barriers between collaboration by Hughes and McCann (2003); and a survey distributed to 
community pharmacists and GPs in rural Australia to determine areas of commonality and 
barriers to collaboration by Norton et al. (2003). The results of these studies are detailed 
within chapter 5 (which explored community pharmacists’ interprofessional interactions). 
However, in summary the studies generally show that although pharmacists and other HCPs 
recognise the value in engaging across professions IPIs are generally limited due to a range 
of barriers within practice. In addition, in chapter 6 the small number of studies addressing 
hospital pharmacists’ interactions with hospital doctors and nurses are described. These 
include key informant interviews and reflective journaling from pharmacists, doctors and 
nurse practitioners to explore the interprofessional working relationships when providing 
team-based care in hospitalised medical patients in Canada by Makowsky et al. (2009b); 
focus groups with Australian nursing, pharmacy, and medical recent graduates to 
determine their perspectives and experiences of interprofessional collaborative practice 
and medication safety by Wilson et al. (2016). The findings from these studies generally 
echoed the studies that focused on community pharmacists interactions discussed above, 
with hospital pharmacists and HCPs once again recognising the benefits of interprofessional 
collaboration yet having limited interactions in practice.  
 
Whilst these studies represent an exploration of some of the IPIs that pharmacists 
undertake with specific HCPs, it is evident from the literature that to date there has not been 
a synthesis of the broader requirements for pharmacists to engage in IPIs, the mechanism 
by which pharmacists undertake such IPIs and the barrier and facilitators to such IPIs.  
2.5. Evidence underpinning interprofessional collaboration 
Interprofessional collaboration is a priority within the healthcare environment largely due 
to a hypothesis that it can improve patient care (World Health Organisation, 2010; 
Department of Health, 2013c). Whilst a range of individual studies have been conducted, to 
date there are no high quality generalisable studies which definitively evidence the specific 
benefits of interprofessional collaboration on improving patient outcomes. For example, 
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one method the DoH uses to assess NHS performance is the Outcomes Framework 
(Department of Health, 2013b; Department of Health, 2016). The framework is used to 
review measurable patient outcomes (such as patient survival for example in cancer, quality 
of life for people with dementia, time spent in hospital by people with long term conditions, 
etc.) in order to assess the success of services (Department of Health, 2013b; Department 
of Health, 2016). The framework however does not contain any specific measure of 
interprofessional teamwork and therefore it is difficult to isolate the specific impact this has 
on such outcomes.   
 
In a recent Cochrane review, Reeves et al. (2017) assessed the impact of interprofessional 
collaborative interventions on patient outcomes. The review identified nine randomised 
controlled trials (RCT) that were suitable for inclusion, however all were considered to have 
low or very low certainty of evidence (see Table 2.2a-c for a summary of the studies). These 
studies were all conducted in high-income countries (Australia, Belgium, Sweden, UK and 
USA) in primary, secondary and tertiary care settings and had a follow-up of up to 12 
months. Eight studies compared and evaluated an interprofessional care intervention with 
usual care and one study compared one type of interprofessional meeting with another 
(Wilson et al., 2004). Strasser et al. (2008) found that the functional status in stroke patients 
may be slightly improved by externally facilitated interprofessional activities and Cheater 
et al. (2005), Deneckere et al. (2013) and Schmidt et al. (1998) found that HCPs’ adherence 
to recommended practices may be slightly improved with externally facilitated 
interprofessional activities or interprofessional meetings. In addition, interprofessional 
checklists (Calland et al., 2011), interprofessional rounds (Curley et al., 1998; Wild et al., 
2004) or externally facilitated interprofessional activities (Strasser et al., 2008) were seen 
to slightly improve overall use of resources, reduce length of hospital stay, or reduce costs. 
Furthermore, Wilson et al. (2004) found that when compared to multidisciplinary audio 
conferencing, multidisciplinary video conferencing may reduce the average length of 
treatment and may reduce the number of multidisciplinary conferences needed per patient 
and the patient length of stay. All of these findings had a low certainty of evidence. Reeves 
concluded in the systematic review that it was unclear whether continuity of patient care 
or collaborative working were improved by externally facilitated interprofessional 
activities due to the very low-certainty for these outcomes. Of note none of the studies 
included reported on patient mortality, morbidity or complication rates. 
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Table 2.2a. Summary of the studies (n=9) included in the Cochrane review conducted by Reeves et al. (2017) which assessed the impact of interprofessional collaborative 
interventions on patient outcomes 
Author Study design, outcomes assessed and the impact of intervention on outcomes 
Black et al. 
(2013) 
Australia 
Method: Cluster-randomised trial to test the effectiveness of an intervention involving non-GP staff in GP practices, on the quality of care for patients with 
diabetes or cardiovascular disease 
Participants: General practitioners, nurses, practice managers, receptionists, and other administrative staff. 60 general practices were randomised to 
receive a 6-month teamwork intervention immediately (intervention, n = 637) or after 12 months (control, n = 548) 
Interventions: To assist non-GP staff (e.g. nurses, administrative staff (practice managers, receptionists) to work as a team with GPs, the intervention 
included a number of activities including: the use of structured appointment systems, recall and reminders, planned care, the use of roles, responsibilities, 
and job descriptions, as well as communication and meetings 
Outcomes assessed: Quality of care (12 month follow up) 
Impact of intervention on outcomes: It is uncertain if externally facilitated interprofessional activities increases patient-assessed quality of care because 
the certainty of this evidence is very low. It is uncertain whether externally facilitated interprofessional activities improve collaborative working, team 
communication, and co-ordination because the certainty of this evidence is very low. 
Calland et 
al. (2011) 
USA 
Method: An RCT of an interprofessional collaborative intervention aimed to determine the effectiveness of procedural checklists for surgical teams during 
47 laparoscopic cholecystectomies. General surgeons were randomly assigned to an intervention (i.e. the use of the checklist) or a control group  
Participants: Ten general surgeon teams consisting of surgeons, anaesthetists and nurses. Twenty- three patients in the control group and 24 in the 
intervention group. Eighteen patients dropped out between the randomisation and the analysis  
Intervention: An intraoperative procedural checklist including preoperative, intraoperative, and post- operative items  
Outcomes assessed: Clinical process or efficiency outcomes: length of operation, discharge status, readmission rates and technical proficiency. 
Collaborative behavioural outcomes: team behaviours (e. g. team communication and co-ordination)  
Impact of intervention on outcomes: Interprofessional checklists may slightly improve overall use of resources, length of hospital stay, or costs (low 
certainty). It is uncertain whether externally facilitated interprofessional activities improve collaborative working, team communication, and co-ordination 
because the certainty of this evidence is very low  
Cheater et 
al. (2005) 
UK 
Method: An RCT where 22 multidisciplinary teams from five acute care hospitals were randomised to an intervention group that participated in a 
facilitated programme on multidisciplinary audit or a control group  
Participants: Nurses, doctors and other HCPs (e.g. pharmacist, social worker, physiotherapist), service support staff (e.g. ward clerk, care assistant), and 
managers. A range of specialties (e.g. surgery, medicine, and nephrology) were included. There were 11 teams with a total of 77 participants in the 
intervention group and 11 teams with a total of 64 participants in the control group  
Intervention: Five facilitated meetings over 6 months with activities designed to support multidisciplinary teams to undertake an audit  
Outcomes assessed: Collaborative audit activity 
Impact of intervention on outcomes: The use of interprofessional activities with an external facilitator or interprofessional meetings may slightly 
improve adherence to recommended practices and prescription of drugs (low certainty). It is uncertain whether externally facilitated interprofessional 
activities improve collaborative working, team communication, and co-ordination because the certainty of this evidence is very low  
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Table 2.2b. Summary of the studies (n=9) included in the Cochrane review conducted by Reeves et al. (2017) which assessed the impact of interprofessional collaborative 
interventions on patient outcomes 
Author Study design, outcomes assessed and the impact of intervention on outcomes 
Curley et al. 
(1998) 
USA 
Method: Randomised trial - Firm trial: patients and staff from inpatient medical wards at an acute care hospital were randomised to one of six medical 
wards. Three wards were allocated to the intervention group that implemented daily interdisciplinary work rounds, and three wards were allocated to the 
control group that continued traditional work rounds  
Participants: Interns and residents in medicine, staff nurses, nursing supervisors, pharmacists, nutritionists, and social workers. There were 567 patients 
in the intervention group and 535 patients in the control group  
Intervention: Daily interprofessional ward rounds 
Outcomes assessed: Length of stay, total charges, orders for administration of aerosols 
Impact of intervention on outcomes: Interprofessional rounds may slightly improve use of resources, length of hospital stay, or costs (low certainty) 
Deneckere 
et al. 
(2013) 
Belgium 
Method: A post-test-only cluster-RCT of 30 teams caring for patients with COPD. 17 intervention teams and 13 control teams examined how the use of 
CPs improved team- work in an acute hospital setting  
Participants: Doctors (i.e. orthopaedic surgeons or pneumologists), head nurses, nurses, and allied health professionals (i.e. physiotherapists and social 
workers). 581 participants: 346 in the intervention teams (N = 17) and 235 in the control teams (N = 13)  
Intervention: The intervention involved the development and implementation of care pathways including 3 components: 1) feedback on team’s 
performance before implementation; 2) receipt of evidence-based key-indicators for implementing care pathways in practice to review; 3) training in care 
pathway development. Control teams: usual care  
Outcomes assessed: Conflict management, team climate for innovation, level of organised care, emotional exhaustion, level of competence, relational co-
ordination  
Impact of intervention on outcomes: The use of interprofessional activities with an external facilitator or interprofessional meetings may slightly 
improve adherence to recommended practices and prescription of drugs (low certainty). It is uncertain whether externally facilitated interprofessional 
activities improve collaborative working, team communication, and coordination because the certainty of this evidence is very low  
Schmidt et 
al. (1998) 
Sweden 
Method: A RCT of 33 nursing homes, 15 experimental homes and 18 control homes, to examine the effects of monthly facilitated multidisciplinary rounds 
on the quality and quantity of psychotropic drug prescribing.  
Participants: Doctors, pharmacists, selected nurses, and nursing assistants 1854 long-term residents: 626 in experimental homes and 1228 in control 
homes  
Intervention: Pharmacist led team meetings once a month over a period of 12 months 
Outcomes assessed: Proportion of patients receiving drugs, number of psychotropic drugs, use of non-recommended hypnotics, use of non-recommended 
anxiolytics, use of non-recommended antidepressant drugs  
Impact of intervention on outcomes: The use of interprofessional activities with an external facilitator or interprofessional meetings may slightly 
improve adherence to recommended practices and prescription of drugs (low certainty) 
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Table 2.2c. Summary of the studies (n=9) included in the Cochrane review conducted by Reeves et al. (2017) which assessed the impact of interprofessional collaborative 
interventions on patient outcomes 
Author Study design, outcomes assessed and the impact of intervention on outcomes 
Strasser et 
al. (2008) 
Method: A RCT, in which patients with a stroke were treated by 31 teams from 31 Veteran Affair rehabilitation units before and after a multifaceted 
intervention, aimed at improving interprofessional collaboration  
Participants: Medical doctors, nurses, occupational therapists, speech-language pathologists, physical therapists, and case managers or social workers. 
464 participants: 227 in the intervention teams (N = 15) and 237 in the control teams (N = 16). Patients with a stroke were randomly assigned to each 
group  
Interventions: Intervention teams: received the following multifaceted intervention: (i) an off-site work- shop emphasising team dynamics, problem-
solving, and the use of performance feed- back data; (ii) action plans (specific team performance profiles with recommendations) for process 
improvement; (ii) telephone and video conference consultations to sustain improvement in collaboration. Control teams only received specific team 
performance profile Information 
Outcomes assessed: Functional improvement (as measured by the change in motor items of the FIM instrument), length of stay (LOS), rates of 
community discharge 
Impact of intervention on outcomes: Externally facilitated inter- professional activities may slightly improve stroke patients’ functional status and may 
slightly improve overall use of resources, length of hospital stay, or costs (low certainty). It is uncertain if externally facilitated interprofessional activities 
improves continuity of care because the certainty of this evidence is very low  
Wild et al. 
(2004) 
USA 
Method: A RCT in which patients in inpatient telemetry ward in a community hospital were randomised to the intervention medical team, which 
conducted interdisciplinary rounds or to the control team, which provided standard care  
Participants: Resident doctors, nurses, a case manager, pharmacist, dietician, and physical therapist. Eighty-four patients were enrolled: 42 in 
intervention and 42 in standard care  
Intervention: Daily interprofessional rounds vs standard care 
Outcomes assessed: Length of hospital stay 
Impact of intervention on outcomes: Interprofessional rounds may slightly improve overall use of resources, length of hospital stay, or costs 
Wilson et al. 
(2004) 
Australia 
Method: A RCT comparing multidisciplinary audio conferencing and multidisciplinary video conferencing with a team that worked at two hospitals  
Participants: Medical staff specialists, medical registrars, nurses, speech pathologist, occupational therapists, social worker, medical students. Fifty 
patients were randomly assigned to each group  
Interventions: Interprofessional audio conferences and video conferences. At each conference session, the audio conferences were conducted before 
the video conferences, with the same interprofessional team  
Outcomes assessed: Number of audio conferences held per patient, number of video conferences held, length of treatment  
Impact of intervention on outcomes: No significant impacts identified 
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2.5.1. Evidence underpinning pharmacists’ interprofessional collaboration 
With the role of pharmacists expanding to take on more advanced clinical roles another 
Cochrane review, this time conducted by Nkansah et al. (2010), focused on health-related 
outcomes of newly implemented clinical pharmacy interventions (such as medication 
counselling and optimisation services). However, the authors found that improvements in 
clinical outcomes (i.e. improvements in blood pressure, cholesterol levels, asthma score, 
etc.) as a result of pharmacist interventions were not always statistically significant and 
importantly had little (if any) explicit focus on the collaborative aspect of interventions. As 
a follow-up to this study, Geurts et al. (2012) undertook a systematic review that primarily 
focused on medication review and reconciliation that were carried out through the 
cooperation of pharmacists and GPs. Some 83 studies were included in the review which 
varied in terms of the interprofessional interventions assessed as well as in the rigour of the 
studies. Although many of the included studies reported positive outcomes in terms of 
patient satisfaction and the resolution of drug-related problems, just three of these studies 
(Makowsky et al., 2009a; Roughead et al., 2009; Roughead et al., 2011) reported significant 
improvements in objective outcomes such as hospital (re)admissions, and these had a low 
certainty of evidence. One of these studies was conducted by Makowsky et al. (2009a) who 
undertook a multicentre, quasi-randomised, controlled clinical trial where 220 patients 
received ‘team care’ through proactive clinical pharmacist services (medication history, 
patient-care during participation in rounds, resolution of drug-related issues, and discharge 
counselling) versus 231 patients that received standard care. They found that team care 
patients experienced fewer readmissions at 3 months (36.2% vs. 45.5%) but not at 6 
months. 
 
Another study conducted by Roughead et al. (2009) reviewed the impact of collaborative 
GP–pharmacist home medication reviews on time until the next hospitalisation in patients 
with heart failure in Australia. Here an intervention group received a service that included 
a GP referral, a home visit by an accredited pharmacist to identify medication‐related 
problems, a pharmacist report with follow‐up undertaken by the GP. In total 273 patients 
received the collaborative home medication review service and 5444 did not. Unadjusted 
results showed a 37% reduction in rate of hospitalisation for heart failure at any time and 
adjusted results showed a 45% reduction among those who had received a home medicines 
review compared with the unexposed patients. Whilst there was a reduction in patient 
hospitalization, the collaborative interprofessional nature of the interventions was unclear 
as it seemed to represent a care schedule that had side-by-side input from two professions 
rather than them collaboratively working together for the patient.  
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Roughead later repeated this study but this time reviewed the impact of GP–pharmacist 
collaborative home medication reviews on bleeds that led to hospitalisation in patients on 
warfarin (Roughead et al., 2011). The intervention once again represented a loose definition 
of collaborative working with HCPs working side-by-side rather than collaboratively. Here 
the 816 patients who received the home service were compared with 16,320 who did not. 
They found a 79% reduction in risk of hospitalisation for bleeding between 2 and 6 months, 
however this was not sustained over time (adjusted results).  
 
A number of further RCTs and reviews of RCTs have been conducted related to a range of 
‘collaborative’ pharmacist interventions. However, many of these studies lack explicit 
descriptions of the collaborative nature of the interventions. The descriptions often 
excluded the frequency, mode (face-to-face, by phone, written, etc.) and content of 
interprofessional interactions making it unclear as to whether true interprofessional 
collaborative working (where HCPs worked together to achieve improved outcomes) had 
occurred or whether the collaboration was simply the transfer of information between 
professionals. Furthermore, it was often the case that the trials compared a service 
conducted by another HCPs (absent of a pharmacist) with a pharmacist intervention that 
was classed as ‘collaborative’ due to the requirement for the pharmacist to inform another 
HCPs of the action or decision they had taken. Nevertheless, a number of studies discussed 
below concluded that having pharmacists make interventions in collaboration with other 
HCPs could benefit a range patient outcomes. 
 
One of these studies was an RCT conducted by Tsuyuki et al. (2016) which highlighted that 
a community pharmacists’ cardiovascular disease (CVD) intervention comprising of a 
Medication Therapy Management review from their pharmacist and CVD risk assessment 
and education (predominantly conducted solely by the pharmacists apart from when 
communicating with doctors following each patient contact – when first conducting 
pharmacist CVD intervention then at a three month review) significantly reduced the risk 
for CVD events (adjusted value of 21% reduction). A similar finding was reported in an 
earlier study by Tsuyuki et al. (2002) which assessed pharmacists’ role in the management 
of cholesterol. This study found that such were the improvements in patients’ cholesterol 
from the intervention (where it was stated that community pharmacists provided 
education, management and referral to GPs) the study was ended early to fully incorporate 
the intervention into practice, however once again the ‘collaborative’ nature of this involved 
a simple referral to GPs for further management.  
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A similar theme was observed across a number of systematic reviews of RCTs featuring 
pharmacist led interventions, including a review of pharmacist care in heart failure (HF) by 
Koshman et al. (2008), in management of dyslipidemia by Charrois et al. (2012) and blood 
pressure (BP) control by Santschi et al. (2014). It was concluded across these reviews that 
pharmacists’ working collaboratively with other HCPs had a positive impact on patient 
outcomes, however it must be noted that these conclusions were often based on studies 
where there was no explicit comparison of interventions that were delivered solely by the 
pharmacist versus those that featured collaborative pharmacist-HCP interventions, where 
some comparison did occur there was no significant difference in outcomes, and the term 
‘collaboration’ was rarely explicitly defined with many often seeing collaboration as 
information transfer between HCPs.  
 
In one study Lalonde et al. (2011) aimed to explore the views of patients and doctors on 
pharmacists’ engaging with doctors in the collaborative management of patients with 
dyslipidaemia. Whilst patients felt they received better follow-up care when pharmacist 
were involved in their care and doctors felt the collaborative management of patients’ 
cholesterol was safe and effective, doctors were concerned that shifting some of the 
management activities to pharmacists may negatively impact their own relationship with 
the patient highlighting a potential issue with pharmacist-doctor interprofessional 
collaboration. A number of other studies also highlighted potential issues with pharmacist 
collaborative practice, one of which was an RCT conducted by Bryant et al. (2011) in New 
Zealand where authors compared a control group with patients receiving a clinical 
medication review conducted by community pharmacists in collaboration with GPs 
(pharmacists met with the patient’s GP to discuss recommendations about possible 
medicine changes) which was followed-up 3-monthly. The authors found that although 
medication reviews helped improve medication appropriateness, patients’ quality of life in 
the domains of emotional role and social functioning were seen to decrease significantly. 
Authors suggested that this may have been because participants possibly felt abandoned as 
27 out of 44 pharmacists either withdrew or did not start the study citing time 
commitments required to conduct the intervention/study. Authors additionally concluded 
that the lack of community pharmacist participation suggested that community pharmacies 
may not be the appropriate environment in which to expand collaborative clinical 
medication reviews within primary care.  
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Furhtermore, a number of other RCTs which explored joint pharmacist-doctor care found 
that these collaborative care methods had no improvement on a number of patient 
outcomes. For example in an RCT conducted by Holland et al. (2005) in the UK authors 
found that a pharmacist led home based medication review service (which included two 
home visits by a pharmacist within two weeks and eight weeks of discharge to educate 
patients and carers about their drugs, remove out of date drugs, inform general 
practitioners of drug reactions or interactions, and inform the local pharmacist if a 
compliance aid is needed) had no improvement on quality of life and in fact increased 
hospital admissions compared to the patients not receiving the service. Of note, the 
interprofessional nature of the service here simply involved information transfer to GPs 
regarding drug reactions and interactions rather than a truly collaborative service. In 
addition, another UK based RCT conducted by Richmond et al. (2010) recruited 760 patients 
across 24 GP practices to compare usual care with those receiving collaborative 
pharmaceutical care undertaken by community pharmacists who interviewed patients, 
developed and implemented pharmaceutical care plans together with the patient’s GP, and 
thereafter undertook monthly medication reviews (both pharmacists and GPs attended 
training before the intervention). The study found that the intervention did not lead to any 
statistically significant change in the appropriateness of prescribing or health outcomes.  
Furthermore, in a similar RCT conducted by Sellors et al. (2003) in Canada comparing usual 
care with interventions where pharmacists conducted face-to-face medication reviews with 
the patients and then gave written recommendations to doctors to resolve any drug-related 
problems, found that although doctors accepted pharmacist recommendations, no 
significant improvements in patient outcomes or medication costs were observed.  
 
With the literature evidencing the benefits of pharmacists collaborative practice having 
equivocal results, a low certainty of evidence and a lack of clarity related to the extent of the 
collaborative nature of each intervention, further work is needed to help evidence the value 
of interprofessional interactions involving pharmacists on patient outcomes. 
2.6. Why is interprofessional collaboration not already the norm? 
Although the incorporation of interprofessional collaboration is being driven both national 
and international deficiencies in interprofessional practice have been evidenced (also see 
section 2.3) with the  Department of Health (2013a) stating that this can result  in time-
delays, duplication of work, wasted resources, frustration and the delivery of poor patient 
care. Reasons for this lack of collaboration may therefore be explained by a number of 
barriers cited within the literature including: lack of access to HCPs due to the time 
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pressures HCPs face (Baxter and Brumfitt, 2008) and physical separation (McDonough and 
Doucette, 2001; Jenkins et al., 2016); historical cultural separation of HCPs (Hall, 2005; 
Kvarnström, 2008; Xyrichis and Lowton, 2008); lack of understanding or poor perception 
of professional roles and responsibilities (Hughes and McCann, 2003); negative perceptions 
and stereotypes (Jelphs et al., 2016); poor communication between HCPs (Long et al., 2003; 
Freeth et al., 2008); professional hierarchy and power relationships (Baker et al., 2011); 
specific characteristics of pharmacists that oppose collaboration (i.e lack of confidence; fear 
of new responsibility; paralysis in the face of ambiguity; need for approval; and risk 
aversion)(Rosenthal et al., 2010a).  
 
Arguably, the most significant barrier to change is that the healthcare environment is still 
very much organised in a uniprofessional manner. It is an environment characterised by 
practitioners regulated by distinct governing bodies and by initial training and education of 
professionals that is unique to each different healthcare profession with limited 
opportunity for shared interprofessional learning. In a review of the literature conducted 
by Hall (2005) she summised that the historic separation of HCPs (whether it be for 
practical, cultural or financial reasons) instils natural barriers to interprofessional working. 
She therefore stated that successful interprofessional practice required sensitivity to the 
varying historical, educational and social norms and values across HCPs.  
 
The lack of understanding and poor perception of one another’s professional roles has been 
identified as a key barrier to interprofessional working in practice, for example in a series 
of interviews with both GPs and community pharmacists’ in Northern Ireland, Hughes and 
McCann (2003) identified that GPs’ perception of pharmacists as ‘shopkeepers’ resulted in 
limited collaboration between the respective professionals. Furthermore, a questionnaire 
distributed to all HCPs employed by East London and the City Mental Health Trust 
conducted by Larkin and Callaghan (2005) found that whilst HCPs were clear of their own 
roles they felt other members of the team did not recognise or understand these roles 
resulting in sub-optimal interprofessional collaboration. The need for HCPs to understand 
other professions roles and responsibilities is vital for meaningful interactions with other 
HCPs in order to utilise expertise appropriately (Falck, 1977), however this is often lacking 
in practice, with Reese and Sontag (2001) suggesting this could be due to the limited 
common interprofessional experiences and education offered to healthcare students and 
professionals. In an ethnographic study conducted by Long et al. (2003) in the UK relating 
to the role of nurses within interprofessional rehabilitation teams, many nurses felt their 
contributions were not valued and that where the boundaries of their role blurred with 
other HCPs this led to professional tensions and rivalry. An example of the negative impact 
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of blurred roles was highlighted in a study by Schindel et al. (2017) (see section 2.4 for 
further details of this study) that found that when the role of the pharmacist overlapped 
with other HCPs roles this created conflict with certain professions believing they had 
autonomy over specific areas of practice, leading to poor interprofessional collaboration.  
 
Long et al. (2003) also recognised that poor communication between HCPs could negatively 
impact interprofessional collaboration particularly when there were mismatches in 
communication styles and perceived variations in ‘power differentials’ which resulted in 
some HCPs believing they had less input or were less appreciated than other professions 
leading to reduced participation in interprofessional collaborative and interprofessional 
education sessions. Similarly, Nugus et al. (2010) conducted 63 interviews, 68 focus groups 
and 209 hours of observation of HCPs within acute and non-acute health services and 
showed that doctors were the dominating profession, assuming responsibility for patient 
management and coordinating roles within the healthcare team. Where this was not 
managed appropriately (i.e. if the doctors were competitive or dominating) other HCPs 
were less inclined to engage. Similar findings were also highlighted by Baker et al. (2011) 
who conducted a series of 25 interviews with a range of HCPs in Canada and identified that 
doctors perceived themselves as the ‘leaders’ and ‘decision makers’ in healthcare and 
pharmacists (and other HCPs) saw themselves as ‘team members’. 
 
A review published by Rosenthal et al. (2010a) discussed a number of characteristics 
commonly associated with pharmacists that they believed negatively impacted their 
interprofessional collaboration including: lack of confidence; fear of new responsibility; 
paralysis in the face of ambiguity; need for approval; and risk aversion. In addition, the 
authors indicated that when pharmacists were found to have reduced input into the 
interprofessional team (comparatively to other professions) this reinforced their own 
negative perception of the profession. This could be reversed once they were successfully 
integrated or embedded within an interprofessional team, with other HCPs within that team 
also quickly appreciating the value of the pharmacist. In addition, as discussed in section 
2.4, pharmacists’ have varying perceptions of their own roles and responsibilities (Elvey et 
al., 2013; Schindel et al., 2017), and although the Royal Pharmaceutical Society (2017b) 
believes that pharmacists should promote their roles to other HCPs in order to improve 
collaboration this may be made more difficult due to the lack of consistency in their 
interprofessional engagements that are dependent on their own individual role. Using 
‘critical incident technique’ interviews on eighteen participants across nine different 
professions in Sweden, Kvarnström (2008) found that the HCP’s specific role, responsibility 
and input to the team had a significant impact on their feelings towards interprofessional 
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collaboration, with those better immersed within the interprofessional team having a more 
positive perception towards current and future interprofessional engagement. These 
factors highlight the importance of understanding both one’s own roles and responsibilities 
as a HCP and those of others. 
 
One challenge organisations face is the limited understanding of the day-to-day 
compositions of interprofessional teams and issues surrounding interprofessional practice. 
This is made increasingly more difficult as Sir Robert Francis (the author of the Mid-
Staffordshire review (Francis, 2013)) highlighted within his Freedom to Speak Up report 
that HCPs often are reluctant to raise concerns about professional (and interprofessional) 
practice (Francis, 2015). Two factors were given prominent focus: (i) fear of repercussions 
that speaking up would have for an individual and for their career and (ii) the futility of 
raising a concern because nothing would be done about it. It was therefore felt that by 
providing a more open platform where staff can readily and safely raise issues this may 
uncover specific local barriers to collaborative practice which when resolved could improve 
the delivery of patient care.  
 
One way the NHS has tried to improve coordination across healthcare settings is by 
reorganising and merging healthcare providers (i.e. merging acute care, mental health and 
community health providers). Fulop et al. (2005) studied such mergers in the NHS and 
found some positive benefits in terms of staffing, training and influence on the local 
healthcare system. They also identified a number of negatives notably: smaller trusts 
perceiving a loss of informality and familiarity; smaller trusts viewing their larger 
counterparts as slow moving and unresponsive; and a difficulty in transferring good 
practice internally due to widespread distrust and staff still perceiving each other as part of 
the old constituent trusts. This highlights a key issue the NHS commonly faces when trying 
to implement widespread change i.e. resistance to change within the workforce. In terms of 
embedding interprofessional collaboration throughout the NHS organisation, the risk is that 
staff who are resistant to change will likely seek to retain uniprofessional habits. This was 
highlighted as an issue by Walshe (2003) in a review of the NHS’s proposed development of 
foundation hospitals. A publication for the NHS Confederation by Edwards (2010) 
summarised the lessons learnt from past NHS major structural re-organisation and 
concluded that less dramatic changes should be considered before implementing major re-
organsiation which are perceived to be unpopular by employees. Indeed, in a study by 
Drinka et al. (1996) (using a questionnaire (n=516) to determine motivational styles of 
various HCPs within the interprofessional team over a 10 year period) it was shown that 
major re-organisation of teams can result in both professional and personal stress which 
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can lead HCPs to become more withdrawn and prone to retreat into their individual 
professional silos, where there is safety, clear limits, recognition of professional values and 
license to work autonomously.  
2.7. How can interprofessional collaboration be improved? 
Improving interprofessional team working presents a complex challenge (see section 2.6). 
In order to achieve and maintain a shift towards embedded interprofessional practice from 
one that is uniprofessional, a change in culture within the healthcare system is required 
which will require a multifaceted approach to achieve (O'Leary et al., 2012). It is often 
suggested that the healthcare organisations should embed the teamworking practices from 
other enterprises and industries. One such area where healthcare organisation may 
translate lessons is from sports teams. The analogy is that like the healthcare environment, 
sports teams require both high levels of individual skill and the ability for team members to 
work together efficiently and effectively to achieve overall success (Cotterill, 2012). There 
are however a number of significant differences between the health and professional sports 
environment that make it challenging for healthcare teams to learn from sports teams. One 
of the key differences is that healthcare teams do not have the luxury of making errors 
(unlike conceding a goal for example) as this can result in patient harm (Francis, 2013; 
Kirkup, 2015). Furthermore, unlike within team sports where the aims are limited and 
consistent over time (for example to score more goals/points than the opposition), the 
desired outcomes for healthcare teams often change due to the complexities and needs of 
individual patients (Jelphs et al., 2016), resulting in the ‘goalposts’ shifting. Whilst achieving 
better teamworking is of value in both environments, with such variation in the numbers 
and expertise of the ‘players’ in healthcare, the complexities and aim of the game (providing 
individual safe patient care) as well as an absence of consistent coaching and license to fail 
limits the ability to directly translate the lessons from team sports to the healthcare 
environment (Reeves et al., 2010b).  
 
One of the foremost efforts to translate learning from an industry to the healthcare 
environment has been from the aviation industry.  In investigating aviation accidents, the 
National Aeronautics and Space Administration (NASA) identified that communication, 
leadership and decision making were accountable for the majority of accidents. A training 
programme known as Crew Resource Management (CRM) was subsequently developed 
which provided all aircraft crew with integrated training in communication, disclosure and 
teamwork behaviours (Helmreich et al., 1999) and has since been evidenced as successful 
in helping reduce accidents involving large aircrafts (Salas et al., 2008). A number of 
healthcare organisations have adopted the CRM approach in a number of specific care 
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settings such as emergency rooms, intensive care units and operating theatres where teams 
directly deal with a defined and specified problem under the leadership of a single 
individual, normally a doctor or surgeon  (Risser et al., 1999; Sexton et al., 2000; Shojania 
et al., 2001). The approach has benefits where the healthcare environment has a structured 
approach (10% of healthcare provision) but limited value in the dynamic environments 
such as on wards and within primary care that comprise around 90% of healthcare 
provision (Green et al., 2001).  
 
Another model which has more recently been implemented in surgical and intensive care 
units is the Formula 1 pit-stop model. A small number of hospitals have aimed to transfer 
the processes implemented by Formula 1 motor racing teams when individuals work in 
concert across a range of roles to effectively and efficiently conduct pit-stops to improve 
teamwork within emergency care settings (Naik, 2006; Catchpole et al., 2007; Merry et al., 
2014). In a landmark UK study conducted by Catchpole et al. (2007) which measured the 
performance of a new handover protocol that was developed through discussions with both 
a Formula 1 racing team and aviation training captains (the CRM approach), clear benefits 
resulting from this approach were evidenced including a significant reduction in technical 
errors on handover, a reduction in the mean number of handover omissions and a reduction 
in the duration of handovers. A later study conducted by Merry et al. (2014) used the 
Formula 1 racing team approach to identify six actions for improving teamwork in cardiac 
surgery: (i) subspecialise and replace tribes with teams; (ii) sort out the leadership while 
flattening the gradients of authority; (iii) introduce explicit training in effective 
communication; (iv) use checklists, briefings, and debriefings and engage in the process; (v) 
promote a culture of respect alongside a commitment to excellence and a focus on patients; 
(vi) focus on the performance of the team, not on individuals. Once again, these studies 
utilised the teamworking approaches within highly structured care settings that require the 
resolution of defined specific problems and input of specific HCPs (within surgery, 
emergency care and intensive care) and did not explore the wider application of these 
methods.  
 
Whilst the studies highlighted here recognise a number of benefits from the implementation 
of aviation and Formula 1 teamworking, these rigid approaches may have a limited 
applicability. Other more general areas of healthcare (which make up the majority of daily 
care delivery (Green et al., 2001)) require much more flexible and dynamic healthcare 
teams in order to combat the variability, complexity and uniqueness of patients’ day-to-day 
health and social needs. HCPs therefore must be trained to integrate into various 
interprofessional teams when called upon, comfortably assuming the role which best meet 
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the patient’s overall care needs. Furthermore, the teams used in both aviation and formula 
1 require specific numbers of staff to proceed (i.e. a plane would not take off without a pilot), 
however within healthcare the staff are ethically bound to help each patient even if 
resources and staff are limited and therefore do not have the luxury to halt care if certain 
HCP team members are absent.  
 
Physically incorporating HCPs into teams has been recognised to have some benefit to 
interprofessional engagement as it enables HCPs to build professional and social 
relationships which increases comfort and confidence within the interprofessional team, 
something identified by McDonough and Doucette (2001) in their model for improving 
relationships between pharmacists and doctors. A review conducted by O'Leary et al. 
(2012) into interprofessional working within hospitals (also discussed in section 2.2) also 
found that co-locating HCPs on interprofessional ward rounds could improve and promote 
interprofessional collaboration.  
 
In a study conducted by that Xyrichis and Lowton (2008), the facilitators and barriers to 
interprofessional teamworking in primary care were summarised following a literature 
review (43 papers included). The benefits of co-locating HCPs alongside each other on 
interprofessional team working were identified and the authors found that the 
incorporation of interprofessional team meetings could help develop interprofessional 
relationships. Additional facilitators were recognised including: creating a climate of mutual 
respect and trust; having clear goals and objectives to the interprofessional collaboration; 
having a range of HCPs (and therefore specialties) involved in the care of patients; and 
assessing the success of collaborative working.   
2.7.1. The role of Interprofessional education (IPE) in improving interprofessional 
collaboration  
Historically within the UK, HCPs have been educated in silos and subsequently work in silos 
regulated by distinct professional bodies. Both undergraduate and postgraduate education 
continues to be predominately a uniprofessional enterprise resulting in limited interaction 
across professional sectors. In a peer-reviewed practice review conducted by Rosenthal et 
al. (2010a) that looked at the barriers to pharmacy practice change in Canada, the authors 
suggested that if the field of pharmacy was to advance and have greater involvement in and 
engagement with the interprofessional team, the profession would need to transition from 
the rigid and historical educational models and embrace innovative and collaborative 
methods of education. One method that is currently being adopted in a variety of healthcare 
programmes is interprofessional education (IPE). Defined as occasions when “two or more 
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professionals learn with, from and about each other to improve collaboration and the 
quality of care” (pg. 6)(Barr, 2002b),  IPE “is the process by which students from different 
professional programmes learn together during certain periods of their education with a 
view to enhancing collaboration and team work, and ultimately improving patient-centred 
care” (pg. 23) (World Health Organisation, 2013). IPE ultimately aims to improve 
interprofessional collaboration and patient care. Although the concept of IPE has been 
around since the 1960s (Barr, 2002a) it has only  recently gained traction in undergraduate 
programmes.  
 
With a range of benefits attributed to IPE that may directly address issues associated with 
uniprofessional practice, IPE is being championed both nationally and internationally. So 
much so that the Lancet Commission stated in 2010 that IPE can be central to the reform in 
healthcare professionals’ education (Frenk et al., 2010). The World Health Organisation 
(2010) responded by issuing specific guidance on IPE, highlighting that it can be integral to 
improving interprofessional relationships and removing barriers between HCPs, leading to 
the delivery of safe, high quality patient care. Here, the WHO summarised that IPE could: (i) 
develop students’ communication skills; (ii) further students abilities to critically reflect; 
(iii) teach students to appreciate the challenges and benefits of working in teams; (iv) 
foster respect among HCPs; (v) eliminate harmful stereotypes; and (vi) evoke a patient-
centred ethic in practice. These benefits align with the findings of a range of studies 
conducted (often based on HCP and service user perceptions – see section 2.7.1.1 for further 
details on IPE studies) which have cited benefits around: (i) the development of students’ 
interprofessional communication and relationships skills (Greiner and Knebel, 2003; 
Carpenter and Dickinson, 2014); (ii) reduction in their levels of professional bias, prejudice, 
stereotypes and rivalry (Freeth et al., 2008; Barr et al., 2017); (iii) recognition of their own 
and other HCPs’ roles and responsibilities (Freeth et al., 2008; Jacobsen et al., 2009); (iv) 
improved trust and respect across professions (Barr et al., 2017) and (v) a greater 
appreciation of safe and good practice (Barr et al., 2017). 
 
With a number of benefits recognised by WHO they therefore concluded that IPE should be 
implemented in both undergraduate and postgraduate healthcare programmes worldwide 
(World Health Organisation, 2013). These international drivers prompted the Department 
of Health (2013a) to provide a statement on the need for greater incorporation of relevant 
and meaningful IPE across UK healthcare education.  
 
As a consequence of these reports (particularly that by Frenk, 2010 and WHO 2010, a 
number of  regulatory bodies including the General Pharmaceutical Council (GPhC) and the 
Chapter 2 
 47 
General Medical Council (GMC) have made IPE a required element of the respective 
undergraduate degree programmes (General Medical Council, 2009; General 
Pharmaceutical Council, 2011). Essentially, policy makers believe that IPE can help equip 
the healthcare workforce with the ability to work effectively across health sectors and deal 
with issues that require the input of the interprofessional teams which will be necessary in 
order to effectively treat the growing numbers of patients with complex conditions and help 
patients cope with chronic illness (Barr et al., 2017).  
2.7.1.1. Evidence surrounding the benefits and development of IPE 
Whilst IPE is an activity that has become relatively commonplace within the pharmacy 
undergraduate curriculum it is clear that in order for students to achieve the beneficial 
outcomes attributed to IPE it must be implemented in a meaningful and relevant way and 
delivered effectively (see chapter 3 for further discussion). One challenge in achieving this 
has been directly measuring the benefits of IPE with much of the evidence surrounding its 
use of low quality.  
 
In an update of a Cochrane systematic review of the literature relating to IPE, Reeves et al. 
(2010c) concluded that although some progress has been made in assessing the 
effectiveness of IPE (having increased from zero relevant studies in their first Cochrane 
review (Zwarenstein et al., 1999) to six studies ten years later) further work is needed to 
understand and evaluate the outcomes of IPE and ultimately demonstrate its benefit. 
Furthermore, of the six studies included (five from the USA one from the UK) just two 
reported positive outcomes of IPE (Morey et al., 2002; Young et al., 2005), two reported a 
mixed set of outcomes (positive and neutral effects) (Brown et al., 1999; Campbell et al., 
2001), and two reported that IPE had no impact on either health care processes or patient 
health care or outcomes (Thompson et al., 2000a; Thompson et al., 2000b) (all studies have 
been summarised in Table 2.3). The absence of high quality evidence is likely due to a 
number of ethical considerations surrounding the use of RCTs in education (Reeves and 
Barr, 2016) and challenges in attributing improved outcomes related to communication and 
teamworking directly to the provision of IPE (Freeth et al., 2005). In its place, many 
evaluations of IPE focus on student and faculty perceptions of IPE which although valuable 
in determining beliefs about IPE they are poor at measuring student’s progress as 
interprofessional practitioners (Thistlethwaite and Moran, 2010).  
 
This led Reeves et al. (2016) to conduct a Best Evidence Medical Education (BEME) 
systematic review of studies which rigorously assessed (using high methodological quality) 
the beliefs and perceptions towards IPE. The review included 46 studies which represented 
Chapter 2 
 48 
a significant increase since the previous review (n=21) (Hammick et al., 2007). Findings 
from the studies indicated that students responded well to IPE and had positive attitudes 
towards IPE. For example McFadyen et al. (2010) employed a longitudinal controlled trial 
design and gathered IPE attitudinal data with the use of two pre-validated surveys with over 
500 students in either an intervention group (n=313) or control group (n=260) and found 
that students from a range of health and social care courses began their pre-registration 
education with strong positive views of the principles behind IPE. The review also showed 
that attitudes and perceptions of one another improved. For example Curran et al. (2007) 
used a mixed method pre- and poststudy quantitative and qualitative evaluation to find  IPE 
was effective in enhancing understanding of the roles of other professions, fostering respect 
and positive attitudes toward interprofessional collaboration, developing collaborative 
competencies, and promoting organisational change. Similarly, the review evidenced that 
students improved their interprofessional knowledge and skills for practice. For example 
Carpenter et al. (2006) used a mixed methods approach of quantitative questionnaires and 
interviews to evaluate a postgraduate IPE programme designed to enable health and social 
care professionals to work together to deliver new community mental health programmes 
and found that students reported statistically significant increases in their knowledge and 
skills in interprofessional team working and use of psychosocial interventions.  
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Table 2.3. Summary of the studies (n=6) included in the Cochrane review conducted by Reeves et al. (2010c) which assessed the effectiveness of interprofessional education 
Author Study design and reported outcomes of IPE activities 
Morey et al. 
(2002) 
USA 
Aim: to improve collaborative behaviour of emergency department staff through the use of a controlled before and after study (CBA) 
Activities: lectures, discussion of videotaped segments of teamwork and clinical vignettes, teamwork exercises (8 hours)  
Participants: Doctors, nurses, technicians, clerks  
Positive reported outcomes: This showed a statistically significant improvement in quality of observed team behaviours between the experimental and control 
groups following training. The clinical error rate significantly decreased from 30.9% to 4.4% in the intervention group (p 1⁄4 0.039)   
Young et al. 
(2005) 
USA 
Aim: to improve competence of mental health practitioners through the use of a CBA 
Activities: presentations, small group discussions, role play and 3–4 day detailing visits, 16 hours of follow-up discussions  
Participants: Psychiatrists, mental health nurses, therapists, case managers  
Positive reported outcomes: This found that mental health practitioners in the intervention group, in comparison to those in the control group, reported 
significantly higher scores in relation to: teamwork; holistic approaches; education about care; rehabilitation methods and overall competency.   
Brown et 
al. (1999) 
USA 
Aim: to enhance practitioners’ communication skills through the use of a RCT 
Activities: 4-hour interactive workshop, two hours of subsequent homework, and a four-hour follow-up workshop (didactic components, role playing, dialogue)  
Participants: Doctors, nurse practitioners, doctors’ assistants, optometrists  
Mixed reported outcomes: This reported that while the communication skills training program did not improve patient satisfaction scores, clinicians’ mean score 
in a survey they completed improved more in the control group than in the intervention group. This improvement, however, was not statistically significant.   
Campbell et 
al. (2001) 
USA 
Aim: to improve effectiveness of collective response of emergency department teams to intimate partner violence through the use of a RCT 
Activities: Two-day information and team planning intervention (didactic instruction, role playing, team planning, team work)  
Participants: Doctors, nurses, social workers, administrators, domestic violence advocates  
Mixed reported outcomes: This study found that the emergency departments which received the intervention recorded significantly higher levels on all 
components of the ‘culture of the emergency department’ system-change indicator (e.g., appropriate protocols, materials such as posters, brochures, medical 
record intervention checklists, referral information and training for staff) and higher levels of patient satisfaction than the emergency departments in the control 
group. There were no significant differences in the identification rates of domestic violence victims in the medical records of the experimental and control groups.  
Thompson 
et al. 
(2000a) 
UK 
Aim: to enhance recognition and management of depression in primary care practices through the use of a RCT 
Activities: Four-hour seminar delivered to the primary healthcare teams (videotapes, small group discussion of cases, role play)  
Participants: Doctors and nursing teams from the participating primary care practices  
Reported no significant impact on outcomes: This study reported no differences between the intervention and control groups in relation to the recognition of 
depressive symptoms. The outcome of depressed patients at six weeks or six months after the assessment did not significantly improve.   
Thompson 
et al. 
(2000b) 
USA 
Aim: to improve identification and management of domestic violence in primary care clinics through the use of a RCT 
Activities: Two half-day training sessions, three training sessions for opinion leaders, newsletter, four additional educational sessions, system support (e.g., 
posters in waiting areas, provider cue cards)  
Participants: Doctors, nurse practitioners, doctors’ assistants, registered nurses, licensed practical nurses, medical assistants 
Reported no significant impact on outcomes: Although documented inquiries about domestic violence increased 3.9-fold at nine months in intervention clinics 
compared to controls and case finding also increased, both were non-significant. The recorded quality of domestic violence patient assistance did not change.  
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However, Reeves et al. (2016) did recognise that the self-report data used in these studies 
represented “a weak measure of knowledge and skills given an individual’s inability to 
assess such gains accurately” (pg. 16) and also felt these studies should be used with caution 
when assessing behavior change. The review also made a number of high level 
recommendations for the effective delivery and research of IPE, including the need for 
educators to ensure that IPE reflects current or future practice in order for sessions to be 
effective. 
 
A small number of studies (most often involving the evaluation of students’ perceptions of 
single sessions through either questionnaires to interviews) have evaluated IPE sessions 
involving pharmacists (for example Jones et al. (2012), Henderson et al. (2013), Coulman et 
al. (2014), Rotz et al. (2015), Myers Virtue et al. (2017), Vogler et al. (2017)). However, the 
study numbers are limited and methodological quality varied (highlighted by the absence 
of these studies from the review by Reeves et al. (2016)). This makes it challenging to 
compare and contrast educational approaches and extrapolate findings further afield, 
leading Carpenter and Dickinson (2014) to conclude that greater levels of research are 
required within the field of pharmacy IPE to further develop and enhance its provision 
within the profession. 
 
In 2017 the UK Centre for the Advancement of Interprofessional Education (CAIPE) 
released IPE guidelines to help educators develop meaningful and relevant IPE using a 
framework (Barr et al., 2017). Whilst this document helped summarise areas of the 
literature and provided discussion on implementing IPE, engaging service users, utilising 
resources, aligning learning and regulation and evaluating IPE, there was limited specificity 
in terms of the specific sessions that would be of value to developing practitioners. The 
recommendations for example did not elaborate on appropriate topics and learning 
outcomes that would be value to students, which HCPs to include in IPE (which ones and 
how many) and the time to introduce sessions. This represents a challenge for educators in 
knowing whether the sessions developed are relevant and reflective of day-to-day practice, 
something Barr et al. (2017) stressed was vital in ensuring sessions are in order for students 
to be actively engaged and see value in sessions (aligning with adult learning theory 
(Knowles, 1973), see chapter 3 for more detail). Given the current limited guidance relating 
to the development and delivery of effective, meaningful and relevant IPE, the paucity of 
literature detailing the IPE undertaken within pharmacy education and a lack of 
understanding about pharmacists’ interprofessional role(s) in practice, developing and 
embedding meaningful IPE is likely to remain a significant challenge for pharmacy 
educators.  
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2.8. Aims and objectives 
Whilst interprofessional teamworking is being promulgated throughout the healthcare 
environment, little is known about the current state of pharmacists’ interprofessional 
practice and it is consequently challenging to ascertain if the required provision of 
interprofessional education within the MPharm degree is effective or reflective of day-to-
day practice. This study therefore aims to characterise the quantity and nature (i.e. topics, 
settings, student groups involved, learning objectives and methods of evaluation and 
assessment) of IPE activities that are taking place in UK MPharm programmes and to 
understand more about the interprofessional interactions that pharmacists currently 
undertake in their practice in Wales. 
2.8.1. Objectives 
In order to achieve the aims six objectives were set. Whilst objective 1 focussed on the 
landscape of IPE within UK schools of pharmacy, objectives 2-6 all focused specifically 
on pharmacists undertaking their practice within community pharmacies and hospitals 
within Wales: 
1. To explore the current provision of IPE within UK MPharm programmes and to 
compare and contrast the IPE sessions pharmacy students are exposed to through the 
dissemination of an online questionnaire to IPE leads in all UK schools of pharmacy 
2. To determine pharmacists’ perceptions of the frequency of their interprofessional 
interactions with other HCPs and wider team members through the dissemination of a 
self-complete questionnaire to pharmacists practicing in Wales 
3. To explore the perceived topics and mode (i.e. by telephone, face-to-face, by email, 
etc) of pharmacists’ interprofessional interactions with other HCPs through the use of 
semi-structured interviews with pharmacists practicing in Wales 
4. To explore the perceived facilitators and barriers to pharmacists’ interprofessional 
practice through the use of semi-structured interviews with pharmacists practicing in 
Wales 
5. To explore the perceived value pharmacists in Wales place on IPE and determine their 
opinions surrounding the design and implementation of undergraduate/postgraduate 
pharmacy related IPE through the use of semi-structured interviews with pharmacists 
practicing in Wales 
6. Having addressed objectives 1 – 5, to make a series of recommendations that may 
help further pharmacists’ interprofessional interactions and support the development 
of meaningful and relevant IPE.  
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3.1. Introduction 
As the third largest healthcare profession in the UK, pharmacists have a responsibility to 
provide pharmaceutical care and deliver advice to patients, the public and other HCPs on 
the safe and effective use of medicines (General Pharmaceutical Council, 2018d). As 
discussed in chapter 2, NHS services are increasingly under pressure particularly as a result 
of increases in life expectancy, a growing population of older adults with complex health 
needs and a failure to recruit nurses and medics. Partly to reduce pressure on NHS services 
and partly to deliver more integrated patient-centred care,  there has been a re-examining 
of the role of the pharmacist to better utilise their skill set as experts in medicines resulting 
in the expansion of the pharmacist roles in recent years (Royal Pharmaceutical Society and 
Royal College of General Practitioners, 2011; Bienkowska-Gibbs et al., 2015; Royal 
Pharmaceutical Society, 2015). Consistent with this has been a transition away from more 
traditional roles that have focussed on medicines supply as a core activity towards patient 
facing clinical activities related to optimising and managing patients’ medicines 
(Department of Health, 2010; Primary Care Workforce Commission, 2015; Carter, 2016).  
 
Given the changing focus of the pharmacist’s role, the initial training and education of 
pharmacists must similarly evolve to ensure pharmacists are fit for contemporary practice 
at the point of registration. In the UK, the initial education and training of pharmacists is 
predominantly through a four-year Master of Pharmacy (MPharm) programme that is 
regulated by the General Pharmaceutical Council (GPhC) followed by a one-year pre-
registration training programme; a small number of providers offer a 5-year programme 
with co-terminus graduation and professional registration. In order to register as a 
pharmacist, candidates must meet the pre-registration performance standards and pass the 
GPhC’s registration assessment (General Pharmaceutical Council, 2018c). Together, these 
ensure that day one pharmacists meet the requirements of the GPhC to “protect, promote 
and maintain the health, safety and wellbeing of members of the public, and in particular 
those members of the public who use or need the services of pharmacy professionals or the 
services provided at a registered pharmacy” (pg. 5)(General Pharmaceutical Council, 2011).  
 
At present there are 31 schools of pharmacy delivering the MPharm degree within the UK, 
28 of which are fully accredited by the GPhC, with three schools provisionally accredited 
(i.e. the provider is working towards full accreditation). The number has grown in recent 
years (there was a total of 29 schools in the 2015/16 academic year when this study was 
conducted)(General Pharmaceutical Council, 2018a). The ‘Future Pharmacists: standards 
for the initial education and training of pharmacists’ document (General Pharmaceutical 
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Council, 2011) sets out the criteria against which providers are accredited for delivery of 
the MPharm programme and pre-registration training and also ensure that day one 
registrants are competent to practise. Whilst the standards do not include an indicative 
curriculum, an indicative syllabus is presented and standard 10 lists a series of 58 outcomes 
that need to be achieved in order to allow entry on to the GPhC register of pharmacists. The 
outcomes are assessed using the classification detailed in Miller’s triangle (i.e. at the knows, 
knows how, shows how or does level, details of which can be found in Table 3.1) (Miller, 
1990). The same outcomes apply to MPharm students and pre-registration candidates, but 
the level of assessment may differ. By the end of the pre-registration year students are 
expected to demonstrate that they meet the standards and outcomes at a show how or does 
level through successfully undertaking a range of practical tasks . Many of these outcomes 
cannot reasonably be addressed at the shows how or does level in the classroom 
environment during the MPharm degree. MPharm programmes are normally re-accredited 
every six years using methodology detailed in the GPhC’s the ‘Future Pharmacists: 
standards for the initial education and training of pharmacists’, with earlier documentation 
such as the ‘Accreditation of Master of Pharmacy Degrees’ documentation (General 
Pharmaceutical Council, 2010) superseded.  
 
Table 3.1. Description of the competency and assessment levels used by the GPhC for MPharm 
accreditation (GPhC, 2011), based on Miller’s triangle (Miller, 1990) 
Competence 
and assessment 
hierarchy 
Description of each competence and assessment level featured within 
the ‘Future Pharmacists’ document (GPhC, 2011) based on Miller’s 
triangle (Miller, 1990) 
Level 1 – Knows Knowledge that may be applied in the future to demonstrate competence. 
Assessments may include essays, oral examinations and multiple choice 
questions 
Level 2 – Knows 
how 
Context-based tests – knows how to use knowledge and skills. Assessments 
may include essays, oral examinations, multiple choice questions and 
laboratory books. 
Level 3 – Shows 
how 
A student or trainee is able to demonstrate that they can perform in a 
simulated environment or in real life. Assessments may include objective 
structured clinical examinations (OSCEs), simulated patient assessments, 
designing, conducting and reporting an experiment, dispensing tests and 
taking a patient history 
Level 4 – Does Acting independently and consistently in the complex situation of an everyday 
or familiar context. Evidence for this level is showing in this context that one 
is able to demonstrate the outcomes in a complex everyday situation 
repeatedly and reliably. Assessments may include OSCEs, taking a patient 
history and a trainee demonstrating things in the pre-registration 
performance standards repeatedly, accurately and safely. The trainee needs to 
be observed doing these things by their tutor and others. 
 
Whilst the content of the curriculum is bespoke in each school of pharmacy, all MPharm 
programmes are required tontegrate content (i.e. teaching across science and practice is 
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linked coherently) and the curriculum must be spiral (i.e. concepts are addressed in an 
increasingly complex manner until the right level of knowledge or competence is achieved) 
(Harden and Stamper, 1999; General Pharmaceutical Council, 2011). Schools must also 
define a clear assessment strategy that demonstrates how students will meet the 
programme learning outcomes, which must include “at least 3,000 hours of directed study 
of pharmaceutically‐relevant subjects” (pg. 3) across the full-time four year programme, 
delivered through a number of different teaching methods (General Pharmaceutical 
Council, 2010).  
 
The standards must be fit for contemporary practice and indeed, the GPhC have stated that 
education and training must “respond to the changing demands made of the profession and 
to allow for innovation at the same time as maintaining high quality practice” (pg. 5) 
(General Pharmaceutical Council, 2011). The regulator has considered emerging areas of 
practice and these are reflected in the ‘Future Pharmacists: standards for the initial 
education and training of pharmacists’ documentation. One such area of emerging practice 
has been interprofessional teamwork. As described in chapter 2, this reflects national and 
international drivers to better integrate HCPs in order to improve patient care through the 
effective sharing of  skills and knowledge when HCPs work in collaboration (Department of 
Health, 2010; World Health Organisation, 2010). Embedding effective interprofessional 
working is not without its challenges, both structural and cultural (see chapter 2). However, 
with structural change seen to have little direct impact on improving healthcare outcomes 
alone (Fulop et al., 2005; Edwards, 2010) the need to affect a cultural change surrounding 
interprofessional working is greater than ever. Within healthcare, professions largely 
define their own identity, values and role in patient care, therefore this, along with their 
own particular approaches to problem-solving and professional priorities, results in HCPs 
commonly operating in professional silos (Hall, 2005). These silos are not confined to 
practice, they often emerge when students begin university, resulting in profound early 
development of interprofessional barriers such as unfamiliar vocabulary, misaligned 
values, approaches and priorities, and a lack of common understanding and respect for 
other HCPs’ roles, responsibilities and knowledge (Long et al., 2003; Hall, 2005; Jones, 2006; 
Kvarnström, 2008).  
 
One method that has been proposed to begin to address these challenges, is the introduction 
of interprofessional education (IPE). This is defined as occasions when “two or more 
professionals learn with, from and about each other to improve collaboration and the 
quality of care” (pg. 6)(Barr, 2002b). IPE enables students from different healthcare 
programmes undertake sessions together and aims to enhance interprofessional 
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collaboration and teamwork, and ultimately improve patient-centred care (World Health 
Organisation, 2013). Although improvements in patient-centred care are central to the 
ethos of IPE there is little conclusive evidence which shows IPE directly benefits patients 
(Illingworth and Chelvanayagam, 2017). Indeed a systematic review into the impact of IPE 
on health outcomes conducted by Reeves et al. (2013) found no robust studies which 
directly evidence benefits to patients. Although many studies into IPE have a low certainty 
of evidence this does not mean IPE is without benefits. A number of studies have cited 
additional specific benefits (see chapter 2 for details) which are thought to help remove 
professional barriers and equip HCPs with the skills to collaborate and work more 
dynamically across sectors (World Health Organisation, 2010; Carpenter and Dickinson, 
2014; Barr et al., 2017). 
 
Such are the perceived benefits of IPE in fostering effective interprofessional collaboration 
in the provision of patient care that it is being championed globally. Indeed, a 2010 Lancet 
Commission, which comprised 20 international professional and academic leaders, 
highlighted the need for major reform in the training of healthcare professionals for the 21st 
century as they believed that healthcare education provision was (and most probably still 
is) fragmented and outdated, ultimately resulting in graduates  who are ill-equipped for 
modern practice (Frenk et al., 2010). The commission suggested that integrating HCPs and 
removing professional silos through the use of IPE was a vital step towards aligning 
healthcare education and arming students with the advanced interprofessional 
collaboration skills needed to provide patient-centred care. This approach was 
subsequently presented to and championed by the World Health Organisation (2013) who 
recommended that IPE should be embedded into all undergraduate and postgraduate 
healthcare training programmes.  
 
The GPhC is one professional regulator which has since moved to incorporate IPE into the 
initial training and education of all undergraduate pharmacists, making it a required 
element of the MPharm curriculum (General Pharmaceutical Council, 2011). As detailed in 
both the ‘Future pharmacists: Standards for the initial education and training of 
pharmacists’ (General Pharmaceutical Council, 2011), schools must provide students with 
environments and experiences which allow interaction with other HCP students. In 
addition, the GPhC have specified a number of outcomes related to IPE that must be 
achieved at the point of graduation (see Table 3.2). Pharmacy students must therefore gain 
practical experience of interprofessional collaboration and this must build year on year in 
a spiral fashion. This can be addressed through IPE based in a variety of settings including 
within practice, simulation settings and through traditional classroom learning.  
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To ensure IPE is implemented in the MPharm, schools must provide a detailed strategy of 
how the programme achieves the standards and outcomes related to IPE as part of the 
(re)accreditation of the programme (General Pharmaceutical Council, 2011). However, as 
schools are empowered to develop their own bespoke programmes against the GPhC 
standards, the GPhC is not prescriptive in terms of the type or extent of IPE that is expected. 
This allows schools some flexibility in designing IPE that fits into their current curriculum, 
helping schools to make compromises between the need for IPE, the outcomes required and 
the learning resources available in order to develop a curriculum which functions in a local 
context (O'Halloran et al., 2006).  
 
A disadvantage of this approach is that it can be challenging for educators to ascertain how, 
when, where and with whom IPE should be conducted in order to provide the most valuable 
learning experiences for students that is contemporary to current practice. Furthermore, 
whilst standard 10 of the ‘Future pharmacists’ document (see Table 3.2) sets out a number 
of outcomes related to interprofessional knowledge and skills, many of these only require 
students to perform at the ‘knows how’ level with just one outcome (to ‘provide accurate 
written or oral information appropriate to the needs of patients, the public or other healthcare 
professionals’) requiring students to ‘show’ they can achieve this during the MPharm 
programme. The limited requirements for MPharm students to ‘show’ how they collaborate 
with other HCPs is perhaps a result of standards which were published 7 years ago and 
therefore the GPhC have stated the need to update these standards to better reflect the 
progression of interprofessional practice (General Pharmaceutical Council, 2017). 
 
However,  IPE has emerging importance in the MPharm degree and this is recognised in a 
number of accreditation and reaccreditation reports (in the public domain at the General 
Pharmaceutical Council (2018a)), which make comments and/or recommendations to 
some schools about their provision of IPE. In these reports the GPhC has provided tailored 
guidance to schools, for example some schools were advised to expand and develop their 
IPE portfolios; “(school A must) redouble its efforts to ensure that the obvious potential for 
interprofessional learning (education) be realised”, “(school B must) articulate a strategy 
that includes meaningful engagement with a range of healthcare professionals”. The GPhC 
also provided advice related to the types of IPE they would like to see in another school, 
stating that “(school C) should continue actively to explore IPE opportunities with other 
local higher education providers, especially in the areas of prescribing, pharmacology and 
therapeutics”. In addition, in one school the GPhC noted that the ethos of a spiral curriculum 
related to IPE was deficient: “(school D should) continue its efforts to incorporate more  
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Table 3.2. Statements relating to the need for interprofessional collaboration within the MPharm degree from the General Pharmaceutical Council (2011) ‘Future pharmacists: 
Standards for the initial education and training of pharmacists’ document 
Standard Statement 
Standard 5: Curriculum delivery and 
the student experience 
The MPharm degree curriculum must include practical experience of working with patients, carers and other healthcare 
professionals. Practical experience should increase year on year. We are not suggesting that on-site placement visits are the only 
way to achieve this. Schools should articulate their strategy for meeting this criterion, which may include on-site placement 
visits, using patients, carers and other healthcare professionals in-class, and simulations.   
Standard 6: Support and development 
for students and trainees  
Students and trainees must work with a range of academic and professional role models. The range must include other 
healthcare professionals.   
Standard 10: Outcomes  
 
Student knows how to: Engage in multidisciplinary team working (outcome 10.1.h) 
Collaborate with patients, the public and other healthcare professionals to improve patient outcomes (outcome 10.2.1.e) 
Play an active role with public and professional groups to promote improved health outcomes (outcome 10.2.1.f) 
Work effectively within teams to ensure safe and effective systems are being followed (outcome 10.2.3.k) 
Student shows how to: Provide accurate written or oral information appropriate to the needs of patients, the public or other 
healthcare professionals (outcome 10.2.4.h) 
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interprofessional learning in the programme and certainly to extend it to years 2 and 4” 
resulting in IPE spanning across the four years. These recommendations demonstrate that 
the incorporation of IPE is at least partly driven by the regulator and perhaps suggests that 
further support and guidance for schools around the implementation of IPE could benefit 
its development in practice. By updating outcomes and standards required for MPharm 
students surrounding interprofessional collaboration this may in turn help further the 
advancement of IPE, with a study by Husband finding that pharmacy education developed 
substantially in response to the release of the 2011 GPhC accreditation standards 
evidencing that educational developments can be driven by the regulator (Husband et al., 
2014). 
 
With regulators and healthcare policy makers driving the incorporation of IPE in healthcare, 
education researchers have been keen to better understand and develop IPE delivery. 
Whilst research in this area varies greatly (see section 3.4 for further discussion), one area 
of particular focus surrounds the educational theory underpinning IPE, with Reeves and 
Hean (2013) arguing that understanding and application of theory is necessary, and whilst 
this has evolved and matured somewhat in recent years, Freeth et al. (2008) found in their 
influential review that the design of IPE is generally absent of explicit educational theory. 
One educational theory which is generally found, albeit not always explicitly, to underpin 
IPE is adult learning theory, with Reeves et al. (2016) finding (in their BEME systematic 
review of the effects of IPE) that sessions were better received when educators had 
designed sessions using the principles of adult learning. This learning theory, also 
sometimes known as andragogy, is the art and science of how adults learn (Knowles, 1973). 
This broad term encapsulates a range of approaches that centre on the notion that adults 
are self-directed and therefore need to see the value of learning something before they learn 
it. 
 
However, given andragogy is a broad umbrella term for a variety of educational methods 
and theories, educators face a challenge in knowing the best approaches and strategies to 
adopt, particularly since there is significant variation in IPE delivery reported in the 
literature. The literature provides exemplars of various approaches to IPE including for 
example problem-based learning (see for example Reeves and Freeth (2002)); simulation-
based learning (see for example Wakefield et al. (2003)); practice-based learning (see for 
example Reeves et al. (2002)); observation-based learning (see for example Guest et al. 
(2002)). Barr (2002b) also suggested that IPE can span (if it doesn’t already do so) the full 
spectrum of learning opportunities / approaches including: case-based learning; exchange-
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based learning; collaborative inquiry; appreciative inquiry; experiential learning; reflective 
learning; simulated learning; continuous quality improvement; etc. Educators are likely 
therefore to need to utilise a blend of these approaches with Barr et al. (2017) summarising 
that there is no single educational approach that addresses IPE and as long as sessions are 
interactive, reflective of practice, hold students interest, evolve over time and create 
opportunities for participants to develop a range of skills that can develop and reinforce 
interprofessional collaborative working then they will be of benefit.   
 
With such varied educational strategies and no explicit guidance on the preferred nature 
and extent of IPE, the development of relevant and meaningful IPE is therefore challenging 
for educators. The need for sessions to be reflective of practice means educators must 
carefully consider the educational methods, learning outcomes and the most appropriate 
HCPs to incorporate into IPE sessions (Knowles, 1973; Parsell and Bligh, 1998; van Soeren 
et al., 2011; Barr et al., 2017) whilst being coconscious of resource constraints and 
competing priorities. This issue is further compounded by limited published literature of 
IPE delivery and development in the field of UK pharmacy education (Carpenter and 
Dickinson, 2014).  
 
In order to add to this limited area of research and guide pharmacy educators this study 
aimed to identify the landscape of IPE sessions that take place within UK schools of 
pharmacy in the Master of Pharmacy programme. To address this, a questionnaire was sent 
to all UK schools of pharmacy to identify:  
 
1. The number of IPE sessions employed in each Schools’ MPharm programme 
2. The range of HCPs taking part in each IPE session 
3. The timing of each IPE session in the MPharm curriculum  
4. The environment in which each IPE session took place (e.g. workshop room, 
simulation suites, etc.) 
5. The educational theme of each IPE session 
6. The learning outcomes set for each IPE session  
7. The methods used to assess whether students have addressed the associated 
learning outcomes 
8. The methods used to evaluate each IPE session. 
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3.2. Methods 
In order to identify the IPE undertaken within UK schools of pharmacy a questionnaire was 
developed. Total population sampling was used to invite all UK schools of pharmacy to 
participate. 
3.2.1. Ethical approval  
Ethical approval was obtained from Cardiff School of Pharmacy and Pharmaceutical 
Sciences Research Ethics Committee prior to conducting this study (see Appendix B).  
3.2.2. Sampling 
In order to help achieve the most representative and generalisable data, total population 
sampling was used (Teddlie and Yu, 2007) to invite an academic from all schools of 
pharmacy providing the undergraduate MPharm programme to participate in the study. At 
the time of the study, from March 2015 until March 2016, there were 29 schools of 
pharmacy delivering the MPharm programme (this has since increased to 31 schools). Of 
the 29 schools, 26 schools were fully accredited and three schools held provisional 
accreditation.  
3.2.3. Recruitment  
An academic involved in IPE provision was identified in each school and was invited to 
participate in the study. These academics were identified through the research team’s 
academic relationships with colleagues in other schools or through information on school 
websites. 
 
Once an academic had been identified, they were contacted by telephone to explain the 
research and to determine if the individual was interested in and suitable for the study; if 
they were not interested or suitable they were asked to name a more appropriate individual 
in the school. Where telephone contact could not be made, an email was sent to inform 
potential participants of the project. If no reply was received, another member of staff was 
contacted.  
 
Once an appropriate academic member of staff had been identified and provisionally 
recruited over the telephone or by email, further information was provided by email 
including an information letter (see Appendix C) as well as a web link to the online 
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questionnaire. A reminder email was sent to respondents if no response was received 4 
weeks after agreeing to participate.  
3.2.4. Questionnaire design 
The questionnaire (see Appendix D) was designed in order to ascertain the IPE that was 
taking place as part of the MPharm programme within UK schools of pharmacy. The 
questionnaire design was informed by current literature in the field of IPE.  Google Docs, a 
free Web-based application in which documents and spreadsheets can be created, was used 
for the questionnaire. This allowed for the questionnaire to be created, edited and 
completed using a secure online platform that made for ease of dissemination and data 
collection. The questionnaire predominantly utilised closed quantitative questions to gain 
valuable information at relative ease to the respondent (Kumar, 2014), but also included 
free-text format qualitative questions in order to gather further information.  
 
The questionnaire was designed to be as short as possible, without compromising the key 
data needed, in order to increase the response rate achieved (Edwards et al., 2009). An 
approximate completion time of 15 minutes was ascertained following an initial pilot of the 
questionnaire (see section 3.2.5). An information page was provided at the start of the 
questionnaire explaining that all responses would be treated confidentially and that any 
publication of the findings would not name any individual or institution. The information 
page also provided instructions on how to complete the questionnaire. 
 
The questionnaire comprised four distinct sections. Section A featured a series of multiple 
choice questions that were used to capture each school’s overall provision of IPE. The 
questions determined: (i) the total number of undergraduate IPE sessions conducted by the 
school; (ii) the total number of student healthcare professions taking part across IPE 
sessions; (iii) the year that IPE was implemented in the school and (iv) if any new IPE 
sessions were being developed but had not yet been implemented by the school. In addition, 
respondents were asked to detail their specific role in the development of IPE in the school.  
 
Section B focused on each individual IPE session that was taking place at the school across 
the 2014/15 academic year. A series of multiple choice and qualitative ‘open’ questions was 
provided for each individual IPE session in order to determine the specifics surrounding 
each session. These questions were used to capture: (i) the title of each session; (ii) how 
long the session had been run; (iii) the year of the MPharm programme in which the session 
took place; (iv) whether the session was compulsory for pharmacy students; (v) what other 
healthcare student professions were involved in the session; (vi) where the session was set; 
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(vii) the topic or theme of the session; (viii) the key learning outcomes for each session; (ix) 
whether these outcomes were measured (and how if applicable); (x) whether the session 
was evaluated (and how if applicable); (xi) whether the session would continue to run in 
the following academic year and if so whether any changes were to be made to the session. 
Respondents were also given the opportunity to make any other comments they deemed 
appropriate to each session. At the end of each page respondents were asked if they 
conducted ‘any other IPE sessions’, if they did they were transferred to a duplicate page 
which asked the same questions about each subsequent IPE session they conducted.  
 
Section C comprised one open qualitative question to determine if any new sessions were 
to be initiated in the coming 2015/16 academic year and if so, what healthcare students 
were involved, the years each profession were in, the topic and location of the session, 
whether learning outcomes would be assessed and whether sessions would be evaluated.  
 
The final section, section D, enabled respondents to make any further comments and 
provide their details if they would like to be contacted about the results of the study.  
3.2.5. Piloting the questionnaire  
Once the initial questionnaire was completed, it was piloted by three academic staff within 
the Cardiff School of Pharmacy and Pharmaceutical Sciences (CSPPS). The staff members 
completed and critiqued the questionnaire for general flow and face validity where 
applicable (Babbie, 2015d), and also advised that an estimate completion time of 15 
minutes was reasonable based on the IPE number conducted at CSPPS, however this may 
have been longer in schools with more sessions than CSPPS. 
3.2.6. Data input 
Once a respondent had completed the online Google Docs questionnaire, data was exported 
and transferred into Microsoft Excel 2011 (version 14.7.2) for analysis.  
3.2.7. Data analysis 
Following data transfer into Microsoft Excel 2011, closed question answers were 
quantitatively compiled to determine overall frequency statistics. Where qualitative 
responses were provided (for example when explaining learning outcomes of sessions) 
deductive thematic analysis was used to identify the relevant information within each text. 
This information was then coded and grouped appropriately, thus enabling quantification 
of these points (Braun and Clarke, 2006; Kumar, 2014). Responses in sections A-C of the 
questionnaire were analysed in this manner as each question purposefully aimed to deduce 
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certain information. In order to highlight the relevance of learning outcomes to pharmacy 
and other HCPs this data was additionally categorised into the seven outcome/standards 
which were present in all of the five largest healthcare professional regulators (GPhC, GMC 
– General Medical Council, GDC – General Dental Council, NMC – Nurse and Midwifery 
Council and HCPC – Health and care Professions Council) as identified by Steven et al. 
(2017). Due to the small number of additional free text comments provided in section D this 
data was presented however direct analysis was unwarranted. 
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3.3. Results 
3.3.1. Response rate 
In total, 17 of the 29 schools of pharmacy took part in the online questionnaire providing 
an overall response rate of 58.6%. Whilst contact was made with a representative from all 
schools of pharmacy there were a number of reasons why some schools didn’t respond 
including: the representative contacted was not the educator most involved in IPE provision 
and the appropriate educator did not respond; although some educators agreed to respond 
ultimately they did not complete the questionnaire (even after reminders were sent); one 
school felt the information was too sensitive to divulge.  Responding schools were coded as 
A-Q for the remainder of this chapter in order to maintain anonymity. Of these, one school 
was provisionally accredited by the GPhC, with the remaining 16 having full accreditation. 
The majority of respondents completing the questionnaire on behalf of the school were the 
school’s IPE Lead or the Director of Education. 
 
One respondent only completed section A (general information related to IPE) and did not 
provide specific details about individual IPE sessions. This respondent indicated that they 
undertook a large number of sessions (n=20) (see Table 3.2) and therefore felt completing 
the full questionnaire would be too time consuming (see Table 3.12). Data analysis was 
therefore completed for 17/29 respondents in section A of the questionnaire, and 16/29 
schools for the remaining sections of the questionnaire.  
3.3.2. General information on schools’ IPE provision  
Section A of the questionnaire was designed to capture an overview of the totality of IPE 
provision at each school: the key data from this section is presented in Table 3.3. The 
common number of IPE sessions undertaken across the 17 schools was difficult to establish 
as there was some disparity between the number of sessions reported in section A of the 
questionnaire and the in-depth description of those sessions captured in section B of the 
questionnaire. Therefore, two different median values for the number of sessions conducted 
across schools could be derived from the data; section A data highlighted a median of 6 and 
a range of 1 to 20 sessions; section B data highlighted a median of 5.5 and a range of 1 to 10 
sessions. Ultimately the data highlighted that schools of pharmacy are likely to undertake 
an average of between 5 and 6 IPE sessions across the curriculum, however it must be noted 
that this data was non-parametric and therefore must be used with caution, particularly 
since there was such a large variation in the number of sessions undertaken across schools 
(1 to 20 sessions).  
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The IPE sessions that were delivered by schools varied considerably in terms of the student 
groups (defined as students from any course, inclusive of both HCP and non-healthcare 
courses) taking part: in school A, IPE was undertaken with students from two other student 
groups whilst for school J it was 12. A median of 6 student groups were engaged with 
pharmacy through IPE sessions, however once again the large range in number across 
schools must be taken into consideration. The earliest introduction of IPE within a school 
was in 1990, with all other schools implementing later than 2002 and the latest first 
implementation of IPE into the MPharm curriculum occurred in school P in 2014.  
 
Table 3.3. A comparison of the number of IPE sessions, number of HCP student groups and the year IPE 
was introduced in the 17 participating schools of pharmacy 
School of 
pharmacy 
(Anonymised) 
Number IPE of 
sessions 
detailed 
(Section A) 
Number of IPE 
sessions fully 
described 
(Section B) 
Year IPE 
introduced 
Total number of 
student groups 
undertaking IPE 
alongside pharmacy 
students 
A 8 7 2011 2 
B 3 4 2008 4 
C 12 10 2013 5 
D 4 4 1990 10 
E 6 5 - 6 
F 5 5 2010 5 
G 6 6 2005 3 
H 1 1 2008 4 
I 4 7 2005 11 
J 6 6 2002 12 
K 3 3 - 7 
L 6 6 2009 7 
M 7 7 2012 5 
N 4 4 2009 9 
O 20 8 2008 6 
P 5 5 2014 5 
Q 20 - - 10 
Total: 17 
Median = 6 
Range = 1-20 
Median = 5.5 
Range = 1-10 
Median = 
2008 
Median = 6         
Range = 2-12 
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3.3.3. Description of IPE sessions conducted by participating schools  
As one school did not provide details for each specific session, the analysis here is limited 
to 16 respondents.  In total, 88 IPE sessions were described.  
3.3.3.1. HCPs with whom student pharmacists undertake IPE sessions  
As highlighted in Table 3.4, 51 of 84 IPE sessions (data was missing for 4 of the 88 sessions) 
featured pharmacy students plus students from just one other discipline. Interestingly, 
some sessions did include high numbers of different student groups, with one school 
reporting the presence of eleven other student groups undertaking an IPE session alongside 
pharmacists. Table 3.5 also shows that across the 84/88 sessions where student groups 
were identified, a total of 26 different student groups were included. Of these, medical 
students were the most common student group, and took part in nearly two-thirds of the 
reported IPE sessions (n=56 sessions). Other notable student HCPs present in over a 
quarter of all reported IPE sessions were nursing students (n=37) and physiotherapy 
students (n=22). Although the majority of the 26 student groups described could be 
categorised as undertaking professional healthcare programmes, a number of student 
groups were not. These included barristers, biology students, pharmacology students and 
sports & exercise science students (n=1 each). One school also conducted IPE sessions with 
students training to be pharmacy technicians.  
 
Table 3.4. The number of student groups that took part in each individual IPE session (n=84)  
Number of student healthcare groups taking part with 
student pharmacists in each IPE session 
Number of sessions (n=84) 
One other 51 
Two others 8 
Three others 3 
Four others 5 
Five others 3 
Six others 4 
Seven others 3 
Eight others 2 
Nine others 1 
Ten others 3 
Eleven others 1 
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Table 3.5. The identity of student groups that took part in each individual IPE session (n=84) 
Student group (n=26)  Number of sessions in 
which student group took 
part (n=84) 
Medicine 56 
Nursing 37 
Physiotherapy 22 
Midwifery 17 
Social Work 13 
Dietetics  
Occupational Therapists 
10 
Biomedical Sciences  7 
Speech + Language therapy  
Dentistry  
Radiography 
6 
Psychology 5 
Operating Department Practitioner  
Optometry 
4 
Audiology  
Mental Health  
Podiatry 
3 
Paramedic 2 
Eight student groups including: Barrister, Biology, Healthcare 
Scientist, Non-medical prescribers, Pharmacology, Pharmacy 
Technicians, Sports & Exercise Science and Youth worker 
1 
Note: Those student groups in italics are non-healthcare related 
3.3.3.2. The location and timing of IPE sessions 
In total, IPE was compulsory for pharmacy students in 80 of the 88 sessions documented 
and all schools had at least one IPE session that was compulsory. For the eight sessions that 
were not compulsory, the proportion of the pharmacy student body that attended was 
described as 50% (n=2), 20% (n=2), 15% (n=2) and 10% (n=2). Of these four were IPE 
placements based in clinical settings, one was a simulation session, one was an IPE 
conference, one was a session with seven other HCPs and one was a workshop with nurses.   
 
The MPharm year group taking part in each session was detailed for all 88 sessions and is 
shown in Table 3.6. This shows a relatively even spread across the four years of the 
MPharm programme, with the first (n=26), second (n=25) and final (n=31) year similar in 
the number of sessions offered; at n=17, the third year featured the lowest number of 
sessions across the participating schools.  
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Table 3.6. The MPharm year group taking part in each individual IPE session (n=88) 
MPharm student years taking part in each session Number of sessions (n=88) 
Year 1 only 23 
Year 2 only 20 
Year 3 only 13 
Year 4 only 26 
Year 2,3,4  3 
Year 1,2 1 
Year 1,4 1 
All four years 1 
 
Although a number (n=8) of different settings for the delivery of IPE were described (see 
Table 3.7), two-thirds of reported sessions (n=57) were based in workshop style rooms 
and thirteen took place in simulation suites. In addition, some IPE took place whilst students 
were on placement (n=6) or in a clinical setting (n=5); other settings were relatively 
uncommon in comparison.  
 
Table 3.7. The setting of each individual IPE session (n=87) 
Session setting Number of sessions (n=87) 
Workshop room 54 
Simulation suite 13 
On placement 6 
Clinical setting 5 
Student choice 
Lecture theatre and workshop room across the same session 
3 
Online 
Conference room 
Practical skills suite 
1 
3.3.3.3. The topic or theme of each IPE session  
Respondents were asked to summarise the topic or theme of each IPE session. On a number 
of occasions respondents characterised the IPE session as featuring multiple topics/themes 
(120 topics/themes stated over 88 sessions) resulting in a total of 45 distinct topics 
identified (see Table 3.8). The two most popular topics for pharmacy students were 
prescribing and care planning, both of which occurred in 13/88 sessions. This was closely 
followed by sessions that involved the understanding of other HCP’s roles and 
responsibilities (n=12), with many suggesting this also encapsulated an understanding of 
the pharmacist’s own role within the team. Team building also featured as a theme in a 
number of sessions (n=9).  
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Table 3.8. The distinct topics / themes associated with each individual IPE session (n=88) (there can be 
more than one theme / topic per session) 
The distinct topic /theme of each session (n=45) Number of sessions 
(n=88) 
Care planning 
Prescribing 
13 
HCP roles and responsibilities 12 
Team building 9 
Patient safety 7 
Professionalism/ ethics 5 
Drug/ family history 
Substance abuse 
4 
Five topics/themes including: Antibiotic choices; Basic life support; 
Consultation skills; Dispensing/clinical checking; Vital signs 
3 
Six topics/themes including: Patient engagement; Service user 
experience; Reducing errors; Mental health; eye conditions; foot 
care 
2 
Twenty-six topics/themes including: Asthma; Care home 
medications; Clinical governance issues; Clinical numeracy; Clinical 
skills; Consent; Dementia; Dysphagia & laryngectomy; Francis 
report outcomes; Gastrointestinal conditions; HCP role conference; 
Infection reduction; Information governance; Laboratory results; 
Medical clerking; Nutrition guidance; Pain cases; Pain management; 
Performance enhancing drugs; Pharmacokinetic workshop; 
Pharmacovigilance; Polypharmacy; Practitioner wellbeing; Team 
working OSCEs; UTIs; Warfarin counseling,  
1 
OSCEs = Objective structured clinical examination UTIs = Urinary tract infections  
3.3.3.4. Learning outcomes associated with IPE sessions 
In total 207 student learning outcomes were listed across 71 sessions (information on 
learning outcomes was not provided for 17 sessions) with a mean of approximately three 
learning outcomes per session (range 1 to 8).  Learning outcomes are listed in Table 3.9, 
grouped by the seven key learning outcome themes which have been identified by Steven 
et al. (2017) to be consistent across the five largest healthcare professional regulators (GMC, 
GDC, GPhC, NMC and HCPC). The mapping shows that nearly half (n=95) of all learning 
outcomes set by educators were focused on ‘teamworking’. These outcomes could be 
divided predominately into ‘understanding/appreciating HCP roles’ (n=35), 
‘understanding/displaying good team working’ (n=30) and ‘understanding/displaying 
good communication with HCPs’ (n=29). The second largest outcome grouping was 
developing ‘skills for practice’ (n=39), which included ‘understanding/displaying good 
communication with patients’ (n=13) and ‘safe prescribing’ (n=4), amongst others. The 
least used outcome theme was ‘ethical approach to practice’ with only six of the 207 
outcomes identified focused on this outcome theme. 
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Table 3.9. The student learning outcomes for IPE session mapped to the seven key learning outcome 
themes identified by Steven et al. (2017) to be consistent across the five largest healthcare professional 
regulators (GMC, GDC, GPhC, NMC and HCPC) 
Theme Learning outcome 
(207 learning outcomes across 71 sessions) 
Number 
of 
sessions  
Teamworking  
Total = 95 
Understanding/appreciating: HCP roles 
Understanding/displaying: Good team working 
Understanding/displaying: Good communication with HCPs 
Understanding: Professional referral 
35 
30 
29 
1 
Skills for practice 
Total = 39 
Understanding/displaying: Good communication with 
patients 
Demonstrating: Safe prescribing 
Demonstrating: Basic lifesaving skills; Apply learning to 
calculations  
Demonstrating: Vital signs assessment skills  
Understanding: Drug issues; Medications management; 
Problem-based learning 
Demonstrating: Clinical decision making; Drug history 
taking; Increased hospital familiarity; Over the counter 
patient management; Physiotherapy assessment; Practical 
injection skills; Providing medical information; Reading 
drug charts 
13 
 
4 
3 
 
2 
2 
 
1 
Patient-centered 
approach  
Total = 21 
Integrating: HCPs to provide holistic patient care 
Understanding: Human factors in care; The patient journey 
Demonstrating: Near miss reporting 
Understanding: Patient compliance 
15 
2 
1 
1 
Knowledge for 
practice  
Total = 16 
Understanding: Mental health issues 
Understanding: Polypharmacy issues 
Understanding: COPD/asthma; Dementia care; Diabetes 
treatment; Drugs in sport foot problems; Gastrointestinal 
symptoms; Intricacies of an eye clinic; Laboratory tests; 
pain; Pharmacovigilance; Pregnancy  
3 
2 
1 
 
Professionalism 
Total = 16 
Understanding/demonstrating: Patient safety exercises 
Demonstrating: Professionalism 
Understanding: Cultural diversity 
Demonstrating: Prioritisation  
Understanding: Professional negligence 
5 
4 
3 
2 
2 
Continuing 
professional 
development  
Total = 14 
Evaluating: Own learning and recognise improvements 
Finding: Information services 
Understanding: Guidance 
12 
1 
1 
Ethical approach 
to practice  
Total = 6 
Understanding: Ethical dilemmas through debate 
Understanding: Confidentiality consent  
4 
1 
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3.3.3.5. Assessment of student learning outcomes  
Students were assessed against the learning outcomes in exactly half of the sessions 
reported (42 out of the 84 sessions – data missing for four sessions) (see Table 3.10).  
Production of a reflective statement or Continuing Professional Development (CPD) entry 
were the most common forms of assessment (n=15). This was followed by OSCEs (objective 
structured clinical examinations) and summative exams which were each used in eight 
sessions as methods of assessing learning outcomes.  
 
Table 3.10. Methods of measuring student outcomes in each individual IPE session (n=42/84) 
Method used to assess learning outcomes Number of sessions 
assessed in this way 
(n=42/84) 
Reflective statement/CPD^ 15 
OSCE (summative, formative and indirect)  
Summative exam 
8 
Formative assessment/feedback 6 
Coursework/ write up/ summative report 3 
Group assignment/ presentation 2 
Six methods including: Critical review; Engagement marking; 
Formative poster presentation; Judged by expert panel; Posting 
learning points online; RCA (not defined) in assessment 
1 
^Two were specifically defined as summative CPD entries, others did not define if summative or 
formative 
3.3.3.6. Evaluation of IPE sessions 
Sessions were evaluated in 57 of the 83 sessions for which an answer was provided (in five 
sessions it was not reported whether evaluation was/was not conducted – missing 
data)(see Table 3.11), with 30 of these evaluations adopting the Readiness for 
Interprofessional Learning Scale (RIPLS) (Parsell and Bligh, 1999) or a similar student 
perception survey. Some universities used mixed methods in order to evaluate the sessions, 
for example a total of nine sessions were evaluated using both RIPLS and student 
interviews. Of the 57 sessions described as evaluated, three did not provide details on the 
evaluation method that was used.  
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Table 3.11. Methods of evaluating each individual IPE session (n=57/83)  
Method of evaluating sessions Number of sessions 
evaluated (n=57/83) 
Student perception analysis (Adapted RIPLS) 12 
RIPLS only 
RIPLS and Student interviews combined 
9 
Evaluation completed by central IPE team 
Online evaluation tool 
6 
Student reflections 5 
Intended learning outcomes questionnaire 4 
Facilitator feedback 2 
Healthcare Team Challenge questionnaire 
Informal qualitative debrief 
1 
Missing 3 
3.3.4. New IPE sessions to be implemented in the next academic year 
Respondents were asked to indicate any new sessions that were starting in the next 
academic year (2015/16).  Eleven schools indicated that they were initiating new sessions 
(see Table 3.12) and a total of 25 new sessions were described.  
 
Similar to existing sessions, the majority (n=13) stated that new sessions would feature 
medical students. The MPharm year group participating in the sessions was spread fairly 
evenly across all four years: Year 1 (n=3), Year 2 (n=4), Year 3 (n=5), Year 4 (n=6). A range 
of 23 different topics / themes associated with the new sessions were described across the 
25 sessions.  
 
The number of sessions each of these schools undertook in 2014/15 was added to Table 
3.12 to highlight the impact the addition of these sessions will have on each school’s overall 
IPE provision. School H, which was undertaking just one session in 2014/15, showed a 
significant expansion of their IPE portfolio with the introduction of four new sessions, 
resulting in this school providing close to the average of 5.5 (SD = 2) sessions per school.  
School C was also seeking to add four sessions, resulting in fourteen sessions overall.  
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Table 3.12. Details of additional IPE sessions planning to be introduced in the following academic year 
(2015/16) 
School MPharm 
year 
group 
HCP Topic (Setting if stated) 2014/15 
IPE no. 
2015/16 
IPE no. 
A Year 4 Medicine - Year 3 Palliative care; syringe drivers, 
prescribing, oral care (Workshop 
room) 
7 8 
C Year 2 Nursing - Year 2 Medicines administration and 
ethical issues 
10 14 
 Year 3 Medicine Primary care placement (Primary 
care) 
  
 Year 3 Nursing - Year 3 End of life care   
 Year 4 Dentistry - Year 4 Interprofessional work between 
the professions 
  
F - Medicine Legislation 5 7 
 - Medicine OSCEs   
H Year 1 Medicine - Year 1 Professionalism, basic health 
monitoring, public health 
1 5 
 Year 2  Medicine - Year 3 Lung disease   
 Year 3  Physiotherapists 
– Year 3 
Cardiovascular challenge: Social 
work symposium with patients 
and carers (lecture theatre) 
  
 Year 4 Medicine and 
Midwifery  
Pregnant, paediatric and aging 
patients 
  
I - - Patient simulation (Simulation 
suite) 
7 9 
 - - Primary care placement (Primary 
care) 
  
J Year 4 Medicine – Year 4 Ward simulation 6 11 
 Year 2 Medicine –Year 2  Renal team based learning   
 - Medicine – Year 5 Prescribing on wards   
 Year 3 Medicine – Year 2 Diabetes experience challenge   
 Year 4 Medicine – Year 4 Polypharmacy   
K - - IPE with GP surgeries 3 6 
 Years 1 - 
4 
- ‘Pharmacist as a clinician’ helping 
students with their professional 
identities 
  
 - - Working with patients with 
learning disabilities and their 
carers 
  
L - - Joint placement sessions 
(Placement) 
6 7 
M Year 1 Speech and 
Language 
Therapy, 
Optometry, 
Dentistry, Social 
Work, Audiology 
and Medicine  
Mapping the professions on a 
patient journey (Large workshop 
space/ hall) 
 
7 8 
N Year 3 Nursing – Year 2 NICE Evidence Search Student 
Champion scheme  
4 5 
O - Medicine Falls and polypharmacy in the 
elderly  
8 9 
Chapter 3 
 
   75 
3.3.5. Qualitative comments 
Respondents were given the opportunity in section D to provide any additional information 
they deemed appropriate and which had not been covered elsewhere within the 
questionnaire; just four respondents left comments which re reproduced in Table 3.13. 
 
Table 3.13. Additional qualitative comments made by respondents (n=4) 
School Comment 
School C This respondent felt that “timetabling has been a constant challenge” when 
aiming to set up and deliver IPE and that within their University they “have a 
Steering Group for IPE in the College”. 
School H Stated they were “moving to a new curriculum in the coming academic year 
therefore many of the sessions are to be piloted and introduced then”. This is 
evident as this particular school only conducted one IPE session however were 
set to introduce four more in the following year, which can be observed in 
section 3.3.4. 
School M 
 
 Felt that “with the mandatory requirement to do IPE in early years when other 
HCPs do not have the same requirements” the IPE sessions are “very hard to 
establish”. They also posed the question; “are negative IPE experiences 
published and what is the long-term effect of this?” 
School Q Stated “we have more than 20 activities across the four years and to deconstruct 
each one into the form that you request is not practical. I am very keen to support 
your research but this must be in a way that is manageable”.  
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3.4. Discussion 
Despite the required nature of IPE within the UK MPharm programme, there remains a 
paucity of literature examining the nature and effectiveness of IPE in undergraduate 
pharmacy education. In this study, a questionnaire was developed and disseminated to UK 
schools of pharmacy to better understand the landscape of IPE in MPharm programmes. 
Over half (n=17/29) of schools delivering the MPharm programme at the time of the study 
responded, providing detailed descriptions of a total of 88 IPE sessions. This data 
highlighted that whilst an average of approximately 5 sessions were delivered in each 
MPharm programme there was a large range across schools, with one school delivering a 
single session and two schools stating they delivered twenty.  
 
O'Halloran et al. (2006) described how “curriculum design is always a compromise between 
the educational idea, the teaching and learning resources available and what will work in a 
local context” (pg. 26). This highlights the challenge faced by pharmacy educators in 
designing and implementing meaningful and contemporary IPE (Carpenter and Dickinson, 
2014), particularly as there is little practical guidance related to IPE design and delivery for 
the MPharm programme (General Pharmaceutical Council, 2011). Pharmacy educators 
must therefore create IPE sessions they believe to be fit for purpose against a context of 
local restraints not least the local availability of students of other healthcare disciplines with 
which to engage (Neocleous, 2014). This has likely resulted in the significant variation in 
the nature and extent of IPE provision across UK pharmacy schools, something that was 
immediately evident when comparing the number of IPE sessions taking place across 
schools. This disparity in IPE provision prompts the question as to whether there is a 
variation in the perceived value of IPE and/or major differences in the challenges faced by 
schools in implementing IPE particularly related to the time and resources needed to 
initiate and sustain sessions.  
 
At present, the GPhC does not publish minimum expectations for the number of IPE sessions 
in the MPharm programme. This is likely due to a lack of consensus on the minimum 
exposure to IPE that is required to enable student practitioners to develop interprofessional 
competencies. With a number of benefits to IPE cited throughout the literature (see section 
3.1) many proponents of IPE do suggest that more is better, with students gaining 
incremental benefits from each session attended (Lapkin et al., 2012; Carpenter and 
Dickinson, 2014; Harden, 2015). Despite the apparent benefit of higher numbers of 
sessions, this must be balanced against the need to ensure that IPE sessions are meaningful 
and not just bolted onto the curriculum to fulfill a perceived quota (Barr et al., 2017). 
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Furthermore, as there is limited high quality evidence surrounding IPE (see chapter 2.7.1 
and Zwarenstein et al. 1999, Reeves et al. 2010c) this explains why the World Health 
Organisation (2013) made the recommendation of IPE implementation ‘conditional’. This 
recommendation for implementation by WHO was based on their belief that there is 
“sufficient evidence to indicate that IPE enables effective collaborative practice which in 
turn optimises health-services, strengthens health systems and improves health outcomes” 
(pg. 18) (World Health Organisation, 2010). The limited evidence related to changes in 
behaviour, organisational practice and benefits to patients/clients (Hammick et al., 2007; 
Reeves et al., 2016) may have therefore contributed to the variation in session numbers 
across universities as educators may be unable to directly pinpoint the beneficial outcomes 
for students.   
 
The desire to expose students to multiple IPE sessions was evident in the data, with 80 of 
the 88 sessions described as compulsory for pharmacy students to attend. For five of the 
eight sessions that were described as being non-compulsory, the settings in which they 
occurred were either during placements or as part of a simulation activity. Historically these 
types of activities are challenging to scale up due to limited capacity in physically 
accommodating large student numbers. This is an issue that has been commonly reported 
in the literature resulting in the need for either large environments or multiple sessions 
(Buring et al., 2009; van Soeren et al., 2011; Neocleous, 2014). Furthermore, two of these 
non-compulsory sessions included seven or more HCPs. Aligning timetables across all of the 
courses or programmes for large numbers of students is likely to have impacted on the 
ability for all students to attend. This is seen to be another significant barrier in the 
literature (Levett-Jones et al., 2012; Lapkin et al., 2013; Carpenter and Dickinson, 2014). 
These logistical challenges can often deter schools from conducting sessions, however 
whether it be due to the rising status of IPE or its requirement within the MPharm 
curriculum (General Pharmaceutical Council, 2011) they are challenges which have as far 
as the data is able to corroborate, for the most part, been overcome in the participating 
schools. In addition to increasing students’ involvement by making IPE compulsory it is 
thought that this can also enhance the status of a session and thus increase students’ 
engagement and commitment (Reeves et al., 2012).  
 
In this study, the majority of IPE sessions (n=54) were described as being set in a workshop 
(classroom) environment, an area which allows for students to engage in discussion and 
work together to address learning outcomes. This workshop setting has been shown to 
increase students’ participation in their learning (Taylor et al., 2012) particularly where 
Chapter 3 
 
 
78 
students work in small groups (Parsell and Bligh, 1998). This format of learning has been 
shown to make IPE more effective (Barr et al., 2017) probably because it is more closely 
aligned to the multidisciplinary team model prevalent in the NHS.  Some IPE sessions were 
described as taking place in a clinical environment either when students were on placement 
(n=6) or in some other clinical settings (n=5). Barr (2000) believes that practice-based IPE 
is more likely to improve the quality of services and benefit users over university-based IPE. 
This draws from the concept of providing authentic learning, an educational theory that 
typically focuses on real-world, complex problems and their solutions. As suggested by 
adult learning theory, students need to see the value of learning, therefore by placing 
students in an authentic practice-based environment this can help them more readily 
recognise relevance and therefore engage in sessions (Jonassen, 1999). In addition to 
providing real-world relevance, this type of learning is by nature highly collaborative with 
tasks requiring students to utilise multiple sources and perspectives to solve complex real-
world problems that cannot be solved individually, therefore ensuring students actively 
collaborate with other healthcare colleagues (Lombardi, 2007). These authentic sessions 
can also make learning more appealing for students (Carpenter and Dickinson, 2014) and 
can enable them to directly observe how each HCP role can impact overall patient care 
(Jacobsen et al., 2009). 
 
The combination of integrating practice-based IPE within a university degree was first 
pioneered at Linkoping University, Sweden, which featured students from a range of 
professions working together to operate a hospital ward with authentic patients (Hammar, 
2000; Wilhelmsson et al., 2009). This long established and novel programme represented a 
successful method of delivering IPE and has subsequently been replicated elsewhere, with 
many universities expressing how this method facilitated students to develop the 
knowledge, skills and attitudes required for the delivery of interprofessional, patient-
centred care (Reeves and Freeth, 2002; Hylin et al., 2007; Hylin, 2010; Brewer and Stewart-
Wynne, 2013).  
   
Whilst some practice-based IPE was identified to take place in some MPharm programmes, 
it represented only a small proportion of the IPE sessions described. This is possibly as a 
consequence of limited capacity, constrained resources within the clinical settings or an 
anxiety by organisations to engage student practitioners in the delivery of healthcare given 
the associated risks (Issenberg and Scalese, 2008). Another key factor pharmacy schools 
must take into account is the potential high financial cost of undertaking practice-based IPE. 
Whilst this is a consideration for all courses, as the UK MPharm degree is defined as a 
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‘science degree’ it does not attract the additional funding that ‘clinical degrees’ such as 
medicine and nursing do. This constrains the ability from to fund placements and may 
therefore further explain why schools sought to undertake IPE outside of practice-based 
sessions.  
 
One setting seen as an appropriate alternative to providing authentic learning outside of 
practice-based sessions is the use of simulation-based learning (Robertson and Bandali, 
2008; Barr et al., 2017). Here simulation and role-playing is used to immerse students in 
the complexities of authentic decision making, helping them develop communication, 
collaboration, and leadership skills (Lombardi, 2007). These clinically-orientated simulated 
environments aim to closely mimic the healthcare practice setting and provide a safe, less 
pressured environment for students to develop interprofessional and technical skills 
(Reeves and van Schaik, 2012). However, in order for these IPE sessions to help build 
professional identities, improve self-awareness and afford students the opportunity to 
practice newly acquired knowledge, sessions must be authentic and maintain realism, 
therefore students should be assigned their relevant professional roles and given tasks that 
are likely to occur in practice (Issenberg et al., 2005; van Soeren et al., 2011). Providing 
simulation-based learning also has other challenges, not least the difficulty in scaling 
simulation to accommodate significant numbers of students (Barr et al., 2017). 
Furthermore, whilst these sessions may provide a less expensive alternative to practice-
based sessions they still require significant investments in resources which may not be 
available to schools and could once again explain why just 13/87 sessions utilised this 
environment, with considerably more favouring workshop rooms  (Barr et al., 2017). As 
such a review of the use of simulation in IPE conducted by Reeves and van Schaik (2012) 
concluded that further research is needed to understand the interprofessional benefits 
students may gain from sessions (in addition to conducting simulation uniprofessionally) 
in order to justify to costs, and therefore recommended that simulation should be part of a 
portfolio of IPE activities rather than the sole methodology.  
 
All of the environments discussed so far enable students to take part in interactive face-to-
face sessions (Abu-Rish et al., 2012). However advances in technology are providing 
alternative platforms for IPE which can overcome logistical issues such as scalability to 
accommodate large numbers of students, timetabling and resource challenges (Lapkin et 
al., 2012), and can help broaden the adoption of IPE (Riesen et al., 2012) whilst maintaining 
the ability for students to achieve interprofessional outcomes such as understanding, 
respecting and valuing professional roles and boundaries (Clouder et al., 2011). In this 
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study however, the use of digital technologies to enable IPE was extremely limited with just 
one out of 87 sessions utilising an online environment to deliver IPE highlighting that 
pharmacy educators either do not have the technological capacity to conduct these sessions, 
or do not believe these sessions are as valuable, something which may likely be the case as 
these sessions lose the face-to-face contact which is a key facilitator in building 
relationships and developing collaborative skills (Carpenter and Dickinson, 2014). This 
therefore led Barr et al. (2017) to state new IPE techniques should not replace traditional 
methods, but should be blended with face-to-face learning, with Reeves and van Schaik 
(2012) believing these varying techniques can complement one another.  
 
There has been much debate within the literature on the optimal time to introduce IPE. 
Some authors, like Carpenter and Dickinson (2014), recognise the argument that until 
individuals have established their own professional identity or have sufficient experience 
to share with other HCPs the benefits of IPE are limited and therefore suggest it should 
commence post-qualification (i.e. during post-graduate study).  However, this belief clearly 
differs from most, with research by Rodger and Hoffman (2010) which surveyed 396 
healthcare educators across 41 countries worldwide finding that 86% of IPE was conducted 
at undergraduate level, and a study by Barr et al. (2014) finding that two-thirds of UK 
universities delivering healthcare courses provided undergraduate IPE. With research into 
undergraduate IPE clearly growing from a time when 70% of that conducted was focused 
on postgraduate IPE (Freeth et al., 2002), the belief that IPE should be incorporated as early 
as possible is also gaining legitimate traction (Hammick et al., 2007; Abu-Rish et al., 2012). 
Indeed, a number of studies have advocated the use of early IPE in order to address the 
development of students’ stereotypical views of other HCPs which are already present from 
the beginning of the undergraduate programme and can quickly become more exaggerated 
(Carpenter, 1995; Tunstall-Pedoe et al., 2003; Lindqvist et al., 2005), thus helping to build 
interprofessional relationships and prevent early development of professional silos and 
tribalism (Barr, 2000). Whilst IPE is required within schools of pharmacy and thus this 
research anticipated its delivery to be widespread, the data clearly showed that schools 
were beginning sessions from year one of the programme and continuing them throughout 
the degree. By providing a series of evolving sessions this can enable students to build on 
previous sessions and knowledge, aligning with the constructivist educational theory which 
considers that learning is the process of constructing new knowledge on the foundations of 
learners already know (Vygotsky, 1978).  
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Variability was observed in the different types of student practitioners that took part in IPE 
sessions. In total, students from 26 different disciplines were involved in IPE in addition to 
pharmacy students across the 88 IPE sessions described. In the main sessions featured 
medical and nursing students, with physiotherapy students also heavily featured. Careful 
consideration needs to be employed when designing IPE to ensure that respondent groups 
add value and are applicable to the theme of the session (Barr, 2002b). Indeed, Barr et al. 
(2017) have suggested that the growing popularity of IPE can result in a pressure to include 
an open-ended list of professions. This can have a detrimental impact on students’ 
perceptions of IPE if they fail to see the relevance to their own practice in engaging with 
particular HCPs. For some of the IPE sessions reported, student groups who took part in IPE 
sessions with pharmacy students were from outside the healthcare disciplines and 
therefore were unlikely to practise alongside pharmacists post-graduation, questioning the 
relevance of these sessions (particularly those where these non-healthcare groups were the 
sole other student group alongside pharmacy students). In a general review of IPE within 
the UK conducted by Barr et al. (2014) they summarised that whilst many educators were 
ambitious and driven to develop and incorporate IPE then needed reminding that these 
sessions should be more than just ticking a box to satisfy a professional body, with students 
wanting to attend sessions that prepare them for future practice.  
 
One challenge to educators in designing meaningful IPE is that there is currently no 
literature that indicates which HCPs pharmacists work with most frequently in practice 
(something explored in chapters 5 and 6). The consequence is that IPE is often developed 
based on the availability of student practitioners from other health disciplines in the local 
area, i.e. convenience is prioritised (Lapkin et al., 2013).  This convenience could also extend 
to occasions where there are obvious alignments in respective student timetables leading 
to opportunistic development of IPE sessions. This perhaps explains why such a range of 
healthcare student groups was seen across the reported sessions. Another factor may be 
synergies with HCP programmes where there is a similar regulatory requirement for 
undergraduates to undertake IPE, e.g. with medical students (General Medical Council, 
2009). 
 
Another reason pharmacy educators may choose to engage with certain professional groups 
can be due to clear and relevant alignments in curricula. This was evident in a number of 
the IPE sessions described by respondents which saw the delivery of common shared topics 
such as prescribing (n=13) with medics, nurses and other prescribing professions. In a 
report related to the ‘Aberdeen Interprofessional Health and Social Care Education 
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initiative’ made to the Scottish Government which reviewed a range of IPE sessions across 
a three year period, Diack et al. (2008) also found pharmacy and medicine students 
recognised the benefits of focusing IPE on prescribing as it helped them understand the 
‘different roles and areas of expertise of doctors and pharmacists in the area of prescribing’. 
Other common topics identified across this current study included care planning, HCP roles 
and responsibilities, team building, patient safety, and professionalism and ethics, all of 
which are relevant for many UK HCP programme curricula therefore allowing for easier 
curriculum alignment (Steven et al., 2017).  
 
The range of factors that influence the choice of HCP student groups engaged alongside 
pharmacy in IPE sessions could also have a similar impact on the number of HCP groups 
involved in each session. In the main, pharmacy students engaged with one other 
professional group during IPE sessions (60%). This is a finding that was supported in a 
literature review of IPE by Abu-Rish et al. (2012) which also showed that of the 83 studies 
reviewed sessions were mostly conducted with just two professions (42%). Some schools 
did report IPE sessions featuring a higher number of professions learning together during 
IPE sessions, with one school having eleven HCP student groups alongside pharmacy 
students during a single IPE session. Although this may enable wider exposure to student 
groups thus increasing the possibility to positively reinforce professional roles and 
stereotypes (Carpenter, 1995), involving more than one other profession can increase the 
scale of IPE thus making alignment of timetables and curricula more challenging (Levett-
Jones et al., 2012). Additionally it may then become a challenge to maintain a relatively even 
balance between professional group numbers (Parsell and Bligh, 1998),  something Reeves 
et al. (2012) argues is crucial in providing effective interprofessional interaction, as they 
believe that on occasions where the dynamic heavily favours one profession this may lead 
the profession to dominate sessions thus inhibiting the other professions engagement.  
 
With the majority of sessions conducted with small numbers of different professional 
groups, other factors to the design of sessions may have contributed to this decision 
including the availability of competent, expert staff to facilitate sessions, a factor which is 
thought to be important in making students to feel more comfortable and increasing their 
likelihood to listen and engage (van Soeren et al., 2011; Abu-Rish et al., 2012), with the value 
of IPE seen to decrease if students believe the facilitator has a perceived lack of expert 
knowledge (Lapkin et al., 2012; Carpenter and Dickinson, 2014; Barr et al., 2017). 
Furthermore, pharmacy educators may have also found that large numbers of different 
professional groups involved in IPE exaggerated the challenge of ensuring relevance across 
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professions, which if not achieved can result in students developing negative connotations 
towards interprofessional working (Barr et al., 2017), thus making it more viable to focus 
on a small number of HCP groups and ensure that all students are actively engaged in 
sessions that accurately reflect their future professional practice.  
 
Another challenge educators face when developing IPE sessions is aligning learning 
outcomes between courses (Barr et al., 2017). This can be problematic when learning 
outcomes for IPE are perceived to be general or vague and not compatible with the demands 
of the respective healthcare programme. This led Steven et al. (2017) to identify a number 
of common learning outcomes which overlapped across the five largest healthcare 
professional regulators in the UK (GMC, GDC, GPhC, NMC and HCPC), creating a framework 
for informing shared learning opportunities in prequalifying IPE curricula. The seven key 
learning outcome themes defined by Steven et al. (2017) were subsequently used within 
this study to frame the 207 outcomes described by respondents across 71 IPE sessions (17 
missing data sets). Of these, teamworking was the most common learning outcome set by 
educators and included getting students to communicate and work together, and often 
aimed to increased students’ understanding of one another’s roles. These learning 
outcomes align particularly well with many of the cited goals for IPE (Greiner and Knebel, 
2003; Freeth et al., 2008; Thistlethwaite, 2012). Of note, Thistlethwaite and Moran (2010) 
found that many institutions assume that students meet the learning outcome of ‘improving 
interprofessional team working’ simply through participating in IPE, i.e. the learning 
outcome is implicit. This may explain why nearly 20% of the sessions described within this 
study did not feature improved interprofessional teamworking as a stated outcome. This 
practice should be challenged as setting specific learning outcomes encourages educators 
to be responsive and flexible in the development of sessions helping ensure students 
achieve the skills or knowledge desired (Reeves, 2012).  
 
Beyond improving interprofessional teamwork, a number of other learning outcomes were 
frequently reported including skills for practice such as communicating with patients and 
prescribing skills, knowledge for practice such as learning about patient conditions, as well 
as improving students’ professional and ethical skills, having a patient-centred approach 
and continuing the student’s professional development. Interestingly, many of those 
learning outcomes set by pharmacy schools for their IPE sessions aligned with the six IPE 
learning outcomes specifically identified by the World Health Organisation (2010): (i) 
teamwork; (ii) roles and responsibilities; (iii) communication; learning and critical 
reflection (i.e. reflecting on own role within the team and transferring to practice); 
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relationships with, and reflecting the needs of, the patient; ethical practice. This data shows 
that IPE provides a platform for educators to equip students with the skills required for 
interprofessional collaboration in practice and can therefore complement the surrounding 
uniprofessional syllabus. 
 
All of the outcomes identified could also be directly mapped onto the learning outcome 
framework developed by Steven et al. (2017). This highlights that the session outcomes had 
relevance across HCP student groups and was not limited to pharmacists (at least for those 
who are part of the five largest UK HCP regulators). This is likely to enhancing students’ 
interest and engagement in sessions (Knowles, 1973; Parsell and Bligh, 1998; Jonassen, 
1999). However, it is important to note that although outcomes align across professions 
they may not be taught to the same extent or depth therefore educators should design 
sessions which include outcomes which are pitched at the right level for all students, 
particularly if sessions are taught between professions in differing year groups, i.e. at 
different points of their professional development (Parsell and Bligh, 1998). Whilst the year 
group of the pharmacy students involved in IPE sessions was captured in this study, the 
year group of the other HCP students taking part was not always clear. It is therefore 
difficult to conclude whether the year groups engaging IPE sessions were deliberately 
selected to align with respective curriculums or were chosen for pragmatic reasons related 
to operational delivery. Nevertheless, it is important to recognise that if there is a clear 
mismatch in the year groups participating in IPE particularly in terms of their level of 
professional development, students may question the relevance of the sessions. This is 
especially true one group of students act as ‘teachers’ in sessions limiting their opportunity 
to learn ‘with, from and about’ their colleagues. This can result in a real or perceived 
imbalance of ‘power’ in the developing professional relationships (Baker et al., 2011; 
Jenkins, 2013; Carpenter and Dickinson, 2014). 
 
One of the major challenges in sustaining IPE is demonstrating its value highlighted by the 
limited number of ‘high quality’ studies around IPE (Zwarenstein et al., 1999; Zwarenstein 
et al., 2005; Reeves et al., 2010c; Thistlethwaite and Moran, 2010; Abu-Rish et al., 2012) due 
to the poor rigour of investigations as well as the “wholesale lack of consistency in defining 
and describing learning outcomes and their assessment” (pg. 507) (Thistlethwaite and 
Moran, 2010). This was something apparent within this study with 17 sessions described 
as not featuring learning outcomes and only half of the IPE sessions featuring any 
assessment of the learning outcomes.  
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Where learning outcomes were assessed the method of assessment was varied. The most 
common measure was completion of reflective accounts or continuing professional 
development (CPD) entries. Whilst these methods help students to reflect on their own 
development and identify areas their collaborative practice may need improvement, they 
do not represent an objective assessment of a student’s understanding or application of the 
skills or knowledge articulated in the learning outcomes. Their value is therefore 
questionable, with Barr et al. (2017) for example suggesting that assessments of IPE should 
aim to directly demonstrate each student’s competencies in collaborative practice, a feat 
which is not easily achieved due to the practical nature of the skills IPE sessions often aim 
to develop. In addition, a small number of sessions utilised written summative assessments 
of learning outcomes including exams and written reviews.  Whilst these assessment types 
can increase the value students place on IPE learning opportunities (Barr et al., 2017), their 
notable drawback is that they are not compatible with assessing communication and 
teamwork skills i.e. they are not constructively aligned with the learning approaches 
(Simmons and Wagner, 2009; Thistlethwaite, 2012).  
 
During the MPharm programme, pharmacy students are required to ‘show’ that they have 
acquired a range of skills or knowledge (Miller, 1990; General Pharmaceutical Council, 
2011). One assessment technique used to measure this is OSCEs, a method which uses 
separate stations to objectively assess students’ clinical competencies (Harden and Gleeson, 
1979). With the GPhC requiring students to ‘show how’ to undertake interprofessional 
competencies such as providing “accurate written or oral information appropriate to the 
needs of patients, the public or other healthcare professionals” (pg. 38) (General 
Pharmaceutical Council, 2011) OSCEs are increasingly used as a method of assessing IPE. 
Indeed, in this study the learning outcomes of eight IPE sessions were described to be 
assessed by OSCEs. It is not clear however whether these were uniprofessional OSCEs,  
interprofessional OSCEs (iOSCEs) or team OSCEs (TOSCEs); iOSCEs and TOSCEs have been 
specifically developed to emphasise the assessment of interprofessional competencies 
(Morison and Stewart, 2005; Simmons et al., 2011; Gordon et al., 2013).  
 
Of note, Thistlethwaite and Moran (2010) and Abu-Rish et al. (2012) have both found that 
educators often dispense with direct assessment of students against the learning outcomes 
and instead focus on evaluations of the sessions themselves through student feedback. 
Indeed, in this current study 57 sessions featured a student evaluation of the session, 
compared to 42 sessions in which students’ learning outcomes were assessed. Of these 
student evaluations, the majority (n=30/57) were through the use of the RIPLS  
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questionnaire developed by Parsell and Bligh (1999) or a similar student perception survey. 
Whilst RIPLS is a well-known and accepted approach to evaluating IPE sessions, Mahler et 
al. (2015) found that it has a number of drawbacks including inaccuracies in the 
measurement and comparison of data (i.e. it has a limited degree of certainty as it measures 
HCP students’ perceptions of IPE and interprofessional working which are often positive 
irrespective of the session), which have been generally been overlooked by researchers in 
need of an instrument. A further drawback to such tools is that they evaluate students’ 
perceptions of their learning and the impact of sessions on that learning. This is a subjective 
measure  and therefore it is difficult to accurately objectively evaluate the value of the 
sessions (Parsell and Bligh, 1999). A further issue is that such surveys may be self-fulfilling 
as students are told that interprofessional practice is positive and beneficial to their 
development. This results in an overwhelming number of such evaluations  demonstrating 
students have  positive opinions of the IPE session in which they have taken part (Rosenfield 
et al., 2011; Abu-Rish et al., 2012; Lapkin et al., 2013; Carpenter and Dickinson, 2014) with 
few studies showing students have a negative opinion of IPE sessions (Thistlethwaite, 
2012). 
 
However, although there are a number of drawbacks to such evaluations, when used 
judiciously and in a mixed methods approach they can be useful in identifying areas of 
improvement needed for the sessions themselves, an approach that was evident across a 
small number of sessions described in this study (questionnaire evaluations and 
interviews). In addition, as IPE is a relatively expensive form of teaching due to its 
interactive nature, the relatively higher student:staff ratio and practical resource 
implications (Abu-Rish et al., 2012), sustained funding and indeed staff engagement is 
essential but often problematic (Freeth et al., 2008). By assessing or evaluating sessions and 
demonstrating sustainability can be ensured.   
 
In addition to RIPLS, a variety of others tools are available including The Interdisciplinary 
Education Perception (IEPS) and The Interprofessional Attitudes Questionnaire (Freeth et 
al., 2005), as well as newer instruments which are grounded in theoretical frameworks to 
measure different aspects of interprofessional competencies (Mahler et al., 2015). These 
include the Interprofessional Education Collaborative Competency Self-Assessment Tool, 
Performance Assessment Communication and Teamwork Tools Set (PACT) and 
Communication Assessment Tool- Team (CAT-T), to name but a few. Indeed, nearly fifty 
evaluation methods are listed on the website of the US National Centre for Interprofessional 
Practice and Education - https://nexusipe.org/measurement-instruments. Of note, with the 
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exception of the RIPLS tool, no schools indicated the use of any other evaluation tool.  The 
inadequacies of the tools employed to evaluate IPE sessions described in this study are in 
agreement with a number of reviews of IPE which have highlighted the need for further 
rigorous mixed method studies to provide greater clarity on the impact of IPE on 
professional practice and patient care (Zwarenstein et al., 1999; Zwarenstein et al., 2005; 
Reeves et al., 2010c; Thistlethwaite and Moran, 2010; Abu-Rish et al., 2012). 
3.4.1. Limitations 
Total population sampling was used to map the landscape of UK schools of pharmacy, and 
although a response rate of 58.6% was achieved, a greater response rate would have been 
beneficial in aiding the generalisabilty of the data (Babbie, 2015d). Indeed, the schools that 
did not respond may have taken novel approaches to IPE that are not present in other 
schools. Furthermore, given the study relied on responses from educators within the 
schools who had specific responsibility for, or interest in, IPE there may have been some 
bias in the responses received as educators may have felt compelled to positively reflect 
their schools IPE strategy. This may have contributed to the feelings of one educator who 
expressed that they would not participate due to the ‘sensitive nature’ of the information 
and may explain why other schools did not participate. Additionally, the competitive nature 
of higher education may have left educators feeling unwilling to share information with 
other schools.  
 
Although the questionnaire was designed to gather required data but be a reasonable length 
to aid participation, as some schools provided information on a large number of sessions 
this resulted in the questionnaire being more time-consuming for some than expected. This 
may have impacted on the nature of their responses which were observed to be brief in 
places, an issue that may also have been compounded by the Google Docs platform which 
required respondents to complete the questionnaire in one go as it contained no save 
function. However, whilst this additional information may have been of interest it is unlikely 
that the further information would have significantly impacted on the conclusions drawn 
from this study.  
 
Retrospectively, an interesting addition to this questionnaire would have been to explore 
the educational theories and strategies that underpinned educators design of IPE (if there 
were any), as this would have helped add to an area of IPE literature that currently lacking 
(Reeves and Hean, 2013). 
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3.5. Conclusion 
This study has explored the landscape of IPE undertaken across UK schools of pharmacy 
(17/29 schools participated) and identified clear variation in all aspects of IPE including: (i) 
the number of sessions conducted by each school (ranging from 1 to 20); (ii) the MPharm 
year group undertaking sessions (relatively evenly spread across all four years); (iii) the 
range of student groups involved in each session (26 different student groups involved 
across the 88 sessions described); (iv) the number of student groups involved in each 
session (ranging from 1 to 11 student groups alongside pharmacy students in a single 
session); (v) the environment in which the sessions took place; (vi) the theme/topic of each 
session; (vii) the learning outcomes for the sessions; (viii) the method (if any) of assessing 
outcomes; (ix) the method (if any) of evaluation outcomes. Whilst the IPE delivered clearly 
varied, there were also some commonalities that were identified across sessions. 
Undertaking sessions alongside one other HCP was most common, with medical students 
taking part in three-quarters of the 88 sessions detailed. The majority of schools delivered 
sessions across all four MPharm years and in the main utilised workshop rooms over 
practice-based and simulation sessions. The learning outcomes educators set for students 
to achieve most frequently focused on the development of interprofessional teamworking 
and communication competencies, however students were rarely assessed on these 
outcomes likely due to the challenge in doing so.  
 
This study has ultimately provided a greater understanding of the current undergraduate 
pharmacy IPE provision in UK MPharm programmes and may help guide pharmacy 
educators to recognise the similarities and differences in their IPE delivery and prompt 
them to reflect on their IPE provision. Whilst certain IPE approaches were favoured by 
educators, it was not possible to ascertain if they are reflective of modern pharmacy 
interprofessional practice and thus of optimal value to students. Therefore, in order to 
further develop effective and relevant IPE it is important to understand pharmacists’ 
interprofessional engagement in the workplace such that meaningful IPE can be developed 
that is authentic to contemporary practice.  
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4.1. Methodology 
As discussed in chapter 2, there has been a significant drive across healthcare sectors to 
integrate HCPs in interprofessional teams in order to provide more efficient and holistic 
patient care (Department of Health, 2010; World Health Organisation, 2010). Pharmacists 
represent the third largest health professional workforce in the UK (General 
Pharmaceutical Council, 2018d) and in recent years there has been a desire to further utilise 
their skills and knowledge resulting in an expansion of the pharmacist role (Royal 
Pharmaceutical Society, 2015). Despite the expansion of the role, there is a concern that in 
the main the profession continues to practice in silos (Ray, 1998; Department of Health, 
2010; Royal Pharmaceutical Society and Royal College of General Practitioners, 2011; 
Primary Care Workforce Commission, 2015). Given the paucity of literature examining 
interprofessional engagements that pharmacists undertake in practice this concern may be 
perceived rather than real. It is therefore important to understand the nature and extent of 
interprofessional practice as well as any facilitators and barriers to such practice in order 
to further advance and support pharmacists’ interprofessional working. This chapter 
therefore discusses the general methodological approach and sets out the general methods 
used to identify the frequency and nature of interprofessional interactions pharmacists 
undertake in pursuit of their professional practice (see section 4.2 and beyond). Whilst this 
chapter details the general mixed methods approach used throughout the studies presented 
in Chapters 5 and 6, the specific nuances and practicalities in conducting the questionnaires 
and interviews in the community and hospital settings are further described within the 
relevant chapter. 
4.1.1. Methodology development 
When conducting research it is important that the research question guides the 
methodological approach (Corbin and Strauss, 2008). The researcher identifies themself as 
a pragmatist (see section 4.1.2 for more details) and therefore priority was given to 
gathering meaningful and relevant data which was applicable to answering the research 
question through whichever methodological approach was most relevant (Johnson and 
Onwuegbuzie, 2004). As the aim of this study was to determine and explore the 
interprofessional interactions (IPIs) taking place between pharmacists and other HCPs, a 
mixed methods approach was best suited to obtain useful data for this complex topic. A 
mixed methods approach refers to one which collects and analyses both quantitative and 
qualitative data to address the aim of the study (Tashakkori and Teddlie, 2010). This 
approach was chosen for this study in order to utilise the varying strengths of the two (often 
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opposing) research methods and reduce the limitations and restrictions of undertaking a 
qualitative or quantitative approach alone (Johnson and Onwuegbuzie, 2004).  
 
This mixed methods study was conducted in a sequential manner – questionnaire followed 
by semi-structured interviews. This allowed the data to be collected iteratively, and findings 
from the quantitative questionnaire were used to inform the qualitative interviews. This  
allows for a more focused and in-depth exploration of the subject (Driscoll et al., 2007). The 
two-step approach commenced with a self-complete questionnaire that was administered 
to large numbers of pharmacists to determine precise, numerical, generalisable data related 
to respondents’ reported frequency of interaction with healthcare team members (HCTMs 
– comprising of HCPs and other staff within the healthcare team). This was then 
supplemented by qualitative, face-to-face, semi-structured interviews with pharmacists to 
explore these complex interactions in more detail, including how and why interprofessional 
interactions occur, thus giving context and meaning to the quantitative data. Using a 
sequential method helped to better select interview participants who could provide further 
information related to particular areas of interest identified through questionnaires. This 
approach also helped to make findings representative of the pharmacist population 
(Creswell and Creswell, 2017) and meant that data could be triangulated (Babbie, 2015b). 
The study was conducted in Wales in the two largest pharmacy practice settings, namely 
community and hospital pharmacy (see chapters 5 and 6 respectively)(General 
Pharmaceutical Council, 2018b). Figure 4.1 provides a general overview of the study design 
and methods used. 
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Figure 4.1. Study design overview for mixed method exploration of pharmacists’ interprofessional interactions in practice 
STEP 1 
Literature search conducted identifying 
research gaps relating to the understanding and 
exploration of the interprofessional 
interactions undertaken by pharmacists in 
professional practice 
STEP 2 
Questionnaire used to determine the frequency 
of interactions between pharmacists and other 
HCTMs in the two largest pharmacy practice 
areas - community and hospital pharmacy 
STEP 3 
Interviews conducted to further explore 
pharmacists’ interprofessional interactions in 
the community and hospital pharmacy practice 
environments 
Questionnaire sent to all 716 
community pharmacies in 
Wales  
Questionnaire sent to all 
hospital pharmacists in 
Wales (approximately 520 
across 19 hospitals) 
Quantitative data analysed using SPSS descriptive 
analysis, with data comparisons made using chi-
squared. Qualitative comments analysed using 
inductive thematic analysis 
Interviews conducted with 
community pharmacists 
from a range of pharmacies 
across Wales 
Interviews conducted with 
hospital pharmacists 
across four Welsh health 
boards 
Deductive thematic analysis was used to 
ascertain predetermined interaction factors 
such as frequency and method. Inductive 
thematic analysis was used to determine 
common themes across the data 
Questionnaire data 
helped inform 
interview schedule 
development Purposive 
sampling used 
to achieve 
participation of 
a cross section 
of pharmacists 
in Wales 
Purposive, 
snowball 
sampling used 
to achieve 
representation 
from a range of 
pharmacists in 
Wales 
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4.1.2. Epistemological and ontological view 
Reflexivity is the notion of being sensitive to the ways the research has been conducted as 
well as the researcher’s own assumptions and experience that may impact on the research 
process (Mays and Pope, 2000). Although the generic qualitative research approach relies 
less on any particular philosophical underpinnings, having an awareness and recognition 
for my own ontology (whether there is an objective reality) and epistemological views (how 
this reality is perceived) is crucial and is shared here for clarity (Caelli et al., 2003).  
 
My own view is that of a pragmatist. This is a philosophy of science which focuses on the 
empirical problems at hand, taking each in turn, resulting in a somewhat flexible social 
ontology (Frankel Pratt, 2016). The pragmatist view is contradictory to the way ontology is 
generally defined, with many researchers categorising themselves as based on their belief 
as to whether there is an objective reality. Bauer and Brighi (2002) believe that pragmatism 
looks “beyond the epistemological stalemate opposing positivism and post-positivism, 
pragmatism invokes a methodological pluralism and disciplinary tolerance [and] 
encourages a multi-perspectival style of inquiry that privileges practice and benefits from 
the complementarity, rather than opposition”. Frankel Pratt (2016) also argues that the 
pragmatist stance is considered as both an epistemological and ontological view as it 
dissolves the specificity and rigidity across the two opposing ontological views, promoting 
flexibility and the belief that embracing and utilising these views can help foster valuable 
and tailored research. This means that, as a pragmatist, my focus is much more on the 
outcomes of research and the use of the most applicable method to achieve these (Johnson 
and Onwuegbuzie, 2004), thus prompting the application of mixed methods which could 
fulfill the aims of determining and exploring the interactions taking place between 
pharmacists and other HCTMs.  
4.1.3. Reflection on previous experience in the area  
Although social researchers aim to be objective when undertaking studies, this can be a 
challenge, particularly as it is not only the researcher’s philosophical views but their own 
past experiences that can also have an impact on the research (Babbie, 2015b). Therefore, 
it is important to acknowledge my own experience and recognise how this might impact the 
study (Caelli et al., 2003). 
 
As these studies focus on community and hospital pharmacists and their experiences, as a 
practising pharmacist with experience in both environments I too have perceptions of the 
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interactions taking place within these areas. Therefore, whilst consciously aiming to remain 
objective and impartial, my subconscious preconceptions may have unintended impact on 
the generation of questions and the development of inductive themes within the data. In 
contrast, my experience may also have a positive impact on the research, as my 
understanding of the area may allow more in-depth determination of themes. My role as a 
pharmacist may also put the participants at ease when undertaking the interviews as I may 
be viewed as a peer rather than simply a probing researcher. I therefore ensured that I 
introduced myself and my professional background before conducting each interview. 
4.2. Study methods 
4.2.1. Study location 
The study was conducted in Wales in the two largest pharmacy practice settings, namely 
community and hospital pharmacy (see chapters 5 and 6 respectively)(General 
Pharmaceutical Council, 2018b). Although the expansion of roles has also seen the 
incorporation of pharmacists into other practice areas particularly GP practices (Primary 
Care Workforce Commission, 2015), due to the recent introduction of these roles combined 
with the relatively small numbers of pharmacists operating in such settings, at least 
comparatively to hospital and community, these ancillary settings were excluded from the 
study.  
 
The research conducted within this thesis was undertaken within Cardiff School of 
Pharmacy and Pharmaceutical Sciences (CSPPS), the only school currently delivering the 
MPharm degree within Wales. The interprofessional interactions of pharmacists within 
Wales was therefore of particular interest and hence all the questionnaire respondents and 
interview participants practiced pharmacy within Wales (see Figure 4.1).  
 
Across the UK the NHS is devolved and managed by each of the four independent countries: 
NHS England, NHS Wales, NHS Scotland and the affiliated Health and Social Care (HSC) in 
Northern Ireland. This project focuses primarily on NHS Wales, therefore where there are 
specific nuances, for example surrounding the role of the pharmacist and other HCPs and 
the delivery of specific pharmacy services, these are directly associated with the Welsh 
healthcare system. Where applicable similarities and/or differences between healthcare 
delivery across countries have been noted. However the variations between NHS nations 
have been noted, as the GPhC regulates all pharmacists across the UK the same minimum 
standards must be met and therefore much of this research is applicable and relevant for 
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pharmacists across the UK and potentially further afield. The structure of the NHS in Wales 
altered dramatically in 2009 by creating 7 distinct Welsh Local Health Boards (LHBs), 
namely Aneurin Bevan Health Board; Abertawe Bro Morgannwg University Health Board: 
Betsi Cadwaladr University Health Board; Cardiff & Vale University Health Board; Cwm Taf 
Health Board; Hywel Dda Health Board; and Powys Teaching Health Board. There are also 
three additional trusts within Wales: Velindre NHS trust, Welsh Ambulance Service and 
Public Health Wales. As the Welsh Ambulance Service and Public Health Wales did not 
directly provide dedicated in-house pharmacy services they were excluded from the study. 
Conversely, as Velindre (a specialist cancer trust) provided dedicated in-house pharmacy 
services within their hospital, pharmacists here were included within the study.  See NHS 
Wales (2018b) for further details surrounding the Welsh NHS structure.  
4.2.2. Ethical considerations 
Ethical approval for the questionnaire and interview studies was obtained from CSPPS 
Research Ethics Committee (see Appendix B).  
 
In addition to University level approval, ethical approval was also sought from the Research 
and Development Committees within each LHB for both the questionnaire (all LHBs 
approved) and interviews (five of six applicable LHBs approved) to be conducted with 
hospital pharmacists. Further ethical approval was granted for both study stages 
(questionnaire and interviews) to be conducted with pharmacists working within Velindre 
University NHS Trust. 
 
Further approval was required and granted from Boots Research Governance Department 
to allow for distribution of the questionnaires and follow up interviews to be conducted 
with community pharmacists working within Boots UK stores in Wales. 
 
Throughout the study, participants were assured of the confidentiality of their responses. 
This meant that personal and identifiable information provided by individuals was not 
discussed with others and the results presented throughout chapters 5 and 6 ensure that 
no individuals can be identified (Wiles et al., 2008). This was chiefly achieved through the 
anonymity of questionnaire participants and the anonymisation of interviews. 
Confidentiality was maintained by keeping any specific details or information which may 
identify participants in either locked cabinets or on password protected computers. This 
information was then deleted or destroyed once the study was completed.   
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4.3. Questionnaire methods 
The first stage of this mixed methods study sought to quantify the perceived frequency of 
interactions (defined as any activity that involves direct engagement/communication with 
another person irrespective of the topic, frequency or nature (i.e. collaboration/teamwork), 
stated as ‘direct personal interactions (either face-to-face, by phone or by email)’ within the 
questionnaire)  between community pharmacists and other HCTMs (comprising of HCPs 
and other staff within the healthcare team) through a self-complete questionnaire which 
was administered to all community pharmacies in Wales. The questionnaire was designed 
to be predominantly quantitative in order to determine precise, numerical and largely 
generalisable frequency data related to pharmacists interprofessional interactions whilst 
remaining relatively quick and easy for the respondent to complete (Johnson and 
Onwuegbuzie, 2004). This method was chosen in order to gain a good understanding of the 
extent of interprofessional interactions taking place which could then help inform 
purposive interviewee selection to enable deeper exploration of findings and gain the most 
valuable data possible (Creswell and Creswell, 2017).    
4.3.1. Sampling 
To ensure that the data collected was representative, purposive sampling was used when 
administering both community and hospital questionnaires (Babbie, 2015c). Purposive 
sampling is a form of non-probability sampling which was used in order to identify 
participants within a specific demography (Teddlie and Yu, 2007). The study purposively 
aimed to achieve participation from a cross section of pharmacists in Wales. This was 
achieved through dissemination to all  community pharmacies (n=716) and hospitals 
containing dedicated in-house pharmacy departments (approximately 520 pharmacists 
spread across 19 different hospitals) working in Wales at the time of the study, which 
helped achieve a large representation of pharmacists aiding the generalisibility of results 
(Babbie, 2015c).  
4.3.2. Inclusion/exclusion criteria 
Although purposive, total population sampling was used to reach all community pharmacies 
and hospital pharmacies/departments across Wales, the cover letter also made it clear that 
all respondents needed to be qualified pharmacists working within the 
pharmacy/department for at least two days a week (see Appendix F). This was to ensure 
that the responding pharmacist had a good understanding of the IPIs occurring within that 
specific community pharmacy or hospital.  
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4.3.3. Questionnaire design 
One of the main aims of this mixed method study was to determine the frequency of IPIs 
pharmacists undertake in practice. Therefore, this predominantly quantitative 
questionnaire was created to directly answer this question and was developed from a 
mixture of prior experience and knowledge of the pharmacy profession by the researcher 
(see section 4.3.3) in addition to having a thorough understanding of the pharmacy and 
interprofessional literature available (see chapter 2 for details of the literature reviewed 
and utilised) and by iteratively amending the questionnaire following pilots (see section 
4.4.5).   
 
The questionnaire (see Appendix E or M) was separated into three sections that were 
designed to facilitate ease of completion through the use of predominantly quantitative 
‘closed’ questions (Kumar 2014). The questionnaire was also designed to be short whilst 
still gathering the desired data and was printed on blue coloured paper to help increase 
response rate (Edwards et al., 2009).  
 
Demographic information for each respondent was gathered in section A. This was tailored 
to the nature of the care setting (community vs hospital), with the primary focus to find out 
the regular ‘position’ of the participating pharmacist (e.g. their managerial/ownership role 
in community or their specific speciality/banding within hospital), the environment in 
which they predominantly operated (e.g. ward, office etc.) and the services they provided.   
 
Section B contained a non-exhaustive table listing common healthcare professionals and 
team members (jointly referred to as HCTMs throughout this thesis) from community, 
primary and secondary care settings. As there is no previous research citing the frequency 
and range of HCPs pharmacists work with in practice a list of possible professions was 
created from professions listed on the NHS careers website (NHS Health Education England, 
2015). Wider members of the healthcare team such as dispensers in the pharmacy and 
receptionists in the GP practice were also included for completeness in determining 
pharmacists’ overall interactions. As the list was not exhaustive a free-text box was included 
for respondents to note the frequency of interaction with any other professions not listed. 
The perceived frequency of interactions could be described on a six-point ordinal scale: at 
least once a day, at least once a week, at least once a month, at least once a year, less 
frequently, never. This scale allowed the respondent to indicate the frequency with which 
they perceived they had ‘direct personal interaction’ with HCTMs, which was defined for 
respondents to include face-to-face discussions, telephone exchanges, or email 
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communication. Ordinal scales such as this have been used widely and effectively 
throughout psychological and educational research and was chosen as this provided a 
pragmatic way to achieve desired results (Stevens, 1946).  
 
Section C of the questionnaire allowed respondents to provide any other comments they 
wished to make regarding their own IPIs.  
4.3.4. Consent 
Consent for participation was implied when the pharmacist completed and returned the 
questionnaire.  
4.3.5. Piloting questionnaires 
The community pharmacist questionnaire was initially piloted with six practising 
pharmacists prior to wider dissemination. During the pilot each participant completed the 
questionnaire and gave verbal feedback regarding any issues related to content and face 
validity (Babbie, 2015d). As a result of the pilot, a number of minor refinements were made 
to the questionnaire including the wording and structure of demographic (section A) 
questions (i.e. suggestions for the range of the number of GP practices community 
pharmacists regularly work with) and the clarity of each HCTM listed in section B (i.e. the 
term Healthcare Assistant added to the Medicines Counter Assistant to aid the general 
understanding of this role). The hospital pharmacist questionnaire was similarly piloted (n 
= 3) and again a number of refinements to the questionnaire were made based on the 
feedback around the wording and structure of the demographic questions (i.e. the 
specialties listed for hospital pharmacists expanded).  
4.3.6. Reliability and validity  
In order to enhance the accuracy of the questionnaire it was important that it was both 
reliable and valid. (Golafshani, 2003). The validity (i.e. the extent to which the questionnaire 
measured the frequency of interactions) is closely associated with reliability (i.e. the ability 
of the questionnaire to measure the frequency of interactions consistently), and a 
questionnaire cannot be valid unless it is reliable. The reliability of each questionnaire was 
therefore objectively measured by determining Cronbach’s alpha in IBM SPSS statistics data 
editor version 20 (SPSS)(Tavakol and Dennick, 2011). Here, the expected correlation of 
the data sets against one with perfect reliability was compared (Riffenburgh, 2012). The 
values determined range between 0 and 1, with values closer to 1 showing higher levels of 
internal consistency (Tavakol and Dennick, 2011). With a Cronbach’s alpha value calculated 
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as 0.880 for the hospital questionnaire and 0.859 found for the community questionnaire 
he questionnaire demonstrated high levels of reliability particularly as values of 0.7 and 
above are generally accepted as appropriately reliable (Bland and Altman, 1997).   
4.3.7. Questionnaire dissemination 
In order for results to be generalisable a high response rate was needed. Paper copies of 
each questionnaire were therefore disseminated as studies have found increased response 
rates when compared to web-based questionnaires (Bälter et al., 2005; Babbie, 2015d). 
Respondents were provided with information and instructions regarding the study in two 
forms. An introduction page preceded the questionnaire detailing how the questionnaire 
should be completed, specifying that all answers provided should be based on the 
pharmacists’ own experiences. A cover letter was also provided that explained the study, 
including study aims and a reassurance of confidentiality when submitting responses 
(Kumar, 2014). The manner in which questionnaires were disseminated was distinct to the 
community and hospital pharmacy sectors; further details can be found respectively in 
chapters 5 and 6. Each questionnaire was uniquely coded so that responses could be 
monitored, and an overall response rate could be calculated as well as to identify non-
respondents such that reminders could be targeted. 
4.3.8. Data handling 
Data from returned questionnaires was input into SPSS for statistical analysis and a 10% 
data check was completed to validate data input (Babbie, 2015d). If no response was made 
to a particular question then a separate ‘missing’ code (‘99’) was used to indicate this. In 
addition, if certain questions had multiple responses then a separate code was given for 
each response.  
 
The frequency of interaction the pharmacist had with different healthcare professionals 
was coded ranging from ‘1’ for ‘at least once daily’ up to a code of ‘6’ for ‘never’. If 
respondents gave no response for a number of HCTMs and did not select ‘never’ for any 
other HCTMs then it was assumed that no interactions occurred and a code of ‘6’ was used 
to indicate the interaction ‘never’ occurred. If the response was unclear or multiple 
frequencies were provided for an individual HCTM then this data was classed as ‘missing’ 
and given a code of ‘99’. Respondents’ qualitative written comments provided in the free-
text ‘other’ boxes or in section C of the questionnaire were input verbatim into Microsoft 
Word 2011 version 14.4.9 (MS Word). The questionnaire code and question number were 
noted next to each comment for qualitative analysis. 
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4.3.9. Data analysis 
Analysis was conducted by two separate methods dependent on the nature of the data.  
4.3.9.1. Quantitative analysis 
Descriptive statistics for the pharmacists’ frequency of interaction with each HCTM and the 
demographic data associated with respondents were generated in SPSS. As the scale used 
was ordinal and therefore non-parametric (data does not fit normal distribution) it was 
important to select and use the appropriate statistical tests and thus exclude tests such as 
median and percentile (Stevens, 1946). One statistical analysis method that was 
appropriate for this data set was Pearson’s chi-squared statistical test (also referred to as 
goodness of fit). This test was chosen as it could compare the distribution of a large sample 
of ordinal frequency data (i.e. the shape of the data) for each profession with each nominal 
population group (i.e. physical location of pharmacists)(Clegg, 2001). The test was used to 
identify the respondents’ demographic traits (i.e. physical location, services provided, etc.) 
that significantly (p values set at p < 0.05) impacted their frequency of interactions with 
other HCTMs when compared with their other pharmacist colleagues. Whilst the statistical 
test identified significant differences between data it does not determine where the 
statistical differences lie and therefore visual comparisons were conducted to understand 
the nature of these differences (Riffenburgh, 2012). Visual comparisons involved a manual 
visual check of the spread of the frequency data for one demographic trait in comparison to 
others when significant differences were seen. This was conducted by the PhD researcher 
and subsequently confirmed by research team. In order to conduct the chi-squared analysis 
the data had to satisfy a number of criteria including less than 25% of cells required an 
expected cell count less than five, and the minimum expected cell count had to be greater 
than one. These parameters ensured that there was enough spread of data across the cells 
to make the test valid (Hinton, 2014). In a small number of cases, in order to fulfill these 
requirements frequency categories were combined. This primarily occurred when no 
participants reported interactions at the ends of the scale i.e. at least once a day or never 
(results in chapters 5 and 6 show the occasions where categories were combined).  
4.3.9.2. Qualitative analysis 
Section C enabled respondents to provide additional comments relating to their IPIs. These 
comments were analysed using deductive thematic analysis to identify any comments 
which reflected the frequency of interaction they had with other HCTMs (Braun and Clarke, 
2006).  
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4.4. Semi-structured interview methods 
Informed by results from stage one (the questionnaire), semi-structured face-to-face 
interviews were sequentially conducted with pharmacists to elucidate the nature of IPIs 
with healthcare professionals (HCPs) and determine the value they place on IPE. This stage 
helped enable triangulation of the research, allowing findings from the questionnaire and 
other areas of interest be further explored (Babbie, 2015b). 
4.4.1. Qualitative research design 
Qualitative research is a valuable tool which can be used to understand the dynamic, 
evolving nature of complex professional relationships (Corbin and Strauss, 2008). The use 
of qualitative research allows more in depth exploration and description of a participant’s 
experiences or beliefs compared to quantitative methods (Babbie, 2015b). 
 
Within pharmacy practice, qualitative research is used with increasing regularity to 
understand complex social, educational and patient orientated problems (Smith, 1998) as 
it helps explore experiences, behaviors, emotions and gathers the participants’ perspectives 
(Auta et al., 2017). There are a large range of qualitative methodologies and approaches 
including narrative, phenomenological, grounded theory, ethnographical and case study 
amongst others which require the researcher to hold or assume a specific philosophical 
(Creswell and Poth, 2017). However, whilst these approaches are frequently used within 
healthcare and pharmacy practice research, this could potentially be because researchers 
feel obligated to use a specific methodological approach, with the hope that this will validate 
and provide a structure to their research process (Denzin and Lincoln, 2008). However, 
Auta et al. (2017) make the case that due to the limitations of these methodologies, such as 
the rigidity in the philosophical and analytical process which may not suit all researchers 
and data sets, the use of a ‘generic qualitative’ research approach is of value. This approach 
seeks to ‘discover and understand a phenomenon, a process, or the perspectives and world 
views of the people involved’ (Merriam, 1998) rather than place significant emphasis on the 
philosophical underpinnings (Caelli et al., 2003). This approach has often been used when 
researchers have been unable to find a methodological approach which suits their study, 
prioritising the research aim over the philosophical stance, with a desire to accurately 
represent participants’ views (Cooper and Endacott, 2007).  
 
After reviewing a range of methodologies, the researcher concluded that a generic 
qualitative research approach would be most suited in order to address the research aim of 
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exploring and understanding pharmacists’ IPIs in practice.  The specific methodological 
approach for the interview design and analysis are therefore discussed below.  
 
Although this generic qualitative approach has less reliance on any prescribed philosophical 
underpinnings, Caelli et al. (2003) believe that it is important to recognise the researcher’s 
philosophical views and personal experience in order to be reflexive throughout the study 
and reduce potential bias (Mays and Pope, 2000); these considerations are highlighted in 
sections 4.3.2 and 4.3.3. In addition, Caelli et al. (2003) also suggests that a clear explanation 
of the specific methods used, and the rigor with which they are conducted, is essential in 
generic qualitative research in order to achieve research clarity and these have therefore 
been described in this methods section.  
4.4.2. Overall qualitative approach 
In order to conduct this research a series of semi-structured qualitative interviews were 
used to explore pharmacists’ interprofessional experiences with HCPs. As the interviews 
followed the questionnaire phase of the study, this allowed for triangulation of data, 
enabling the interview to be more focused and explore areas of interest such as the HCPs 
pharmacists most frequently interacted with (identified through questionnaires)(Babbie, 
2015b). The participants’ method of communication, nature and content of IPIs, facilitators 
and barriers to IPIs, past experiences and views of IPE, and topics (if any) they learnt from 
other HCPs were all explored.  
4.4.3. Sampling 
As discussed in section 4.2.1, purposive sampling is a form of non-probability sampling 
which is used to identify participants within a specific demography (Teddlie and Yu, 2007). 
This sampling method was therefore used for interviews as it enabled careful selection of 
participants where further exploration and data triangulation was desired (e.g. those 
working in community pharmacies in certain locations or with a particular role or positions 
within the hospital). This method enables a greater depth of information to be gathered 
from a smaller number of cases in comparison to probability sampling (Teddlie and Yu, 
2007). Snowball sampling was also used when needed, with participants recommending 
other possible interviewees that fit the desired participant inclusion criteria (King and 
Horrocks, 2010a; Babbie, 2015c). At the end of the study, the objective was to have 
representation from a minimum of one participating pharmacist in each of the different 
demographic characteristics (see chapters 5 and 6 for specific sampling frameworks) in 
order for the data to reflect the overall pharmacist population in Wales (Mays and Pope, 
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2000; Creswell and Creswell, 2017). It must also be stated that for the purposes of the study, 
whilst the interviews sought to expand on the findings of the questionnaire phase of the 
research, prior completion of the questionnaire was not a prerequisite for taking part in the 
interviews. This allowed for a larger sampling range and encouraged involvement of those 
who may have been previously disengaged. Participants were provided with the same pre-
interview information irrespective of whether they had participated in the questionnaire 
study.  
 
A definitive sample size was difficult to state before conducting the study as the aim of 
recruitment was to include participants (from a range of demographic backgrounds) until 
there was a strong repetition of data and themes and the aims of the study had been 
achieved (Corbin and Strauss, 2008; Malterud et al., 2015). Although methodologies such as 
grounded theory employ the notion of ‘theoretical saturation’ (where sampling is continued 
until no new insights are obtained, no new themes identified and no issues are found related 
to a category of data (Corbin and Strauss, 2008)) researchers have argued that this is 
challenging to achieve and is not appropriate for all studies, particularly those of an 
exploratory nature as is the case here (O’Reilly and Parker, 2013; Morse, 2015). One concept 
recently adopted by qualitative researchers is ‘information power’. This is a form of internal 
validity that determines the potential of available data to provide access to new knowledge 
by assessing factors such as the sample adequacy, data quality and variability of participants 
rather than just focusing on the sample size (Malterud et al., 2015). As the interviews 
explored the personal nature of individuals’ interprofessional experiences, by gathering 
rich data from pharmacists with a range of experiences and demographic characteristics 
across Wales, recruitment continued until it was judged that the sample size was sufficiently 
large and varied that the researcher could be confident that the sample had accurately 
achieved the aims of the study i.e. to elucidate the nature of IPIs with healthcare team 
members and determine the value they place on IPE. To achieve a high level of information 
power a constant comparison technique was utilised during the inductive thematic data 
analysis process (see section 4.3.13.2)(King and Horrocks, 2010a) which enabled 
continuous reflection of the data so that it could be identified when high quality dialogue 
was being gathered, strong repetition of data and themes were occurring, there was little or 
no generation of new data or themes in later interviews and the aims of the study had been 
achieved (Bowen, 2008; Malterud et al., 2015).  
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4.4.4. Arranging the interviews 
The scheduling of interviews was undertaken to ensure that, where possible, there was a 
two-day interval between each interview (preferably longer) to allow for reflection on the 
interview schedule and refinement of questions and prompts where necessary. This helped 
to develop a schedule that was guided by participants’ experiences rather than just based 
on preconceived notions, making the data more relevant and accurate (King and Horrocks, 
2010a). Where this was not possible and multiple interviews had to be conducted on the 
same day, (i.e. when interviewing a number of participants within the same hospital) gaps 
of one hour between interviews were scheduled and a minimum of four days was left before 
conducting the next interviews to allow for reflection on the multiple interviews. 
 
During the recruitment process all participants received an information sheet (see 
Appendix 4.2), a cover letter (see Appendix 4.3), and a consent form (see Appendix 4.4). On 
reading these documents, if the pharmacist was happy to proceed a mutually convenient 
time for the interview was arranged (see chapters 5 and 6 for specificities on participant 
recruitment). 
4.4.5. Participant consent 
Prior to commencing the interviews, informed written consent was obtained from each 
participant (see Appendix 4.4). The completed consent forms confirmed the participant had 
read and understood the information sheet and that participation was voluntary. This also 
confirmed that participants were willing for interviews to be audio-recorded and that 
anonymised verbatim quotes could be used in publications.  
4.4.6. Interview setting 
Interviews were conducted face-to-face in the pharmacists’ workplace. Face-to-face 
interviews were chosen over telephone interviews as research by Irvine (2011) has 
suggested that telephone interviews are often shorter and less detailed than face-to-face 
interviews and can lead to a lack of rapport between interviewer and participant. 
Interviews were arranged to take place in a quiet space which was free from distractions to 
ensure that the flow of the interview was not interrupted and the recording was of a high 
quality (King and Horrocks, 2010a). Further details of the specific interview settings used 
for community and hospital pharmacists can be found in chapters 5 and 6. 
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4.4.7. Interview schedule for data collection 
The interview schedule was developed to explore the nature of pharmacists’ IPIs and the 
value they place on IPE, and specifically used findings from the questionnaire phase of the 
study, the limited research related to pharmacist interactions within the literature and 
personal background knowledge within the area of pharmacy to achieve this (see section 
4.3.3). In addition, by undertaking iterative reflection on the schedule after each interview, 
these factors helped to create a schedule that was predominantly guided by participants’ 
experiences, making the data more relevant and accurate (King and Horrocks, 2010a). 
 
A semi-structured interview schedule (see Appendix 4.5) was used to guide the interviews, 
enabling a range of topics to be covered whilst having the flexibility to explore other areas 
of interest where applicable (Kvale, 2007; King and Horrocks, 2010a). Before commencing 
the interviews the interview structure (including key interview topics) was described to 
participants to help aid their understanding  and make them feel more comfortable with the 
interview process (Kvale, 2007). This briefing included a description of the interview 
schedule which was split into four areas; section A - brief pharmacist information and 
opening questions, section B - reflective card exercise, section C - interprofessional 
experiences with HCPs, section D - Closing questions. 
 
The first part of the interview, section A, asked the pharmacists’ about their previous and 
current practice experience in order to contextualise participants’ responses during 
analysis (Patton, 1990).  This section also comprised a set of brief questions designed to 
‘ease’ the participant into the interview (Kvale, 2007) and to ensure the participant had a 
basic level of understanding of IPIs.  
 
Following these short questions, section B contained a reflective ‘ranking exercise’ that was 
used to help the participant to reflect upon their own interprofessional practice within their 
current role and help immerse the participant in the interview. In this exercise, cards 
labelled with relevant healthcare professionals identified from the NHS careers website 
(NHS Health Education England, 2015) were given to the participant and they were asked 
to rank their perceived level of interaction with these HCPs from ‘most frequent’ to the ‘least 
frequent’. Any professions that participants felt they didn’t interact with could be removed 
from the ranking exercise. As the aim of the interviews was to explore pharmacists’ IPIs, 
other ‘non-professional’ team members such as those based within the pharmacy (e.g. 
dispensers) and GP staff (e.g. receptionists) were not directly explored during the 
interviews, however participants were free to discuss these if and when relevant.   
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Following this ranking exercise, section C explored interprofessional experiences with the 
three professions pharmacists in general interact with most frequently as identified during 
the questionnaire phase of the study (this differed dependent on community/hospital 
setting – see chapters 5 and 6). In addition, if the interviewees identified other HCPs with 
which they personally interacted more frequently than the top three HCPs identified from 
the questionnaire data then these were also explored. Here a variety of questions were 
asked to elucidate their personal interprofessional experiences within the pharmacy they 
are currently working in including the method of communication (face-to-face, by phone, 
email etc.), the focus and content of the interaction and any facilitators and barriers to their 
IPIs. Participants were also given the opportunity to discuss any other professions they felt 
were relevant. 
 
The final part of the interview, section D, included more general questions surrounding 
interprofessional working. This included determining the participant’s experience of 
interprofessional education, what IPE, if any, the participant felt would be beneficial to 
support their practice, and their thoughts on the frequency of their own interprofessional 
working (i.e. whether more/less would be desired).  
 
During the interview where participants gave incomplete explanations or further 
elaboration was needed the interviewer would use probes to elicit more complete 
statements (Babbie, 2015d).  
 
The interviews were expected to last around 20 minutes in order to cover the topics 
required whilst also recognising the demands on the interviewees’ time in their work 
environment (Babbie, 2015d) (time was estimated based on pilot interviews, see section 
4.3.10). However, this timeframe was flexible enabling participants to continue beyond this 
estimated time if they so wished.  
4.4.8. Pilot interviews 
Once the interview schedule was designed (see section 4.3.9) three pilot interviews were 
completed in order to refine the interview schedule and ensure content validity (Turner III, 
2010). These pilot interviews were undertaken with practising pharmacists who provided 
valuable verbal feedback on both the structure of and questions within the interviews 
(Turner III, 2010). The pilot interviews helped identify flaws, limitations, omissions and any 
other ‘weaknesses’ within the interview design and afforded the opportunity to make 
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specific changes to the order of questions (so that the interview ‘flowed’ and was not 
disjointed) and wording (so that they were open and not leading) prior to commencing the 
study as well as identifying certain prompts which elucidated valuable and relevant 
information (Kvale, 2007). The pilot also helped identify the estimated duration of 
interviews, which led to the interview schedule becoming more focused as unnecessary 
questions could be cut so meaningful data could be gathered without rushing through 
interviews. Furthermore, conducting these pilots also helped familiarise the interviewer 
with the interview schedule which helped the interview flow more freely which helps make 
the participant feel more comfortable (Babbie, 2015d). Pilot interviews were recorded but 
were not included in the final data analysis as they were specifically used to develop the 
interview schedule and interviewer rather than gather data.  
4.4.9. Interview completion 
Interviews were audio recorded using a Phillips Digital Pocket Memo device and data files 
were stored on a password encoded laptop until transcription was complete. When 
conducting the interviews the interviewer was dressed similarly to the pharmacists (smart 
work clothing) to make both participant and interviewer feel more at ease during the 
interview whilst still retaining the respect of the participant (Babbie, 2015d). 
4.4.10. Interview transcription 
Interview recordings were transcribed ad verbatim from Phillips SpeechExec Version 1.1 
into MS Word. It was essential that responses were transcribed exactly as given in order to 
ensure coding was accurate and representative of the answers provided by the participant 
(which included the use of pauses and the use of field notes where relevant for 
contextualisation) therefore each transcription was checked for accuracy by listening to the 
recording while reading through the transcript (Babbie, 2015a).  
 
Where possible, full verbatim transcriptions were completed and shared with the research 
team before beginning the next interview. This allowed for continuous reflection  on the 
interview schedule, making the interview process more iterative and allowing alterations 
where applicable such as the addition of further questions and prompts related to areas of 
particular interest (King and Horrocks, 2010a).  
4.4.11. Data Analysis 
There are a number of methods that can be used to analyse qualitative data. In this study, 
the most applicable method was thematic analysis, which was conducted iteratively 
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throughout. Here two separate techniques were used to identify themes or patterns within 
the data; the theoretical or deductive ‘top down’ approach and the inductive ‘bottom up’ 
approach (Braun and Clarke, 2006). The deductive thematic approach was conducted first 
to identify specific, preconceived areas of interest. This was followed by inductive thematic 
analysis to determine any other themes discussed throughout the interviews. Both thematic 
analysis approaches were done manually by the PhD researcher (by printing codes, no 
software was used). 
4.4.11.1. Deductive thematic analysis 
Deductive thematic analysis is driven by the researcher’s preconceptions allowing detailed 
analysis of certain specific areas of interest (Braun and Clarke, 2006). Here, data was 
identified based on areas of interest such as the nature and content of IPIs, the method of 
interaction (e.g. face-to-face/over the phone) and the frequency of interaction. After 
familiarisation with the transcripts, each transcription was deductively analysed to 
determine participant responses to four main themes; (i) the number of times each 
healthcare profession(al) was mentioned, (ii) the frequency of interaction with each HCP, 
(iii) the reasons for HCP interactions, (iv) the method of communication. Here each 
transcript was manually read through to identify participants responses for each of the four 
themes. Analysis of data outside of these four themes was conducted via inductive thematic 
analysis.  
4.4.11.2. Inductive thematic analysis 
As the deductive approach limits analysis to areas of preconceived interest, inductive 
thematic analysis was used to generate themes that were strongly linked to the data (Patton, 
1990). Here, the coding of data was driven by the data itself enabling the development of 
data-specific themes (Braun and Clarke, 2006). However, as described in section 4.3.2 and 
4.3.3 it must be recognised that although this analysis was data driven, it is challenging to 
completely divorce oneself from previous preconceptions, theoretical and epistemological 
views. Therefore, even with measures taken to minimise the possibility of bias, some 
subconscious analytical bias may have taken place (Braun and Clarke, 2006).  
 
When completing the inductive thematic analysis the King and Horrocks (2010b) three 
stage approach was adopted: (i) descriptive coding (descriptive codes were written on each 
transcript and then reviewed when typing into a MS Word document), (ii) interpretive 
coding (the codes were printed and physically grouped into relevant sub-themes), (iii) 
overarching themes (the sub-themes were then further grouped to identify key themes by 
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physically moving the printed codes/sub-themes whilst ensuring the original meaning was 
not lost, spider diagrams were created to show how sub-themes were linked or not). See 
Table 4.1 for a more detailed description of the steps used within this approach. This 
process was augmented by the systematic use of constant comparison which compared the 
identified codes and categories with the rest of the data to establish more inclusive themes 
that directly reflected as many data nuances as possible (Pope et al., 2000). Although all 
thematic analysis was conducted by the PhD researcher the themes and sub-themes were 
reviewed by the supervisory team to ensure clarity. 
 
Table 4.1. Description of the three stage King and Horrocks (2010b) inductive thematic analysis 
approach used for interview analysis 
Stage one 
Descriptive coding 
This stage began with reading through the transcripts produced (see 
4.2.10) and data familiarisation. Relevant material which helped 
understand the participants views, experiences and perceptions were 
highlighted and brief notes were made that summarised these views. 
These brief notes were then reviewed and descriptive codes were 
created, ensuring they accurately represented the initial statement. 
This process was then repeated for all transcripts. 
Stage two 
Interpretive coding 
This stage helps interpret the data as a whole. Here the descriptive 
codes were grouped together where common meaning is shared and 
given an interpretive code or ‘sub-theme’. It was important that the 
transcripts were constantly referred back to in order to retain the 
context for each code and ensure the interviewer’s overall 
interpretation was correct. This process is known as respondent 
validation and was employed throughout the stages of the analysis to 
help reduce the likelihood of interpretation errors occurring (Mays 
and Pope, 2000). 
Stage three 
Overarching themes 
This was the final step which helped identify the overarching themes 
that characterise the key concepts drawn from the interviews. 
Although the stages one and two were driven by the data alone, this 
stage can draw directly on theoretical or practical stances which 
underline the study, as long as they were supported by the data (King 
and Horrocks, 2010b). Here spider diagrams were used to help 
understand the overall nature of the data and how the sub-themes and 
themes interlinked. 
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Chapter 5 – Which healthcare professionals do community 
pharmacists work with? 
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5.1. Introduction 
Community pharmacies represent a significant part of the primary care service within the 
UK, with NHS England (2013) reporting that 438 million visits are made to community 
pharmacies every year for health related problems; this is more visits compared to any 
other healthcare provider. Pharmacists are the third largest healthcare professional 
workforce in the UK, behind doctors and nurses, and community pharmacy (alongside 
hospital pharmacy) is the most common setting in which pharmacists practise (General 
Pharmaceutical Council, 2018d).  
 
Community pharmacists are commonly viewed as ‘generalists’ as they provide broad 
ranging pharmaceutical care. There are a number of definitions of pharmaceutical care but 
for the purposes here, can be defined as the responsible provision of drug therapy for the 
purpose of achieving definite outcomes that improve a patient’s quality of life on a daily 
basis, in those with a variety medical conditions (Wilson and Barber, 2013). In order to 
achieve this, there is a requirement for cooperation with the patient and HCPs, in designing, 
implementing and monitoring a therapeutic plan that will produce therapeutic outcomes 
for the patient and enables pharmacists to effectively manage long-term conditions(Wilson 
and Barber, 2013). In addition, a major element of the community pharmacist’s role has 
been the management of patients presenting in the pharmacy with care needs and the 
subsequent management of minor conditions that can be treated ‘over-the-counter’.  
 
It has been acknowledged that community pharmacists represent an underutilised 
healthcare resource (Mossialos et al., 2015; Primary Care Workforce Commission, 2015; 
Royal Pharmaceutical Society Wales, 2015). Primary care faces unprecedented challenges 
largely as a consequence of a growing population of older adults and constraints in the 
secondary care setting  (British Medical Association, 2014). The expanded use of 
community pharmacists to support the delivery of primary care services is seen as one 
mechanism to ameliorate such issues (Royal Pharmaceutical Society, 2016). Community 
pharmacists have extensive pharmaceutical and health related knowledge and are ideally 
located to offer ready access to patients.  For example, a higher proportion of the population 
of England live within a 20 minute walk of a community pharmacy (89.2%) compared with 
a GP practice (84.8%) (Todd et al., 2015). This allows for accessible and patient oriented 
care (Department of Health, 2013a).  
 
The UK government has had a long-standing interest in developing and exploiting 
community pharmacy starting as early as 1992 when a Joint Working Party on 
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pharmaceutical care was established alongside the Royal Pharmaceutical Society (Noyce, 
2007). However, whilst there has been a determination to utilise community pharmacy 
more effectively for a number of years it was not until the early 2000s when the NHS plan 
was published that this really gained traction. The plan specifically stated that “patients 
want to see all NHS staff used more effectively, with an expanded role for GPs and 
pharmacists” (pg. 135) (Department of Health, 2000). The plan indicated that pharmacists 
should be supported to provide greater clinical input into patient care through the delivery 
of pharmaceutical advice to both patients and other HCPs and that pharmacists should 
transition from the historic role of primarily dispensing prescriptions i.e. supply of 
medicines towards more patient facing clinical roles. However, over a decade later this 
ambition had not been realised as demonstrated in an observational study of community 
pharmacists’ roles across a working week in ten community pharmacies in London, 
England, in 2011 (Davies et al., 2014). Davies and colleagues found that the majority of 
pharmacists’ time was still spent on providing technical dispensing roles and not patient-
centred care.  
 
Subsequently a range of parties have undertaken further work to consolidate the principles 
articulated in the NHS plan (Welsh Assembly Government, 2011b; NHS England, 2013), in 
order to improve the provision of pharmaceutical care in the primary care setting, reduce 
NHS costs and help to secure the future of community pharmacy (Smith et al., 2013). In a 
‘call to action’ for community pharmacy, NHS England (2013) recognised that community 
pharmacists can and do play a  vital role in optimising patients’ medicines and providing an 
alternative care pathway to general practice, unscheduled and emergency care primarily by 
helping manage patients with long-term conditions and minor ailments. NHS England 
(2014b) vowed to support these activities through the development of electronic systems 
to improve pharmacists’ access to relevant and necessary patient information.  
 
To ensure that primary care services are delivered effectively and efficiently a number of 
bodies, including the Department of Health, believe that fostering an environment in which 
pharmacists work closely with GPs and other HCPs is essential (Department of Health, 
2013a; NHS England, 2014a; Bienkowska-Gibbs et al., 2015; Royal Pharmaceutical Society 
Wales, 2015). In addition, professional regulators including the Royal College of General 
Practitioners, the Royal College of Nursing and the Royal Pharmaceutical Society have 
directly expressed the need to develop interprofessional relationships across primary care 
to help optimise pharmaceutical care, reduce medication errors and improve the provision 
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of patient care (Centre for Workforce Intelligence, 2014; Royal College of General 
Practitioners, 2014; Bienkowska-Gibbs et al., 2015; Royal Pharmaceutical Society, 2016). 
 
This drive to further integrate HCPs coincides with recent WHO programmes and inquiries 
within NHS trusts (see chapter 2 for more detail) that have also recommended the need for 
improvements in interprofessional collaboration in order to deliver more efficient, patient-
centred care (World Health Organisation, 2010). Whilst some of those inquiries have 
primarily focused on secondary care (Andrews and Butler, 2014; Kirkup, 2015), reports 
such as the Mid Staffordshire review by Francis (2013) recognised the negative impact of 
poor communication across care sectors. Francis’ review specifically highlighted that 
effective patient care is reliant on the timely and accurate transfer of information both from 
one HCP to another and from one sector to another. In practice, Francis noted that HCPs 
rarely sought such guidance and information from other HCPs, which potentially leads to 
sub-optimal clinical decisions and patient outcomes.  
 
The Primary Care Workforce Commission (2015) also recognised and campaigned for 
greater use of community pharmacists. One area they particularly highlighted was the need 
to expand the provision of a wider range of interprofessionally integrated patient services 
featuring pharmacists, which they believed could ultimately reduce the strain on GPs and 
further integrate pharmacy into the primary care interprofessional team. The services 
provided through community pharmacies have expanded as a result. Beyond the Essential 
pharmacy services that must be provided by an NHS contracted pharmacy such as 
dispensing, repeat dispensing, disposal of unwanted medicines, promotion of healthy 
lifestyles and support for self-care (Welsh Assembly Government, 2017a), there has been 
the introduction of Advanced services and Enhanced services that can serve promote 
interprofessional integration. Advanced services are services which community pharmacies 
can choose to provide subject to meeting criteria; these services vary between England and 
Wales. The services provided in Wales include: (i) medicine use reviews (MURs) – a review 
of patients’ medications (introduced in 2006); (ii) discharge medication reviews (DMRs) – 
management of medicines following the discharge of a patient from a care setting 
(introduced in 2011) (Hodson et al., 2014; Community Pharmacy Wales, 2017; Welsh 
Assembly Government, 2017a). Much like the Advanced services it is believed that the 
Enhanced services require community pharmacists to interact with other HCPs in order to 
ensure the continuity of care of patients (Primary Care Workforce Commission, 2015). 
Enhanced services are additional services authorised by the local Welsh health board (or 
clinical commissioning groups in England) in order to address the needs of the local patient 
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population (Welsh Assembly Government, 2017a), improve access to care and reduce the 
burden on other healthcare services. The Enhanced services provided in Wales, which were 
historically undertaken by GPs and nurses, include supervised administration of prescribed 
medicines, smoking cessation, syringe and needle exchange, supply of emergency hormonal 
contraception (EHC), travel vaccinations, blood pressure monitoring and diabetes testing, 
amongst others (Community Pharmacy Wales, 2017) and provide opportunities for 
pharmacists to expand their practice and have greater involvement within the 
interprofessional team.   
 
In 2011 Van and colleagues undertook a study to investigate the nature and extent of 
interactions between community pharmacists and GPs, with a particular focus on the 
impact provision of pharmacy services had on these interactions (Van et al., 2011). The 
authors found that the pharmacist’s role in the provision of essential services, and 
particularly the clinical check of prescriptions, stimulated the initiation of the majority of 
interactions between pharmacists and GPs. In such instances, pharmacists contacted the GP 
to inform them of the identified issue(s), to suggest amendments to the prescription or seek 
clarifications to resolve the issue(s) (Royal Pharmaceutical Society, 2017a). 
Interprofessional collaboration is also a key component in the provision of many advanced 
and enhanced services such as medicine use reviews (MURs) where correspondence with 
the GP is required to effectively review and manage patients’ medications. However, in a 
systematic review into the extent of pharmacist-GP collaboration arising from medication 
reviews (district from MURs but aligned in terms of outcomes) by pharmacists, Kwint et al. 
(2013) concluded (from the twelve suitable randomised control trials (RCTs) included) that 
more intensive collaboration between pharmacists and other HCPs was required in order 
to achieve higher implementation rates of recommendations arising from the review of 
medicines. This was reinforced in a later ethnographic study into the use of MURs in UK 
community pharmacies by Latif and colleagues who found that there was little interaction 
between community pharmacists and GPs related to the MUR services. The authors 
concluded that until greater levels of interprofessional collaboration are realised, extended 
pharmacy services are unlikely to reach their full potential (Latif et al., 2013a; Latif et al., 
2013b).  
 
The desire for community pharmacy to integrate as part of interprofessional teams 
stretches beyond primary care; there is some evidence, for example in case studies and 
research articles summarised by Ham et al. (2010), to suggest that greater interprofessional 
working across primary and secondary care boundaries will provide more timely and 
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accurate information transfer and thus reduce hospital (re)admissions. Efforts have been 
made to bridge the divide at least in terms of transfer of pharmaceutical care through the 
introduction of the discharge medicines reviews (DMR) service in Wales. The DMR service, 
operated by community pharmacists, aims to ensure that changes made to medicines in 
secondary care are continued when the patient returns to primary care and ensures 
patients or their carers understand such changes and how to effectively manage their 
medicines. The service in and of itself facilitates community pharmacists to undertake 
interprofessional interactions across sectors and with a range of HCPs (Community 
Pharmacy Wales, 2017).  
 
The shift in role of the community pharmacist is not unique to the UK. In Canada for 
example, Schindel et al. (2017) used a mixed method approach to survey (n=416) and 
interview (n=75) Canadian community and hospital pharmacists about their perceived 
roles and identified that many pharmacists have accepted and do provide a greater level of 
patient-centered care, however there were some inconsistencies with respect to their own 
definition of their roles and responsibilities, with some participants reluctant to relinquish 
drug distribution roles and take up newer more patient-centred responsibilities. They also 
demonstrated that study participants generally believed that “collaboration and 
relationships with other healthcare professionals were essential” (pg. 148) for the provision 
of effective patient care. Pharmacists’ views on their role was similarly investigated by Elvey 
et al. (2013) who conducted interviews with 43 UK pharmacists and found nine distinct 
professional identities of pharmacists “reflecting some degree of role ambiguity and lack of 
clear direction and ownership of what makes pharmacists unique” (pg. 322). Indeed, in a 
practice review article that focused on barriers to change within the pharmacy profession, 
Rosenthal et al. (2010a) highlighted that historical cultural aspects and a personality ‘type’ 
of pharmacists characterised by a  lack of confidence, fear of new responsibility, paralysis 
in the face of ambiguity, need for approval and risk aversion, continue to be barriers which 
must be overcome in order for the profession to properly realise its potential in the 
provision of effective patient-centred care. They also recognised that pharmacists’ 
perceptions and articulation of their own roles and responsibilities varies, therefore making 
it challenging in delivering a coherent message of the role of the pharmacist to other HCPs. 
The Royal Pharmaceutical Society (2017b) has indicated that a failure to articulate a 
coherent definition of the role of the pharmacist and indeed the wider pharmacy team has 
the potential to negatively impact interprofessional integration in practice.   
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Despite a variety of government and regulatory agencies indicating the underutlisation of 
community pharmacists and a drive for pharmacists to deliver greater interprofessional 
working (Department of Health, 2010; Royal Pharmaceutical Society and Royal College of 
General Practitioners, 2011; Centre for Workforce Intelligence, 2014; Primary Care 
Workforce Commission, 2015), within the literature there is only a limited sense of the 
current state of community pharmacists’ IPIs. A number of studies have explored 
community pharmacists’ interactions with general practitioners (GPs) through a variety of 
quantitative and qualitative methods (see section 5.4 for further discussion) (Norton et al., 
2003; Dobson et al., 2006; Liu et al., 2010; Snyder et al., 2010; Bradley, 2012; Bardet et al., 
2015). However, beyond engagement with GPs, little is known about the types of 
professionals that community pharmacists interact with, the frequency, mode, content or 
reason for interactions or any barriers and facilitators which may impact IPIs. This limited 
knowledge of the IPIs occurring in practice means that understanding community 
pharmacists’ current role within the interprofessional team is a challenge. This makes it 
difficult to determine areas of practice where development or improvements may be 
needed in order to deliver interprofessional, patient-centred care in the primary and 
community care settings. Furthermore, with community pharmacists’ IPIs generally 
unknown, this makes it challenging for educators to design meaningful and contemporary 
interprofessional education which prepares students for current practice (Barr et al., 2017).  
 
This mixed method study therefore aims to explore the interprofessional interactions that 
take place between community pharmacists and other HCPs during their current scope of 
practice and to explore pharmacists’ views on the value of IPE. The approach adopted was 
in two stages: (i) a self-complete questionnaire was administered to all community 
pharmacies in Wales to determine pharmacists’ reported frequency of interaction with 
HCTMs; (ii) this quantitative approach was subsequently followed by a series of face-to-face 
semi-structured interviews with a number of community pharmacists based in Wales to 
explore the nature of interprofessional interactions and determine their previous exposure 
to IPE and the value they place on IPE.    
 
These two sequential elements aimed to identify and/or explore community pharmacists’ 
(based within Wales) perceived views in a number of areas including: 
1. Community pharmacists’ perceived frequency of interactions with other HCTMs 
2. Community pharmacists’ perceived topic of interprofessional interactions with 
other HCPs 
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3. The mode through which community pharmacists perceived their interprofessional 
interactions with other HCPs took place (e.g. by telephone, face-to-face) 
4. The perceived facilitators and barriers to community pharmacists interprofessional 
interactions with other HCPs 
5. The perceived value community pharmacists place on IPE 
6.  Community pharmacist’s opinions on the design and implementation of relevant 
and meaningful undergraduate/postgraduate pharmacy related IPE.  
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5.2. Methods 
In order to pragmatically and thoroughly address the research aims, to determine and 
explore community pharmacists’ interprofessional interactions (IPIs) and the value they 
place on IPE, the use of mixed methods was chosen as this attracts benefits from both 
quantitative and qualitative methodological approaches (Johnson and Onwuegbuzie, 2004). 
The study was conducted in two parts:  
 
Stage one – Questionnaire: The first stage of this study sought to quantify the reported 
frequency of interactions between community pharmacists and other healthcare team 
members (HCTMs) using a self-complete questionnaire which was administered to all 
community pharmacies in Wales. 
 
Stage two – Semi-structured interviews: Informed by results from stage one, semi-
structured interviews were conducted with community pharmacists to elucidate the nature 
of the IPIs in which they engage and to determine the perceived value of IPE.    
 
A broad overview of the methods employed is described in chapter 4 - General Methods. 
The following section however provides specific detail on the methods employed here. 
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5.2.1. Stage one – Questionnaire determining community pharmacists’ frequency of 
interaction with other healthcare professionals and wider team members 
This section describes the specific methods for the design, recruitment and dissemination 
of a questionnaire to community pharmacies in Wales which sought to determine the 
frequency of interaction between community pharmacists and other HCTMs (comprising of 
HCPs and other staff within the healthcare team).  
5.2.1.1. Questionnaire design 
A questionnaire was developed to determine community pharmacists’ reported frequency 
of interactions with other HCTMs. The questionnaire consisted of three sections (see 
Appendix E). Section A was designed to determine demographic information associated 
with the respondent pharmacist in terms of the nature of their role and the characteristics 
of the community pharmacy in which they practise. In section B, respondents were asked 
to indicate their reported frequency of “direct personal interaction” with each of 26 HCTMs 
using a 6-point ordinal scale (at least once a day, at least once a week, at least once a month, 
at least once a year, less frequently, never). The list of the 26 HCTMs in the questionnaire 
was adapted from the NHS careers website (NHS Health Education England, 2015) and can 
be seen in Table 5.1. A free text box was also provided in section B where respondents 
could list any ‘other’ professionals they interact with beyond those listed. Section C allowed 
respondents the opportunity to provide any comments relating to their IPIs.  
 
Table 5.1. List of the 26 HCTMs, identified from the NHS careers website, included in section B of the 
questionnaire, categorised according to their sector of practice 
Primary care HCTMs based in GP practice 
General practitioner (GP) GP practice manager GP receptionist 
Health visitor Midwife^ Nurse - Community 
Pharmacist - Primary care   
Primary care HCTMs based outside the GP practice 
Care home staff Dentist Optician 
Vet   
Secondary care HCTMs 
Dietician^^  Doctor - Hospital Nurse - Hospital 
Occupational therapist^^ Paramedic^^ Pharmacist – Hospital 
Physiotherapist^^ Podiatrist^^ Radiographer^^ 
Social worker^^ Speech and language therapist^^  
Community Pharmacy HCTMs 
Accredited checking 
technician^ 
Dispenser/Technician^ Medicines counter assistant 
Pre-registration Pharmacist^   
^ = HCTMs who can also have a role in secondary care 
^^ = HCTMs who can also have a role in primary care 
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5.2.1.2. Sampling and dissemination 
To ensure that data was representative of the community pharmacist population within 
Wales, purposive sampling (Babbie, 2015d) of all 716 community pharmacies across the 
country (Welsh Assembly Government, 2017a) was undertaken. A list of community 
pharmacies in Wales was obtained from Community Pharmacy Wales (2015). 
Questionnaires were mailed to community pharmacies rather than directly to community 
pharmacists. This was partly because a mailing list of all pharmacists was not available but 
also so that the impact that the community pharmacy itself (including its location and the 
provision of services from the pharmacy) had on the frequency of interprofessional 
interactions could be determined.  
 
Pharmacies were sent a mailing ‘package’ directly addressed to ‘the pharmacist’ that 
comprised the questionnaire (see Appendix E), a cover letter (see Appendix F) and a free-
post return envelope. The cover letter indicated that respondents needed to be a qualified 
pharmacist who worked within that specific pharmacy for a minimum of two days a week 
to ensure they had a good understanding of the interprofessional interactions that are 
characteristic of the community pharmacy in which they practise. If more than one 
pharmacist fit the criteria at the pharmacy just one pharmacist was required to complete 
and return the questionnaire.   
 
Dissemination of the questionnaire to each community pharmacy was by 2nd class post 
mailed on Friday 6th February 2015. Questionnaires were uniquely coded in order to 
determine the pharmacies from which a returned questionnaire had been received. A 
duplicate reminder mailing ‘package’ was sent to non-respondents three weeks after the 
initial mailing. All questionnaires returned by 20th March 2015 were considered for analysis 
representing a 6-week data collection period. On the small number of occasions where 
multiple responses were received from the same pharmacy (i.e. return of both the first and 
second questionnaire following dissemination of the ‘reminder package’), the questionnaire 
received from the first mailing was used alone in data analysis.  
5.2.2. Stage two – Semi-structured interviews exploring the nature of 
interprofessional interactions between community pharmacists and healthcare 
professionals  
Following the questionnaire element of the study which identified the frequency of 
interaction between community pharmacists and other healthcare professionals and team 
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members, a qualitative approach was employed to explore the nature of these interactions, 
specifically the HCPs community pharmacists interacted most frequently with. This was 
achieved through face-to-face semi-structured interviews with community pharmacists 
from a variety of backgrounds. The interviews focused on a number of broad topic areas 
including: (i) identifying the HCP which they interact with most frequently; (ii) the mode by 
which their interprofessional interactions take place; (iii) the content of their 
interprofessional interactions; (iv) barriers and facilitators to interprofessional 
interactions; (v) the participants’ views on IPE. This section describes the specific nuances 
for conducting these interviews, however a broad overview of the methods used for these 
interviews can be found in chapter 4. 
5.2.2.1 Participant recruitment 
Purposive, snowball sampling was used to recruit pharmacists with a range of experiences 
and demographic characteristics across Wales. Recruitment continued until the sample size 
was sufficiently large and varied to ensure data encompassed views across the community 
pharmacy sector and constant comparison methodology identified strong repetition of data 
and themes and study aims had been achieved (Bowen, 2008; Malterud et al., 2015) (see 
chapter 4).  
 
The data gathered from stage one of this study (the questionnaire) informed the design of 
the interview schedule and the recruitment process to ensure that data gathered was 
meaningful and more representative of the overall community pharmacist population in 
Wales (Creswell and Creswell, 2017). A number of considerations were therefore made 
when recruiting potential participants to ensure the population sample covered a broad 
range of demographics. The initial recruitment phase aimed to identify a number of 
pharmacies which varied with; (i) health board; (ii) their co-location with other healthcare 
service providers, (iii) their location (City/Town High Street, Rural/Village, etc.), (iv) the 
size of the pharmacy company (independent vs multiple pharmacies). Once suitable 
pharmacies were identified, recruitment emails were sent addressed to the pharmacist. 
This recruitment email provided details about the interviews and specified that in order to 
participate pharmacists must work regularly (at least two days a week) within the 
addressed pharmacy. Those pharmacists who fulfilled this requirement and were willing to 
take part were encouraged to reply by email or phone directly the research team. Upon 
receipt of an expression of interest from a pharmacist they were sent (by email) further 
detail about the interviews in the form of a cover letter (see Appendix G), information sheet 
(Appendix H) and consent form (see Appendix I). After reading this information 
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pharmacists who then consented to take part in the interviews were contacted by telephone 
and a mutually convenient time to conduct the interview was arranged. Written completion 
of the consent form was obtained from the participant on the day of the interview. 
 
At the end of each interview, participants were asked if they could recommend possible 
interviewees who fulfilled other desired demographic criteria to broaden the population 
(purposive, snowball sampling).  
5.2.2.2. Interview setting 
Interviews were conducted face-to-face in the participant’s workplace. As all participants 
were practising community pharmacists, the interviews were conducted in the community 
pharmacy in which they were employed. The participant was asked to provide a quiet space 
for the interviews to ensure the interview was free from distractions and the recording was 
of a high quality (King and Horrocks, 2010a). In all cases, the interviews took place in the 
consultation room. As the interviews were specifically related to the participant’s 
experiences in that pharmacy, this setting may have also been beneficial in aiding the 
participant’s recall of interactions (Coughlin, 1990).   
5.2.2.3. Data Collection 
The interview schedule (see Appendix K) was developed based on: (i) data gathered in stage 
one of this study; (ii) existing literature on pharmacist interactions with other healthcare 
practitioners and (iii) the personal knowledge of the researcher within the field of 
pharmacy. The interview schedule was separated into four parts (sections A to D) as 
described in chapter 4. In the first part of the schedule, section A, participants were asked 
about their current and previous experience of pharmacy practice. The questions were  
brief and aimed to ease the participant into the interview (Kvale, 2007). Section B 
comprised a reflective ‘ranking exercise’ that was used to help the participant to reflect 
upon their own interprofessional practice within their current role and help immerse the 
participant in the interview. In this exercise participants were asked to rank cards labelled 
with seventeen relevant HCPs (see Table 5.2) based on their reported level of interaction 
with these HCPs. The members of the wider healthcare team such as pharmacy dispensers, 
GP receptionists and other pharmacists were excluded from this exercise (see chapter 4 for 
an explanation). 
 
In the third part of the interview, section C of the schedule, participants were asked about 
their interactions with the GP, community nurse and dentist i.e. the three professions 
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identified in stage one of the study as those with which respondent pharmacists indicated 
they interacted with most frequently (see section 5.3.1). In addition, if during the ranking 
exercise any participant indicated that one or more of their top three interactions was with 
a different HCP from these, the interactions with the additional HCPs was also explored. The 
final part to the interview, section D, included general questions about interprofessional 
working and the participant’s past experiences of IPE.  
 
Table 5.2. List of the 17 HCPs identified from the NHS website used during the interview frequency of 
interaction 
Dentist Nurse - Community Podiatrist 
Dietician  Nurse - Hospital Radiographer 
Doctor - Hospital Occupational therapist Social worker 
General practitioner (GP) Optician Speech and language therapist 
Health visitor Paramedic Vet 
Midwife Physiotherapist  
 
In this part of the study, the analysis represents a secondary analysis of data that was 
obtained by a final year pharmacy student as part of their MPharm research project. This 
was done in order to enable the student to gain experience in undertaking research as well 
as to aid the time consuming data collection process. Whilst all aspects of the study 
including development of the interview schedule, recruitment of participants and thematic 
data analysis were conducted by the PhD researcher, the interviews themselves were 
practically prosecuted by the pharmacy student who was provided with training in 
interview methodology and conducted three pilot interviews under the observation of the 
researcher. This allowed feedback from the researcher to improve interview delivery 
(Babbie, 2015d). All interviews were transcribed ad verbatim by the student but were 
reviewed by the researcher to ensure final transcripts were accurate and representative 
(Babbie, 2015a). Interviews were conducted with an interval of at least two days to enable 
transcriptions to be completed allowing for reflection to take place in order to iteratively 
finesse the interviews through alterations of or additions to the interview schedule (King 
and Horrocks, 2010a). 
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5.3. Results 
As with study methods (see section 5.2), the results have been separated into the two 
research stages: (i) stage one - questionnaire; (ii) stage two - semi-structured 
interviews. 
5.3.1. Stage one – Questionnaire determining community pharmacists’ frequency of 
interaction with other healthcare professionals and wider team members 
In this study, purposive sampling was used to determine the frequency of interactions 
between community pharmacists and other HCTMs (comprising of HCPs and other staff 
within the healthcare team) from a cross section of community pharmacists regularly 
practicing in Wales. To achieve this a questionnaire was disseminated to all 716 community 
pharmacies in Wales.  
5.3.1.1. Response rate 
Of the 716 pharmacies mailed, 443 questionnaires were returned from the two mailings, an 
initial mailing and a reminder, providing an overall response rate of 61.9%; the response 
rate after the first mailing was 40.2%. 
5.3.1.2. Respondent demographics 
Section A of the questionnaire was concerned with collecting demographic data related to 
the responding pharmacist and the community pharmacy in which they practise. The 
questionnaire featured eight areas related to the participants’ demographics: (i) the health 
board the pharmacy belonged to; (ii) the respondent’s role within the pharmacy; (iii) the 
number of GP practices the pharmacy serves; (iv) the number of additional staff working 
within the pharmacy dispensary;  (v) the size of the community pharmacy company; (vi) 
the locality of the  pharmacy; (vii) whether the  pharmacy is co-located with another 
healthcare provider and (viii) the services provided out of the pharmacy. Of the 443 
respondents 438 completed all eight questions in section A.  
5.3.1.2.1. Spread of respondents across Local Health Boards 
Each respondent was asked to indicate which Local Health Board (LHB) the pharmacy they 
work in is associated. Table 5.3 shows the distribution of respondents across the seven 
Welsh LHBs. Whilst the number of pharmacies in each LHB varies significantly (range 23 – 
155) the percentage response within these LHBs remained consistent (mean 61.9%  4.9). 
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Table 5.3. Distribution of community pharmacist respondents (n=443) across all seven Welsh Local 
Health Boards (LHBs) 
Local Health 
Board (LHB) 
 
Number of 
respondents 
(n=443) 
Percentage of 
total 
respondents 
(%) 
Number of 
pharmacies in 
each LHB 
(n=716) 
Response rate 
within LHB (%) 
Abertawe Bro 
Morgannwg 
75 16.9 125 60.0 
Aneurin Bevan 77 17.4 130 59.2 
Betsi Cadwaladr 107 24.2 155 69.0 
Cardiff & Vale 70 15.8 107 65.4 
Cwm Taf 44 9.9 77 57.1 
Hywel Dda 55 12.4 99 55.6 
Powys 15 3.4 23 65.2 
5.3.1.2.2. Respondents’ role within the community pharmacy 
Pharmacists were asked to specify their role within the pharmacy; just one respondent did 
not complete this (n=442). Figure 5.1 shows that more than half of the respondents were 
managers (57.5%), with over a third either owning the pharmacy or classing themselves as 
the ‘regular pharmacist’ (but not owner or manager). Just 32/442 were relief or locum 
pharmacists. The ‘other’ category (n=5) included three pre-registration pharmacists, one 
superintendent pharmacist and one stated other but did not specify their role; all 
respondents were included in the frequency of interaction data analysis (see section 
5.2.2.3).  
 
 
Figure 5.1. Role of the respondents (n=442) in the community pharmacy  
5.3.1.2.3. Number of GP practices community pharmacists perceived the pharmacy 
regularly serviced  
Respondents were asked to indicate the number of GP practices they perceived/understood 
the pharmacy regularly serviced; data was categorised into four bands. Figure 5.2 indicates 
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that over half of the pharmacies (56.9%) regularly served between 2 and 5 GP practices. 
 
Figure 5.2. Number of GP practices community pharmacists (n=438) perceived their pharmacy 
regularly serviced in a typical week  
5.3.1.2.4. Number of additional staff working in the pharmacy 
Respondents were asked to indicate how many staff work in the pharmacy’s dispensary on 
a daily basis to help understand the respondent’s working environment. The number of staff 
reported to work in the dispensary was highly variable (see Figure 5.3), however the mode 
value was three additional pharmacy staff (n=111). Of note, two pharmacies reported they 
had no dispensary staff except for the pharmacist and 78 respondents indicated they 
worked with more than five members of staff.  
Figure 5.3. The number of additional staff regularly working alongside the community pharmacist 
(n=443) in the dispensary  
5.3.1.2.5. Size of the company in which the respondent practised 
Respondents were asked to indicate the number of pharmacies operated by the parent 
company or organisation for which they worked.  Data was categorised into ‘independent’ 
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pharmacies ( 6 pharmacies within the company) and  ‘multiple’ pharmacies ( 7 
pharmacies within the company); these categories reflect those used by Welsh Assembly 
Government (2017a). The majority (68.5%, n=302) of respondents indicated they worked 
in pharmacies categorised as ‘multiple’ pharmacies compared to 139 (31.5%) in 
independent pharmacies (total of 441 respondents completed this question).  
5.3.1.2.6. Locality of the community pharmacy 
Respondents were asked to indicate the locality of the pharmacy by selecting one of the five 
predefined options (refined during piloting) or by indicating an ‘other’ locality. Figure 5.4 
shows the distribution of the 441 respondents (2/443 missing) across localities. The 
majority of pharmacies (92.1%) were described as being located either on high streets or 
residential suburbs in towns or cities, or in rural areas or villages. Just 21/441 respondents 
indicated their pharmacy was in an out-of-town supermarket or retail park. Fourteen 
respondents stated the pharmacy was in a different (‘other’) locality; six of which were 
based within a ‘medical centre’, three in a GP practice and five who did not identify the 
locality of their pharmacy.  
 
Figure 5.4. The locality of each respondents’ community pharmacy (n=441)  
5.3.1.2.7. Co-location of the community pharmacy with other healthcare providers 
Respondents were asked to indicate if the pharmacy was directly attached to (physically co-
located alongside) a GP practice, dental practice, opticians or any ‘other’ healthcare 
provider. The majority of respondents (n=342, 77.2%) indicated that their pharmacy was 
not attached to any other healthcare provider. The remaining 101 pharmacies (22.8%) 
stated they were attached to another healthcare provider of which fourteen were attached 
to multiple healthcare providers (see Table 5.4). The most common healthcare provider 
that pharmacies were co-located with was the GP practice (n=77, 76.2% of respondents 
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who were co-located alongside of other healthcare providers). Co-location with other 
providers was less common but was predominantly with opticians (n=15, 14.9%) and 
dental practices (n=10, 9.9%). Twenty-one respondents stated they were attached to an 
‘other’ healthcare provider not listed (20.8%), which included podiatry clinics (n=4), 
community nurses (n=2) and physiotherapy services (n=1).  
 
Table 5.4. Community pharmacies reporting attachment to more than one healthcare provider (n=14) 
Healthcare providers the pharmacy is attached to Frequency (n=14) 
GP and other 4 
GP, Dentist, Optician and other 3 
GP and Optician 2 
GP and Dentist 2 
GP, Dentist and other 2 
Optician and Dentist 1 
5.3.1.2.8. Services provided from the pharmacy 
Respondents were asked to detail the Advanced services provided by their pharmacy, 
results of which are shown in Figure 5.5. The majority of pharmacies (n=422, 95.3%) 
undertook MURs, of which 25 reported that this was the only Advanced service they offered. 
MURs and DMRs were provided more commonly than the common ailment scheme (CAS) 
where just 34 of 443 pharmacies (7.7%) delivered this service. Thirty-one pharmacies 
(6.9%) reported undertaking MUR, DMR and CAS with 28 of these also indicating that they 
undertook ‘other’ services. Of note sixteen pharmacies (3.6%) reported that they do not 
provide any additional services beyond those specified in the core NHS community 
pharmacy contract. 
 
Figure 5.5. Number of community pharmacist respondents (n=443) providing MUR, DMR, CAS and 
‘other’ additional services 
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The ‘other’ category allowed respondents to state any additional services provided that 
were not listed within the questionnaire. In total twenty additional services were identified 
across 328 respondents (74.0%), many of whom stated that they provide more than one 
additional service. These other services primarily described Enhanced services (see Table 
5.5) such as emergency hormonal contraception (EHC) (n=248, 56.0% of all 443 
respondents) and smoking cessation (n=161, 36.3%).  
 
Table 5.5. Enhanced services provided from community pharmacies in this study  
Enhanced service Number of 
respondents 
providing 
the service 
Percentage of  
respondents (n = 
443) 
Emergency hormonal contraception (EHC) 248 56.0% 
Smoking cessation 161 36.3% 
Supervised consumption  111 25.1% 
Needle exchange 72 16.3% 
Flu vaccine 70 15.8% 
Just in case boxes 34 7.7% 
MAR chart scheme 29 6.5% 
Two services including: Blood pressure checks, 
Care/nursing home services 
7 1.6% 
Inhaler technique counselling 6 1.4% 
Two services including: Travel health/vaccinations, 
Waste reduction scheme  
5 1.1% 
Three services including: Erectile dysfunction, Hair 
retention, Malaria prophylaxis 
4 0.9% 
Three services including: Cholesterol testing, Diabetes 
testing, Minor ailment scheme, 
3 0.7% 
Two services including: Meningitis vaccination, Weight 
management 
2 0.4% 
5.3.1.3. Community pharmacists’ perceived frequency of interaction with other 
healthcare team members 
Section B of the questionnaire was concerned with the overall perceived frequency of 
interaction between the 443 responding pharmacists and healthcare professionals / team 
members. Findings are displayed in Table 5.6 and Figure 5.6 showing the percentage of 
responding pharmacists who indicated they work with HCTMs at least once a month and at 
least once a week (Table 5.6 also shows daily interactions). Although 443 responded to the 
questionnaire these percentages were individually determined from the specific response 
rate per HCTM which varied (some individual frequency data per HCTM was missing as 
shown in Table 5.6) with a mean response rate of 439/443 received across all 26 HCTMs. 
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The data shows that those HCPs based within the GP practice were reported by community 
pharmacists to represent the most frequent perceived source of interaction, with the 
majority of pharmacists reporting that they interact with GPs (98.2%) and community 
nurses (80.0%) at least once a month. Of note, GP receptionists were identified as the 
member of the wider healthcare team that community pharmacists interacted with most 
frequently (99.8% at least once a month and 99.1% at least once a week).  
 
In terms of daily interactions, community pharmacists indicated that they interact most 
frequently with those HCTMs similarly located within the community pharmacy such as 
dispenser/technician (D/T) (95.5% of respondents) and medicines counter/healthcare 
assistant (MCA) (93.9% of respondents). This high level of daily interaction was otherwise 
only reported with GP receptionists (90.5% of respondents), with significantly lower 
proportions of pharmacists interacting with HCPs on a daily basis, the highest of which was 
the GP (37.6% of respondents). 
 
Outside of the GP practice and community pharmacy settings, doctors and nurses based 
within the hospital setting were sources of frequent interaction with pharmacists: 54.4% 
and 33.0% of respondents respectively reporting interactions at least once a month. 
However, this relatively high level of engagement was not observed for other professionals 
similarly located in the hospital setting.  Other professions that were often represented in 
distinct primary care premises like community pharmacy were dentists and opticians. The 
data revealed that dentists ranked third overall in terms of the reported frequency of 
interaction with community pharmacists (42.1% of respondents at least once a month).  For 
opticians, the interactions were reported to be less frequent (only 14.1% of respondents at 
least once a month).  
 
A significant proportion of respondents indicated that they frequently engage in 
interactions with other pharmacists. For example, 71.7% of community pharmacists 
reported interacting with hospital pharmacists at least once a month and 60.7% with 
primary care pharmacists. In addition, 61.1% of respondents interacted at least once a 
month with HCTMs based within care homes. 
 
Interestingly none of the respondents reported interactions with midwives, occupational 
therapists, paramedics, physiotherapists, podiatrists, speech and language therapists or 
vets on a daily basis and none of the respondents interacted with a physiotherapist on a 
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weekly basis. A small number of respondents also indicated their frequency of interaction 
with HCTMs outside of the 26 types listed within the questionnaire through the ‘other’ free 
text box provided. These included: the drug and alcohol team (n=12); community 
psychiatric nurse (n=5); carers (n=5); the LHB pharmacist (n=3); other LHB team members 
(n=3). Interactions with these groups were described as at least once a month.  
 
Table 5.6. Percentage of community pharmacists reporting that they interact with each HCTM at least 
once a month/week/day, ordered by ‘at least once a month’ 
HCTM Response rate 
per HCTM 
(max. 443) 
At least once a 
MONTH 
At least once a 
WEEK 
At least once a 
DAY 
GP receptionist 441 99.8% 99.1% 90.5% 
General practitioner (GP) 442 98.2% 84.4% 37.6% 
Dispenser/Technician 
(D/T) 
442 97.5% 96.2% 95.5% 
Medicines counter/ 
healthcare assistant (MCA) 
441 96.4% 95.9% 93.9% 
Nurse – Community 440 80.0% 49.1% 10.9% 
Pharmacist – Hospital 442 71.7% 21.3% 1.6% 
GP practice manager 442 65.8% 31.4% 9.1% 
Care home staff 432 61.1% 45.4% 17.1% 
Pharmacist – Primary care 438 60.7% 31.5% 7.1% 
Doctor – Hospital 434 54.4% 19.8% 4.2% 
Accredited checking 
technician (ACT) 
432 50.2% 47.7% 39.4% 
Dentist 439 42.1% 12.3% 11.2% 
Nurse – Hospital 439 33.0% 7.5% 0.9% 
Health visitor 439 30.3% 9.8% 1.6% 
Social worker 442 26.0% 5.4% 0.7% 
Pre-registration 
Pharmacist 
443 15.3% 9.9% 8.8% 
Optician 440 14.1% 5.9% 0.9% 
Vet 443 12.9% 2.3% 0.0% 
Midwife 433 11.5% 1.8% 0.0% 
Occupational therapist 441 2.3% 0.5% 0.0% 
Paramedic 442 2.3% 0.9% 0.0% 
Physiotherapist 438 2.3% 0.0% 0.0% 
Podiatrist 440 1.8% 1.1% 0.0% 
Dietician 428 1.6% 0.7% 0.2% 
Speech and language 
therapist 
443 0.9% 0.2% 0.0% 
Radiographer 441 0.5% 0.2% 0.2% 
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Figure 5.6. Percentage of community pharmacists interacting with HCTMs at least once a month or once a week, ranked in descending order by the at least once a month category 
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5.3.1.4. Impact of demographic characteristics on respondents’ reported frequency of 
interactions with HCTMs 
Throughout the questionnaire, a number of demographic characteristics were captured 
including the size of the pharmacy company that respondents worked for, the locality of the 
pharmacy, whether the pharmacy was attached to other providers and the services 
provided from the pharmacy. In order to understand if any of these characteristics 
significantly impacted on the frequency of interactions with HCTMs, chi-squared statistical 
analyses were undertaken (significance was set at p < 0.05).  
5.3.1.4.1. Impact of the size of the pharmacy company (independents vs multiple) on 
respondents’ reported frequency of interaction with HCTMs 
The Welsh Assembly Government (2017a) defines two categories of pharmacies namely  
independent pharmacies (a company with 6 or fewer pharmacies) or multiple pharmacies 
(a company with more than 6 pharmacies). Statistical analysis comparing staffing numbers 
with the size of the pharmacy group (see Table 5.7) was conducted to determine if this 
reflected findings of the General Pharmaceutical Council (2018b) who found that 
independent pharmacies employed more staff. The analysis of the questionnaire data 
highlighted that there was a significant difference between pharmacy company sizes when 
comparing the number of staff employed. A visual comparison of this data was then 
conducted to understand and determine the nature of this statistical difference (i.e. identify 
where the difference in the data is through looking at the trends of the data side by side). 
This visual comparison revealed that (like the GPhC findings) multiple pharmacies were 
significantly more likely (p=0.006) to employ larger numbers of dispensary staff. For 
example in independent pharmacies 11.5% of respondents reported there were one or less 
dispensary staff versus 5.6% in multiples and 12.9% of respondents from independents 
reported more than five dispensary staff versus 19.9% in multiples (see Table 5.7 to view 
the raw data and see the trends of staff employment dependent of pharmacy company size). 
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Table 5.7. A comparison of the number of dispensary staff working in independent and multiple 
community pharmacies. Multiple pharmacies were observed to employ significantly (p < 0.05) more 
dispensary staff than independents 
Number of 
dispensary staff 
Independent pharmacies ( 6 
pharmacies) (n=139) 
Multiple pharmacies (> 6 
pharmacies) (n=302) 
 
Number of 
respondents 
Percentage of 
respondents 
Number of 
respondents 
Percentage of 
respondents 
0 2 1.4% 0 0.0% 
1 14 10.1% 17 5.6% 
2 28 20.1% 72 23.8% 
3 33 23.7% 78 25.8% 
4 25 18.0% 55 18.2% 
5 19 13.7% 20 6.6% 
More than 5  18 12.9% 60 19.9% 
 
As significantly more staff worked within multiple pharmacies, statistical analysis was 
undertaken to determine if this had any impact on pharmacists’ IPIs. When comparing 
independent and multiple pharmacies, a significant difference in the reported level of IPIs 
was identified for 5 of the 26 HCTMs (see Table 5.8). HCTMs based within the GP practice 
accounted for three of the five professions where statistical differences in the frequency of 
interactions was identified, namely community nurses, midwives and primary care 
pharmacists. Once again visual comparisons were conducted by the research team to assess 
the trends of the data to better understand the reasons why there were significant 
differences between these pharmacy company sizes.  This process showed that pharmacists 
working within independent pharmacies tended to report higher levels of interaction with 
midwives and community nurses, however as no clear pattern emerged within the data for 
primary care pharmacists it was difficult to determine whether it was pharmacists working 
in independent or multiple groups that had more frequent interactions. The raw data can 
be seen in Table 5.8 in order to exemplify this visual comparison process. 
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Table 5.8. HCTMs where significant differences (p < 0.05) in the frequency of interaction was identified 
when comparing community pharmacists practising in independent or multiple branch pharmacies 
HCTM 
Independent 
vs multiple 
pharmacy  
At least 
once a 
DAY 
At least 
once a 
WEEK 
At least 
once a 
MONTH 
At least 
once a 
YEAR 
Less 
than 
once a 
YEAR 
Never 
ACT 
(p=0.005) 
Independent 
(n=136) 
47 
34.6% 
5 
3.7% 
2  
1.5% 
2  
1.5% 
3  
2.2% 
77 
56.6% 
Multiple 
(n=294) 
121 
41.2% 
31 
10.5% 
9  
3.1% 
9  
3.1% 
13  
4.4% 
111 
37.8% 
Community 
Nurse 
(p=0.001) 
Independent 
(n=139) 
18 
12.9% 
66 
47.5% 
37 
26.6% 
7 
5.0% 
3 
2.2% 
8 
5.8% 
Multiple 
(n=299) 
30 
10.0% 
101 
33.8% 
99 
33.1% 
44 
14.7% 
18 
6.0% 
7 
2.3% 
Midwife 
(p=0.039) 
Independent 
(n=134) 
0^ 
0.0% 
1^ 
0.7% 
16 
11.9% 
38 
28.4% 
40 
29.9% 
39 
29.1% 
Multiple 
(n=297) 
0^ 
0.0% 
7^ 
2.4% 
26 
8.8% 
51 
17.2% 
106 
35.7% 
107 
36.0% 
Pre-
registration 
Pharmacist 
(p<0.001) 
Independent 
(n=139) 
9 
6.5% 
1 
0.7% 
2 
1.4% 
13 
9.4% 
23 
16.5% 
91 
65.5% 
Multiple 
(n=302) 
30 
9.9% 
4 
1.3% 
22 
7.3% 
52 
17.2% 
66 
21.9% 
128 
42.4% 
Primary 
care 
pharmacist 
(p=0.015) 
Independent 
(n=137) 
7 
5.1% 
33 
24.1% 
46 
33.6% 
29 
21.2% 
4 
2.9% 
18 
13.1% 
Multiple 
(n=299) 
24 
8.0% 
74 
24.7% 
81 
27.1% 
63 
21.1% 
35 
11.7% 
22 
7.4% 
^= Categories that were combined for each specific demographic characteristic when conducting the 
chi-squared analysis; Bold percentage = percentage of respondents that is comparatively higher 
when comparing interactions frequencies with each HCTM dependent on the pharmacy company 
size 
 
In addition, respondents working for multiple pharmacy were found to have a significantly 
greater frequency of interactions with ACTs and pre-registration pharmacists compared to 
independent pharmacies. Significance could not be tested for the level of reported 
interactions with D/Ts and MCAs as the data did not fulfill chi-squared criteria, however 
visual comparisons suggested pharmacists based within multiple pharmacies reported 
higher levels of interaction with these team members (95.0% of pharmacists working in a 
multiple pharmacy interacted on a daily basis with MCAs and 91.3% within independent 
pharmacies, and 97.7% interacted daily with dispensers/technicians in multiples and 
90.6% in independents).  
5.3.1.4.2. Impact of co-location of the pharmacy with other healthcare service 
providers on respondents’ reported frequency of interactions with HCTMs 
Some 23% (n=101) of respondents reported that the pharmacy in which they practise was 
co-located with one or more healthcare provider (e.g. GP, optician, dental practice etc). The 
majority of these were co-located with GP practices (n=77). An chi-squared analysis was 
undertaken to determine if co-location alongside other HCPs had any impact on the 
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reported levels of interprofessional interactions. Table 5.9 highlights those HCTMs where 
a significant difference was found in the pharmacist’s reported levels of interprofessional 
interaction when the pharmacy was co-located with a GP practice. By using this raw data to 
undertake a visual comparison (see chapter 4.3.9 and section 5.3.1.4.1 for further 
explanation of this process) this showed that when the pharmacy was co-located, the level 
of reported interprofessional interactions with those HCTMs similarly based within the GP 
practice (GPs, community nurse, GP practice manager, health visitor, midwife) was 
significantly greater (p < 0.05) when compared to pharmacists based in pharmacies that 
were distinct from the GP practice. This increased level of interaction was limited to HCTMs 
based within the GP practice and not other HCPs with the exception of paramedics, a 
professional group not routinely practising within or from GP practices (Woollard, 2006).   
 
Only a small number of responding pharmacists indicated that their pharmacy was co-
located with an optician (n=15) or dentist (n=10) and therefore a chi-squared analysis could 
not be conducted as the data did not meet required criteria. However, although statistical 
significance could not be demonstrated, of note 66.6% (n=10/15) of respondents working 
in pharmacies co-located with opticians reported interacting with opticians at least once a 
month compared to 12.3% (n=52/425) of pharmacists who were not co-located, and 80.0% 
(n=8/10) of respondents working in pharmacies co-located with dentists interacted with 
dentists at least once a month compared to 41.3% (n=177/429) of pharmacists who were 
not co-located.  
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Table 5.9. HCTMs where significant differences (p < 0.05) were found when comparing frequencies of 
interaction depending upon whether the respondents’ community pharmacy is co-located with a GP 
practice 
 
HCTM 
Pharmacy  
co-location 
with GP 
practice 
At least 
once a 
DAY 
At least 
once a 
WEEK 
At least 
once a 
MONTH 
At least 
once a 
YEAR 
Less than 
once a 
YEAR 
Never 
HCTMs routinely located within a GP practice that show significant difference in the 
frequency of interaction when comparing pharmacies co-located with a GP practice and 
those that are not (p<0.05) 
General 
Practitioner 
(GP) 
(P<0.001) 
Yes (n=77) 50 
64.9% 
23 
29.9% 
4^ 
5.2% 
0^ 
0.0% 
0^ 
0.0% 
0^ 
0.0% 
No (n=365) 116 
31.8% 
184 
50.4% 
57^ 
15.6% 
6^ 
1.6% 
1^ 
0.3% 
1^ 
0.3% 
GP practice 
manager 
(P=0.001) 
Yes (n=77) 13 
16.9% 
25 
32.5% 
27 
35.1% 
8 
10.4% 
3^ 
3.9% 
1^ 
1.3% 
No (n=365) 27 
7.4% 
74 
20.3% 
125 
34.2% 
81 
22.2% 
41^ 
11.2% 
17^ 
4.7% 
Health 
Visitor 
(P<0.001) 
Yes (n=76) 1 
1.3% 
14 
18.4% 
26 
34.2% 
14 
18.4% 
12 
15.8% 
9 
11.8% 
No (n=363) 6 
1.7% 
22 
6.1% 
64 
17.6% 
82 
22.6% 
107 
29.5% 
82 
22.6% 
Midwife 
(P<0.001) 
 
Yes (n=76) 0^ 
0.0% 
1^ 
1.3% 
18 
23.4% 
18 
23.4% 
22 
28.6% 
18 
23.4% 
No (n=364) 0^ 
0.0% 
7^ 
2.0% 
24 
6.7% 
71 
19.9% 
124 
34.8% 
130 
36.5% 
Nurse 
(community) 
(P<0.001) 
Yes (n=76) 24 
31.6% 
30 
39.5% 
16 
21.1% 
5^ 
6.6% 
0^ 
0.0% 
1^ 
1.3% 
No (n=364) 24 
6.6% 
138 
37.9% 
120 
33.0% 
47^ 
12.9% 
21^ 
5.8% 
14^ 
3.8% 
HCTMs not routinely located within a GP practice that show significant difference in the 
frequency of interaction when comparing pharmacies co-located with a GP practice and 
those that are not (p<0.05) 
Paramedic 
(P<0.001) 
Yes (n=76) 0 
0.0% 
1 
1.3% 
3 
3.9% 
12 
15.8% 
13 
17.1% 
47 
61.8% 
No (n=364) 0 
0.0% 
3 
0.8% 
3 
0.8% 
35 
9.6% 
100 
27.3% 
225 
61.5% 
^= Categories that were combined for each specific demographic characteristic when conducting the 
chi-squared analysis; Bold percentage = percentage of respondents that is comparatively higher 
when comparing interactions frequencies with each HCTM dependent on the pharmacy co-location 
alongside a GP practice 
5.3.1.4.3. Impact that the provision of advanced services provided from pharmacies 
had on respondents’ reported frequency of interactions with HCTMs 
Discharge medicines reviews (DMRs)  are a type of Advanced pharmacy service which aims 
to improve the transfer of pharmaceutical care between healthcare sectors and promote 
interactions between community pharmacists and primary and secondary care HCPs (Ham 
et al., 2010; Royal Pharmaceutical Society Wales, 2015). Of the 443 respondents, 357 
reported that they provide the DMR service versus 86 that do not. An analysis was 
undertaken to determine if pharmacists working in pharmacies that deliver the DMR 
service reported higher levels of interaction with HCPs. The chi-squared analysis plus visual 
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comparison (see chapter 4.3.9 and section 5.3.1.4.1 for further explanation of this process)  
revealed that community pharmacies providing the DMR service reported significantly (p < 
0.05) increased interactions with hospital pharmacists but not with other professions (see 
Table 5.10). The data showed that 75% of those pharmacists practising in community 
pharmacies that provide the DMR service reported interacting with hospital pharmacists at 
least one a month compared to 48% of pharmacists who do not provide this service.  
 
Table 5.10. Community pharmacists providing the DMR service reported significantly (p < 0.05) higher 
levels of interaction with hospital pharmacists 
HCTM 
Pharmacy 
provides 
DMR service 
At least 
once a 
DAY 
At least 
once a 
WEEK 
At least 
once a 
MONTH 
At least 
once a 
YEAR 
Less than 
once a 
YEAR 
Never 
Hospital 
pharmacist 
(p=0.021) 
Yes (n=357) 
6^ 
1.7% 
72^ 
20.2% 
189 
53.1% 
68 
19.1% 
14 
3.9% 
5 
5.8% 
No (n=86) 
1^ 
1.2% 
15^ 
7.4% 
34 
39.5% 
26 
30.2% 
5 
5.8% 
5 
5.8% 
^= Categories that were combined for each specific demographic characteristic when conducting the 
chi-squared analysis 
 
Only a small minority of the pharmacists surveyed did not provide the medicines use review 
(MUR) service (n=21/443), therefore an analysis of the impact of the service on 
interprofessional interactions was not possible.  
5.3.1.5. Summary of the qualitative comments provided within the questionnaire 
The final section of the questionnaire comprised a free text comments box for respondents 
to add any further information they deemed appropriate to the study. A total of 25 of the 
443 respondents provided comments. These comments fell into six broad categories: (i) 
participants’ relationships with healthcare professionals; (ii) perceived benefits to IPIs; (iii) 
perceived barriers to IPIs; (iv) perceived facilitators to IPIs; (v) methods of improving IPIs; 
(vi) reasons for, and frequency of, participants’ interactions with specific HCPs. The full raw 
data is presented in Appendix K and the information was used to inform the stage two – 
semi-structured interviews.  
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5.3.2. Stage two – Semi-structured interviews exploring the nature of 
interprofessional interactions between community pharmacists and healthcare 
professionals 
This section describes the results for the qualitative interviews with community 
pharmacists which aimed to explore and better understand the IPIs taking place in 
community pharmacy practice and determine the value pharmacists placed on IPE.  
5.3.2.1. Participants  
In this study, 14 interviews were conducted at which point it was determined that the 
sample represented a cross section of community pharmacists, there was strong repetition 
of data and themes, and the study aims had been achieved (Bowen, 2008; King and 
Horrocks, 2010a; Malterud et al., 2015). The participants recruited had a range of 
characteristics that included variations in: (i) the length of time working within the 
community pharmacy branch in which the interview took place; (ii) the depth of experience 
of interprofessional education; (iii) co-location with other HCPs; (iv) the location of the 
participants pre-registration training; (v) the location of the community pharmacy (e.g. 
city/town high street, rural, etc.); (v) the health board in which the pharmacy operated; (vi) 
the size of the company for which the community pharmacy operated.; (vii) the university 
of study of the participant and (viii) the year participants graduated from university. Table 
5.11 provides details of these demographic variations for each participant however in order 
to maintain anonymity the Local Health Board (LHB) and location of the participants have 
been excluded and more generally summarised. The pharmacists interviewed were 
recruited from three of the seven Welsh LHBs: (i) Cardiff and Vale University Health Board 
(UHB) (n=7); Abertawe Bro Morgannwg UHB (n=4) and (iii) Aneurin Bevan UHB (n=3). 
Pharmacists worked across a range of locales including: (i) city/town high street (n=5); (ii) 
rural/village pharmacies (n=5) and (iii) city/town residential suburbs (n=4).  Participants 
were not recruited from other LHBs primarily due to limited response from potential 
participants, geographical convenience, limited time to conduct the study and the belief that 
strong repetition of data and study aims had already been achieved. 
 
As the participants were asked specifically about their experiences in the particular 
pharmacy where the interview took place, it was important to identify the time each 
participant had worked in that specific branch in order to understand the impact this may 
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have on their interprofessional experiences. The length of time participants had been 
employed in the branch varied significantly, from 8 months to 33 years.  
 
Participants also varied in their experience of IPE. Six participants had undertaken IPE 
during their undergraduate studies, three had postgraduate experience and the remaining 
five had no experience of IPE. However, of those that had no experience one described 
exposure to learning that was led by doctors, and two others acknowledged they had 
teaching surrounding interprofessional working although this could not be classified as IPE 
as no other professions were present. These experiences were often drawn out when 
discussing whether they had ‘training in interprofessional working’, with two participants 
unaware of the concept of IPE. During the interviews P11 also acknowledged that hospital 
pharmacists may have the chance to gain more interprofessional experience compared to 
community pharmacists as they rotate around different wards. P4 stated that they are 
aware that other universities, outside of Cardiff, do joint learning with HCPs, i.e. have shared 
lectures. 
 
Throughout the analysis of the interviews it was evident that a number of demographic 
traits of participants and their pharmacies had little or no perceived impact on the 14 
participants’ interprofessional interactions, including: (i) pre-registration training location; 
(ii) pharmacy locality (i.e. rural, city/town, etc.); (iii) health board and (iv) size of pharmacy 
company. Whilst these factors are absent from the interviews it must be noted that (as with 
all the qualitative data published) this is not generalisable and the completion of more 
interviews may have identified these as impacting IPIs (see 5.4.1. limitations). 
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Table 5.11. Characteristics of each community pharmacist interview participant (n=14) 
Participant 
number 
Year 
registered  
University of 
study (Cardiff or 
another UK Uni) 
Previous 
experience of 
IPE 
Sector of Pre-
registration training 
Time worked in 
branch  
Pharmacy 
classification 
Co-location with 
another HCP 
P1 2000 Cardiff Yes (PG) Community 6 yrs Independent  No 
P2 2012 Cardiff No Community 3 yrs Multiple  No^ 
P3 2012 Cardiff Yes (PG) Hospital  4 yrs Independent No 
P4 2012 Cardiff No Hospital 1.5 yrs Independent No 
P5 1980 Other No Community 33 yrs Independent Optician  
P6 2015 Cardiff Yes (UG) Community 8 mnths Independent No 
P7 2005 Other Yes (UG) Hospital 3 yrs Multiple  GP^ & Dentist 
P8 2013 Cardiff Yes (UG) Community 1.5yrs Multiple  Optician 
P9 2013 Cardiff Yes (UG) Community 1 yr Multiple  No 
P10 2007 Other Yes (UG) Community 5 yrs Multiple  GP^ 
P11 2015 Cardiff Yes (UG) Community  1.5 yrs Multiple  No 
P12 2010 Cardiff No Community 5 yrs Multiple  GP^ 
P13 2002 Other Yes (PG) Hospital 4.5 yrs Independent GP^ & Dentist 
P14 2002 Cardiff No Community 4.5 yrs Multiple GP^ 
GP^ = General Practitioner surgery, which may also contain other professions generally located alongside GPs (eg. community nurses, health visitors, midwives). 
No^ = Although not attached was in close proximity to a GP surgery (around 100 metres away)
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5.3.2.2. Deductive data analysis 
Deductive thematic analysis was employed to identify: (i) participants’ frequency of 
interactions with other HCPs; (ii) the nature of participants’ interprofessional interactions; 
(iii) the mode with which the interactions occurred; (iv) any areas where participants learnt 
from other HCPs during interactions; (v) the topics participants would like to learn from 
other HCPs; (vi) participants’ suggestions for the design and implementation of IPE. All 
participants understood the term ‘interprofessional interactions’ to be broadly “any sort of 
communication that we have with other healthcare professionals” (P13).  
5.3.2.2.1. Healthcare professionals discussed during the interviews 
 A number of different HCPs were discussed throughout the interviews in addition to GPs, 
community nurses and dentists (the three most frequently interacted with HCPs as 
identified within the questionnaire phase of this study). For some participants, the ranking 
exercise revealed that they interacted with other HCPs more frequently than GPs, 
community nurses and dentists. For these participants, the HCPs they selected were 
discussed in detail as well.  Participants also had the opportunity to discuss any other HCPs 
or members of the wider healthcare team that they felt were of relevance to the study. This 
resulted in discussions about a further 17 HCTMs. Social workers (11/14) and hospital 
doctors (9/14) were discussed by participants most frequently with all other professions 
mentioned by five or fewer participants (see Table 5.12). Of the 17 HCPs that featured in 
the ranking exercise three HCPs were not mentioned by any participants namely 
occupational therapists, radiographers & speech and language therapists. Physiotherapists 
were only mentioned by one participant but only to state that they had no interprofessional 
interaction with this HCP.  
 
Table 5.12. Number of community pharmacist interviews in which interactions with a HCTM was 
discussed (max. n=14) 
HCTM Number of participants 
Three HCTMs including: Community nurse, Dentist, GP 14/14 
Social worker 11/14 
Hospital doctor 9/14 
Three HCTMs including: District nurse, Hospital nurse, Optician 5/14 
Three HCTMs including: Health visitor, Secondary care staff, Vet 4/14 
Three HCTMs including: Dietician, Hospital Pharmacist, Other 
pharmacists 
3/14 
Three HCTMs including: Carers, Local addiction doctors, Midwives 2/14 
Four HCTMs including: Care home staff, Paramedic, Physiotherapist, 
Podiatrist 
1/14 
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5.3.2.2.2. Participants’ frequency of interaction with HCPs 
During the interviews, when participants discussed a HCP, the participant’s reported 
frequency of interaction was determined (see Table 5.13). The data showed that all 
participants interacted with GPs at least once a month, with nine stating they interacted at 
least once a week, and four stating they interacted on a daily basis with GPs. Although all 
participants also stated the frequency they interacted with dentists (n=14) the frequency of 
interaction was more varied, with half of the participants (n=7) interacting at least once a 
month but no participant interacting daily. Ten participants stated their frequency of 
interaction with community nurses with eight of these participants indicating they 
interacted with nurses at least once a month and one participant indicating they had daily 
interactions.  
 
Table 5.13. A comparison of the frequency of interaction between community pharmacists and HCPs 
discussed during the interviews (n=14) 
HCP At least 
once a 
day 
At least 
once a 
week 
At least 
once a 
month^ 
At least 
once a 
year^^ 
Less 
frequently 
Never 
GP (n=14) 4 9 1 - - - 
Dentist (n=14) - 3 4 3 3 1 
Community 
nurse (n=10) 
1 5 2 1 - 1 
Hospital Doctor 
(n=9) 
- - 3 3 1 2 
Social Worker 
(n=6) 
- 4 1 1 - - 
District Nurse 
(n=5) 
- 2 3 - - - 
Hospital Nurse 
(n=4) 
- - 2 1 - 1 
Optician (n=4) 1 2 - 1 - - 
Midwife (n=2) 1 - - - - 1 
Health visitor 
(n=1) 
- 1 - - - - 
Dietician (n=1) - - - - - 1 
^The term occasionally was given an ‘at least once a month’ frequency  
^^ The terms not often and rarely were given an ‘at least once a year’ frequency 
5.3.2.2.3. The content of participants’ interactions with other healthcare professionals 
The content of participants’ interactions with HCPs broadly fell into two categories (see 
Tables 5.14a and b), namely ‘clinical’ interactions and ‘practical’ interactions. Clinical 
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interactions were defined as those occasions where the pharmacists and HCP engaged to 
discuss ‘clinical scenarios’ in order to benefit the clinical care of the patient, examples here 
would include dose confirmations or resolution of drug interactions. Practical interactions 
were defined as occasions where there was interaction with a HCP to discuss non-clinical, 
practical or logistical patient issues, such as the supply of medications (e.g. when there was 
a manufacturing delay) and prescription writing errors which were clerical/administrative 
mistakes and not clinical in nature. All topics identified by participants fell into one of these 
two categories. To do this it was important to clarify the context of interactions, for example 
pharmacists contacted GPs to discuss the clinical implications of DMRs (clinical interaction) 
as well as to inform GPs when the DMR was conducted (practical interaction).  
 
It was evident from the data that the majority of interactions with GPs, community nurses 
and dentists involved discussions about the prescribing of medications and associated 
clinical or practical issues. This included confirming doses, discussing drug-drug 
interactions, discussing patient allergies, highlighting NHS blacklisted items and other 
issues associated with prescriptions. Discussing prescribing errors was a particular feature 
of interprofessional interactions with dentists, with P11 stating that “dentists can’t prescribe 
well”, and P4 believing “they’re historically not great at writing scripts so they will write 
things incorrectly or wrong formulations”. One reason for this was potentially because the 
majority of prescriptions are handwritten by dentists as P9 explained “because dentist 
prescriptions are handwritten that is a massive issue because the handwriting isn’t the best 
and you can’t understand what they’ve written then you have to call them, so a lot of the time 
it is for that reason and that would be 90% of the calls”.  
 
Interactions with GPs often featured discussions about patients as well as the provision of 
patient services. One service where pharmacist-GP interactions was particularly strong was 
the DMR service; “we do discharge reviews, it’s quite important to speak to the GP because 
they know best anyway and if anything needs to change” (P6). However, participants also 
acknowledged how interprofessional interactions relating to other services, such as MURs, 
was not occurring as much as desired and represented a missed opportunity for 
collaboration in order to improve patient care; “ with MUR forms… recommendations you put 
in, I don’t think they even read them half the time because you don’t get anything back so that 
is the only problem” (P11). 
 
Community nurse discussions largely focused on the use of dressings and the stock/supply 
of medications; “a lot of the time about dressings so they do a lot of dressing orders through 
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us” (P7).  These interactions were similar to those of the district nurse; “it’s pretty much the 
same interaction (between community nurse and district nurse)” (P4). 
 
Interactions with social workers were seen as “a big thing” (P9) often concerning the 
patient’s wellbeing, medication adherence or a source of information; “sometimes you can’t 
speak to the patients so you speak to the social worker… if anything’s changed then its best to 
speak to them (rather) than the patient” (P6), “they (social workers) will often ring us again 
because we are the ones who have the maximum contact with clients” (P1). 
 
Participants reported that they frequently interacted with professionals in secondary care, 
including hospital doctors, nurses and pharmacists, particularly related to discharge from 
or admission to hospital. This often involved an exchange of information to ensure seamless 
transfer of care; “when we need to interact with secondary care like that its more often for 
admission or discharge” (P1). Of note, interactions with these secondary care HCPs were 
found to be similar to their primary care counterparts, with participants reporting 
occasions where they contacted hospital doctors to discuss patients and address 
prescription issues such as doses or drug interactions; “so often again we get in contact with 
the doctors in the hospital to clarify prescriptions so we can give them to the patients” (P8).  
 
Interactions with opticians, were nearly always reported to be related to the referral of 
patients from one service to another with direct contact with the optician a rare occurrence; 
“typically erm someone would walk in with symptoms such as pain in the eye or if they’ve had 
it for a long period of time and its really red or something like that where we wouldn’t feel 
comfortable to sell them something before they’re seen, erm so we’ve got these referral cards 
that we can write on and then they can take that upstairs obviously to the optician or to 
anybody on the high street” (P6). 
  
Interactions with health visitors (HV), whilst less common, often involved pharmacists 
referring young patients for specialist advice or discussions about childhood vaccinations, 
formulations needed for babies, or administrative issues with prescriptions written by the 
HV. On the single occasion where a participant described interacting with a midwife this 
was related to the use of baby milk; “midwives are actually really good at teaching me about 
baby milks” (P7). Dieticians were the final profession with whom participants specifically 
described interprofessional interactions. Two participants described having discussed 
wasted nutritional drinks and the provision of lactose free medications; “mainly we get 
contacted by them or we try contact them if patients are wasting a lot of… you know a lot of 
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patients are prescribed Ensure® and drinks, we get masses back” (P2), “(we) had a query last 
week from a dietician, we have got one lady who’s query lactose intolerant so asked us to 
source all her medication in lactose free form” (P13). 
 
Further details relating to the clinical and practical reasons for interprofessional 
interactions can be seen in Tables 5.14a and 5.14b.
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Table 5.14.a.  The reasons community pharmacist interview participants (n=14) reported interacting with HCPs, categorised as either clinical or practical interactions, and the 
number times each reason was discussed across the 14 interviews 
HCP Clinical interactions (interactions about clinical scenarios to 
benefit clinical patient care)  
Practical interactions (interactions about non-clinical, 
practical or logistical patient issues) 
GP (n=14) Dose confirmation (n=8), Patient discussions (n=7), Clinical 
prescription queries (n=4), Drug interactions (n=3), Stopping 
medications (n=3), Medication clarification (n=2), Alternative 
medications (n=2), Compliance aids (n=2), Pharmacist providing 
medication information (n=1), Prescribing habits (n=1), Controlled 
drugs (n=1), Checking blood results (n=1), DMRs (n=1), MURs (n=1) 
Medication stock/supply (n=9), Prescription writing errors (n=3), 
Delivery of medications (n=2), Referral for flu jabs (n=1), Informing 
GP on use of services (n=1), GP determining medication costs (n=1), 
Informing GP of discharge medicine review (n=1), Urgent 
prescription for pharmacy to complete (n=1) 
Dentist (n=13) Dose confirmation (n=7), Drug interactions (n=3), Antibiotic allergies 
(n=2), Discuss drugs with narrow therapeutic window (n=1), Dentist 
checks drug history with Pharmacist (n=1) 
Prescription writing errors (n=6), Blacklisted items on Rx (n=4), 
Medication stock/supply (n=3), Branded vs generic medication 
(n=1) 
Community 
nurse (n=13) 
Dressing discussions (n=6), Patient discussions (n=4), Medication 
advice (n=4), Vaccinations/injections (n=3), Drug interactions (n=2), 
Dose confirmation (n=2), Prescribing advice (n=2), Syringe drivers 
(n=1), Malaria advice (n=1) 
Medication stock/supply (n=5), Inform CN on flu jabs done (n=1), 
CN looking up bloods for P (n=1), When GP not available (n=1) 
Social workers 
(n=11) 
Patient discussions - addiction patients (n=3), Medications changing 
(n=1) 
Patients difficulty with medications - compliance (n=4), Patient 
discussions (n=3), SW using MAR charts (n=2), Hospital 
admission/discharge (n=1), SW picking up patient medications 
(n=1), When Pharmacist can’t get through to patient (n=1) 
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Table 5.14.b. The reasons community pharmacist interview participants (n=14) reported interacting with HCPs, categorised as either clinical or practical interactions, and the 
number times each reason was discussed across the 14 interviews 
HCP (number of 
participants who 
commented) 
Clinical interactions (interactions about clinical scenarios to 
benefit clinical patient care) 
Practical interactions (interactions about non-clinical, practical 
or logistical patient issues) 
Hospital Doctor 
(n=8) 
Dose confirmation (n=5), Patient discussions – addiction patients 
(n=1), Drug interactions (n=1), Doctor checks drug history with 
pharmacist (n=1) 
Prescription writing errors (n=4), Hospital admission/discharge 
(n=2) 
Hospital Nurse 
(n=5) 
Speak to specialist diabetes/Parkinson’s nurses about patients 
(n=1), Discharge prescriptions (n=1) 
Hospital admission/discharge (n=5), Nurse is gatekeeper to Doctor 
(n=1), Discharge blister packs (n=1) 
District Nurse 
(n=5) 
Dressing discussions (n=2), Prescribing advice (n=1), Medication 
advice (n=1) 
Medication stock/supply (n=1), Nurse collecting patient medications 
(n=1) 
Opticians (n=5) Pharmacist refers patients for examination (n=5), Optician refers 
patients for purchasing (n=5) 
Optician purchased general products from pharmacy (n=1) 
Health Visitor 
(n=4) 
Referral with baby queries (n=2), Medication advice (n=1), Dose 
clarification (n=1), Vaccinations (n=1), MAR chart discussions (n=1), 
Formulation/ administration discussions (n=1) 
Prescription writing errors (n=1) 
 
Hospital 
Pharmacist 
(n=3) 
 Hospital admission/discharge (n=3) 
 
Dieticians (n=2) Whether medications were lactose free (n=1) Wasting liquids (n=1) 
Midwives (n=1) Baby milk discussions (n=1)  
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5.3.2.2.4. Mode of interaction 
The reported mode of interaction with HCPs was also elucidated during the interviews (see 
Table 5.15). Interactions could generally be categorised into three modes: (i) face-to-face 
interactions; (ii) interactions that took place over the telephone (iii) a mixed approach that 
included face-to-face interaction and a telephone conversation.  Some participants reported 
interactions by other methods including through referral cards, faxes and via another HCP 
(namely the GP) but these were less common. In addition, both the pharmacist and GP were 
seen to initiate interactions with one another, whilst for community nurses, it was more 
common that the nurse initiated communication. 
 
Data presented within Table 5.15 shows that the reported mechanism of interaction varied 
depending on the HCP, for example interactions with the dentist were mainly conducted 
over the phone (11/13) however a mixed approach of both face-to-face and over the phone 
was the case for community nurses (9/14). Other forms of communication included a letter 
which was received from a dietician regarding lactose free medications and faxed 
prescriptions from the hospital doctors. In addition, participants added how interactions 
with HCPs were occasionally facilitated through the general practice; “we just contact the 
surgery, they put us in touch with the dietician or the surgery will contact the dietician” (P2). 
 
Co-location with HCPs was also found to have an impact on the reported mode of 
interaction, something which was particularly evident when examining the pharmacist-GP 
interaction. Here the data showed that 4 of the 5 participants who were co-located with GPs 
had face-to-face contact (as well as phone contact), “well obviously it’s just next door so if I’ve 
got a query I’ll pop in and we can nip in between appointments” (P13). This was in contrast 
to those participants who were isolated from the GP practice; “over the phone yeah I’ve never 
met them face-to-face” (P11). This finding was similarly described with dentists, as both 
participants who were co-located with dentists reported frequent face-to-face contact. For 
nurses, face-to-face interactions was the primary mode of interaction irrespective of co-
location; “some do come in if they want to drop in a prescription for someone” (P9), “they quite 
often phone us from the patients’ home or erm they’ll come in if they’re on route to the patient” 
(P13). However, some participants also believed that interactions with nurses was aided by 
close proximity; “because the surgeries that we deal with that are right near us, I am so much 
closer to the GPs and the nurses because I can see them whereas the other ones I don’t 
physically see them it’s just a phone conversation and I think that makes a difference” (P2). 
Co-location had a limited impact on pharmacist-optician interactions, with only one of two 
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participants who were co-located with opticians interacting face-to-face, the other used 
referral cards to communicate. 
 
Table 5.15. A comparison of community pharmacist interview participants’ modes of communication 
with different HCPs  
Healthcare  
Professional 
Telephone 
only 
Face-to- 
face only 
Mixed 
approach^ 
Other/Addition 
information 
GP (n=14) 10 0 4 P contacts GP (n=6) 
GP contacts P (n=5) 
Community Nurse 
(n=13) 
3 1  9 P contacts CN (n=1) 
CN contacts P (n=3) 
Dentist (n=13) 11 0 2  
Hospital Doctor (n=5) 5 0 0 Faxes new Rx (n=2) 
Social Worker (n=4) 2 0 2  
District nurse (n=4) 2 2 0  
Optician (n=4) 0 1 0 Referral card (n=3) 
Hospital Nurses (n=3) 3 0 0  
Health visitor (n=2) 1 1 0  
Dietician (n=2) 1* 0 0 Letter (n=1)  
Midwife (n=1) 0 1 0  
* = also through the GP            ^ = mixed approach included both face-to-face and telephone  
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5.3.2.2.5. Other healthcare team members of note 
All interviews featured discussion of the interactions with GPs, dentists and nurses, 
participants were then afforded the opportunity to discuss any other HCTMs they felt were 
important. A general overview of interactions with these HTCMs is presented in Table 5.16.  
 
Table 5.16. Descriptive overview of community pharmacists’ interactions with other HCTMs not 
previously categorised due to limited information provided across interviews 
Podiatrists Only one participant (P5) had IPIs with podiatrists due to co-location within the 
pharmacy (podiatrist run clinic within pharmacy; 8-10 appointments once a week). 
IPIs were not professional in topic, with the only clinical information gained from the 
patients and not directly from the Podiatrist.  
Care home 
staff 
Care home staff were stated as P4s most frequent HCP interaction (4-5 times per day) 
because the pharmacy engaged with a large number of care homes, handling and a 
significant number of queries from the staff regarding prescriptions. Care home staff 
often asked in-depth medical queries which the pharmacist dealt with directly. 
Vet Four participants mentioned their interactions with vets (P3,P7,P10,P13). The IPIs 
with vets were often because a practice was close by, therefore the pharmacy dealt 
with veterinary prescriptions, however this was not common. One participant (P7) 
stated that their previous pharmacy was in a rural area leading to more frequent IPIs. 
This participant also stated that they found interactions with the Vet challenging 
when the pharmacist refused to supply medications for animals. 
Carers Carers were reported by some participants to be helpful in discussing patient issues, 
particularly about patients capacity to swallow medications and medication 
administration (MAR charts and dossett boxes) (P3 and P4) 
Drug and 
alcohol team 
doctors 
Participants P1 and P10 stated they speak to these doctors (GPs/consultants/mental 
health doctors), with P10 stating this is every now and then about correct 
prescribing, particularly dates on prescriptions.  
Other 
Pharmacists 
P10 had a meeting with cluster pharmacists to discuss DMRs. P3 and P4 stated how 
they would recommend/direct patients to other pharmacies, particularly when out 
of stock. One participant stated that they learnt the most from other pharmacists, 
particularly about bisphosphonate breaks, with another learning about endorsing.  
Paramedic P12 mentioned how as they are on a busy street they may need to contact paramedics 
if patients are unwell. 
Physiother-
apist 
Only one participant mentioned physiotherapists and this was to state that they don’t 
have a great deal of interaction (P13). 
Secondary 
care staff 
Here four participants (P1, P2, P9, P13) stated how they interacted hospitals staff 
regarding admission and discharge of patients. The specific HCPs were not always 
referenced participants mentioned ‘hospital staff’. P13 did elaborate and stated these 
were mainly doctors and secretaries. P9 also indicated how some hospitals are better 
than others at informing them about medication changes that have occurred within 
the hospital effecting IPIs.  
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5.3.2.3. Inductive data analysis 
This section describes the results of an inductive thematic analysis of interview transcripts 
which was used to identify themes within the interviews. This yielded six main themes and 
a series of associated subthemes (see Table 5.17). 
 
Table 5.17. Themes/subthemes identified through inductive, thematic analysis of community 
pharmacist interviews (n=14) 
Theme Subtheme 
1. Perceived benefits of 
interprofessional 
interactions 
1.1. Benefits to the patient 
1.2. Benefits to the pharmacist and other HCPs 
2. Perceived barriers to 
interprofessional 
interactions 
2.1. Lack of time leading to busy/stressed pharmacists and 
HCPs 
2.2. Difficulty in accessing HCPs  
2.3. Lack of understanding or poor perception of 
professional roles 
2.4. Having poor interprofessional relationships  
2.5. Restrictions in HCPs passing information to 
pharmacists 
2.6. Negative attitudes of HCPs 
3. Perceived facilitators to 
interprofessional 
interactions 
3.1. Having good relationships with HCPs 
3.2. Building good relationships with HCPs over time 
3.3. HCPs being easily accessible 
3.4. Improving lines of communication between HCPs 
3.5. Pharmacists having good interpersonal skills 
3.6. Providing a high-quality pharmacy service 
4. Impact of co-location on 
interprofessional 
interactions 
4.1. Not being co-located alongside HCPs has a negative 
effect on interactions 
4.2. Being co-located alongside HCPs benefits interactions 
5. Learning from and 
educating about 
interprofessional 
interactions 
5.1. Pharmacists can learn from other HCPs 
5.2. Pharmacists don’t learn from all HCPs 
5.3. Benefits and suggestions for IPE in pharmacy 
6. Impact of the receptionist 
on interprofessional 
interactions 
6.1. Receptionists’ broker role in HCP interactions  
6.2. Receptionists’ broker role as a barrier to interactions 
6.3. Receptionists being helpful in resolving patient issues 
6.4. Need for a good relationship with receptionists 
5.3.2.3.1. Perceived benefits of interprofessional interactions 
The benefits of interprofessional interactions (IPIs) were separated into two subthemes: 
1.1. Benefits to the patient 
1.2. Benefits to the pharmacist and other HCPs 
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1.1. Benefits to the patient 
With the exception of participant 6 (P6), all participants stated IPIs could provide patient 
benefits. Of these, helping to achieve a “better level of care” (P12) was the most frequently 
stated benefit (n=6) with P13 believing that “obviously you need to communicate with each 
other to get the best outcomes for patients”. In addition, participants felt IPIs could “help solve 
a lot of patient issues” (P3) including prescription problems and gave them a “fuller picture” 
(P7) of each patient thus helping make practice more seamless resulting in quicker 
resolution of issues and stopping patients going back and forth between HCPs.  Participants 
also believed IPIs helped improve medication optimisation for patients and gave them 
“more enhanced care, (and) more personalised care” (P4). Other reported patient benefits 
included an improvement in safety as IPIs helped “query or clarify stuff which ultimately 
leads to patient safety and making sure that patients get the best out of their healthcare that 
we provide” (P8). 
1.2. Benefits to the pharmacist and other HCPs 
Eight participants stated that there were potential benefits of IPIs to the pharmacist and 
associated HCPs with a perception that such interactions could help all parties being the 
most frequently reported benefit (n=4). IPIs were said to allow HCPs to gain “reassurance 
and confidence” (P1) from one another and provided an insight into “their ways of thinking” 
(P1). Participants also viewed IPIs as learning opportunities which could help fill 
knowledge gaps when solving problems and get the most out of one another; ‘if we have any 
er questions or any gaps in our knowledge if we can ring a doctor up or someone that you have 
a good relationship… then you can solve problems” (P6). Interactions were also reported to 
“help build relationships so that if there are any problems the doctor can contact us or us 
contact them and not have to trouble patients” (P2). This was seen to enable easier access to 
one another and also reinforce the pharmacist’s own role, for example as an “antibiotic 
guardian” (P1). IPIs were also reported to help relieve pressure on other services; 
“interaction between two health professionals who are fairly close locally in theory then should 
also then play a role in NHS Wales to take the pressure off the other health professionals i.e. 
GPs and A&E” (P1). 
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5.3.2.3.2. Perceived barriers to interprofessional interactions 
The barriers to IPIs were divided into six subthemes: 
2.1. Lack of time leading to busy/stressed pharmacists and HCPs 
2.2. Difficulty in accessing HCPs 
2.3. Lack of understanding or poor perception of professional roles 
2.4. Having poor interprofessional relationships  
2.5. Restrictions in HCPs passing information to pharmacists 
2.6. Negative attitudes of HCPs  
2.1. Lack of time leading to busy/stressed pharmacists and HCPs 
P11 summarised the lack of time within the healthcare environment by stating that “no 
healthcare professionals have time to communicate and learn from one another”. A number 
of participants alluded to the limited amount of time pharmacists have to engage with other 
HCPs, with P7 believing that “the pressure on community pharmacists is getting on to 
breaking point”. P12 felt that even though having more IPIs would be a benefit, the patient 
facing role of the pharmacists is the priority; “you would give a much better care if you could 
do more (interactions) but I’m not sure if it would be possible to have much more of the time 
without something else giving… you’re patient facing and that you have to deal with the 
patient first”. P11 also felt that the pharmacy “would lose business” if they spent more time 
doing other things like IPIs. These factors contributed to the sense that even when there are 
reasons to interact finding time to do so can be difficult meaning pharmacists don’t then go 
out of their way to interact; “(even) when there is a reason for us to interact because of time 
constraints it’s difficult… (because of) time constraints we don’t always go out of our way to 
engage” (P7).  
 
In addition to pharmacists’ limited time for interactions, a number of participants indicated 
that other professionals were similarly time constrained. This was said to be most acute for 
GPs due to a perceived heavy workload and the demands of such a patient facing role; “their 
timing is stretched a lot erm I really do think there needs to be more GPs readily available… 
they don’t have time (to interact) because whenever they’re in surgeries they’re running clinics 
or doing XYZ” (P9), “I guess they’re busy… they have surgery most of the time and they do 
house visits, sometimes we can’t get in touch with them so we have to wait like a day or two, 
by that time the patient is waiting as well” (P2) . These constraints often meant that GPs 
commonly have to ring pharmacists back; “often when I ring they always in surgery so they’ve 
got to ring us back erm 9 times out of 10” (P8). The GP’s limited ability to respond can also 
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leave pharmacists and patients frustrated; “they’ll say oh I’ll deal with it once all the patients 
are in, that then can leave a patient being frustrated because they come in with a prescription, 
you’ve identified an error or an issue, you try to speak to the GP, and have to say to the patient 
well we’re going to have to wait until 12.30-1 o’clock to speak to the GP”. Although many 
participants were conscious of the demands of the GP’s role, these factors resulted in 
hesitation in initiating an interaction at certain times for one participant; “you don’t want to 
interrupt them from what they are already doing… very few things would happen in primary 
care that can’t wait until the end of the morning or afternoon surgery, should they need to be 
interrupted in the middle of surgery it would have to be particularly important, almost 
emergency in nature” (P1). P11 summarised how the shortage of time for all HCPs impacted 
interactions, stating that “lack of their time, lack of our time” was the biggest barrier to 
conducting IPIs. 
2.2. Difficulty in accessing HCPs 
The difficulty in accessing HCPs was stated as the “biggest barrier” to interactions by P11. 
Participants found it challenging to get hold of a number of professionals including GPs, 
hospital doctors (and other secondary care staff), community nurses and dentists. GPs were 
most frequently identified as the professional group that was the most challenging to get 
hold of, both due to their time constraints (see theme 2.1) as well as the broker role of the 
receptionist (see theme 6.2). 
 
In contrast, in secondary care the main challenge was identifying the correct person to 
contact; “we would have to chase them up to find out actually what they were prescribing erm 
and that is actually very difficult I find to actually get hold of that doctor when you need them 
erm sometimes it can take a day, a day or two or someone will have to do erm more research 
on who actually prescribed it because you can’t actually, from the signature see who signed 
the prescription” (P9). 
 
Another reason alluded to by both P10 and P11 was that they do not have direct contact 
numbers for some HCPs, which makes it challenging to contact professionals. A further 
complication articulated was that even with a direct contact number it was difficult to 
ascertain which specific HCP was looking after certain patients; “we don’t really have a 
contact, we have to go through the surgery to contact the district nurse so it would be quite 
beneficial to be able to contact the district nurse directly erm or know which patients are being 
seen by a district nurse” (P10).  
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2.3. Lack of understanding or poor perception of professional roles 
During the interviews some participants articulated that they did not understand certain 
HCP roles, this resulted in difficulties when trying to appropriately signpost patients to 
relevant professions; “I would tell the patients to get in touch with a podiatrist, but I didn’t 
actually know where or how it works” (P2). Similarly, HCPs were also described to have a 
limited understanding of the role of the pharmacist and could thus be dismissive to the role, 
“some doctors are a bit dismissive (of the pharmacist’s role)” (P3) which was perceived to 
lead to an underutilisation of the pharmacist’s skill set. Some participants went on to 
suggest reasons for this, including the GP’s belief that the pharmacist is only engaging with 
them to make money, “they don’t appreciate that pharmacists are doing it to take the pressure 
off them not to just take their money” (P7), or to take away GP services. This made it 
challenging when new pharmacy services are commissioned as these can become barriers 
to interactions; “certain services I feel this can build barriers and conflict, like the influenza 
vaccine, probably the one that has caused a little bit of that of late over the last 2-3 years” (P1). 
In addition, when HCPs did not understand the pharmacist role this made interactions 
challenging and in some cases caused conflict between the HCPs, with P11 stating that 
hospital nurses “don’t tend to understand that we need a prescription so they can get a bit 
arsey at times” and P7 describing how “it was difficult because each time we spoke to them 
(vets) it was more some form of conflict, some form of disagreement that we had to get them 
round to why we were saying no (to dispensing medication for animals)”. 
2.4. Having poor interprofessional relationships  
A number of participants stated having poor interprofesisonal relationships with HCPs and 
their associated practices can negatively impact interactions; “(I) used to have more 
interaction I suppose because when we had a regular GP here he might ask what particular 
patient erm certain aspects about them but because they don’t know me now and I don’t really 
know them we don’t get much of that… its primarily just query-onic” (P5). It was suggested 
that this could be due to the number of HCPs they need to engage with; “it’s quite hard here 
because we’ve got so many surgeries that we work with we don’t get to know them” (P6).  
2.5. Restrictions in HCPs passing information to pharmacists 
One particular issue reported was that of patient confidentiality when, in some cases, HCPs 
were unwilling to share patient-related data. This meant that pharmacists were hampered 
in their provision of care; “we don’t get anything sent to us and I know it’s a lot to do with 
confidentiality why we don’t but that’s fair enough, if the lines of communication were there 
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that we could contact the GPs for certain issues or something like that then I think it would 
improve a lot more” (P9).  
2.6. Negative attitudes of healthcare professionals  
The attitude of HCPs also had an impact on some participants interprofessional 
engagement. This was particularly evident with P9 and community nurses who articulated 
that “they believe, some of them, that they’re doctors at times so they have that attitude and 
aura about them” which made communication particularly difficult.  
5.3.2.3.3. Perceived facilitators to interprofessional interactions 
The facilitators to IPIs were separated into six subthemes: 
3.1. Good relationships with HCPs 
3.2. Relationships building over time 
3.3. HCPs easily accessible 
3.4. Improving lines of communication between HCPs 
3.5. Pharmacists having good interpersonal skills 
3.6. Providing a high-quality pharmacy service 
3.1. Good relationships with HCPs 
A number of participants acknowledged they enjoy having IPIs, they have good 
relationships with HCPs and they feel part of the GP practice team, with P13 stating that 
they “wouldn’t change anything”’ regarding their interactions as “they have a good set up” 
with the practice next door and felt there was no barriers to these interactions. Two 
participants (P14 and P4) also stated how staff within the GP practices in the area were 
open and helpful and willing to take the pharmacist’s advice seriously, which enhanced the 
productivity of the interactions, with P14 stating that they “can pop over and highlight 
concerns with them you know, they don’t just brush me off, they do take me seriously, more 
than I have in previous experiences working as a community pharmacist”. “Nice healthcare 
professionals” (P3) also helped aid interactions by being more welcoming and helpful, thus 
making pharmacists, like P3, more willing to engage. 
 
A number of participants alluded to positive experiences with dentists, stating that they 
were good at getting back to the pharmacists, they acknowledged and accepted the 
pharmacist’s advice, they were helpful, and they seemed to have more time to interact than 
GPs. P9 felt they and the GPs understood the interactions were for the patients and had 
Chapter 5 
 
 
158 
respect for one another resulting in “100% of the time (had) a positive outcome”. P3 also felt 
that some GPs appreciated the role of the pharmacist stating that within one GP practice 
“they really appreciate everything we do in pharmacy, but yeah in some other surgeries they’re 
a bit more difficult”. Three participants also made direct reference to the good, prompt, to-
the-point interactions with community nurses, which helped encourage both parties to 
engage with each other. P7 also felt that they were “open and appreciative of each other’s 
roles and understanding what we do” which helped focus interactions and meant that 
professional expertise was properly utilised.  
3.2. Relationship building over time 
A number of participants also acknowledged how relationships build over time, with P1 
stating “the more interaction you have then clearly you build relationships with people and 
that familiarity would carry in your practice and then, erm, probably build better 
relationships”. Participants also stated that it takes time to get to know the HCP well and be 
on “first name terms” (P6), however when this does happen this helps make interactions 
more comfortable and builds trust. P5 also acknowledged how relationships with some 
HCPs that were initially negative improved over time; “we initially had no interaction at all 
with nurses… they were very obstructive when I phoned up… they just said they weren’t 
interested… (then once got to know them) they started coming in and we actually got on well 
with the nurses so we now deal with them quite a lot” (P5). P6 also felt that getting to know 
one another and understanding what each other wants would be beneficial, saying it “would 
just be nice to kind of get to know them and just see who you’re actually speaking to and see 
kind of what they would like from us and just get that chance to sit down and think okay what 
we want and build that, so everyone knows what they want from each other really”.  
3.3. HCPs easily accessible 
Although a small number of participants stated that access to dentists was challenging, five 
participants stated how easy they found it to contact them, with P1 emphasising that “dental 
practices tend to have an open-door policy where it is easy to communicate” with P11 adding 
“they’re probably easier to get through to than GPs, tend to have a bit more time I think, they 
are quite happy to come to the phone and talk directly”. In addition, P6 also articulated that 
there were no barriers to communicating with GPs believing “what they have in place works 
quite well”, although all other participants felt there were barriers to this interaction (see 
theme 2.2). 
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3.4. Improving lines of communication between HCPs 
Nine participants acknowledged that they would like more communication with HCPs.  A 
number of methods to increase communication were suggested including improving lines 
of communication for example with call back systems, direct emails or by attending GP 
practice meetings. In addition, the production of a ‘formulary’ of direct line telephone 
numbers to HCPs was suggested as something which may help; “I don’t actually know who 
the midwife for the area or for the surgery is, so you always go back to the GP but the GP has 
so much to do so there needs to be like a formulary or something” (P2). Although six 
participants suggested attending GP practice meetings, one participant was unsure if the 
GPs would actually want the pharmacist to attend as they each belong to different 
companies; “they’ve got their own business and we’ve got a different business, we’re not linked 
at all so they probably wouldn’t want me involved in a lot of their meetings because they don’t 
have me being nosey probably” (P10). In contrast, P2 stated the benefits of such meetings to 
the practice; “I think what’s really important is trying to have that time to meet these doctors, 
once we started doing these multidisciplinary meetings with the surgeries around the corner, 
we have been able to share our workload because we do the smoking service here and flu, 
they’re aware of it, they’re able to send people to us and that takes the load off them, but if you 
don’t have that time to actually go and speak to them, it’s a bit more difficult”. One participant 
(P12) already engaged in meetings within the practice to which they were attached and felt 
that meeting other doctors outside of that practice would also be beneficial. 
 
Some participants felt that the NHS/LHB could help encourage relationships and make 
HCPs aware of pharmacy services; “the NHS isn’t really helping build those relations as 
certain services can build barriers and conflict” (P1). Another suggestion was that 
undergraduate placements can also help interprofessional engagement in the future; “put 
on placement in a variety of sort of situations, I think that would be good” (P1). 
3.5. Pharmacists having good interpersonal skills 
One participant stressed the importance of the pharmacists’ own communication skills to 
ensure that they provide a solution to the HCP when posing a problem and empathising with 
other HCPs; “You have you have a degree of empathy there, to understand that you don’t really 
want to pose someone another problem, you know if you give someone another conundrum 
you really want to offer some answers as well, rather than making someone’s life harder, you’ll 
only annoy somebody” (P1). 
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3.6. Providing a high-quality pharmacy service 
Providing a high-quality pharmacy service can help interactions as it enables community 
nurses to be aware of the availability of products and gives the GP confidence that pharmacy 
can be the first port of call for any problems; “We’ll do it (sort out the supply of medications 
for a prescription) the next day usually and they (nurses) appreciate that” (P5), “they know 
we provide a good service here so any problems they’ve got we tend to be their first port of 
call” (P13). Certain services were described as driving the need for interprofessional 
communication, with for example the minor ailment service stimulating interactions with 
opticians and providing information to the GPs on services that their patients had used such 
as flu jabs and smoking cessation; “we have access to a minor eye ailment service…there’s an 
optician probably 500m away from us and so the referrals end up going back and forth erm 
that would probably be at least daily, it’s actually quite a useful tool…I always just let them 
(GPs) know which patients are on it (smoking cessation), erm yeah like we speak to them 
nearly every day” (P1). Additionally, the provision of ONPOS (Online Non-Prescription 
Ordering Service) was reported to have helped improve interprofessional relationships 
with community nurses; “we take part in an enhanced service scheme called ONPOS which is 
about supplying dressings, but ultimately, due to those, interactions relations have built” (P1).  
 
Participants believed that by providing services this shares the workload between HCPs; 
“we have been able to share our workload because we do the smoking service here and flu, 
they’re aware of it, they’re able to send people to us and that takes the load off them” (P2). 
This can therefore help take pressure of HCPs, “like doing the travel clinic to take pressure 
off nurses” (P7), however some participants commented that some HCPs don’t always 
appreciate this; “they don’t appreciate that pharmacists are doing it to take the pressure off 
them not to just take their money” (P7). P11 also believes “offloading services to pharmacy” 
would free up GP time further. 
5.3.2.3.4. Co-location with HCPs and interprofessional interactions 
The impact of co-location with other HCPs on participants’ IPIs was separated into two 
subthemes: 
4.1. Not being co-located alongside HCPs has a negative effect on interactions 
4.2. Being co-located alongside HCPs benefits interactions  
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4.1. Not being co-located alongside HCPs has a negative effect on interactions 
Participants indicated being remote from other HCPs reduces the frequency of interaction, 
this was particularly evident from P10’s statement regarding dentists; “(interactions are) 
more difficult because they’re spread out so far away, there isn’t a dentist really that near to 
here so it would be a case of we don’t deal with them very often so we’re not familiar with the 
way they work and things like that really”. In some cases, when pharmacists were not co-
located alongside HCPs this meant IPIs became non-existent, something that P12 found 
occurred with the community nurse; “there aren’t any upstairs at the moment so I don’t have 
any interaction”’ (P12). Additionally, not being co-located was also seen to impact on the 
focus of interactions with P1 stating that “other GPs that are perhaps further away, the 
interactions will solely involve making prescription interventions” compared to more in-
depth clinical conversations about specific patients with those co-located. P9 also felt that 
within community practice “it’s not like the hospital, so you’re not working as a massive 
multidisciplinary team within one roof er so when you are making calls to these different 
community (HCPs) whether it’s the GP or dentist you’re getting straight to the point, certain 
issue and you’ll deal with it and that’s it”. This impact of physical separation on interaction 
was reiterated by P11 who felt that within community pharmacy they are “quite ostracised, 
we don’t really have any interactions with other professionals”.  
4.2. Being co-located alongside HCPs benefits interactions 
In contrast, being co-located alongside HCPs was reported to have a positive effect on IPIs. 
For example, P1 highlighted the advantage of the hospital environment in encouraging 
collaboration, “in a hospital environment that (IPIs) is probably encouraged because that is 
just there, everybody is on the ward together”. This co-location helps build relationships and 
makes interactions more accessible as pharmacists can directly approach the HCPs; “I think 
in a location like there where everyone’s next door to each other its easy isn’t it because you 
all know each other and speak to each other” (P1), “well obviously it’s just next door so if I’ve 
got a query I’ll pop in and we can nip in between appointments or erm they will quite often 
pop in” (P13). In addition, P2, described how a GP practice was “literally like 100m down the 
road” and found this to be a real benefit; “I am so much closer to the GPs and the nurses 
because I can see them whereas the other ones I don’t physically see them it’s just a phone 
conversation and I think that makes a difference”. They also felt that being further away 
would be a barrier to interactions; “I think if they were further away it would be much 
harder”. 
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As discussed in section 5.3.2.2.4 the impact of co-location on the mode of interactions was 
clear, with those co-located with GPs stating they interact more often in a face-to-face 
manner compared with those detached from other HCPs where phone communication was 
the sole mode of interaction;  “I’ll go and pop and see them next door just because it’s easier 
to do it face to face” (P15), “the doctor will then come down and talk to us” (P12). However, 
although face-to-face interactions was seen as preferable this was also dependent on “how 
busy we are here” (P15), and that it “depends on the doctor” as to whether the interaction is 
face-to-face or over the phone (P12). In addition, P7, who was co-located with GPs, found 
that with pressure on pharmacy reaching “breaking point” they did not have time to wait to 
interact with GPs face-to-face and therefore would ring in a similar fashion to those 
pharmacies not co-located; “if we want to speak to them we phone them because otherwise 
we’re standing outside their room waiting to see them and it’s too busy for me to go and stand 
there for 5 or 10 minutes”. Similarly, P8 stated how they always interacted by phone even 
though the GP practice was only a “5 minute walk away”, and P1 felt that the distance 
between themselves and the opticians would have no bearing on interactions.  
5.3.2.3.5. Learning from and educating about interprofessional interactions 
Learning from and educating about IPIs was separated into three subthemes: 
5.1. Pharmacists can learn from other HCPs 
5.2. Pharmacists don’t learn from all HCPs 
5.3. Benefits of and suggestions for IPE in pharmacy 
5.1. Pharmacists can learn from other HCPs 
A number of participants suggested there is lots to learn from other HCPs with P13 stating 
they learnt something “most days” and P1 believing “you should view any interaction as a 
learning process”. Ten of the twelve participants reported learning about specific topics 
from doctors including; unusual doses, alternative/new products, medical procedures and 
local guidelines. GPs broad knowledge base was seen to help pharmacists learning, however 
the in-depth knowledge of specialised HCPs was also seen to be of benefit; “their (midwives) 
skills are so set as such a small range so they give you so much information just for that range 
whereas GP/community pharmacist we’re kind of covering a lot of stuff, maybe in not quite as 
much depth” (P7). Although community nurses were seen as slightly more specialised with 
learning often focused on dressings, wounds and vaccinations, it was also felt that nurses 
helped educate the pharmacist about each patient’s conditions and needs. Other HCPs 
where participants reported specific specialised learning was from hospital doctors 
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regarding new medications, dentists regarding off-license toothpaste in children, and health 
visitors and midwives regarding baby milk and reflux.  
5.2. Pharmacists don’t learn from all HCPs 
A number of participants expressed that they hadn’t learnt anything from particular HCPs 
including GPs (n=2), community nurses (n=4), dentists (n=6) and opticians (n=1). One 
participant, P9, was very strong in their belief that they did not learn from any HCPs as 
interactions were “straight to the point” and “to learn something you would go out and learn 
it yourself, the information is readily available on the internet or any other resources so you 
can learn it yourself”’. Time constraints were also seen to be a contributing factor in not 
learning from HCPs; “just finding the time to do it which is really difficult” (P7). However, a 
number of participants (n=7) suggested that although they may not have learnt anything 
directly from HCPs, interactions helped identify their own learning needs; “they don’t teach 
me things but they give me things that I have to learn” (P7). This is particularly evident when 
the HCP has a query and the pharmacist is unsure of the answer; “I didn’t really know much 
about it but after looking I learnt a bit about it” (P3), “it’s normally queries that I get from 
them and kind of teach yourself then go back to them with what the answer is” (P11).  
5.3. Benefits of and suggestions for IPE in pharmacy 
From participants’ experiences of IPE they found it “useful” (P2), “quite important” (P3), 
“valuable” (P7) and found that, along with peers taking part, the IPE sessions experienced 
were “good” (P11). A number of benefits related to IPE were articulated by the participants 
including reducing barriers between HCPs and increasing the understanding of HCP roles; 
“(IPE was conducted) so that people understood each other’s roles a bit better and their 
limitations on what they could do so that you would have a bit more of an understanding on 
what you could ask or what they wouldn’t be able to do” (P12).  Improving the understanding 
of one another’s roles was also the most frequently suggested topic for IPE sessions (10/14 
participants), with P11 believing this could also help increase the respect HCPs, in particular 
doctors, have for the pharmacists; “a lot of them (doctors) are newly qualified they don’t 
really know what pharmacists do so could be something to try and get them to work closer 
together… doctors would maybe have a little bit more respect for pharmacists (then)”. 
 
Doctors and nurses represented the two HCPs that participants suggested IPE should be 
undertaken with and many participants believed that IPE with pharmacists, doctors and 
nurses together would be beneficial. Beyond improving understanding of HCP roles, a 
number of additional suggestions for themes for IPE with doctors were provided including 
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managing patients, counseling patients (eg. surrounding the management of depression and 
related medications), understanding GP specific prescribing patterns, drug/product advice, 
understanding the information/knowledge doctors have, OTC diagnosis skills, common 
doctor issues, doctors’ terminology/abbreviations and getting information from doctors. 
IPE with nurses was thought to also help pharmacists “appreciate kind of the level of their 
learning that they’ve had they then can appreciate how to use pharmacists” (P7) and could be 
focused on pharmacists showing nurses where drug information comes from.  Other 
broader themes for IPE were suggested with P14 feeling that dealing with difficult HCPs 
(GPs and receptionists in this case) and management skills could also be helpful, with P13 
believing that asthma could be a topic that may link multiple HCPs. A number of participants 
also suggested that more IPE is needed, believing it should run through the MPharm 
programme and continue once qualified; “The (IPE) courses that I had on my undergraduate 
course were really good anyway… I think maybe more of them…  probably from an earlier 
stage as well so from first year all the way to fourth” (P11).  
5.3.2.3.6. Impact of the receptionist on interprofessional interactions 
One healthcare team member who was frequently mentioned throughout the interviews 
was the GP receptionist. Receptionists are part of the wider multidisciplinary team and play 
a vital role in the interactions taking place between pharmacists and other HCPs 
(predominantly those within the GP and dental practices). As such, the impact of the 
receptionist on IPIs was explored and four subthemes emerged: 
6.1. Receptionists’ broker role in HCP interactions  
6.2. Receptionists’ broker role as a barrier to interactions 
6.3. Receptionists being helpful in resolving patient issues 
6.4. Need for a good relationship with receptionists 
6.1. Receptionists’ broker role in HCP interactions  
Receptionist were seen to have a large impact on HCP interactions due to their ‘broker’ role 
(Burt, 2005) where they are the first person the pharmacist spoke to when trying to engage 
with HCPs, “it will probably go through to the receptionist first then to the GP” (P12), “usually 
you speak to a receptionist first” (P1). Receptionists then either direct the participant 
through to the relevant HCP, “the receptionist are quite open to getting them (the HCP) to 
come and talk to you” (P11), or they pass a message on to the HCP and potentially relay that 
information back to the pharmacist; “they write down the details on a message to the doctor… 
and if they (HCP) feel they need to contact me then they will or if they feel that the receptionist 
can do it then they’ll write a message back which I can then get that information from them” 
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(P8). A number of participants recognised the receptionist’s broker role is there to protect 
the HCP; “they have to protect that the GP is on a very structured day, it’s very busy, it depends 
on the seriousness and nature of your problem (as to whether you will be put through to the 
GP)” (P1). 
6.2. Receptionists’ broker role as a barrier to interactions 
Although many participants acknowledged the broker role of the receptionist, both P4 and 
P6 saw the receptionist as the “main barrier” to HCP interactions. These participants 
indicated that the receptionists they interact with believe they can directly solve issues and 
are therefore reticent to connect the pharmacist with the HCP.  This was acknowledged by 
a number of other participants; “in some surgeries the receptionists make it very difficult… I 
feel that sometimes the receptionist are the barrier, they will try to do anything they can to 
you know, just get rid of you basically” (P3), “the receptionists don’t want to put you through 
so they’ll try and find a way of not giving you access to them” (P11) “the receptionist will act 
as a go-between and I’d say it’s probably 1 in 20… 1 in 10 phone calls to the GP where I’ll speak 
directly to them” (P4). P11 also felt it was only if they were unhappy with a response from 
the receptionist that they would continue until they are put through to the HCP; “with the 
receptionist its only if I’m not really happy with what they’ve said that I’ll request to go 
through”. A number of participants echoed this, with P6 feeling that you have to persist in 
order to get through to the HCP; “sometimes you eventually get through but they do try and 
answer it and kind of end it there but you have to persist with it and say you actually want to 
speak to the GP”. P1 also felt that although the receptionist tries to help they rang to speak 
to the HCP and not the receptionist, “sometimes it is difficult to get through the receptionist 
and they’ll try and answer the question by looking at the patients notes but generally if I’m 
ringing to speak to a doctor, I want to speak to a doctor”, which can lead to frustration 
particularly as some participants felt information exchange is often slower with the 
receptionist than when speaking directly to the HCP; “it’s a lot more of a faster exchange 
conversation (with the HCP) than, you know, when it is with a receptionist because you don’t 
have to explain anything” (P4). 
 
A number of participants felt that receptionists restrict their access to HCPs as they believe 
that pharmacists are just contacting the GP in order to increase their own profit; “I think 
they’re a bit skeptical of us perhaps in thinking that we’re just trying to get more revenue and 
more scripts” (P4), “I think that sometimes they think ‘oh they’re just trying to get a profit’” 
(P3). These issues could potentially result from a lack of awareness of the pharmacists’ role 
by the receptionist, with two participants stating it would be beneficial to train the 
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receptionist on the role of the pharmacists; “maybe the receptionist training would be the 
best thing for it but that’s generally the only barrier that we have” (P4), “training GP 
receptionists in terms of them knowing what a pharmacist does” (P3).  
6.3. Receptionists helpful in resolving patient issues  
Participants found receptionists to be helpful in a number of ways including dealing with 
prescription queries (which involved discussions about quantity, dosing and formulation 
issues), especially when the HCP is unavailable; “normally they’ll deal with it… if it’s dose 
query they’ve (GPs) normally written in the notes why it is that or if it’s from a consultant” 
(P11). This meant that engaging with the receptionists could lead to faster resolution of 
issues; “(the) majority of the time we will speak to the receptionists at the surgery because 
they can deal with it quicker… I don’t need to speak to the GP we have a relationship… they 
(GPs) don’t have time to deal with that and we don’t have time to wait for them to call us back 
so we deal with the receptionists there they get the issues sorted for us most of the time” (P9). 
The receptionist was also seen to contact the pharmacists on behalf of the HCP in order to 
check dose queries (GP) and drug histories (dental). In contrast to a number of participants 
who felt that receptionists were barriers to IPIs (see theme 6.2) some found that those 
receptionists that did understand the role of the pharmacist were helpful in facilitating 
interactions with HCPs and solving issues; “in the surgery nearest us the receptionist is very 
good and they don’t mind us speaking to the doctors or getting us through, they realise that 
we do have a vital part to play and we are trying to help and solve problems and things like 
that” (P3). 
6.4. Need for a good relationship with receptionists 
A number of participants recognised the benefits in having a good relationship with 
receptionists, “it is about the relationship you have with their support staff as well” (P1). 
Participants have also suggested that by having shared understanding of roles and a good 
relationship this helps make interactions less formal and ensures the receptionist is more 
willing to help; “I think the fact that we have built up such a good relationship with the 
receptionist in there I think that this makes it easier and they sort of believe, they trust what I 
say so for example if I send someone in because I think they need to be seen by a doctor, they 
will try and fit them in because I’ve said that they need to go in so, we’ve got quite a good 
relationship in that aspect so that makes it easier” (P10).  
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5.4. Discussion 
In recent years the pressure on primary and secondary care services within the UK has 
increased due to a number of factors but particularly a growing aging population 
(Bienkowska-Gibbs et al., 2015) resulting in a transition for community pharmacists away 
from the provision of traditional supply type services such as repeat dispensing to include 
more clinically focused services  and take greater advantage of pharmacists’ unique skillset 
as experts in medicines (Dobson et al., 2006; Department of Health, 2010; Carter, 2016). As 
a consequence community pharmacists are increasingly required to interprofessionally 
integrate and collaborate (Department of Health, 2010; Centre for Workforce Intelligence, 
2014; NHS England, 2014a; Royal Pharmaceutical Society, 2015), however, there is 
currently a  paucity of literature exploring the specific IPIs that community pharmacists 
engage in during their practice, making it challenging to understand and develop 
pharmacists’ interprofessional skills.  This study therefore aimed to identify those HCPs that 
community pharmacists in Wales interact with and to explore the nature of these 
interactions. A mixed methods approach was adopted using both questionnaires and semi-
structured interviews helping triangulate the data. Together these methodological 
approaches identified the HCPs community pharmacists work with most frequently (i.e. the 
questionnaire identified the quantity of interactions, with primary care doctors, nurses and 
dentists identified as the most frequent) and explored the nature of these IPIs (i.e. the 
interviews explored the quality of interactions alongside the quantity helping to triangulate 
data) including any facilitators or barriers, of which the value of IPE in aiding these was 
determined.  The initial questionnaire achieved a high response rate from the 716 Welsh 
community pharmacies across all seven health boards (61.9%  4.9) providing confidence 
in the generalisability of the results Following the questionnaire, 14 semi-structured 
interviews were conducted and whilst this was not exhaustive this sample represented a 
cross section of community pharmacists, there was strong repetition of data and themes, 
and the study aims had been achieved (Bowen, 2008; King and Horrocks, 2010a; Malterud 
et al., 2015).  
 
. In this current study, many participants expressed the belief that interprofessional 
working can help achieve a greater understanding of the patient and their condition and 
was said to lead to the provision of quicker, safer and more patient oriented care, reflecting 
the national and international focus of interprofessional collaboration (World Health 
Organisation, 2010; Department of Health, 2013a) and the recent NHS inquiries (Francis, 
2013; Andrews and Butler, 2014; Kirkup, 2015). This data also reflected the findings of West 
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et al. (2013) who compiled and presented the results from the extensive data collected 
within the NHS staff survey undertaken annually between 2006 and 2009 (e.g. the response 
in the 2009 survey represented 390 separate trusts and 154,726 individual employees). 
This study identified that NHS staff in their own right have recognised the positive impact 
of engaging in interprofessional teamwork had on patient care, with participants expressing 
the belief that providing successful interprofessional care could ultimately reduce the 
likelihood of patient mortality.Despite the drivers for interprofessional collaboration (see 
chapter 2 and Reeves et al. (2017)) there is little high-quality evidence which shows that 
patient care is enhanced through effective interprofessional collaboration.  
 
Participants within this study stated that their interactions with HCPs helped to: improve 
the exchange of knowledge, gain an understanding of the ways other HCPs think and 
reinforce the pharmacist’s own role within the healthcare team. These are factors that have 
been previously identified within the literature, and are indeed are commonly set as 
learning outcomes for IPE (Greiner and Knebel, 2003; Freeth et al., 2008; Thistlethwaite, 
2012; Carpenter and Dickinson, 2014; Barr et al., 2017). Of note, participants also felt that 
IPIs enabled them to build relationships which helped them to feel more 
comfortable/confident in approaching HCPs with queries or problems.  
 
Within primary care, the GP practice is seen as the central hub of patient care (Royal College 
of General Practitioners, 2014), this was reflected in both the questionnaire and interview 
data with participants working most frequently with HCPs based in this area. Interestingly, 
previous studies by Van et al. (2011) and Bradley (2012) found that community 
pharmacists interactions with GPs were infrequent. Whilst the definition of infrequent is 
subjective, community pharmacists within the study presented here differed as they 
reported that interactions with GPs were more frequent than with any other profession, 
with a significant number of respondents to the questionnaire indicating that they 
interacted with GPs on a daily basis. This is perhaps a consequence of the drive to better 
utilise community pharmacists within the interprofessional team to reduce the demand on 
GP practices (British Medical Association, 2014), possibly indicating that there has at least 
been some ‘culture change’ in the collaborative practice between pharmacists and GPs 
which was desired by the Royal Pharmaceutical Society and Royal College of General 
Practitioners (2011). 
 
Participants in the semi-structured interviews reported a variety of reasons for their 
interactions with GPs. In total, twenty different clinical and practical reasons for IPIs were 
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elucidated from the interviews, with clinical interactions often collaborative and related to 
the resolution of prescription issues and discussions about the patients’ medications, and 
practical issues generally involving the exchange of information, such as informing GPs of 
pharmacy services used by the patient or stock issues. These findings mirrored that of Van 
et al. (2011), which showed, through the use of qualitative interviews with both GPs and 
pharmacists in Australia, that interactions varied between administrative issues with the 
dispensing process and clinical discussions relating to areas such as changes to drug 
therapies and medication adherence. . Furthermore, the collaborative IPIs described by 
participants in this current study based on clinical queries (which accounted for more than 
half of interactions reported) were reported to benefit interprofessional relationships, with 
participants stating that when pharmacists and GPs had regular communication about 
clinical issues this helped build rapport and trust which in turn helped them work more 
effectively together. In addition, the interview data also showed that GPs were comfortable 
in approaching pharmacists about issues, however pharmacists on the whole recognised 
that they more frequently initiated interactions. This showed similarities to a study by 
Snyder et al. (2010), who used mixed methods to explore pharmacist-GP interactions in the 
USA, and found that pharmacists tended to be the professional whom normally initiated the 
interaction.  
 
In addition to collaborating with GPs, the Primary Care Workforce Commission (2015) 
indicated that in order for community pharmacists to provide the best advice and care in 
complex areas of medication management they should do so in collaboration with all 
members of the general practice team including community nurses, midwives, health 
visitors, managers and administrators (e.g. receptionists). In both the questionnaire and 
interview elements of this study, it was clear that community pharmacists heavily engage 
with community nurses (4/5 community pharmacists interacting at least once a month). Of 
note, this contrasted findings from While et al. (2005) who used a questionnaire to explore 
interactions between UK community pharmacists and nurses. Whilst While reported that 
pharmacists and nurses ultimately had an underlying willingness to engage, their 
interactions were said to be limited. The findings in this current study therefore suggest in 
Wales at least the workforce has moved on and collaborative practice between these 
professions has advanced since While’s 2005 study.  
 
Interactions with community nurses were identified to be both clinical and practical in 
nature. Once again those of a clinical nature tended to be collaborative and surrounded 
areas such as dressings, wound management, patient discussions, vaccinations and 
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medication advice as well as dose confirmation and prescribing advice. These clinical 
interactions form the basis for those more practical ‘information exchange’ interactions 
such as stock and supply of medicines, informing the nurse when the pharmacist had 
undertaken a flu jab, and utilising the nurses prescribing capacity when the GP was not 
available. Whilst the topic of interaction did vary slightly perhaps due to the more recent 
advancement in pharmacist roles (i.e. the incorporation of advanced and enhanced 
pharmacist services), these results ultimately aligned with further findings from While et 
al. (2005) who identified that pharmacist-nurse interactions primarily focused on the 
nurse’s role in prescribing, protocol development, or resolving dispensing issues.  
 
Findings from the questionnaires employed in this study indicated that community 
pharmacists interact fairly frequently with health visitors and midwives based in the GP 
practices. These professionals were discussed by participants during interviews on a 
number of occasions, with interactions primarily initiated by pharmacists asking for advice 
surrounding paediatric assessment or treatment, leading to collaborative discussions about 
the care of patients.  
 
Within primary care, HCPs can also be based outside of GP practices in their own distinct 
premises. This is often the case with dentists, a profession which was observed to have high 
levels of engagement with community pharmacists (identified as the third most frequently 
interacted with HCP). Dentists were characterised by participants as having poor 
prescribing skills more often than any other profession. As such community pharmacists 
had to work collaboratively with them to ensure the medicines supplied to patients were 
appropriate. Participants also indicated that many dentists continue to issue hand written 
prescriptions that were often illegible prompting some to suggest transition to electronic 
prescriptions was needed. Opticians are also another profession who are located in distinct 
premises, however interactions were reported to be infrequent and often indirect (i.e. 
through the use of referral cards).  
 
In this study three-fifths of pharmacists reported that they interacted with care home staff 
at least once a month. The nature of these IPIs was not generally addressed by participants 
in the interviews, with just one participant stating that interactions with these staff were 
related to in-depth medical queries due to the large number of prescriptions they dealt with 
from this area, howeverthese interactions could be explained by the Royal Pharmaceutical 
Society (2016) recent belief that by making pharmacists a central part of the care home 
Chapter 5 
 
 
171 
team patients’ medicines could be better optimised and managed to reduce harm, 
inappropriate medicine use and waste. 
 
As well as the drive to better integrate HCPs in the primary care setting, there has been 
considerable work undertaken to ‘join up’ health and social care services (Barr et al., 1999; 
Meads and Ashcroft, 2005; Reeves et al., 2010b; Welsh Assembly Government, 2011a), with 
the NHS Future Forum (June 2011) producing a series of reports expressing the need for 
greater collaborative working across these areas (NHS Future Forum, 2011a; NHS Future 
Forum, 2011b). This Forum particularly highlighted how the current model of health and 
social care discouraged this practice, leading the authors to state how the “health service 
now needs to drive integration in a way that has simply never happened to date” (pg. 7) 
(NHS Future Forum, 2011a), a notion which was consolidated when the Health and Social 
Care Act 2012 was released by the Department of Health (2012) which stated the 
imperative need for greater collaboration throughout health, education and social care and 
across both primary and secondary care. The need for close ties between health and social 
care was reinforced within this current study as interview participants felt that interacting 
with social workers was important within practice and was viewed as a ‘big thing’. One key 
reason for this was because pharmacists believed many social workers, much like 
themselves, had good relationships with patients and were valuable sources of information 
about patients. This led to collaborative interactions related to patient compliance, 
medications changes (especially when discharged from hospital), supervised consumption 
of medications in substance misuse patients and the wider holistic care of the patient 
beyond health matters. Whilst interview participants indicated a clear benefit in 
interactions with social workers, the questionnaire element of the study revealed that only 
a quarter of pharmacists interact with social workers on a monthly basis which suggests 
that the integration of health and social care, at least in a pharmacy context, is far from 
complete. 
 
Whilst it is recognised that greater levels of information transfer between HCPs across care 
settings could help reduce hospital readmission (Ham et al., 2010), community pharmacists 
IPIs with professionals based within secondary care were reported to be relatively 
infrequent in this current study. However, whilst community pharmacists reported low 
levels of interaction with the majority of secondary care HCPs, a significant number did 
indicate that they interact with hospital doctors, pharmacists and nurses at least once a 
month. Unsurprisingly, the interactions were commonly related to patient admissions to or 
discharge from hospital. Primarily, the interactions were associated with ensuring adequate 
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transfer of information from secondary to primary care rather than full collaborative 
engagement of HCPs. Such information sharing is thought to help deliver the NHS aim of 
bridging the gap across care sectors, improving the flow of patient information and 
ultimately achieving a greater level of continuity of care for patients (NHS England, 2014b; 
Primary Care Workforce Commission, 2015).  
 
In order to fully utilise community pharmacists’ potential, UK government agencies are 
supporting community pharmacists to deliver an expanding range of patient services 
(Mossialos et al., 2015). As a byproduct, these services also aim to reduce the strain on other 
areas of practice (Centre for Workforce Intelligence, 2014). In interviews, participants 
supported this aim stating that new services can relieve pressure on other HCPs and free 
up time in order for HCPs to potentially engage in more interprofessional working. 
However, although there is an intention to provide services such as MURs, DMRs, minor 
ailment schemes, etc. in an interprofessional manner, there is little evidence to suggest that 
this is occurring. Bradley (2012) found that on the whole pharmacy services “did not 
require frequent, if any, contact with GPs or GP practices” (pg. 132).  Similarly, Van et al. 
(2011) found that although the provision of services had some positive impact on 
interactions between GPs and pharmacists they did not always lead to interprofessional 
engagement. Seemingly, this current study, for the most part, reinforced these findings, with 
little mention by participants in interviews that the provision of new services had resulted 
in an increase in interprofessional interactions.  For example, in an analysis that compared 
the frequency of interactions with HCPs based on whether the pharmacy provided 
discharge medicines review (DMR) service showed that the service had little impact on IPIs, 
with the only significant increase in interactions with hospital pharmacists. This is 
surprising as the DMR service aims to improve the transfer between care sectors (Royal 
Pharmaceutical Society Wales, 2015) and provide more integrated interprofessional care to 
ultimately reduce hospital admissions (Ham et al., 2010). As such the service should be a 
partnership between community pharmacists, GPs, secondary care prescribers and 
pharmacists. In a review of the DMR service conducted by Hodson et al. (2014), the authors 
similarly concluded that greater levels of interprofessional communication between the 
hospital, community pharmacist and GP were needed and indeed it was not uncommon for 
GPs to be  unfamiliar with the service. One proposed solution that may help to facilitate 
information transfer between care settings during discharge is electronic/online DMRs and 
discharge advice letters (cf paper based). In a study conducted by Mantzourani et al. (2017), 
17 pharmacists were interviewed to assess their opinions on a pilot version of NHS Wales’ 
online Choose Pharmacy platform. The study found that interviewees perceived the online 
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method to streamline the completion of the DMR and improved continuity of care between 
primary and secondary sectors.  
 
Although the impact of other Advanced services such as medicines use reviews (MURs) on 
IPIs could not be determined, previous research would suggest that there is little evidence 
that pharmacists and other HCPs (such as GPs) engage interprofessionally in the delivery of 
this service. In a qualitative study involving ten weeks of ethnographic observations and 
patient interviews about the MUR service in two English community pharmacies, Latif et al. 
found that there was little evidence suggesting that pharmacists and GPs were working 
collaboratively or communicating outcomes resulting from MURs and felt that until this 
interprofessional culture improves it is unlikely that extended pharmacy services will reach 
their full potential (Latif et al., 2013a; Latif et al., 2013b). Indeed, one pharmacist 
participating in the interviews described in this study indicated that although the provision 
of the MUR service could possibly lead to more opportunities for interprofessional 
interactions, GPs often didn’t read the MUR feedback provided by pharmacists resulting in 
a potential missed opportunity for collaboration and the improvement of patient care. 
Although the provision of services was not generally seen to impact interprofessional 
interactions, it was still perceived by participants that the delivery of high quality clinical 
services and advice to HCPs would increase the likelihood interprofessional interactions. In 
a model for improving relationships between pharmacists and doctors developed by 
McDonough and Doucette (2001) this was similarly found to be of importance when 
developing collaborative working relationships. The authors indicated that HCPs begin to 
develop expectations surrounding pharmacists’ abilities and competence over time, 
highlighting the importance of providing good services to prompt future interactions and 
utilise each other’s skills and build relationships. 
 
The Welsh Government have recently introduced the ‘2018/19 Collaborative Working 
Scheme’ (Community Pharmacy Wales, 2018) which aims to develop and improve 
community pharmacists’ collaborative relationships with GPs and other HCPs. This scheme 
was introduced in October 2017 and provides a monetary incentive (up to £1500) for 
community pharmacists to engage with primary care clusters in a number of specified 
areas. Whilst this helps encourage community pharmacists’ collaborative engagement in 
areas such as promotion of services, only one of the schemes requires pharmacists to 
actively undertake interprofessional engagement (attending a primary care cluster 
meeting). Too often such schemes promote transactional relationships rather than 
embedding true interprofessional care.   
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With the role of the community pharmacist expanding this has meant that wider use of the 
pharmacy support staff is needed in order to move pharmacists away from dispensing roles 
and allow them to engage in more clinical tasks which utilise their skill set (Primary Care 
Workforce Commission, 2015). This wider utilisation of pharmacy staff was evident within 
the questionnaire element of this study and pharmacists were seen to interact with 
pharmacy team members more than any other HCPs or HCTMs on a daily basis. Statistical 
analysis indicated that companies that operate multiple pharmacies (company has more 
than 6 pharmacies) employed significantly more staff than independent pharmacies, a 
finding also reported by the General Pharmaceutical Council (2018b). In order to transition 
community pharmacists from the traditional supply role it may be necessary to encourage 
or indeed smaller independent groups to enhance the pharmacy team.  
 
It was interesting to note that few community pharmacists reported that they interact with 
any HCP on a daily basis. This mirrors the findings of a mail questionnaire study sent to 
community pharmacists across Canada which explored their interprofessional experiences 
in practice and found that although pharmacists expressed willingness to engage in 
collaborative interprofessional working, actual rates of participation remains low (Dobson 
et al., 2006). In addition, in an observational study of community pharmacists’ daily roles 
across ten English pharmacies conducted by Davies et al. (2014), the authors found that less 
than 5% of pharmacists’ time was related to ‘health-related communication’, the definition 
of which included IPIs as well as other activities that involved communication. 
 
One of the major barriers to interprofessional engagement cited by a number of participants 
in this current study was an apparent lack of time for interactions. The expanding role of 
the community pharmacist meant that a number of participants felt they had additional 
pressure and time constraints on their daily scope of practice leaving little time to engage 
in IPIs.  This barrier has previously been recognised for community pharmacists within the 
literature, with Van et al. (2011) indicating that nearly all pharmacists and GPs in their study 
cited a lack of time as the main reason for not working together, with several pharmacists 
noting that GPs were not always easily accessible. The interviews in this current study 
support these findings with participants suggesting that of all HCPs, the GPs time was most 
stretched, a feature similarly highlighted by the ‘your GP cares’ movement (British Medical 
Association, 2014), and were also stated to be the most challenging HCP to access. Bradley 
(2012) also explored community pharmacist-GP relationships and found that these time 
pressures resulted in reduced interprofessional working, particularly when interviewees 
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felt the benefits of interprofessional interactions did not outweigh the time and effort 
required. These challenges were reinforced by interview participants within this study, 
with many stating that the lack of availability of the GP often resulted in delays in resolution 
of issues, with others participants indicating that the time needed to conduct 
interprofessional interactions could result in a loss of business. These issues were further 
compounded with some pharmacists feeling reluctant to interrupt GPs, something which 
has been termed by Bradley (2012) as the ‘pharmacist-GP game’ where pharmacists 
tactically manage and avoid potential conflict in GP interactions.  
 
One method some HCPs (i.e. GPs, dentists and hospital doctors) use to protect their time is 
through the receptionist’s ‘broker’ role (Burt, 2005). This role gives the receptionist the 
ability to facilitate or impede information flow to community pharmacy (Swinglehurst et al., 
2011), perhaps explaining why questionnaire respondents had more frequent interactions 
with receptionists than with any HCP. Although a number of participants recognised the 
importance of the receptionist’s role in protecting HCP time and felt that receptionists can 
help deal with a number of queries, many participants found this a frustrating and slow 
process and indeed some participants cited the receptionist as the main barrier to 
interactions. Although there were a number of reasons for this, some participants felt that 
receptionists continuously tried to ‘get rid of the pharmacist’ primarily because they didn’t 
understand the pharmacist’s role and felt they were just trying to get money rather than 
aiding the patient. This frustration was similarly echoed by interviewees within the Bradley 
(2012) study where the authors found that this ‘broker’ role often resulted in less direct 
communication with HCPs, with many also questioning the ability of receptionists to make 
appropriate judgements relating to the need for pharmacists to access the HCP. 
 
Having more direct access to HCPs was something Van et al. (2011) found improved 
collaboration and helped develop interprofessional relationships, a finding reinforced by 
interviewees within this current study. One technique the Primary Care Workforce 
Commission (2015) believes could improve interprofessional integration is through co-
location of HCPs within the same premises. Unlike in secondary care, where the full 
spectrum of HCPs are situated within the same building, within primary care, different 
professional groups tend to be housed in distinct premises (e.g. the community pharmacy 
vs. the GP practice). In a literature review of factors which foster interprofessional 
interactions in primary care, Xyrichis and Lowton (2008) recognised that having HCPs 
physically co-located alongside one another was vital for achieving successful 
interprofessional teamworking. In recent years, in an attempt to combat the general 
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professional separation seen within primary care, there has been a drive to establish ‘health 
centres’ where a wider clinical offering is delivered by an interprofessional team (Vincent 
et al., 2011). Whilst this is not a new concept, the implementation of health centres has not 
gained the desired traction and therefore NHS England (2014b), the Primary Care 
Workforce Commission (2015) and the Royal Pharmaceutical Society (2017b) have all 
recently emphasised the need to physically integrate HCPs including community 
pharmacists. This lack of physical co-location within primary care was clear within the 
questionnaire data with less than a quarter of respondents indicating that the community 
pharmacy in which they practised was attached to another healthcare provider. For those 
that were co-located, the majority were attached to GP practices (n=77/101). 
 
The benefit of co-locating HCPs is supported by the data in this study. Indeed, pharmacists 
whose working environments were co-located with a GP practice reported significantly 
higher levels of interaction with HCPs similarly co-located within the practice (namely GPs, 
community nurses, midwives and health visitors). This represents the first data which 
identified a positive impact of co-location on frequency of interprofessional interactions 
and has been published within the Journal of Interprofessional Care (see Appendix L for 
abstract) (Jenkins et al., 2016). These quantitative findings were supported by interview 
data with those participants co-located with other HCPs indicating they had increased 
frequency of interactions. These participants felt that by increasing the number of 
interactions through co-location this also increased the level of confidence each HCP had in 
each other’s professional and clinical competence, something McDonough and Doucette 
(2001) also acknowledged in their review of pharmacist-GP collaborative relationships. In 
addition, interviewees recognised a number of other interprofessional benefits to being co-
located alongside other HCPs including having increased opportunity to develop 
relationships with HCPs, the removal of the barrier of the receptionist as they could directly 
interact face-to-face with HCPs, having easier access to HCPs which encouraged 
collaboration (especially with HCPs they wouldn’t generally engage with otherwise) and 
feeling more incorporated into the healthcare team thus reducing the feeling of professional 
isolation reported by a number of interview participants based in distinct premises.  
 
This study found that the majority of community pharmacists’ interprofessional 
interactions take place over the phone. Co-location was however reported to promote 
increased levels of face-to-face interactions with HCPs.  This has been found to help build 
relationships and improve collaboration between pharmacists and other HCPs (Brock and 
Doucette, 2004; Snyder et al., 2010). These finding were reinforced by interview 
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participants who believed that not engaging face-to-face or knowing the HCP personally 
negatively impacted on both the frequency of interaction and the nature of the interaction 
(making interactions shorter and more limited). The data found within the interviews in 
combination with the published frequency data (Jenkins et al., 2016) therefore strongly 
supports the recent drive to move community pharmacists from separate distinct premises 
into larger interprofessional health centres (Primary Care Workforce Commission, 2015; 
Royal Pharmaceutical Society, 2017b).  
 
Of course, culture and norms influence interprofessional practice (Hall, 2005) and therefore 
co-location should not be seen as the panacea for increasing interactions. Indeed, some 
interview participants stated that that co-location was not essential for interactions with 
some HCPs. This was made particularly evident by one participant who stated that their co-
location alongside opticians had no impact on interactions as they still interacted indirectly 
via referral cards. Furthermore, another participant who was co-located with GPs found 
that even with the apparent close-proximity engaging with GPs face-to-face was challenging 
and rarely occurred due to time constraints. Another interesting finding was that face-to-
face interactions with community nurses were seen to occur irrespective of co-location, 
with participants stating that nurses would often make the point of coming into the 
pharmacy to drop off or collect patient prescriptions, however this did occur less frequently 
than when pharmacists were co-located alongside this profession. 
 
One way the Welsh Assembly Government (2015) (and also NHS England (2014b)) aimed 
to reduce interprofessional segregation and further utilise the skills and knowledge of 
pharmacists was rather than associating community pharmacies with GP practices, to 
creation a new role for pharmacists directly in the GP practice. These pharmacists are 
commonly referred to as primary care or GP practice pharmacists. These pharmacists 
directly support the provision of pharmaceutical care out of the GP practice and are not 
involved in the supply of medicines. To do this GP practice pharmacists undertake patient 
consultations to monitor and rationalise patients repeat prescriptions, improve medication 
adherence and conduct specialist reviews (particularly if they are prescribers) to optimise 
patients medications in certain areas (i.e. anticoagulation, diabetes, etc.)(Primary Care 
Workforce Commission, 2015). It seems that this role is starting to become embedded 
within GP practices in Wales with nearly two-thirds of community pharmacists surveyed in 
this study interacting with GP practice pharmacists at least once a month. Whilst the 
Primary Care Workforce Commission (2015) and findings from this study suggest that by 
co-locating pharmacists within GP practices this can help maximise IPIs (Jenkins et al., 
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2016), there is a paucity of literature focused on the interprofessional role of GP practice 
pharmacists and further exploration in this area is needed.   
 
Access to some HCPs, particularly those in secondary care and those with no physical base, 
was seen by participants as a particular barrier. With most interactions reported to be by 
phone or fax, finding the correct contact number for the appropriate HCP was highlighted 
as a real challenge. Some methods suggested to overcome this included creating a central, 
dynamic and comprehensive list of all HCPs, their contact details and the patients they look 
after, providing direct email access to one another or having functional call back systems. 
Another method suggested was the implementation of regular interprofessional meetings 
with HCPs. This method has previously been cited within the literature with Snyder et al. 
(2010) suggesting that face-to-face meetings are important in establishing and maintaining 
communication with HCPs, and McDonough and Doucette (2001) suggesting that having 
periodic face-to-face meetings could enhance personal and professional relationships. Of 
note, multidisciplinary meetings featuring pharmacists was a practice incentivised by the 
2018/19 Collaborative Working Scheme, with community pharmacies eligible for claiming 
a one off payment of £500 if they demonstrated understanding of primary care cluster 
priorities through attendance at primary care cluster meetings (Community Pharmacy 
Wales, 2018).   
 
Another challenge a number of participants faced was that some HCPs were said to be 
unwilling to share patient information. This was most commonly said to be an issue with 
GPs and receptionists and was reported to result in increased challenge in pharmacists 
conducting their clinical role and leaving pharmacists feeling distrusted by their HCP 
colleagues. One way the NHS in Wales is aiming to improve access to patient information is 
through the development of IT systems across primary care which will allow community 
pharmacists and HCPs to work more closely together and share key patient information 
(Primary Care Workforce Commission, 2015). The summary of care record (SCR) system 
currently in place throughout NHS England is analogous where an electronic summary 
of patients’ key clinical information is available (with the patient’s consent) to authorised 
healthcare professionals to support the provision of care. The SCR is currently in place for 
96% of the English population (Pharmaceutical Services Negotiating Commitee, 2018). 
Whilst NHS Wales (2018c) have now introduced a similar system (entitled the ‘Welsh GP 
Record’) across large areas of Wales, access is currently limited to hospital pharmacists, 
technicians, doctors and nurses, and although there are plans to enable community 
pharmacist access to this information this is yet to occur. However, when this is adopted in 
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the near future it is likely that community pharmacists’ IPIs will be impacted. Although 
collaborative interactions such as resolving clinical issues with GPs and nurses are likely to 
continue, other interactions related to the general transfer of patient information may 
decrease in frequency as pharmacists will have more direct and efficient access, bypassing 
barriers such as the GP receptionist. With technological advances continually occurring, 
community pharmacists’ IPIs may have to adapt to other new innovative methods of 
conducting interprofessional practice. A key distinction is that such advances should 
facilitate interprofessional collaboration.  
 
The need to develop and nurture relationships was highlighted by all interviewees. A 
number of participants recognised that where they had poor relationships with other HCPs, 
this often resulted in a general negativity towards interactions from both parties. These 
poor relationships were often for a number of reasons including occasions when the 
pharmacists did not provide resolutions to issues resulting in friction between 
professionals, or due to the demands of the pharmacist resulting in them having to engage 
with large numbers of different HCPs making it challenging to build relationships. 
Participants also commented that their interprofessional relationships improved over time 
and recognised that being on first name terms with HCPs made interactions more 
comfortable, increased trust and improved communication between the HCPs. The concept 
that relationships build over time is not new, with both McDonough and Doucette (2001) 
and Brock and Doucette (2004) recognising this in interactions between community 
pharmacists and GPs. McDonough and Doucette (2001) also acknowledged that having good 
communication skills, being open, empathising and taking time to listen and engage helped 
improve collaborative relationships, points that were similarly raised across in the 
interviews discussed in this study. Interview participants also acknowledged that strong 
personal relationships with the receptionist made liaising less formal and enabled them to 
utilise their broker role to facilitate interactions rather than hinder them. This was 
something that was also found through social network analysis of interviews with 
community pharmacists which explored their interactions with GPs conducted by Bradley 
(2012), who described how pharmacists recognised the importance of building 
relationships with receptionists so that they “facilitated their queries rather than impeded 
them” (pg. 120).  
 
Participants indicated that certain professional groups were easier to forge relationships 
with than others. For example, participants found that dentists generally accepted and 
trusted the pharmacists’ advice and were easy to access, especially when compared to GPs. 
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A profession where relationships were occasionally seen to be difficult was with community 
nurses, with some participants feeling that nurses often believed themselves to be “above” 
the pharmacists, which could possibly be due to a lack of understanding of respective 
professional roles. Previous research has identified that professional background has a 
direct influence on attitudes towards interprofessional working, with Braithwaite et al. 
(2012) reporting that allied healthcare professions had more positive attitude towards IPIs 
and IPE than doctors and nurses, and Reid et al. (2006) and Chang et al. (2009) also 
reporting that doctors viewed interprofessional working less positively than a range of 
other professionals.  
 
The lack of understanding of each other’s professional roles was seen as one of the largest 
barriers to interactions in this study and had a significant impact on the perceived respect 
received from other HCPs which has frequently been recognised as an issue in the literature 
(Hughes and McCann, 2003; Barrett et al., 2005; Larkin and Callaghan, 2005; Kvarnström, 
2008; Baker et al., 2011; Carpenter and Dickinson, 2014). This was an issue that was 
particularly prominent with GPs, with participants believing that some GPs were dismissive 
of the community pharmacists role, with one questionnaire respondent stating that GPs saw 
pharmacists as ‘shopkeepers’ rather than essential healthcare providers, a term which has 
previously been acknowledged in a number of studies which explored community 
pharmacist-GP collaboration and resulted in participants within these studies believing that 
GPs did not value the pharmacists’ advice (Hughes and McCann, 2003; Dobson et al., 2006; 
Van et al., 2011; Bradley, 2012). One participant stated that this was especially prominent 
in community pharmacy, articulating that hospital pharmacists gain more respect from 
doctors. However, whilst pharmacists interviewed by Snyder et al. (2010) also recognised 
resistance to collaboration from doctors, they stressed that they understood that these IPIs 
were for the patients benefit and would therefore continue to push for communication and 
collaboration even when met with resistance. Poor knowledge of professional roles can also 
be detrimental to the patient as participants acknowledged that this can make it difficult in 
determining the appropriate professional to signpost patients, thus leading to possible 
underutilisation of HCPs who are most appropriate to address patient care needs.  
 
In addition to embracing other professional roles, another barrier to interactions is the need 
for HCPs to fully embrace the collaborative models of practice proposed by the NHS and 
professional associations (Department of Health, 2010; Royal Pharmaceutical Society and 
Royal College of General Practitioners, 2011; Primary Care Workforce Commission, 2015). 
Ray (1998), who reviewed the practice of interprofessional working with reference to the 
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pharmacy profession, believes that the professional potential of pharmacists is likely to 
remain unfulfilled and further isolation away from other primary care HCPs could occur if 
pharmacists do not remove themselves from their professional silos. Although many 
pharmacists recognised the need for interactions, it was clear throughout the studies that 
work is still needed to engage more pharmacists in interprofessional practice, with more 
emphasis needed to make this collaborative working the norm rather than a bolt on to 
practice (Carpenter and Dickinson, 2014; Barr et al., 2017).  
 
A number of interviewees expressed the benefits undertaking IPE can have on collaborative 
practice. For those more recent pharmacy graduates who had greater levels of IPE 
experience compared to pharmacists who had been qualified longer (presumably owing to 
the recent requirement made by the GPhC to incorporate IPE in all MPharm courses), they 
felt that the sessions they previously undertook were valuable and beneficial in improving 
their understanding and respect for other professional roles and helped the HCPs involved 
recognise how they could utilise one another’s specific skill sets. These findings 
corresponded with studies by Pollard and Miers (2008) and Pollard et al. (2012) who 
identified that qualified HCPs who had previous undergraduate IPE experience felt better 
prepared for interprofessional working, had more self-awareness of their position in a team 
and had greater awareness of possible barriers to interactions. Participants suggested that 
IPE sessions should be conducted at both undergraduate and postgraduate level and should 
be integrated throughout all four years of the MPharm programme. Participants indicated 
that this repeated exposure to IPE can help enhance the natural development of 
interprofessional collaboration and relationships over time. It has also been recognised by 
Lindqvist et al. (2005), Tunstall-Pedoe et al. (2003) and Carpenter (1995) that HCP students 
rapidly developed strong stereotypical ideas of their own and other professions which 
could be detrimental to collaboration, therefore introducing IPE to the curriculum early 
could help prevent such stereotypes developing. In addition, by incorporating IPE across 
the MPharm programme this would create a spiral curriculum design (see Harden and 
Stamper (1999)) enabling students to progress their interprofessional skills as they 
navigate the programme. This could also further align schools with the MPharm programme 
requirements set by the General Pharmaceutical Council (2011) for both incorporation of 
IPE and the development of a spiral curriculum.   
 
Participants also made suggestions relating to the IPE they would like to see conducted 
which included engagement with doctors and/or nurses. There were also suggestions for 
the focus of these sessions including the management of patients and their medications, 
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dealing with difficult HCPs and personal management skills. It became clear from both the 
findings of this study and the literature that conducting IPE with doctors and nurses 
particularly would be beneficial in helping remove a number of barriers identified including 
the negative attitudes of HCPs towards engaging in IPIs with pharmacists and the GPs’ 
negative perception of the role of the pharmacist (Hughes and McCann, 2003; Barrett et al., 
2005; Larkin and Callaghan, 2005; Reid et al., 2006; Kvarnström, 2008; Thistlethwaite and 
Moran, 2010; Baker et al., 2011; Braithwaite et al., 2012; Carpenter and Dickinson, 2014).  
 
Another theme that emerged from interviews was the need to ensure that IPE is meaningful 
and relevant to each profession taking part, a key factor recognised elsewhere in the 
literature, with Barr et al. (2017) believing that if this is not achieved IPE can cause more 
harm than good. Whilst it was evident throughout the interviews that interprofessional 
interactions occurred organically even when participants had undertaken little or no 
training in interprofessional working, it was also clear that there was much room for 
improvement. In providing IPE that is relevant to the practice of community pharmacists 
this could help foster interprofessional interactions and relationships and ultimately 
increase the frequency with which they are undertaken. The delivery of formal IPE could 
also be valuable in developing mechanism for HCPs to learn from one another in practice 
given participants had mixed opinions on whether they learnt from HCPs in practice. A 
number of participants felt that each interprofessional interaction should be viewed as a 
learning opportunity and articulated that they learnt from HCPs most days. It was evident 
during the interviews that GPs were the profession pharmacists learnt from most often, 
particularly when it came to the introduction of new guidelines and treatments, followed by 
community nurses who taught pharmacists about dressing, wounds and vaccinations. Some 
participants stated that they did not learn anything from any HCPs due to time constraints 
in practice, however, many also recognised that even if direct learning from HCPs did not 
occur IPIs regularly prompted self-directed learning to react to queries or issues discussed.   
 
Throughout this study it was evident that interactions between HCPs were varied. Some 
pharmacists clearly had frequent and productive engagement with a range of HCPs, 
whereas others had very little interprofessional interactions and tenuous relationships with 
other HCPs. This therefore highlights an opportunity for a range of facilitators including co-
location of HCPs and the incorporation of relevant IPE to help enhance this 
interprofessional collaboration by developing of interprofessional relationships and 
improving the understanding of one another in practice.  
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5.4.1. Limitations 
The mixed method approach used in this study aimed to utilise the benefits of both 
qualitative and quantitative methods and thus reduce the limitations of undertaking a single 
methodological approach (Johnson and Onwuegbuzie, 2004). However, a number of 
limitations remained.   
 
Within stage one (questionnaire) although a response rate of 61.9% was achieved, a greater 
response rate would have been beneficial in aiding the generalisabilty of the data (Babbie, 
2015c). In addition, as the questionnaire was used to gather participants’ self-reported 
(perceived) frequency of interactions with other HCTMs this may have resulted in possible 
recall bias and thus under or over reporting compared to actual practice. This margin for 
error within the data is important to recognise when analysing the statistics, with the data 
being valuable as a guide to the variations in pharmacists’ interaction frequency rather than 
a definitive figure. 
 
The questionnaire tool itself may also have been limited by participants understanding of 
the questions. This was particularly relevant for section A (the demographic questions), for 
example respondents were asked about the number of GP practices they ‘regularly’ worked 
with in a typical week, therefore the term regularly may have been perceived in a different 
way by respondents. This question was also based on the pharmacists’ knowledge of this 
which may have been varied. Additionally, the terms for the locality of the pharmacy were 
highly descriptive (honed during piloting) and therefore respondents perceptions of these 
may have varied. This may have similarly been the case surrounding the understanding of 
whether the pharmacy was ‘directly attached’ to another healthcare provider.   
Furthermore, whilst the term ‘interaction’ was broadly defined as any communication 
pharmacists had with HCPs participants may have interpreted this differently and possibly 
interpreted this as clinical interactions rather than other more general communication. The 
interviews were later used to triangulate the data gathered here and could help clarify the 
topic of interactions.  
 
Furthermore, whilst the chi-squared tests determined where statistical differences were 
between the non-parametric data, the test did not determine the direction or cause of this 
difference therefore visual comparisons where needed identify this. As this is a manual 
method of analysis this has a risk of error and although this was aimed to be reduced by 
having a number of research team members undertaking the processes this cannot be fully 
mitigated.   
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A limitation of stage two of the study (semi-structured interviews) also related to 
participant recruitment. As the study progressed it became clear that recruiting 
participants from North and West Wales was not practicable due to a number of factors 
including distance, time and response to participation requests. Therefore although the 
study achieved a strong repetition of themes (Malterud et al., 2015) participants from these 
demographic areas may have had different views on IPIs due to variations in pharmacy 
locations (possibly rural) and the provision of services, as well as the use of the Welsh 
language in conducting interactions. Furthermore, as results were based on personal 
experiences it is difficult to conclusively state that recruitment of more participants in 
general would not have impacted the data and themes generated (Morse et al., 2002; Bowen, 
2008; Corbin and Strauss, 2008). 
 
One limitation in this study was that the researcher who designed the interview schedule 
and conducted data analysis (the thesis author) did not directly undertake the interviews 
(these were conducted by a final year MPharm student). This may have resulted in possible 
loss of unspoken or implied data provided through body language and other social cues 
(Babbie, 2015d). Additionally, as discussed in chapter 4 the researchers personal views and 
experience impacts qualitative research, therefore although the thesis author undertook all 
other aspects of the project (including interview schedule design and analysis) the semi-
structured nature of the interview may have resulted in the student probing different areas 
than if undertaken by the thesis author. The students limited experience within practice and 
in the research area of interprofessional collaboration and education where particular areas 
that differed significantly to the thesis author. Furthermore, as a student the interviewees 
responses may have differed than if interviewed by a qualified pharmacist ‘peer’ (i.e. the 
thesis author) as they may have felt inclined to provide further explanation of topics they 
believed the student had reduced understanding of. These limitations were aimed to be 
reduced by providing the student with thorough interview training and supervised pilots, 
as well as the thesis author reflecting on the interviews in advance of the next interview. 
 
A further limitation to the interview approach is that of demand characteristics. This is 
where, according to Orne (1962), participants make inferences as to the purpose of an 
experiment and respond either accordingly or in contrary to the perceived purpose of the 
study as a result of environmental cues (such as the interviewer’s body language, tone of 
voice, and facial expressions (Kirk, 1982)). This can result in participants aiming to ‘please’ 
the interviewer by providing responses they believe are of value. Furthermore, as 
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interviews were conducted in the participant’s workplace (for convenience) this meant that 
distractions and disruptions which could impact the data gathered (Babbie, 2015d) 
occasionally occurred, particularly as 13/14 participants were the sole responsible 
pharmacist within their stores resulting in a number of issues/queries being directed to 
them during the interview.  
 
Another limitation to both stages of this study was that the study population centred solely 
on pharmacists within Wales, and although the GPhC regulates pharmacists from across the 
UK and therefore there will be many similarities with other UK countries, as NHS healthcare 
is devolved into the four UK countries there may evidently be some differences in 
pharmacists interprofessional practice. Further work would be required in order to explore 
these similarities and differences.    
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5.5. Conclusion 
This study has provided a greater understanding of the IPIs community pharmacists 
undertake in practice. Stage one (questionnaire) identified the HCPs community 
pharmacists most frequently interacted with, namely GPs and community nurses based in 
GP practices and dentists often based in distinct primary care premises. Stage two (semi-
structured interviews) determined the topics and mode of interactions, which often varied 
between being clinical and practical issues which were mainly addressed over the phone. 
Interactions with GPs, nurses and dentists tended to be collaborative to ensure patients 
were prescribed the appropriate medications. IPIs with secondary care HCPs were less 
frequent than with primary care HCPs and were often relates to transfer of patient 
information rather than collaborative working. When community pharmacists operated in 
premises that were co-located with GP practices, their reported levels of interaction were 
significantly more frequently with those HCPs similarly co-located i.e.  GPs, community 
nurses, midwives and health visitors and were more commonly face-to-face in nature. Co-
location also helped reduce a number of barriers to interactions recognised throughout the 
interviews including limited access to HCPs and the broker role of the receptionist, although 
barriers such as time constraints were not observed to benefit from this physical co-
location. One method suggested by participants in the study to improve IPIs was the 
incorporation of relevant and meaningful IPE into undergraduate and postgraduate 
education and most preferably with doctors and nurses. It was felt these sessions could aid 
understanding of and respect for one another’s professional roles and improve 
communication skills, both factors participants suggested were facilitators of 
interprofessional collaboration. In addition, many participants commented that 
interprofessional relationships improved over time and therefore suggested that 
implementing IPE as early as possible into the MPharm curriculum and continuing this into 
postgraduate education could prevent the development of professional stereotypes. 
Although community pharmacists were seen to engage with other HCPs it is clear that 
further work is needed to achieve fully integrated and collaborative interprofessional 
practice.  
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Chapter 6 - Which healthcare professionals do hospital 
pharmacists work with? 
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6.1. Introduction 
Although ‘treatment’ modalities related to diagnostics, surgery, imaging and devices have 
advanced in recent years, medicines remain the most common therapeutic intervention. 
Over 97% of patients residing in hospital take medicines (NHS Wales, 2018a) with £800 
million spent on prescribed medicines in Wales each year and the number of prescribed 
items having increased by 46% in the 10 years prior to the report conducted by the Auditor 
General for Wales (2016). Medicines are also associated with waste estimated to cost some 
£10 million per annum in Wales (National Assembly for Wales, 2018). The Auditor General 
for Wales (2016) has also highlighted the potential for around £8.3 million in savings 
through improved prescribing practices. As such, the safe and effective management of 
medications along with their prudent use is a crucial aspect of providing the best care 
possible to patients. Much like within community pharmacy, the role of the hospital 
pharmacist has expanded in recent years and has moved away from the practical tasks that 
have historically been associated with pharmacy such as dispensing medications 
(Department of Health, 2010; Carter, 2016). Whilst progress has been made towards 
pharmacists providing clinical patient facing services in the secondary care sector, Carter 
(2016) has suggested that further progress is needed to ensure pharmacists are removed 
from some of the historic technical roles such as purchasing, storage, manufacture, quality 
testing and supply of medicines in the hospital, as they are a poor use of pharmacists’ time 
and skills. To do this they stated that trusts should undertake a ‘Hospital Pharmacy 
Transformation Programme’ to ensure that “hospital pharmacies achieve their benchmarks 
such as increasing pharmacist prescribers, e-prescribing and administration, accurate cost 
coding of medicines and consolidating stock-holding by April 2020 so that their pharmacists 
and clinical pharmacy technicians spend more time on patient-facing medicines 
optimisation activities” (pg. 9)(Carter, 2016). 
 
Ultimately, hospital pharmacists must be employed within the secondary care setting to 
best utilise their skills as experts in medicines and to ensure they have a direct influence on 
the clinical care provided to patients. One key role pharmacists undertake is ensuring each 
medication is appropriate for the patient. Pharmacists will consider a number of  factors 
including the dose, route of administration, potential adverse effects, interactions with 
existing medications, contraindications in patients with certain conditions (such as cardiac 
failure, renal disease or liver disease) or if pregnant/breastfeeding and the patients’ general 
lifestyle (NHS Wales, 2018a). In order to fulfil this role, pharmacists commonly carry out 
daily ward rounds where they utilise multiple sources of information including the patient’s 
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drug charts and notes as well as interacting with the patients themselves and with other 
HCPs. In addition to conducting their own ward rounds, pharmacists are increasingly 
involved in interprofessional ward rounds and MDT meetings. These provide pharmacists 
the opportunity to have direct interaction with other HCPs where they can provide expert 
advice about a patient’s medications and deliver interprofessional holistic patient care. 
 
Adjunct to the provision of daily inpatient care is the management of patients’ mediations 
on both admission and discharge. When patients are admitted to hospital, pharmacists have 
a role in ensuring that the medication patients receive in hospital reflects and is a 
consequence of that received within the community. Therefore, pharmacists often conduct 
medicine reconciliations where they utilise multiple sources of information including 
primary care records and HCPs to accurately align medications as patients traverse across 
sectors. In addition, hospital pharmacists manage patients’ discharge prescriptions, 
ensuring that patients are appropriately supplied with and counselled on their medications 
and that any information relating to changes in a patient’s medications, such as reasons for 
medications stopping or starting, is transferred to the relevant primary care practitioners 
(NHS Wales, 2018a). This role in transferring information between HCPs helps ensure 
continuity of care across the secondary and primary healthcare sectors, with the 
importance of timely and accurate information transfer vital in preventing hospital 
(re)admissions (Ham et al., 2010). The expansion of the clinical pharmacist role has also led 
hospital pharmacists to take on roles outside of the ward environment in areas such as the 
emergency department and outpatient clinics where advanced practitioner pharmacists 
(often independent prescribers) can build up their specialist skills in assessing and 
managing patients with pharmaceutical interventions (NHS Wales, 2018a). Whilst some 
expansion in these areas has occurred there is clearly room for further involvement of 
pharmacists, particularly since a study commissioned by NHS Health Education England 
(2016) found that of the 18,613 patient cases examined within emergency departments, 
36% had the potential to be clinically managed by a pharmacist.  
 
Consistent with the maturation of the clinical pharmacist role in secondary care has been 
the need for pharmacists to engage in multidisciplinary collaboration with other HCPs 
(Kaboli et al., 2006; Carter, 2016). This has partly been driven by workforce demands and 
the drive to integrate the health workforce led by the World Health Organisation (2010) but 
also as a consequence of a number of inquiries within NHS trusts (Francis (2013), Andrews 
and Butler (2014), Kirkup (2015) and Carter (2016)) which have documented exemplars of 
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ineffective interprofessional team working in hospitals that has directly resulted in poor 
patient care.   
 
As a profession that was primarily focused on the supply of medicines against a prescriber’s 
orders, it has taken time to integrate pharmacists into multidisciplinary clinical teams 
within both primary and secondary care. There is evidence however that multidisciplinary 
team work is becoming embedded in the role. For example, in a recent survey by the General 
Pharmaceutical Council (2018b), pharmacists indicated that providing information and 
advice to HCPs was their primary activity. Interprofessional integration not only supports 
better patient care but it also affords professional growth. For example, in a study 
conducted by Rosenthal et al. (2010b) the role of the hospital pharmacist was often found 
to be impersonal.  However, when pharmacists were integrated within the interprofessional 
team they were better appreciated by both patients and colleagues as they had a greater 
understanding of their own role within the wider healthcare team. 
 
This drive to further integrate pharmacists within the interprofessional team has been 
reinforced by the Royal Pharmaceutical Society (2017c) in their Professional Standards for 
Hospital Pharmacy Services document. This document highlighted the need for pharmacists 
to work regularly alongside doctors, nurses and other members of interprofessional team 
to give clinical advice on the appropriate selection of patients’ medications. In a separate 
document (the Pharmacy Workforce Summit Report) they also believed that in order to do 
this  pharmacists’ roles and responsibilities need to be better promoted and articulated to 
ensure that HCPs have a greater understanding of the value pharmacists bring to the 
interprofessional healthcare team (Royal Pharmaceutical Society, 2017b).  
 
Although there are a variety of UK studies that have explored community pharmacists’ 
interactions with general practitioners (GPs), little is known about pharmacists 
interprofessional interaction in the hospital environment. One area of limited literature 
surrounds hospital pharmacists’ role in liaising with healthcare professionals in the 
primary care setting when patients are discharged from hospital (Eggink et al., 2010). The 
seminal paper in this area was a systematic review of pharmacists’ clinical interventions 
conducted by Kaboli et al. (2006). Whilst the review reported that the hospital pharmacists’ 
role in reconciling medications and aiding the discharge process improved patient 
outcomes, the studies included in the review did not identify the nature of the 
interprofessional interactions or activities that were necessary in order to ensure 
continuity of care. Only a very limited number of studies have aimed to address hospital 
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pharmacists’ interactions with other HCPs (namely hospital doctors and nurses) but include 
(i) a study by Makowsky et al. (2009b) who conducted key informant interviews and 
reflective journaling from pharmacists, doctors and nurse practitioners to explore the 
interprofessional working relationships when providing team-based care in hospitalised 
medical patients in Canada and (ii) focus groups with Australian nursing, pharmacy, and 
medical recent graduates conducted by Wilson et al. (2016) which aimed to determine their 
perspectives and experiences of interprofessional collaborative practice and medication 
safety. 
 
Given that hospitals contain a wide spectrum of HCPs all co-located in the same building, it 
might be assumed that the environment naturally promotes pharmacists’ interprofessional 
collaboration (as found for pharmacists in the primary and community sectors (Jenkins et 
al., 2016)). However, it is difficult to understand if this is the case given the paucity of 
published research identifying the frequency and nature of interprofessional interactions 
that take place in the hospital environment.  This lack of knowledge of the current landscape 
makes it difficult to ascertain where development or improvements to current practice or 
education and training are needed in order to embed effective interprofessional, patient-
centred care that improves patient outcomes.  
 
This mixed method study therefore aims to explore the interprofessional interactions that 
take place between hospital pharmacists and other HCPs during their current scope of 
practice and to explore pharmacists’ views on the value of IPE. The approach adopted is in 
two stages: (i) a self-complete questionnaire administered to all hospitals containing 
dedicated in-house pharmacy departments in Wales to determine hospital pharmacists’ 
reported frequency of interaction with HCTMs; (ii) face-to-face semi-structured interviews 
with a number of hospital pharmacists based across a range of hospitals in Wales to explore 
the nature of IPIs and to determine the value they place on IPE.    
 
These two sequential elements aimed to identify and/or explore hospital pharmacists’ 
(based within Wales) perceived views in a number of areas including: 
1. Hospital pharmacists’ perceived frequency of interactions with other HCTMs 
2. Hospital pharmacists’ perceived topic of interprofessional interactions with other 
HCPs 
3. The mode through which hospital pharmacists perceived their interprofessional 
interactions with other HCPs took place (e.g. by telephone, face-to-face) 
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4. The perceived facilitators and barriers to hospital pharmacists interprofessional 
interactions with other HCPs 
5. The perceived value hospital pharmacists place on IPE 
6.  Hospital pharmacist’s opinions on the design and implementation of relevant and 
meaningful undergraduate/postgraduate pharmacy related IPE.  
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6.2. Methods  
In order to pragmatically and thoroughly address the research aims, to determine and 
explore hospital pharmacists’ interprofessional interactions (IPIs) and the value they place 
on IPE, the use of mixed methods was chosen as this attracts benefits from both quantitative 
and qualitative methodological approaches (Johnson and Onwuegbuzie, 2004). The study 
was conducted in two parts:  
 
Stage one – Questionnaire: The first stage of this study sought to quantify the reported 
frequency of interactions between hospital pharmacists and other healthcare team 
members (HCTMs) using a self-complete questionnaire which was administered to all 
hospitals in Wales containing dedicated in-house pharmacy departments. 
 
Stage two – Semi-structured interviews: Informed by results from stage one, semi-
structured interviews were conducted with hospital pharmacists to elucidate the nature of 
the IPIs in which they engage and to determine the perceived value of IPE.    
 
A broad overview of the methods employed for both community and hospital pharmacists 
is described in chapter 4 – General Methods. The following section however provides 
specific detail on the methods employed here.  
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6.2.1. Stage one – Questionnaire determining hospital pharmacists’ frequency of 
interaction with other healthcare professionals and wider team members 
This section describes the specific methods for the design, recruitment and dissemination 
of a questionnaire to hospital containing dedicated in-house pharmacy departments in 
Wales which sought to determine the frequency of interaction between hospital 
pharmacists and other HCTMs (comprising of HCPs and wider healthcare team members).  
6.2.1.1. Questionnaire design 
A questionnaire was developed to determine hospital pharmacists’ reported frequency of 
interactions with other HCTMs. This questionnaire was adapted from the questionnaire 
used to determine the frequency of interactions between community pharmacists and 
HCTMs (see chapter 5). The questionnaire was piloted (see chapter 4.3.5) and validity was 
determined to be 0.880 (see chapter 4.3.6). The questionnaire consisted of three sections 
(see Appendix M). Section A sought to determine demographic information about the 
respondent including the hospital the respondent worked in as well as details surrounding 
the respondent’s role including their speciality (e.g. cardiology/aseptics/etc.) and the 
setting in which they primarily worked (e.g. ward/office based/etc.). In section B 
respondents were asked to indicate their reported frequency of ‘direct personal interaction’ 
with each of a list of 29 HCTMs using a 6-point ordinal scale (at least once a day, at least 
once a week, at least once a month, at least once a year, less frequently, never). The list was 
adapted from that used in the community questionnaire to ensure relevancy to secondary 
care. This meant separating the hierarchical roles of hospital doctors and including the ‘drug 
and alcohol team’; a full list of all 29 HCTMs provided can be found in Table 6.1.  
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Table 6.1. List of the 29 HCTMs, identified from the NHS careers website and previous community 
questionnaire, included in section B of the questionnaire, categorised according to their sector of 
practice 
Primary care HCTMs based in GP practice 
Drug and alcohol team^ General practitioner (GP) GP practice manager 
GP receptionist Health visitor^ Midwife^ 
Nurse - Community Pharmacist - Community Pharmacist - Primary care 
Primary care HCTMs based outside the GP practice 
Care home staff Dentist Optician 
Vet   
Secondary care HCTMs 
Dietician^^  Doctor - Consultant Doctor - Junior (FY1/FY2) 
Doctor - Registrar (ST1-3) Nurse - Hospital Occupational therapist^^ 
Paramedic^^ Physiotherapist^^ Podiatrist^^ 
Radiographer^^ Social worker^^ Speech and language therapist^ 
Hospital pharmacy HCTMs 
Accredited checking technician^^ Dispenser/Technician^^ Medicines counter assistant^^ 
Pre-registration Pharmacist^^   
^ = HCTMs which can also have a role in secondary care 
^^ = HCTMs which can also have a role in primary care 
 
A free text box was also provided in section B where respondents could list any ‘other’ 
professionals they interact with in addition to those listed. Section C allowed respondents 
the opportunity to provide any comments they had with respect to the interprofessional 
interactions they undertake. 
6.2.1.2. Sampling and dissemination 
To ensure that responses collected were representative of the hospital pharmacist 
population within Wales, purposive sampling (Babbie, 2015c) was used. The aim was to 
reach all pharmacists working within Welsh hospitals that contain dedicated in-house 
pharmacy departments. A list of 18 hospitals across six Welsh LHBs which contained 
pharmacy departments was identified from the NHS Wales (2016) website and was 
corroborated by contacting senior pharmacists within each health board. Additionally, 
Velindre hospital in Cardiff (a specialist cancer hospital not directly associated with the 
Welsh NHS LHBs) was also invited to take part due to the hospital employing a number of 
hospital pharmacists. Of note, one Welsh LHB, Powys Teaching Health Board, did not have 
any hospitals containing dedicated pharmacy departments and subsequently did not 
directly employ any hospital pharmacists at the time of the study. Gatekeepers acting as 
‘project champions’ were utilised within each hospital. Gatekeepers were identified and 
recruited through either the All Wales Patient Safety and Quality Group or the Chief 
Pharmacist within the hospital or health board. All gatekeepers were pharmacists working 
within the hospital and often had a role which included research and development.  
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Once gatekeepers were recruited for all 19 hospitals they were asked to provide the number 
of pharmacists working within the hospital (where exact numbers were unknown estimates 
were given).  Gatekeepers were then directly mailed a package that comprised 
questionnaires (see Appendix M) and cover letters (see Appendix N) sufficient for the 
reported number of pharmacists within the hospital (plus an additional 10%). The 
gatekeeper was then responsible for disseminating the questionnaire and cover letter to all 
pharmacists within the hospital and for collecting and returning them to the research team 
upon completion.  To do this they were asked to send out a recruitment email informing 
their hospital pharmacist colleagues of the project; a template email was provided 
(Appendix O). An electronic version of the cover letter was also attached to the email to 
provide further information on the study. The cover letter indicated that respondents 
needed to be a qualified pharmacist who worked within that specific hospital for a minimum 
of two days a week to ensure they had a good understanding of the interprofessional 
interactions that are characteristic of the hospital in which they practise. 
 
The date on which the questionnaires were disseminated varied for each hospital and was 
dependent on gatekeeper availability.  Generally, dissemination took place over a 6-week 
period per hospital between March and July 2016. Gatekeepers were prompted to 
disseminate a reminder email three weeks after the initial recruitment email. Responses 
were collated by the gatekeepers and sent back to CSPPS for analysis. Questionnaires were 
uniquely coded so that the research team was aware of which hospital’s responses had been 
received and could identify those gatekeepers where reminders were required.  
6.2.2. Stage two – Semi-structured interviews exploring the nature of 
interprofessional interactions between hospital pharmacists and healthcare 
professionals  
Following the questionnaire element of the study, which identified the frequency of 
interaction between hospital pharmacists and other healthcare professionals and team 
members, a qualitative approach was employed to explore the nature of these interactions, 
specifically the HCPs hospital pharmacists interacted most frequently with. This was 
achieved through face-to-face semi-structured interviews with a variety of hospital 
pharmacists. The interviews focused on a number of broad topic areas including: (i) 
identifying the HCP which they interact with most frequently; (ii) the mode by which their 
interprofessional interactions take place; (iii) the content of their interprofessional 
interactions; (iv) barriers and facilitators to interprofessional interactions; (v) the 
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participants’ views on IPE. This section describes the specific nuances for conducting these 
interviews, however a broad overview of the methods used for these interviews can be 
found in chapter 4. 
6.2.2.1. Participant recruitment 
Purposive, snowball sampling was used to recruit pharmacists with a range of experiences 
and demographic characteristics across Wales. Recruitment continued until the sample size 
was sufficiently large and varied to ensure data encompassed views across the hospital 
sector and constant comparison methodology identified strong repetition of data and 
themes and study aims had been achieved (Bowen, 2008; Malterud et al., 2015) (see chapter 
4).  
 
The data gathered from stage one of this study (the questionnaire) and findings from the 
community pharmacist study (see chapter 5) informed the design of the interview schedule 
and the recruitment process to ensure that data gathered was meaningful and 
representative of the overall hospital pharmacist population in Wales (Creswell and 
Creswell, 2017). The initial recruitment phase aimed to identify a number of suitable 
pharmacists across a range of demographic categories that included: (i) the hospital thst 
participants worked (including size of hospital); (ii) the health board of the hospital; (iii) 
length of time working within the hospital; (iv) participants’ speciality (e.g. surgery, 
cardiology, etc.); (v) participants’ current professional grading (NHS banding); (vi) depth of 
experience of interprofessional education; (vii) the location of the participants pre-
registration training; (viii) participants previous community experience; (ix) university of 
study and (x) the year participants graduated from university. The Aneurin Bevan 
University Health Board was excluded from the study as ethical approval was not 
forthcoming. As within stage one of this study (see section 6.1.2.1) Powys Teaching Health 
Board was also excluded as none of the hospitals within this LHB contained a dedicated 
pharmacy department.  
 
Participant recruitment was generally through the gatekeepers used within stage one 
(questionnaire) of the study as they were able to suggest possible participants who 
regularly worked within the hospital at least two days a week and fit the demographic 
characteristics required. The gatekeepers provided potential participants with the study 
cover letter (see Appendix P) and information sheet (Appendix Q). Upon receipt of this 
information if potential participants were interested in taking part the gatekeeper provided 
the research team with the potential participant’s email address in order that a formal 
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recruitment email could be sent. The email detailed a proposed interview time (often pre-
arranged through the gatekeeper), provided a consent form (see Appendix R) and a copy of 
the information sheet and cover letter (for completeness). Written consent was then 
obtained from the participant on the day of the interview.  
 
At the end of each interview, participants were asked if they could recommend possible 
interviewees who fulfilled other desired demographic criteria to broaden the population 
(purposive, snowball sampling).  
6.2.2.2. Interview setting 
Interviews were conducted face-to-face in each pharmacists’ hospital. The gatekeeper 
helped to arrange a suitable quiet space for the interviews to ensure the interview was free 
from distractions and the recording was of a high quality (King and Horrocks, 2010a). As 
the interviews were specifically related to the participant’s experiences in that hospital, 
conducting interviews in the workplace environment may have been beneficial in aiding the 
participant’s recall of interactions (Coughlin, 1990).   
6.2.2.3. Interview Schedule Data Collection 
The interview schedule (see Appendix S) was developed based on: (i) the interview 
schedule developed for the community interviews (see chapter 5); (ii) data gathered in 
stage one of this study; (iii) existing literature on pharmacist interactions with other 
healthcare practitioners and (iv) the personal knowledge of the researcher within the field 
of pharmacy. The interview schedule was separated into four parts (sections A to D).  In 
section A, participants were asked about their current and previous experience of pharmacy 
practice. The questions were brief and aimed to ease the participant into the interview 
(Kvale, 2007). Section B comprised a reflective ‘ranking exercise’ that was used to help the 
participant reflect upon their own interprofessional practice within their current role and 
help immerse the participant in the interview. In this exercise participants were asked to 
rank cards labelled with fifteen relevant HCPs (see Table 6.2) based on their reported level 
of interaction with these HCPs. The members of the wider healthcare team such as 
pharmacy dispensers, GP receptionists and other pharmacists were excluded from this 
exercise (for an explanation see chapter 4). 
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Table 6.2. List of the 15 HCPs identified from the NHS website included in the ranking exercise 
Dentist Nurse Podiatrist 
Dietician  Occupational therapist (OT) Radiographer 
Doctor Optician Social worker (SW) 
Health visitor (HV) Paramedic Speech and language 
therapist (SALT) 
Midwife Physiotherapist (Physio) Vet 
 
In section C of the schedule, participants were asked about their interactions with hospital 
doctors, hospital nurses and dietician i.e. the three professions identified in stage one of the 
study as those with which respondent hospital pharmacists indicated they interacted with 
most frequently (see section 6.3.1 for stage one results). In addition, if during the ranking 
exercise any participant indicated that one or more of their top three interactions was with 
a different HCP, the interactions with the additional HCPs was also explored. The final part 
to the interview, section D, included general questions about interprofessional working and 
the participant’s past experiences of IPE.  
 
The questionnaire was piloted (n = 3) and a number of refinements were made based on 
the feedback around the wording and structure of the demographic questions. 
 
In a number of cases, multiple interviews were conducted on a single day at a particular 
hospital site; this was for the purposes of convenience. Where this occurred, a one hour 
break between interviews was used to enable time for reflection on the previous interview 
and adaptation of the interview schedule where appropriate (King and Horrocks, 2010a; 
Babbie, 2015a). All interviews were transcribed verbatim by the thesis author and were 
reviewed on three occasions to ensure final transcripts were accurate and representative 
(Babbie, 2015a). The aim was for all transcriptions to be completed before the next 
interview(s) took place to aid the reflective process (King and Horrocks, 2010a). Further 
details on the general methodology employed including deductive and inductive thematic 
analysis approaches can be found in chapter 4. 
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6.3. Results  
As with study methods (see section 6.2), the results have been separated into the two 
research stages: (i) stage one - questionnaire; (ii) stage two - semi-structured 
interviews. 
6.3.1. Stage one – Questionnaire determining hospital pharmacists’ frequency of 
interaction with other healthcare professionals and wider team members 
In this study, purposive sampling was used to determine the frequency of interactions 
between pharmacists and other HCTMs (comprising of HCPs and other staff within the 
healthcare team) from a cross section of hospital pharmacists regularly practising in Wales. 
To achieve this ‘gatekeepers’ were utilised to disseminate the questionnaire to all hospital 
pharmacists (approximately 520) within each of the 19 hospitals in Wales containing in-
house pharmacy departments.  
6.3.1.1. Response rate 
In total, from the estimated population of 520 pharmacists across the hospitals surveyed, 
270 questionnaires were returned giving an overall (estimated) response rate of 51.9%.  
6.3.1.2. Respondent demographics 
Section A of the questionnaire was concerned with collecting demographic data related to 
the responding pharmacist and the hospital in which they practise. This was focused on five 
particular areas: (i) the health board associated with the hospital they worked in; (ii) the 
size of hospital; (iii) the participant’s NHS grading (banding); (iv) any particular specialism, 
and (v) the particular environment (e.g. ward, office etc) in the hospital they work in. All 
270 participants completed each of the five questions in this section. Respondents could 
provide multiple responses to the questions (iv) and (v), therefore a secondary question 
asked them to state their primary specialism and environment. These follow up questions 
yielded lower responses; primary specialism (n=226/270), regular working environment 
(n=256/270).  
6.3.1.2.1. Spread of respondents across Local Health Boards 
Whilst the estimated number of hospital pharmacists in each LHB varied significantly 
(range 15 – 116) the percentage of pharmacists responding by board was generally 
consistent across six of the seven LHBs (including Velindre)(range 50.4 – 68.8%), however 
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Cardiff & Vale UHB had a much lower response rate of 24.3%, impacting the overall mean 
and standard deviation across the LHBs (51.9  15.4%) (see Table 6.3). Completed 
questionnaires were received from all 19 hospitals surveyed, with the number of 
respondents per hospital ranging from 6 to 33 responses. Details of responses per hospital 
have not been individually presented in order to preserve anonymity. 
 
Table 6.3. Distribution of hospital pharmacist respondents (n=270) across the Welsh Local Health 
Boards  
Local Health Board 
(LHB) 
Number of 
respondents 
(n=270) 
Percentage of 
total (%) 
Number of 
pharmacists 
in each LHB 
(approx.) 
Percentage of 
pharmacists 
responding (%) 
Abertawe Bro 
Morgannwg 
58 21.5 115 50.4 
Aneurin Bevan 33 12.2 48 68.8 
Betsi Cadwaladr 76 28.1 116 65.5 
Cardiff & Vale 28 10.4 115 24.3 
Cwm Taf 40 14.8 70 57.1 
Hywel Dda 25 9.3 41 61.0 
Velindre* 10 3.7 15 66.7 
Velindre* = not technically not a Welsh LHBs, however included due to presence of a in-house 
dedicated pharmacy department within the hospital 
6.3.1.2.2. The size of hospital each pharmacist work within 
Respondents were asked to describe the size of the hospital they worked within based on 
the number of beds. Figure 6.1 indicates that the highest number of respondents worked 
within a hospital with 500 to 700 beds with smaller hospitals, (fewer than 299 and 300 to 
499) representing less respondents. This also provided a sense check as responses could be 
correlated with the known size of each hospital - all respondents stated size aligned with 
the known size for their specific hospital. 
 
 
Figure 6.1. The size of the hospital each pharmacist (n=270) worked within  
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6.3.1.2.3. The grade of the pharmacist in the hospital 
Respondents were asked to state their grade within the hospital based on NHS banding (a 
pay scale ranging from band 6 to band 9 for qualified pharmacists). Respondents were 
primarily at band 8 (n=177; 66%) with just one respondent a band 9 pharmacist and four 
respondents additionally indicating that they were pre-registration pharmacists (band 5) 
(see Figure 6.2). 
 
 
Figure 6.2. The grade of the pharmacist (n=270) within the hospital  
*Other = Band 5 pre-registration pharmacists (trainees who are not yet fully qualified) 
6.3.1.2.4 Respondents’ specialist area of practice  
Respondents were asked to identify all the specialisms they undertake and their primary 
specialism if more than one. Although all respondents indicated they have specialism 
(n=270), just 226 (44 missing) indicated their primary specialism, with 16 stating they did 
not have a specialism.   
 
In total 17 specialisms were listed within the questionnaire, with only one, ‘complex health’, 
that was not selected by any respondents. In addition, 102 respondents stated 27 ‘other’ 
specialisms not directly listed within the questionnaire, with 68 of these respondents 
indicating one of these ‘others’ as their primary specialism. In total 43 specialisms were 
reported by respondents, 39 of which were at least one respondent’s primary specialism. 
Figure 6.3 shows all those specialisms that at least five respondents undertook and also 
highlights the number of respondents who stated each as their primary specialism. In 
addition to Figure 6.3 there were 18 other specialisms stated by less than five respondents.  
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 Figure 6.3. The specialisms more than five hospital pharmacist respondents undertook and the number of times these were respondents’ primary specialism 
*These were specialisms that were not listed within the questionnaire and were stated by respondents in the ‘other’ section
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6.3.1.2.5. The environment in which the respondent practises 
The environment in which each pharmacist practised was also explored; respondents had 
the opportunity to indicate more than one environment. This resulted in 629 selections 
across all participants (n=270), with the ward being the most frequent working 
environment (222/270). Although all respondents stated a work environment just 234 
stated the environment they worked in most frequently (36 missing). The data also showed 
that the majority of respondents’ primary working environment was the ward (n=138), 
followed by the office (n=64). Although a large proportion of respondents worked within 
the dispensary (n=198) this was rarely respondents primary working environment (n=11).  
Figure 6.4 shows all those environments that at least five respondents worked within and 
also highlights the number of respondents who stated each as their primary working 
environment.  
 
In addition to the five options provided within the questionnaire 37 respondents indicated 
eight ‘other’ environments they worked within. The only ‘other’ environment where more 
than 5 respondents worked within was the ‘clinic’.  This accounted for six of nine 
respondents who stated an ‘other’ option was their primary working environment.  
 
 
Figure 6.4. The environments more than five hospital pharmacist respondents worked within and the 
number of times these were respondents’ primary working environment 
Clinic* = An environment stated as an ‘other’ option by respondents  
222
198
121
39
26
12
138
11
64
12 6 0
0
50
100
150
200
250
Ward Dispensary Office Aseptics Clinic* Primary care
N
u
m
b
er
 o
f 
re
sp
o
n
d
en
ts
Enviroment pharmacists worked within
Enviroment worked within
Respondents' primary working
environment
Chapter 6 
 
 
205 
6.3.1.3. Frequency of interaction between hospital pharmacists and other healthcare 
team members 
Section B of the questionnaire was concerned with the overall frequency of interactions 
between the 270 responding pharmacists and other HCTMs. Findings are displayed in 
Table 6.4 and Figure 6.5 which show the percentage of responding pharmacists who 
indicated they work with HCTMs at least once a month and at least once a week (Table 6.4 
also shows daily interactions). These percentages were based on the response rate per 
HCTM which varied (also shown in Table 6.4), with a mean response rate of 268/270 was 
received across all 29 HCTMs.  
 
Much like their community pharmacist counterparts, hospital pharmacists reported that 
they interact most frequently with doctors and nurses, with nearly all pharmacists 
reporting they interact at least once a month (doctors - 99.6%, nurses - 98.5%), and at least 
once a week (doctors - 94.1%, nurses - 94.8%) and a significant majority interacting on a 
daily basis (doctors – 77.4%, nurses – 87.0%). Interactions with hospital doctors were 
across the hierarchical levels but seniority appeared to impact on the frequency with which 
the interactions occurred. For example, although the highest percentage of pharmacists 
interacted with junior doctors on a daily basis (70.5%), pharmacists’ had the most weekly 
interactions with registrars (88.5%) and interacted with consultants more than all other 
level of doctors on a monthly basis (97.8%). 
 
In common with the findings from the community pharmacist questionnaire (see chapter 
5), the data shows that pharmacists’ reported interactions were most frequent with HCTMs 
who were similarly located with them, in this case within the hospital. In addition to hospital 
doctors and nurses this included dieticians (where 62.5% of respondents reported to 
interact on a monthly basis) and physiotherapists, occupational therapists and midwives 
(where over a third of respondents interacted at least once a month). Except for hospital 
doctors and nurses the level of regular daily interactions tended to be low with all other 
HCPs irrespective of their location, with the highest proportion of pharmacists (7.1%) 
interacting with dieticians on a daily basis. Daily interactions were however much more 
frequent with HCTMs within the pharmacy team such as dispenser/technicians (D/Ts) 
(where 91.5% of respondents interacted daily) and accredited checking technicians (ACTs) 
(88.5%). 
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The impact of co-location was most evident when respondents’ daily interactions with 
doctors and nurses. For example, 87.0% of pharmacists interacted with hospital nurses on 
a daily basis, compared to 3.0% with community nurses. Similarly, 77.4% of respondents 
interacted with hospital doctors on a daily basis compared to just 3.7% interacting with GPs 
at the same rate. Additionally, none of the respondents reported that they interact more 
frequently with community nurses than hospital nurses, however of note, two respondents 
indicated that they interact more frequently with GPs than hospital doctors. One of these 
respondents was the band 9 pharmacist who completed the questionnaire, and the other 
was a band 8 pharmacist who did not state any specialism.  In common with community 
pharmacists, respondents reported that they interact more frequently with GP receptionists 
rather than HCPs based within GP practices. Interactions with other primary/community 
care HCPs also tended to be infrequent with no hospital pharmacist interacting on a daily 
basis with dentists, health visitors, opticians, paramedics, podiatrists or vets.  
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Table 6.4. Percentage of hospital pharmacists reporting that they interact with each HCTM at least 
once a month/week/day ordered by ‘at least once a month’ 
Member of healthcare 
team 
Response rate 
per HCTM 
(max. 270) 
At least once 
a MONTH 
At least once 
a WEEK 
At least 
once a DAY 
Doctor (All) 269 99.6% 94.1% 77.4% 
Doctor - Hospital 269 99.3% 93.3% 77.4% 
Dispenser/Technician 270 98.9% 98.5% 91.5% 
Nurse (All) 269 98.5% 94.8% 87.0% 
Nurse - Hospital 269 98.5% 94.8% 87.0% 
ACT  269 97.8% 96.3% 88.5% 
Doctor - Consultant 268 97.8% 84.7% 39.9% 
Doctor - Registrar (ST1-3) 269 94.8% 88.5% 52.4% 
Doctor - Junior (FY1/FY2)  268 92.5% 84.3% 70.5% 
Pre-registration 
Pharmacist 
268 90.3% 82.1% 51.9% 
Pharmacist - Community 269 82.2% 37.2% 2.2% 
GP receptionist 269 79.2% 61.3% 22.3% 
Nurse - Community 268 66.4% 38.8% 3.0% 
Pharmacist – Primary 
care 
268 62.7% 27.6% 4.5% 
Dietician  269 62.5% 30.5% 7.1% 
GP 268 53.4% 20.5% 3.7% 
Care home staff 270 50.4% 12.2% 0.4% 
Physiotherapist 267 46.4% 22.8% 6.4% 
Occupational therapist 267 39.3% 20.6% 5.6% 
Medicines counter/ 
Healthcare assistant 
265 37.7% 23.4% 14.7% 
Midwife  268 35.8% 15.3% 1.9% 
Drug and alcohol team 270 32.2% 8.5% 0.4% 
Social worker 269 23.0% 7.1% 0.4% 
Speech and language 
therapist 
270 19.6% 6.7% 0.4% 
GP practice manager 269 16.7% 6.3% 0.7% 
Paramedic 266 12.4% 2.6% 0 
Radiographer 267 9.7% 6.0% 2.2% 
Health visitor 269 5.2% 0.7% 0 
Dentist 269 4.1% 1.1% 0 
Podiatrist 266 4.1% 0 0 
Opticians 270 1.1% 0.4% 0 
Vet 266 0.4% 0 0 
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Figure 6.5. Percentage of hospital pharmacists interacting with HCTMs at least once a month/week, ordered by at least once a month 
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6.3.1.3.1. Additional professionals which respondent reported they interact with 
Beyond the 29 HCTMs listed in the questionnaire, a number of respondents reported 
interactions they had with ‘other’ HCTMs. Table 6.5 shows the additional 33 HCTMs 
respondents reported interacting with at least once a month.  
 
Table 6.5. Number of respondents interacting at least once a month with additional HCTMs stated in 
‘other’ category of the questionnaire 
HCTM (n=33) Number of participants  
‘Specialist’ nurses 15 
Clerical staff 11 
Assistant technical officer 
Hospital doctor 
Other hospital pharmacists 
6 
 
Healthcare support worker/ nurse auxillaries 
Managers  
5 
Domestics/ housekeeping 
Lecturers/ tutors  
Pathology 
4 
Drug company employees 
Microbiologists 
Porters 
Public health staff 
3 
Eight HCTMs including: Psychologist, Nurse director, 
Medical director, Occupational therapy technician, Finance, 
Medical receptionists/ secretaries, Service improvement 
facilitators, Biochemists 
2 
Eleven HCTMs including: Play specialist, MHRA staff, 
Immunisation coordinator, Hospital smoke free counsellor, 
Informatics NWIS staff, NHS England patient safety head, 
Welsh assembly staff, Clinical coding staff, Haemotology 
staff, Human resources staff, Phlebotomist 
1 
6.3.1.4. Impact of demographic characteristics on respondents’ reported frequency of 
interactions with HCTMs 
The questionnaire was used to capture a number of demographic characteristics of the 
respondents. Statistical analysis using the chi-squared test was undertaken (significance 
was set at p < 0.05) to determine if any of these characteristics correlated with reported 
frequency of interaction with HCTMs. A number of characteristics did not meet the criteria 
necessary to undertake a chi-squared test. These included a comparison of the reported 
frequency of interaction against (i) respondent’s health board; (ii) their primary specialism 
and (iii) the environment in which the respondent primarily practised. Analysis was 
however conducted to determine whether the frequency of reported interprofessional 
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interactions correlated with either the size of the hospital the respondent worked in or their 
professional grading.  
6.3.1.4.1. Impact of the respondents’ professional grading (NHS banding) on their 
frequency of interactions with HCTMs 
It was hypothesised that the seniority of pharmacists may increase their interactions with 
other HCTMs as they may have more experience and knowledge about professional roles. 
The data captured did suggest that pharmacists at lower grades reported that their primary 
work environment was on the ward whist for those at band 8 and above tended to primarily 
work in an office environment (see Table 6.6).  
 
Table 6.6. A comparison between the hospital pharmacists pharmacist’s professional grading (NHS 
banding) and their primary working environment within the hospital 
Banding Ward Dispensary Aseptic 
Office 
based 
Total 
Band 6 
38 
95.0% 
1 
2.5% 
1 
2.5% 
0 
0% 
40 
17.8% 
Band 7 
26 
78.8% 
2 
6.1% 
1 
3.0% 
4 
12.1% 
33 
14.7% 
Band 8 
74 
48.7% 
8 
5.3% 
10 
6.6% 
60 
39.5% 
152 
67.5% 
Total 
138 
61.3% 
11 
4.9% 
12 
5.3% 
64 
28.4% 
225 
100% 
 
Chi-squared analysis of NHS band against reported frequency of interaction revealed that 
there was a significant difference (p < 0.05) for 16 of the 29 HCTMs listed in the 
questionnaire; (Band 9 (n=1) and Band 5 (n=4) pharmacists were excluded from the 
analysis as their numbers did not meet the threshold for chi-squared analysis).  Visual 
comparisons of the data (in which data was visually compared by the PhD research and 
confirmed by the supervisory team to determine which demographic group worked most 
frequently with a HCTM when significant differences were found – see chapter 4.3.9 for 
further explanation and other examples such of this process such as chapter 5.3.1.4) for 
these 16 professions indicated that senior pharmacists (band 8) were seen to have 
increased levels of interaction with consultants (p=0.005), the paramedics (p=0.041) and 
radiographers (p=0.044).Pharmacists at lower bands (6 and 7) were determined to have 
significantly more frequent interactions with the thirteen remaining HCTMs. It was found 
that band 6 pharmacists had the most frequent level of interaction with ACTs (p=0.003), 
care home staff (p=0.001), community pharmacists (p=0.003), dietician (p=0.006), the drug 
and alcohol team (p= 0.008), GP receptionists (p=0.000), hospital nurses (p=0.003), junior 
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doctors (p=0.005), pre-registration pharmacists (p=0.002) and speech and language 
therapist (p=0.003).For band 7 pharmacists the most frequent level of interaction when 
compared to other bands was with community nurses (p=0.024), occupational therapists 
(p=0.028), and vets (p=0.039). 
6.3.1.4.2. Impact of the size of the hospital on respondents’ frequency of interactions 
with HCTMs 
The respondents in this study worked in hospitals of varying sizes related to the number of 
beds.  It was hypothesised that the size of the hospital may impact on the number of HCTMs 
present in the hospital with for example a wider range of services and specialism in larger 
tertiary hospitals compared to smaller general hospitals. This may in turn impact at least 
on the opportunity for interprofessional interactions particularly given the findings in 
chapter 5 and in Jenkins et al., 2016 that demonstrated a positive correlation between co-
location and frequency of interactions. A chi-squared analysis was therefore conducted to 
analyse the impact of hospital size on reported frequencies of interprofessional 
interactions; hospitals were categorized into three groups: (i) fewer than 499 beds, (ii) 500 
to 700 beds, (iii) more than 700 beds. A validation step was undertaken to ensure that there 
was an even distribution of pharmacists by band (6, 7 and 8) across these hospital 
categories as this was shown to significantly impact on frequency of interaction (see 
6.3.1.4.1).  
 
Of the 29 HCTMs compared, seven were found to have statistically significant difference (p 
< 0.05) between the sizes of hospitals. Of note, for six of the seven HCTMS where a 
significant difference was found, increased interactions were seen for the smaller hospitals 
rather than the larger hospitals when conducting visual comparisons of this data. These six 
HCTMs were:  with hospital nurses (p=0.04), midwives (p=0.009), pre-registration 
pharmacists (p=0.000), primary care pharmacists (p=0.013), speech and language 
therapists (p=0.033), and vets (p=0.001). The only HCTM where working in a larger hospital 
(more than 700 beds) resulted in reports of more frequent interactions was with dieticians 
(p=0.006).   
6.3.1.5. Description of the qualitative comments provided within the questionnaire 
The final section of the questionnaire provided a free text comments box for respondents 
to add any further information they deemed appropriate to the study. A total of 20 of the 
270 respondents made comments. The raw data is presented in Appendix T and the 
information was used to inform stage two of this study i.e. the semi-structured interviews.  
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6.3.2. Stage two – Semi-structured interviews exploring the nature of 
interprofessional interactions between hospital pharmacists and healthcare 
professionals 
This section describes the results for the qualitative interviews with hospital pharmacists 
which aimed to explore and better understand the IPIs taking place as pharmacists practise 
in hospitals and to determine the value pharmacists place on interprofessional education.  
6.3.2.1. Participant demographics 
In this study, 15 interviews were conducted at which point the sample represented a 
sufficient cross section of hospital pharmacists, constant comparison indicated strong 
repetition of data and themes, and the study aims had been achieved (Bowen, 2008; King 
and Horrocks, 2010a; Malterud et al., 2015). Table 6.7 details the demographic 
characteristics of participants; in order to maintain anonymity the hospital and health 
board each participant works in has been excluded. In total participants were recruited 
from five different hospitals associated with four of the five Welsh LHBs eligible for this 
study: (i) Abertawe Bro Morgannwg University Health Board (UHB) (n=6); (ii) Betsi 
Cadwaladr UHB (n=2); (iii) Cardiff and Vale UHB (n=3); (iv) Cwm Taf UHB (n=4). 
Participants were not recruited from the fifth LHB (Hywel Dda UHB) and Velindre hospital 
primarily due to limited response from potential participants, geographical convenience, 
limited time to conduct the study and the conclusion that strong repetition of data and study 
aims had already been achieved.  
 
Consideration of each participants’ specific demographic characteristics was important 
during the thematic analysis of interviews, particularly those that were seen to directly 
impact pharmacists’ frequency of interactions determined within the questionnaire such as 
the professional grade and primary working environment (see section 6.3.1.4). Having 
awareness of participants’ primary specialism and their community pharmacy experience 
was also important as these factors were seen to influence interactions. However, 
throughout the interviews there was little evidence that the hospital size and LHB directly 
impacted participants IPIs.   
 
The university that participants attended and the year that they qualified impacted on the 
undergraduate IPE that they had experienced. Participants that had graduated more 
recently and generally been exposed to more IPE during undergraduate studies probably as 
a consequence of the expansion of IPE in the MPharm programme in recent years as 
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described in chapter 3, they also generally had a better recollection of the specific IPE they 
undertook. 
 
For those participants who described having engaged in postgraduate IPE, this was often 
during the pre-registration year or as part of a postgraduate clinical diploma. In the main, 
these sessions were often described as either training/learning alongside another HCP(s) 
about a certain topic, teaching conducted by another professional (often medics) or a 
teaching session about the topic of interprofessional working. The sessions described rarely 
featured pharmacists directly working alongside other HCPs; “when I first took up the role 
in stroke there is a [name] accredited two day understanding stroke care course which 
everybody new to stroke has to go on this course and each service has someone from theirs 
giving a talk about their role and what to expect from a stroke patient, so it’s not directly 
working with them but its understanding what they do” (P8). One participant (P4) did state 
how they undertook a formal IPE session with doctors and nurses at postgraduate level 
within the hospital. Another participant (P9) also delivered postgraduate IPE for pre-
registration pharmacists, newly qualified doctors, nurses and midwives. Four others 
delivered teaching to other HCPs on a non-medical prescribing course, medicine course and 
to qualified HCPs on specific topics such as antimicrobial and renal medications. 
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Table 6.7. Descriptive demographic characteristics of each hospital pharmacist interview participant showing the range of personal experiences and pharmacy locations 
Participant 
no’ 
Year 
registered  
University of 
study (Cardiff 
or another UK 
Uni) 
Previous IPE 
experience 
Area of Pre-
registration 
training 
Years worked 
within the 
hospital  
Specialism (current rotation 
in brackets) 
Community 
pharmacy 
experience 
Professional 
grading / 
NHS band 
P1 2014 Cardiff Yes (UG) Hospital 4 Cardiac No 7 
P2 2012 Cardiff Yes (PG) Hospital 3 Renal  Yes 7 
P3 2016 Cardiff Yes (UG) Hospital  2  Rotational (renal) No 6 
P4 2017 Cardiff Yes (UG + PG) Hospital 0.25  Rotational (surgery) No 6 
P5 1980 Other Yes (UG + PG) Hospital 15  Renal  No  8  
P6 2016 Cardiff Yes (UG) Hospital 2  Rotational (general medicine) No 6 
P7 2013 Cardiff No Hospital 2.5  Rotational (admissions + ITU) No 7 
P8 2005 Cardiff Yes (PG) Hospital 12 Stroke Yes 8  
P9 2000 Cardiff Yes (PG + also 
delivers IPE) 
Community 15  Women’s health + dispensary Yes 8  
P10 2007 Cardiff No Hospital 3  Admissions + E&T Yes 8  
P11 2017 Cardiff Yes (UG) Hospital 1.25  MI + surgery No 6 
P12 2015 Cardiff Yes (UG) Hospital 3.25 Rotational (surgery) No 7 
P13 2010 Other Yes (UG + PG) Hospital 7 Pharmacovigilance + MI + 
transplant 
 8  
P14 2014 Other Yes (UG + PG) Community 0.25 Rotational (admissions) Yes 6 
P15 2010 Cardiff No Hospital 7  Antimicrobial Yes 8  
LJM = Liverpool John Moores, UG = undergraduate, PG = postgraduate, MI = Medicines information, ITU = Intensive care unit, E&T = Education and training
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6.3.2.2. Deductive data 
Deductive thematic analysis was employed to identify: (i) participants’ frequency of 
interactions with other HCPs; (ii) the nature of participants’ interprofessional interactions; 
(iii) the mode with which the interactions occurred; (iv) any areas where participants learnt 
from other HCPs during interactions; (v) the topics participants would like to learn from 
other HCPs; (vi) participants’ suggestions for the design and implementation of IPE. All 
participants understood the term ‘interprofessional interactions’ to be broadly 
“communicating and working with other healthcare professionals to achieve a common goal 
for the patient” (P4).  
6.3.2.2.1. Participants’ reported frequency of interactions with healthcare professions  
During the initial part of the interview, participants were asked to rank fifteen HCPs based 
on their perceived frequency of interaction with each HCP. Those which the participant felt 
they did not interact with at all could be discarded. Table 6.9 shows the rank order of each 
participants’ frequency of interaction with the HCPs included in the exercise. This ranking 
process was often influenced by the professional grading of participants with those more 
senior pharmacists such as P5 (band 8) stating they interacted with a large number of HCP, 
in this case 13 out of the 15 HCPs given to rank, and junior pharmacists such as P11 (band 
6) stating they interacted with just 2 of the 15 HCPs (doctors and nurses). In addition to the 
ranking exercise, throughout the interviews where a participant discussed a particular HCP, 
they were asked to quantify their frequency of interaction with that HCP (see Table 6.8). 
 
In common with findings from the questionnaire phase of this study (see section 6.2), the 
data showed that participants interact most frequently with hospital-based doctors and 
nurses. All fifteen participants reported that they interact on a daily basis with doctors and 
nurses and ranked them both as either their first or second most frequently interacted with 
HCP; “I interact with doctors most frequently and if anything nurses would be a close second” 
(P14), ‘them (nurses) and the doctors are the main ones I will speak to every day most of the 
day’ (P1). The impact of co-location was also evident as during the ranking exercise, 
interactions with the community-based doctors (GPs) and nurses were much less frequent, 
with some participants failing to state any level of interaction with these professions.  
 
All participants bar one included dieticians during the ranking exercise with participants 
indicating that they were their third most frequently interacted with HCP. Seven 
participants stated they had weekly interactions with dieticians and four of these indicated 
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interactions were on a daily basis. None of the participants reported that they interact with 
dieticians in the primary or community sector. Physiotherapists (physios), speech and 
language therapists (SALT) occupational therapists (OTs) and midwives also featured 
during some participant’s ranking exercise; for some participants they represented their 
third most frequent source of interprofessional interactions.  However, interestingly a 
number of participants did not acknowledge any interaction with these professions.  This 
variation in the scope of interactions was often explained by the participant as a 
consequence of their particular specialism or working environment, or their experience as 
a practitioner.  
 
Beyond the ranking exercise, participants were asked more generally about their own 
perceptions of the frequency with which they interact with other HCPs. In total eight 
participants felt they had the right number of interactions, with one participant (P5) 
indicating that on occasions, the level of interactions was sufficient to distract them from 
their own service delivery; “way too much, ha… sometimes you do need those boundaries so 
that you can concentrate on your own service delivery as well”. The other six participants felt 
they could, and would like to, undertake more interactions as they recognised the benefits, 
however some felt they needed to overcome barriers to achieve this; “I think there are so 
many benefits to more joined up working and interprofessional working so I don’t think you 
can ever have too much so I think the more the better really” (P10), “I would say I would like 
a bit more, just to try and get more comfortable really to knock down any barriers really” 
(P14). 
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Table 6.8. The frequency of interaction hospital pharmacist participants (max. n=15) stated they had 
with HCPs  
Healthcare Professional At least 
once a 
day 
At least 
once a 
week 
At least 
once a 
month^ 
At least 
once a 
year^^ 
Less 
frequently 
^^^ 
Hospital Doctor (n=15) 15 - - - - 
Hospital Nurse (n=15) 15 - - - - 
Dietician (n=10)  4 3 - 2 1 
Physio (n=7) 2 2 - 2 1 
OT (n=7) 1 1 1 4 - 
SALT (n=5) - 1 2 2 - 
SW (n=5) - 1 1 2 1 
Radiographer (n=4) - - 1 1 2 
GP (n=2) - 1 - 1 - 
Community Nurse (n=2) - 1 - 1 - 
Midwife (n=2) - 1 - - 1 
Dentist (n=1) - 1 - - - 
Optician (n=1) - - 1 - - 
Paramedic (n=1) - - 1 - - 
^The term occasionally was categorised as ‘at least once a month’ frequency  
^^ The terms not often and rarely were categorised as ‘at least once a year’ frequency, 
^^^ The term (very) very rarely was categorised as ‘less frequently’ frequency 
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Table 6.9. The relative ranking hospital pharmacist participants indicated with respect to the level of interaction with fifteen HCPs provided during the ranking exercise; data 
are provided in descending order i.e. the HCP with which the participant reported interacting most frequently are at the top 
P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13 P14 P15 
Nurse Nurse Doctor Doctor Doctor Nurse Doctor Nurse Doctor Doctor Doctor Nurse Nurse Doctor Doctor 
Doctor Doctor Nurse Nurse Nurse Doctor Nurse Doctor Nurse Nurse Nurse Doctor Doctor Nurse Nurse 
Physio. Diet. Physio. Diet. Diet. Diet. Diet. SALT Midwife Midwife  OT OT Physio. Diet. 
Diet. Physio. SW Physio. Physio. OT Physio. Diet. Dentist Diet.  Diet. SW Diet. Midwife 
OT OT OT HV SW SALT Midwife OT Diet. Physio.  SALT SALT Para.  
SALT SW Diet.  Para.  Dentist Physio. Para. OT  Physio. Diet. SW  
Radio. SALT Radio.  Pod.  SALT SW Pod. SALT  Midwife Midwife   
Midwife Radio.   Radio.  SW Optician SALT Para.  Dentist Dentist   
    Optician  OT  Radio. SW  Radio. Physio.   
    HV     HV  HV HV   
    SALT     Optician   Para.   
    OT     Pod.      
    Dentist     Dentist      
Diet. = Dietician, HV = Health visitor, OT = Occupational therapist, Para. = Paramedic, Physio. = Physiotherapist, Radio. = Radiographer, SW = Social worker, SALT = Speech 
and language therapist
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6.3.2.2.1.1. Other professions of note  
Participant 5 was keen to point out that engagement is needed with a vast array of team 
members outside of those that might be termed direct medical professionals. Interactions 
with technical staff, secretaries, research colleagues, drug companies and private 
organisations (for procurement, treatment protocols and service delivery), IT engineers 
and patient representatives/bodies (to help design services) were all mentioned as 
important stakeholders to deliver a successful care service. In addition, P5 also commented 
that “the most obvious one that is missing to me from here is the patient, and again it just 
highlights how we develop the services around systems and not the individuals that are using 
it”. P9 also suggested that they had interactions with pathology and microbiology staff for 
culture sensitivities and antibiotic choice. 
6.3.2.2.2. Participants’ mode of interaction with other HCPs 
Participants reported mode of interaction with each HCP was determined during the 
interviews and is presented in Table 6.10. Interactions could generally be categorised into 
three modes: (i) face-to-face; (ii) over the telephone and (iii) interactions where written 
communication was used, e.g. medical notes or by email. A number of participants used a 
blend of these mechanisms during their engagements with different HCPs, however face-to-
face communication was the most common mechanism of interaction used in 53 of the 55 
secondary care HCP IPIs described across the interviews. Face-to-face interaction was often 
said to be as a consequence of both professions being physically present, particularly on the 
wards and within ward rounds. In this regard, certain HCPs were seen to be more readily 
available for face-to-face interactions such as nurses and junior doctors, with other HCPs 
such as senior doctors being available more infrequently, resulting in a potential barrier to 
face-to-face interactions (see section 6.2.2.3.4).  
 
Where interactions with secondary care HCPs were not face-to-face it was often explained 
that this was due to the pharmacists being ‘off the ward’ in either the dispensary or offices, 
or the that the HCP they needed to get hold of was not readily accessible on the ward at that 
time. In this case the participants often phoned HCPs, or in certain cases used email. A 
number of participants suggested how this could be challenging as they didn’t always know 
how to contact another HCP. Another method that was used to communicate with HCPs was 
through written notes in patients’ medical records. In the main, this was often a practice of 
more junior pharmacists, with many participants recognising that face-to-face was the 
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preferable mechanism for interaction. One participant also used video conferencing with 
consultants and other HCPs to interact remotely across different geographical locations.  
 
Interactions with HCPs based within primary care were exclusively by telephone with the 
exception of one senior participant who described a face-to-face educational session. One 
participant also mentioned the ‘broker’ role of the GP receptionist, a theme identified during 
the community pharmacist interviews (see chapter 5). A number of participants also 
described who generally initiated the interactions. In interactions with doctors, of the eight 
who commented, six suggested that it was the pharmacist that generally initiated the 
interactions. The other two participants felt that it was an even mix between the 
professions, with both approaching one another regularly. This sense of a shared approach 
to initiating interactions was a common theme in terms of interactions with nurses, with 
eight of twelve participants indicating that interactions were as frequently initiated by 
nurses as by pharmacists.  Four participants did not share this view, they indicated that 
nurses were more likely to approach the pharmacist.   
 
Table 6.10. A comparison of hospital pharmacist participants’ (max. n=15) modes of communication 
with different HCPs  
HCP Face-to- 
face only 
Face-to-face 
and 
telephone 
Face-to-
face and 
written 
Face-to-face 
telephone, 
and written 
Telephone 
only 
Hospital Nurse 
(n=15) 
7 4 1 2 1 
Hospital Doctor 
(n=14) 
4*  4 - 6 - 
Dietician (n=10) 9 - 1 - - 
GP (n=6) - 1 - - 5 
OT (n=6) 4 - 1 - 1 
Community 
Nurse (n=4) 
- 1 - - 3 
SW (n=4) 2 1 - - - 
Physio (n=3) 3 - - - - 
SALT (n=2) 2 - - - - 
Dentist (n=1) - - - - 1 
Midwife (n=1) 1 - - - - 
Paramedic (n=1) 1 - - - - 
* = one also included video conferencing           
6.3.2.2.3. The nature of participants’ interactions with other HCPs 
The nature of participants’ interactions with HCPs broadly fell into two categories, ‘clinical’ 
interactions and ‘practical’ interactions. Clinical interactions were defined as those 
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occasions where the pharmacist and HCP engaged to discuss clinical situations in order to 
benefit/enhance the clinical care provided to patients. Examples would include discussions 
about drug doses, administration, interactions, etc. Practical interactions were defined as 
occasions where there was interaction with a HCP to discuss non-clinical, practical or 
logistical patient issues, such as the supply of medications or governance issues. The nature 
of participants’ interactions with various HCPs was deduced from the interviews and is 
presented in Tables 6.11a-c. 
 
It was evident from the data that interactions with hospital doctors were predominately 
focused on clinical issues such as appropriateness of medicines particularly in areas such as 
dosing, interactions, formulation, indication, and biochemical results (see Table 6.11a). 
There was some focus on discharging patients. These were in part practical discussions 
about discharge but also clinical discussions focused on “making sure that medications are 
suitable for discharge” (P13). Guidelines were sometimes used to frame clinical discussion; 
“they prescribe what they think is appropriate but according to our antibiotic guidelines not 
necessarily appropriate” (P1). Although interactions with General Practitioner (GPs) were 
sometimes clinical in nature (see Table 6.11b), P5 stated how “the interactions are very 
different” between the sectors, with P14 believing that “within community it is a bit more 
straightforward” and interactions in hospital are more complex. GP interactions were 
primarily focused on the communication of patient medication information on either 
admission or discharge to hospital and providing advice where necessary.  
 
Unlike doctors where interactions were mainly clinical, pharmacists were seen to interact 
with hospital nurses for both clinical and practical reasons (see Table 6.11a). This was 
summarised by P9; “nurses tend to know more about the patients (compared to other HCPs), 
so if you want to know something about the patients themselves, whether they still take a 
medication or whether they have stopped, what their blood pressure has been like since they 
have been in, whether their next INR appointment has been booked, all that sort of stuff the 
nurses are a wealth of information.. so we rely on them a lot actually’. One topic of interaction 
all fifteen participants engaged with nurses about was the administration of medicines as 
drug compatibility in IV lines and a patient’s ability to swallow had impact on both 
practitioners scope of practice; “speak to nurses we are giving advice on administering things 
which improves patient safety” (P1). Patient discharge was another common area of 
discussion between pharmacists and nurses. However, unlike the clinical discussions in this 
area with doctors, interactions were more focused on practical issues associated with 
getting patients home; “they are more pressured to get patients out so they would contact us 
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more about whether prescriptions are done” (P6). Interactions with community nurses also 
involved patient discharge however these interactions had a greater focus on ensuring the 
nurses were aware of the medications they needed to administer and the clinical impact of 
this (see Table 6.11b). One common theme was engaging with nurses who run warfarin 
clinics. Pharmacists engaged with these practitioners to determine doses and INR levels, 
and arrange appointments on discharge; “INR clinic appointments, issues with peoples’ 
warfarin, we have contacted nurses for that outside (of the hospital)” (P9). 
 
The nature of interactions with nurses tended to be dependent on the seniority of the nurse. 
Participants interacted with senior nurse practitioners (including specialist nurse 
prescribers and sister) about their specialist area of expertise and often utilised their 
prescribing skills as it was felt it was easier to interact with them rather than getting hold 
of doctors (see Table 6.11b); “we’ve actually got loads of nurses pracs who do the 
prescribing, they are very, very handy when you can’t get hold of a doctor and because of the 
fact they have the nursing background as well as the prescribing background they are very 
very good” (P1). Practical interactions also occurred with senior nurses, particularly 
‘sisters’, about issues such as discussing incidents and checking controlled drug (CD) levels. 
Four participants indicated that they interacted with nurses of all seniority levels including 
nursing assistants; “often they (nursing assistants) can tell you quite a bit about the patient, 
obviously not medication wise but if there is anything they wanted, erm, what diet are they on 
for example, so I can tailor the medicines administration to that” (P8). 
 
Interactions with dieticians primarily involved discussions on the clinical use of total 
parenteral nutrition (TPN) and practical implications thereof (see Table 6.11b). This 
included discussions on the use of nasogastric (NG) and percutaneous endoscopic 
gastrostomy (PEG) tubes in patients; “you would speak to the dietician is if someone has been 
started or is currently on TPN” (P2). Participants also discussed with dieticians the 
management of patients’ electrolytes (such as potassium and sodium) and tailoring patients 
dietary and medication needs to account for these blood results as well as the holistic care 
of the patient; “every dialysis patient that I see is joint with a dietician because these patients 
come with sodium restrictions, potassium restrictions, phosphate restrictions, fluid 
restrictions … dietician goes through the patients typical diet… I can tailor drug therapy” (P5). 
Practical engagement surrounding the stock and supply of dietary feeds also occurred. 
 
Interactions with physiotherapists appeared to focus primarily on pharmacists providing 
medication advice in areas such as pain management and cystic fibrosis, and the 
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physiotherapists informing pharmacists of patients with dexterity/mobility problems 
which could impact medication choice (see Table 6.11b). One participant also believed that 
the physiotherapist’s knowledge overlapped with OTs as they both had good overall 
knowledge of the patients; “OTs tend to have, and the physios, they sort of know the whole 
picture, what’s the family background, what’s the living status of the patient…” (P8).  OTs were 
also found to be helpful in recognising patients who had difficulties in taking medications 
and thus interacted with pharmacists with respect to compliance aids, particularly on 
patient discharge, with a number of participants believing that OTs, along with social 
workers (SWs), could help improve these discharges; “I think that interaction between social 
workers and occupational health could probably be improved, and if it was improved we would 
have smoother discharges” (P7), “making sure that they are able to take their medications 
appropriately when they are going home and thinking about whether they need a blister pack 
(compliance aid) and that sort of thing and it is usually the OTs and the social workers who 
might be involved” (P13). Interactions with SALT mainly concerned the patient’s ability to 
take medications with SALTs informing pharmacists about patients for example with 
swallowing difficulties. Pharmacists were then able to advise on suitable formulations; 
“obviously if they (SALT) deem the patient nil-by-mouth then it is an NG tube so that again is 
for us to determine how they administer the meds” (P8). Reasons for IPIs with these HCPs can 
be found in Table 6.11c. 
 
A number of participants suggested that interactions with midwives were similar to those 
with hospital nurses; “it would be quite a similar interaction to how I would rate the nurses 
interaction” (P10). They were also found to be a good source of general patient information, 
particularly in relation to pregnancy and breastfeeding and the use of medicines in such 
patients. Whilst a number of practical interactions were listed with midwives (see Table 
6.12c) these were all suggested by one participant (P9) as they were the lead pharmacist 
for ‘obstetrics and gynecology’ and therefore involved in a range of practice and policy work 
with midwives; “I am involved in all of the procedure writing, so any maternity procedures 
that involved medicines” (P9). Just two participants described their interactions with 
dentists and these were focused on dental prescriptions received into the dispensary. 
Interactions with other professions that are detailed in Table 6.12c (opticians, paramedics, 
podiatrists, radiographer, vets and ambulance staff) were all attributed to a single 
participant and were generally described as rare (see section 6.3.2.2.1), for practical 
reasons (such as weekly medication collection by paramedics), or indirect (i.e. through 
referral of patients to the optician service).  
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Table 6.11.a.  The reasons pharmacists reported interacting with HCPs, categorised as either ‘clinical’ or ‘practical’ interactions. ‘n =’ refers to the number times each reason 
was raised across the 15 interviews 
HCP (number of 
participants who 
commented) 
‘Clinical’ interactions (interactions about clinical scenarios to benefit clinical patient 
care)  
‘Practical’ interactions (interactions about 
non-clinical, practical or logistical patient 
issues) 
Hospital doctor 
(n=15) 
Medication appropriateness/choice (n=7), Medication issues/clarification (n=7), 
Appropriateness of medication dose (n=7), Patient discharge (n=7), Medication 
monitoring/blood levels (n=6), Prescribing errors (n=6), Medication interactions (n=6), 
Medication guidelines (n=5), Patient care plans (n=5), Prescribing in patients with poor renal 
function (n=4), Discussions about patient blood results (n=4), Prescribing for specific 
indications (n=3), Prescribing of new drugs (n=3), Discussions about medications the 
pharmacist is not comfortable with (n=3), Discussions about patients mineral/electrolyte 
levels and if replacement needed (n=2), Antibiotic stewardship (n=2), Switching 
formulation/route of medications (n=2), Medicines reconciliation (n=2), Side effects (n=1), 
Contraindications (n=1), Requesting blood levels (n=1), Allergies (n=1), Day-to-day patient 
management (n=1), Uncharted medications (n=1), Prescribing outside of guidelines (n=1), 
Patient non-compliant (n=1) 
Medication stock/supply (n=3), Clinical 
Governance (n=3), Audits/research (n=1),  When 
doctors oversee prescribing course (n=1), Risk 
management (n=1), Staff management (n=1), 
Policies and procedures (n=1), Finances (n=1), 
Designing/planning services (n=1), When 
pharmacist oversees some junior doctors training 
(n=1), Informing doctors of prescribing the 
pharmacist has conducted (n=1) 
Hospital nurse 
(n=15) 
Medication administration (how to give, swallowing difficulties, IV rates etc) (n=15), Patient 
information (how coping/weight etc) (n=12), Medication information and advice (n=5), 
Patient care plans (n=3), Patients social history (n=3), New/changes to medications (n=3), 
Whether drugs have been given (n=3), Compliance aids (n=2), Drug chart issues (n=1), Nurses 
to prescribe when can’t get hold of doctors (n=1), Consultant preferences for medications 
(n=1), Patients blood pressure (n=1), Clinical discussions (n=1), Side effects (n=1) 
Patient discharges (n=9), Medication stock/supply 
(n=7), Arranging bloods to be done for drug 
monitoring/electrolytes etc (n=6), Controlled 
drug checks/issues (n=4), Ward governance 
(n=1), Referring to specialist medical teams (n=1), 
Weighing patients (n=1) 
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Table 6.11.b. The reasons pharmacists reported interacting with HCPs, categorised as either ‘clinical’ or ‘practical’ interactions. ‘n =’ refers to the number times each reason was 
raised across the 15 interviews 
HCP (number of 
participants who 
commented) 
‘Clinical’ interactions (interactions about clinical scenarios to 
benefit clinical patient care) 
‘Practical’ interactions (interactions about non-clinical, 
practical or logistical patient issues) 
Dietician (n=15) Total parenteral nutrition (n=13), Mineral/electrolyte levels (n=6), 
Tailoring patients’ diet/medication (n=5), Patient feeding/refeeding (n=4), 
Medication administration (swallowing etc.) (n=3), Ward rounds for specific 
diseases (n=2), Dietary supplements (n=1), Patient non-compliance (n=1) 
NG/PEG tubes (n=6), Dietary medication stock/supply (n=3), Diet 
gets pharmacist to pass on information to doctors (n=1) 
General 
Practitioner (GP) 
(n=14) 
Medicines reconciliations (n=6), Relaying information on discharge (n=4), 
Medicines information queries (n=3), Similar to hospital doctor engagement 
about medications (n=3), Medication/prescribing advice to GP (n=2), 
Antibiotic courses (n=2), Guidelines (n=2), Medication formulary (expensive 
items)(n=1), Patient information from GP (n=1), Compliance aids (n=1) 
Administrative role between GP and HCP (n=1) 
Community 
nurse (n=10) 
Warfarin appointments/levels (n=3), Patient discharges (n=3), MI queries 
(n=2), Patient care packages (n=2), Compliance aid (n=2), Vaccinations 
(n=1), Insulin doses (n=1) 
Medications given on discharges community nurses need to 
administer (n=3), Stock/supply of medications (n=2), Sending 
medication charts (n=1), Getting blood samples (n=1) 
Physiotherapists 
(Physio) (n=7) 
Medication information (n=4), Patient mobility/dexterity (n=3), Patient 
discharges (n=1), Patient social history (n=1), Pain management (n=1), 
Cramps/restless leg (n=1), Cystic fibrosis patients (n=1), Nebulisers (n=1) 
 
Senior nurse 
practitioners 
(n=7) 
Specialist clinical knowledge (n=4), Prescribing (n=3), Patient 
discharges (n=1), General patient information (n=1), Patient non-
compliance (n=1) 
Incidents/investigations (n-2), Controlled drug checks (n=1), 
Clinical governance (n=1), Ward logistics (n=1) 
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Table 6.11.c. The reasons pharmacists reported interacting with HCPs, categorised as either ‘clinical’ or ‘practical’ interactions. ‘n =’ refers to the number times each reason was 
raised across the 15 interviews 
HCP (number of participants 
who commented) 
‘Clinical’ interactions (interactions about clinical scenarios to benefit 
clinical patient care) 
‘Practical’ interactions (interactions about non-
clinical, practical or logistical patient issues) 
Social worker (n=6) Non-compliant patients (n=3), Patients discharged with social care package 
(n=3), Patients social history (n=1), Medication reconciliation (n=1), Addiction 
patients (n=1) 
 
Speech and language 
therapist (n=6) 
Patient medication access (swallowing difficulties, NGs etc.)(n=6), Crushing 
medications (n=2), Food  supplements on discharge (n=1) 
 
Occupational therapist 
(n=6) 
Patients with difficulties taking medications (n=6), Compliance aids (n=4), 
Complex discharge (n=2), Patient social history (n=2), Medication issues (n=1) 
 
Midwives (n=4) Similar interactions to nurses (n=3), Medication in pregnancy/ breast feeding 
(n=2), General patient discussions (n=2), Medications management/queries 
(n=2) 
Clinical governance (n=2), Errors and prevention 
(n=1), Medication storage (n=1), Patient groups 
directions (n=1), Ward planning (n=1) 
Dentist (n=2) Anticoagulation (n=1), Medication doses (n=1), non-formulary items (n=1) Medication stock/supply (n=1) 
Nursing assistants (n=2) Patient care plan (n=1), Patient diet (n=1) Weighing patients (n=1), Patient positioning (n=1) 
Paramedic (n=1)  Collecting of medication (n=1) 
Ambulance staff (n=1)  Logistics in transporting patients (n=1) 
Opticians (n=1) Patients with visual problems (indirect interactions)(n=1)  
Podiatrist (n=1) Prescription issues (n=1)  
Radiographer (n=1) Central line unblocking (n=1)  
Vet (n=1) Animal medication overdose management (n=1)  
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6.3.2.2.4. Participants’ learning from other HCPs 
Having recognised during the community pharmacist study (see chapter 5) that learning 
from other HCPs was a theme within the data, the hospital pharmacist interviews were 
deductively analysed to determine the topics which hospital pharmacists learnt from other 
HCPs; data is shown in Table 6.12. 
 
Table 6.12. Identification of the topics of learning from HCPs that participants described  
HCP (number of 
participants who 
commented) 
Topic of learning  
Doctor (n=14) Medical examinations (n=6), Complex conditions (n=4), Medication 
evidence (specialist/new drugs)(n=4), Doctors perspective and approach 
(n=3), Guidelines/Evidence base (n=3), Acronyms (n=2), Diagnosis (n=2), 
Prescribing (n=2), Reading ECGs (n=2), Their background medical 
knowledge (n=2), Clinical areas (n=1), Clinical experience (n=1), 
Communication skills (with other HCPs/patients - leaders)(n=1), Difficult 
experiences (n=1), Improved assertiveness (n=1), Medical histories (n=1), 
Medications required/not in surgery (n=1), Physiology (n=1), Strategic 
management (n=1), Swallowing difficulties (n=1),Treatment courses (n=1) 
Nurse (n=10) Medical equipment use (e.g. ventilators, renal filters)(n=5), Physical 
administration of medications (n=5), Nurse perspective of patient care 
(holistic approach) (n=3), Delivery of services/care (n=2), Brand/old drug 
names (n=1), Communication (n=1), Consultant preferences (n=1), 
Prescribing (n=1), Specialist medical areas (n=1), Specialist medications 
(n=1) 
Dietician (n=9)  Total parenteral nutrition (n=4), Dietary advice (n=2), Food impacting 
electrolytes (n=2), Refeeding (n=2), NG tube use (n=2), Patient feeds (n=1), 
Professional roles (n=1) 
Physio (n=2) Mobilisation of patients (n=2) 
Midwife (n=2) Gas and air use (n=1), Explanation of patient notes (n=1) 
SALT (n=1)  Medication in patients with certain diets (n=1), Professional roles (n=1), 
Reasons why patients need certain diet (fluoroscopy) (n=1) 
 
It was suggested within the interviews that pharmacists have a lot to learn from other HCPs; 
“I think we have to learn from other specialities” (P5), “there is valuable information to get 
from all of them (HCPs)” (P6). In total fourteen of the fifteen interview participants 
articulated that they had directly learnt from doctors most commonly about medical 
examinations (such as checking for signs of infection) and background evidence for 
medicines (such as discussing new clinical trial papers), with P14 believing interacting with 
doctors could be “like (having) our own private lecturers”. P12 also suggested that they 
learnt from difficult experiences they had when interacting with doctors.  
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Some participants felt that they learnt the most from senior staff, particularly senior 
doctors, “a lot of these consultants and things have read a million journal articles for the same 
drug so they know everything, so I have learnt a lot from that” (P7), with P15 suggesting that 
they hadn’t learnt from junior doctors; “not necessarily with the junior doctors, I think they 
benefit from us more than anything”. However, P2 acknowledged that the seniority of nurses 
they learnt from corresponded with their own personal professional grading; “I mean as a 
junior pharmacist I probably appreciated the band 5 nurses more in terms of learning… now I 
probably learn more off the specialist dialysis nurses because my work and my remit has 
extended more into seeing dialysis patients having other considerations for why erm effects 
may be occurring other than drugs, having a more holistic approach” (P2). 
 
The main areas participants were seen to learn from nurses related to the physical 
administration of medications and the use of medical equipment. Nine participants also 
indicated that they had learnt from dieticians, particularly in terms of total parenteral 
nutrition. Not all participants felt that they had learnt from dieticians, with some (n=4) 
directly stating this; “I haven’t really learnt anything from a dietician per say” (P3). 
Additionally, beyond doctors, nurses and dieticians, occasions participants were found to 
have learnt from other HCPs was limited. However, some participants recognised that 
although they may have not directly learnt from a HCP, interactions prompted them to 
develop their learning in certain areas; “I think yeah their role has pushed me towards 
learning things rather than learning things specifically from them” (P6). It was also felt by P5 
that being part of an interprofessional team can help the pharmacists develop as they can 
learn from other professions, especially with regards to soft skills such as patient 
communication; “I think there is a lot of soft intelligence we gather from being part of the 
team”. Furthermore, a number of participants felt they were able to directly apply the 
‘things’ they learnt from other HCPs on future occasions. 
 
In addition, many participants recognised the opportunity for reciprocity with other HCPs 
and indicated that they felt HCPs had learnt from the pharmacist; “they are normally 
learning about the medication from us” (P4). This was clearly the case for four participants 
who were directly involved in providing educational training to other HCPs (P5, P9, P10, 
P15). All four contributed to postgraduate training in different manners; yellowcard use 
(P10), antibiotic use (P15), prescribing and drug histories (medicines reconciliation) (P9) 
and medications use in patients with poor kidney function (P5). These sessions primarily 
involved doctors and nurses in both secondary and primary care, with P5 also teaching on 
the non-medical prescribing (NMP) course. With the exception of P10, all participants were 
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involved in undergraduate HCP teaching. This was mainly with respect to medical students, 
although P9 had also had experience in conducting IPE with medical, pharmacy and 
midwifery students. 
 
Although participants recognised undertaking IPE as one way they learnt from other 
professions, there were also a number of other opportunities that were described including: 
(i) attending educational sessions ran by other HCPs; (ii) undertaking the non-medical 
prescribing course; (iii) attending a teaching session related to dealing with ‘difficult HCPs’ 
led by another pharmacists; (iv) attending a session about methods of interacting with 
doctors from a pharmacist-turned-doctor; (v) having other pharmacists/tutors 
encouraging interactions; (vi) attending lectures from all HCPs involved in specialism about 
roles and responsibilities when beginning new specialism; (vii) attending MDT meetings or 
clinics – ‘observational IPE’; (viii) spending time specifically shadowing other HCPs on 
wards (doctors and nurses); (ix) attending training led by other HCPs. 
6.3.2.2.5. Topics participants would like to learn from other HCPs 
Participants were asked during the interview if there were any additional topics they would 
like to learn from HCPs. Table 6.13 shows that doctors (especially senior doctors) were the 
profession that most participants indicated they would like to learn from and 
predominantly in improving clinical knowledge and diagnostic skills. One participant 
specified their senior pharmacist as the key person they would like to learn from. Two other 
participants felt that they would like to know more about the roles and responsibilities of 
dieticians and physiotherapists. 
 
Table 6.13. Identification of the areas participants would like to learn from other HCPs 
HCP (number of participants 
who commented) 
Topic that participants would like to learn from HCPs 
Doctor (n=5) Reading ECGs (n=2), Cardiology (n=1), Diagnostics (n=1), 
Dialysis (n=1), Medical history taking (n=1), Medical/scientific 
writing (n=1), Microbiology (n=1), Minor ailments (n=1), 
Observe surgery (n=1), Prescribing (n=1), Reading brain scans 
(n=1), Therapy reasoning (n=1) 
Dietician (n=1) Roles and responsibilities (n=1) 
Physiotherapist (n=1) Roles and responsibilities - what they monitor and review with 
patients (n=1) 
Senior pharmacist (n=1) Leadership (n=1), NHS structure and funding (n=1) 
  
Chapter 6 
 
 
230 
6.3.2.2.6. Participants’ suggestions for the design and implementation of IPE 
During the interviews eight of the participants recognised a number of benefits to IPE 
including: (i) reducing barriers between HCPs; (ii) observing a different approach to dealing 
with issues and the provision of care; (iii) helping deal with confrontation from other HCPs; 
(iv) providing a formal environment to give feedback to one another (PG IPE); (v) 
appreciating and recognising roles and responsibilities of each HCP; (vi) improving soft 
skills such as communication; (vii) aiding the development of interprofessional 
relationships; (viii) helping improve attitudes towards the pharmacy profession. 
 
Throughout the interviews participants provided a number of suggestions related to the 
implementation of IPE which have been summarised in Table 6.14. A number of 
participants believed that it was important to implement IPE with the professions most 
relevant to professional practice; “I would include the people that you are more likely to come 
into contact with on the wards or in whichever sector of pharmacy they were going to be using 
or working in” (P13). It was clear from the interviews that those professions that 
participants felt were most relevant were doctors and nurses, with all participants believing 
they should be involved in IPE sessions with pharmacists; “I think medics and nurses would 
probably be most beneficial, because they are who you sort of interact with most” (P9), “I 
would always find those are the two core professions that we are working with” (P4), “I 
definitely think it would be a good idea for nurses to be there, as well as doctors” (P6). It was 
also felt by P6 that IPE with doctors would be of benefit no matter what sector pharmacists 
worked in (primary or secondary care); “I know not everyone goes into hospital but they are 
still going to talk to the GP at the end of the day aren’t they, that would benefit (to do IPE with 
them)” (P6). 
 
Other participants disputed this and believed that although nurses and doctors should be 
included, IPE should be extended to incorporate all HCPs to aid understanding of roles and 
responsibilities; “each and every one of them, what exactly their role is and what benefit they 
could have to the rest of us” (P6) “as for one particular person to be with I couldn’t say, because 
they have all got their own value… they need to understand each other’s roles” (P8), “I think 
we would be short sighted if we just did it with doctors” (P9). However, some questioned this 
and felt that there should be a dialogue to see if other HCPs would want to be involved in 
IPE with pharmacists; “I think it would be their opinion to say whether they think they should 
be there” (P6). 
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Table 6.14. Participants’ suggestions for the design and implementation of IPE 
Participant HCP(s)  Topic 
P1 Drs and nurses Understanding roles and responsibilities of HCPs and their 
training, case presentations  
P2 Drs and nurses Clinical, logistical and practical issues – knowing HCTMs to 
contact, following procedures, clinical governance, 
communication 
P3 Drs and nurses Anticoagulation in surgery, CDs with nurses, antibiotics with 
Drs, new charts 
P4 Drs and nurses Understanding roles and responsibilities of HCPs conditions 
and medications, relative to practice, patient centred  
P5 All HCPs Understanding roles and responsibilities of HCPs, building 
relationships  
P6 All HCPs 
(especially Drs 
and nurses) 
All HCPs: Understanding roles and responsibilities of HCPs and 
their views of pharmacists, case-based scenarios where HCPs 
work together and teach one another  
Drs and nurses: Role play of ward-based scenarios seeing 
patients - patients on admission and discharge (not emergency 
scenario)  
P7 Drs, nurses, 
SALT, OT, SW 
Discharge in elderly/stroke patients, have real HCPs in OSCEs 
P8 All HCPs Understanding roles and responsibilities of HCPs 
P9 Drs, nurses, 
(midwives) 
Learning different patient approaches from one another, 
observe HCPs in practice, communication skills 
P10 Drs, nurses, 
dentists 
All HCPs: Soft/transferable skills, communication, patient care 
skills, approaching a patient, prioritisation, bedside manner, 
holistic care  
Drs: Drug delivery and physiology  
P11 Drs and nurses Understanding roles and responsibilities of HCPs, 
communication, level of medication knowledge 
P12 Drs, nurses, 
dieticians, OTs, 
physiotherapists 
Understanding roles and responsibilities of HCPs, safe 
discharge of complex patient  
P13 All HCPs 
Drs, nurses, SW 
Patient perspective, project where all HCPs contribute 
P14 Drs and nurses Minor ailments 
P15 Drs and nurses 
(dieticians) 
Virtual patient management where all HCPs can contribute 
OT = Occupational therapist, SALT = Speech and language therapist, SW = Social worker 
 
The belief that sessions need to be relevant to practice was also important to participants 
when considering the topic of potential IPE sessions, and participants suggested that 
practising professionals should be consulted when designing and implementing IPE so that 
it is contemporary to current practice and not just a ‘tick box’ exercise; “what (IPE) we did 
was not realistic to what actually happens, so I didn’t find either of them beneficial” (P6), “it 
needs to be rather than a tick in this box … more tailored constructive feedback to your 
students which would require perhaps someone who works in the field to know what they are 
looking for and how representative that is of real life, so whether they are actually there doing 
it or whether they are there critiquing the whole set up of it” (P2). One participant (P6) also 
recognised that developing a session which is relevant and meaningful for all professions is 
difficult to achieve; “it is a hard situation to set up, it’s really hard”. The topic most frequently 
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referred to was understanding roles and responsibilities of HCPs (n=7), other suggestions 
included learning ‘soft skills’ such as communication and patient bedside manner. Doing 
this through the incorporation of patient-focused case studies was also frequently 
recommended; “more of a workshop, that had case studies” (P6), “more of a virtual patient, 
patient management kind of topic, where everyone can contribute” (P15). Whatever the topic 
P1 stated the importance of identifying and informing students of the learning outcomes of 
the IPE sessions before conducting them so that they are aware of what the sessions are 
aiming to achieve. 
 
There were mixed opinions voiced by participants as to the best time to implement IPE. A 
number of participants suggested incorporating IPE as early and frequently as possible, 
with the belief that professional stereotyping starts while undertaking undergraduate  
study and can create barriers between HCPs; “in university we are a bit separated aren’t we 
in our different areas, so when you start working yeah obviously you work together as a team 
but there is that initial barrier” (P10), “being able to work as a multidisciplinary team is going 
to [be] of benefit to patients so if you can ingrain that into people from the very beginning I 
think it would stop people thinking that they need to work in isolation…I think it (IPE) is 
something that needs to be frequent, rather than just like a one off session” (P13),  “I think if 
we learnt from a young age together and appreciated each other skills and what we bring to 
the table … I think it could be really beneficial” (P10).  
 
However, others (n=4) felt that IPE should only be undertaken at postgraduate level once 
there is a greater awareness of one’s own roles and responsibilities; “I don’t think the 
students are going to benefit each other that much, all of them I would assume haven’t had 
that much experience within a hospital or within an environment which they, they won’t know 
the problems and the barriers they are going to face yet” (P2), “I think you would have to teach 
that in practice” (P5), “I think it might be more beneficial in postgrad after you have started 
doing the job like I know medics have a lot of placements and stuff but as pharmacists you 
don’t so you don’t really have an accurate idea of what the job is and it might differ from 
community to hospital in terms of what you know and expect from the other person” (P11).  
 
One participant (P9) also suggested that the time IPE is conducted may be dependent on the 
profession; “I guess as you go further on towards the end of the medical degree and pharmacy 
degree there are probably more complex things then that you wouldn’t necessarily want a 
student nurse to be in on”. However, this participant also felt that incorporating topics such 
as communication in early years could be relevant across professions; “the things that you 
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would cover at a foundation level, the first two years, there’s a lot of stuff really that they could 
actually do together, basic things on you know learning how to communicate with a patient, 
consultation skills” (P9). It was also felt that participating in IPE before starting new 
rotations would be beneficial to build up confidence in the specialism and build 
relationships.  
 
Participants also recognised a number of additional challenges to undertaking IPE such as 
logistical challenge in organising sessions and getting large numbers of different 
professional groups together at the same time; “logistics is the biggest things really, how we 
get everyone together at the right time” (P10), “lots of groups of different people, it would be 
quite hard to organise” (P12).  
 
The setting of IPE was mentioned occasionally, with participants some participants 
reflecting on their own experiences to make recommendations about the need for 
environments which facilitates engagement such as workshop rooms and on the ward; “if 
they were set out in groups on tables and there were cases to work through which you could 
help” (P6). 
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6.3.2.3. Inductive data analysis 
This section describes the results of the inductive thematic analysis that was used to identify 
themes within the interviews. Four main themes and associated subthemes were deduced 
and are outlined in Table 6.15. 
 
Table 6.15. Hospital interview themes/subthemes generated through inductive thematic analysis 
Theme Subtheme 
1. Perceived benefits of 
interprofessional 
interactions 
1.1. Improving patient safety and care 
1.2. Improving information exchange 
1.3. Utilising the professional skills of each HCP 
1.4. Professional development of HCPs 
1.5. Building personal interprofessional relationships 
2. Perceived barriers to 
interprofessional 
interactions 
2.1. Lack of time leading to busy/stressed HCPs 
2.2. Difficulty in accessing HCPs 
2.3. Lack of understanding or poor perception of 
professional roles 
2.4. When new in an interprofessional team 
2.5. Pharmacist role creating barriers 
3. Perceived facilitators to 
interprofessional 
interactions 
3.1. Building good relationships with HCPs over time 
3.2. Pharmacists and HCPs having good interpersonal 
skills  
3.3. Pharmacists and HCPs being easily accessible (co-
location) 
3.4. Mutual understanding and appreciation of 
professional roles and responsibilities   
3.5. Taking part in interprofessional ward rounds and 
team meetings 
3.6. Development and incorporation of education 
methods including interprofessional education 
4. Impact of doctors’ 
seniority on interactions 
4.1. Additional challenges when interacting with senior 
doctors compared to junior doctors 
4.2. Value of interacting with senior doctors 
4.3. Impact of pharmacists’ seniority on interactions with 
senior doctors 
4.4. Impact of doctors’ seniority on interactions with 
pharmacists 
6.3.2.3.1. Perceived benefits of interprofessional interactions (IPIs) 
The perceived benefits of IPIs were separated into five subthemes: 
1.1. Improving patient safety and care 
1.2. Improving information exchange 
1.3. Utilising the professional skills of each HCP 
1.4. Professional development of HCPs 
1.5. Building personal interprofessional relationships 
Chapter 6 
 
 
235 
1.1. Improving patient safety and care 
All participants recognised that working interprofessionally could improve patient care in 
some way with many participants expressing how vital it is to have a patient-centred 
approach; “it’s (about) the patient at the end of the day, that’s the main focus, and by all of us 
working together hopefully we give them the best care” (P8), “the best way… to provide the 
best for our patients is joined up working, there is nothing worse than, you know, if you see 
things like duplication of care, poor communication, breakdown in communication all those 
kind of things that ultimately lead to patient suffering and distress” (P10). Participants also 
felt that interprofessional working improved the efficiency of the care provided for example 
in making discharges “smoother” (P7) and “more streamlined” (P4). One participant, P5, also 
stated that by working interprofessionally they witnessed objective measureable 
improvements in patients’ conditions (through blood marker measurements); “in terms of 
markers for CKD-MBD (chronic kidney disease- mineral bone density) once we started doing 
joint pharmacist-dietician regular interventions we moved to the top of that league table 
across the UK”. In addition, by providing truly interprofessional services this “also means 
that budgets are amalgamated and so as services develop and change and technology replaces 
certain things there is more ability to adapt to modern ways of delivering healthcare” (P5). 
1.2. Improving information exchange 
Over half of the participants (n=8) acknowledged the positive impact IPIs have on the 
exchange of patient related information between HCPs; “I need to be able to speak to the 
doctors or the nurses to communicate to them what the issue is and how to resolve this” (P1), 
“we have got our expertise as medicines experts but obviously then you have got the other 
healthcare professionals that look at it from a different aspect and I guess by having those 
discussions you get a much more well-rounded picture of things and in order to then provide 
the best care for the patients” (P9). These interactions are also helpful in improving the 
efficiency of information exchange as HCPs can provide information to pharmacists which 
they may not be aware of (and vice versa) and can enable other HCPs to reinforce messages 
to either the patient or other HCPs when the pharmacist is absent; “they (patients) may tell 
different people different things, so you do need that communication” (P1), “because they 
(nurses) have more interaction… they can reiterate those messages and follow through the 
treatment plans” (P5). It was also suggested that IPIs helped provide a more consolidated 
care system which enabled all HCPs to interact more effectively and thus communicate the 
same message to patients, reducing possible confusion and duplication of care for both 
patients and HCPs; “there isn’t the treatment management plan that I have come up with that 
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the dietician is contradicting or the nurse or the doctor is contradicting so there is a consistent 
message” (P5). 
1.3. Utilising the professional skills of each HCP 
One key benefit to IPIs which was stated by eleven participants was that interactions 
enabled the ultilisation of other HCPs skills and knowledge making it easier to resolve 
complex patient issues; “each of the different disciplines will have specialist areas of expertise 
for that patient, I think it is very erm important to be able to recognise where your competence 
boundaries lie… to recognise where you have approached a subject which is outside you areas 
of expertise but have an awareness of knowing who to refer to” (P2). The different ways each 
HCP approached problems also made interactions beneficial; “I think what the medics bring 
to the table is that they allow us to help see those grey areas, erm and just see things from a 
different perspective” (P9), “the dietician has a different angle of the way they approach it… 
they look outside of our little pharmacological box and consider other things” (P2). By 
including and utilising the skills of other HCPs this can “create a holistic approach” (P5) to 
patient care and improve the efficiency in which patient receive expert care.  
1.4. Professional development of HCPs 
It was acknowledged that IPIs could help improve awareness of other HCPs roles and 
responsibilities as well as reinforcing the pharmacist’s own role; “(an IPI) helps you to 
develop yourself and you know you have a prominent role in the multidisciplinary team” (P12). 
In addition, P5 believed that “your practice changes to make sure that your communication 
to them (HCPs) is robust, that you understand their pressures and trust them to do things” and 
working interprofessionally “has allowed people to push to the top of their professional 
game”. P8 also felt IPIs could then help them prioritise and tailor their work appropriately. 
Additional specific topics participants learnt from other HCPs has been detailed within 
section 6.3.2.2.4. 
1.5. Building personal interprofessional relationships 
Participants recognised that by interacting with HCPs they built social relationships which 
could be beneficial both for themselves and also for conducting future professional 
interactions; “because we work with them day to day here so they become your friends and 
colleagues” (P5), “in terms of benefits for me it’s just another relationship I have with another 
person, so its another friendship… so it’s quite a nice social aspect to it as well” (P7). 
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6.3.2.3.2. Perceived barriers to interprofessional interactions 
The barriers to IPIs were separated into five subthemes: 
2.1. Lack of time leading to busy/stressed HCPs 
2.2. Difficulty in accessing HCPs 
2.3. Lack of understanding or poor perception of professional roles 
2.4. When new to an interprofessional team  
2.5. Pharmacist role creating barriers 
2.1. Lack of time leading to busy/stressed HCPs 
The limited time and stressed, busy nature of both pharmacists and HCPs work in the 
hospital setting was raised as an issue by twelve participants. This was particularly evident 
when attempting to engage with both doctors and nurses; “it’s not as easy talking to a doctor 
as they are short of time” (P14), “you can tell when they (nurses) are quite stressed and they 
are rushing around” (P12). This resulted in a reluctance for some participants to interact 
with certain HCPs as they didn’t want to waste colleagues time, interrupt them or increase 
their stress; “a lot of the time you feel like you don’t want to interrupt them (HCPs) you can 
see they are rushing around and busy” (P11), “you do try not to interact with them (doctors) 
as much as possible and keep bothering them, because they do have their ward round and I 
don’t want to disturb them” (P14). In addition, P12 suggested there were things they didn’t 
want to “bother a doctor with” so “just let the nurse know and they can sort it out”. 
2.2. Difficulty in accessing HCPs  
Another substantial barrier to interactions was the difficulty participants had in accessing 
certain HCPs. Eight participants found that this was mainly due to HCPs not being co-located 
on the wards and therefore interactions were not organic. This was particularly the case 
with dieticians, SALT, OTs and SWs; “I don’t speak to them (dieticians) normally just because 
if I’m honest they are not normally on my wards” (P1) “the ward I am on now they haven’t got 
a specific occupational therapist there all the time, speech and language therapist they just 
get referred patients so they just come to see a patient” (P12). This professional separation 
was increased when the pharmacist did not work within a specialism or ward that required 
the input of particular HCPs. This limited access also occurred when the pharmacist 
themselves were not based on the ward, something that P9 found challenging as it meant 
interactions were not face-to-face; “other pharmacists are very face-to-face with the doctors 
at ward level… most of mine are over the telephone I would say or by email… I kind of have 
much more of a barrier really than other pharmacists do because if pharmacists are at ward 
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level they are working with those teams, they have kind of got instant access to the doctors, 
whereas with the service I provide from down here (in the dispensary) I have got to try and get 
hold of somebody… you can bleep them and sometimes it’s over an hour and you can still get 
no reply” (P9). 
 
In addition, when HCPs were stretched and busy (also see theme 2.1) this made accessing 
them harder, with participants suggesting this could be due to the low numbers of HCPs 
(because of lack of funding); “if they are really busy, if they have got a whole bay of patients 
it can be quite hard to get hold of them” (P4), “nowadays because they are in such high demand 
of nurses and when they are there they need to be on wards with patients rather than having 
a discussion with me” (P2), “similar (barrier) to the doctors I suppose, being busy, because they 
are very short staffed at the moment” (P3).  
 
When HCPs or the pharmacist were not directly on the wards participants recognised the 
difficulty they faced in accessing the ‘right’ HCP and which HCP was dealing with certain 
patients; “the biggest barrier is when they (doctors) are not on the ward and trying to contact 
them, or you don’t know who is actually looking after the patient” (P4), “doctors can be in 
theatre so trying to get hold of them when you need them is really difficult… you have got to 
find someone else then and just try to convince them that this is needed for this patient even 
though it is not their patient” (P1). This was made more difficult when the pharmacist did 
not know how to contact certain HCPs; “they don’t carry a bleep and they don’t carry a phone” 
(P2), “I wouldn’t know how to contact them (dieticians)” (P6).  
 
The physical separation from HCPs based in primary care made interactions more 
challenging for many participants (n=7); “GPs it is a lot more difficult to get hold of” (P7), “in 
community there are more barriers (to interactions)” (P14). This was often because it was 
difficult to interact with them (predominately GPs) straight away and they would often have 
to ring back, “I would say because it is difficult because you have to wait for a call back usually 
don’t you, you can’t just get straight through, so that has limited my interaction” (P6), which 
was a challenge as pharmacists didn’t tend to have direct access to a fixed phone number; 
“if you are covering three wards you are all over the hospital you can’t give them a number to 
ring you back on” (P7). These IPIs were also said to be less satisfactory as they were 
exclusively via the phone rather than face-to-face. This was said to make interprofessional 
relationships more difficult to establish; “they are a lot more formal, erm so that relationship 
hasn’t really developed” (P13), “I think you haven’t got that relationship with the GPs that we 
have got within the immediate team you work with… it’s just that unfamiliarity with that 
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doctor” (P8). An additional barrier P9 found when contacting primary care HCPs was the 
‘broker role’ of the receptionists (also see chapter 5.3.2.3.6); “the receptionists, haha, they 
are the usual barrier”.  P9 suggested that receptionists were often reluctant to allow access 
to the GPs therefore they would have to negotiate to gain access to the HCP; “I’ve found is 
that you have to be assertive and you have to stress the importance of why you have to speak 
to the doctor because otherwise the attitude you kind of get is, erm, you know they are very 
busy and they are not going to be able to speak to you today”. Furthermore, P7 found 
interactions were made increasingly challenging as those doctors within the GP practice 
were not always the patient’s regular doctor “a lot of the time I have rang GPs it has been a 
locum GP in and the regular GP isn’t there so they can’t answer the question and what have 
you”. 
2.3. Lack of understanding or poor perception of professional roles 
It was clear throughout the interviews that HCPs’ understanding of each other’s 
professional roles and responsibilities was vital in order to engage in meaningful IPIs. A 
number of participants (n=6) recognised that various HCPs did not have an understanding 
or appreciation of the pharmacy role; “I think the problem with pharmacy as well is people 
don’t know what we do” (P6). Furthermore, six participants stated that they felt other HCPs 
had poor perceptions of pharmacists’ role in practice; “the biggest barrier I had in the 
beginning was their (midwives) perception of pharmacy” (P9), “you can tell they (doctors) are 
not really fussed, you can tell when you go to approach them and they are like ‘oh what do you 
want’ kind of thing… because some people do see pharmacy as people who point out mistakes 
and things like that” (P12), “doctors thought of us as, I don’t want to use the word cash cows.. 
more or less” (P14). This also bred negative attitudes towards pharmacists making 
interactions more challenging; “they (doctors) didn’t particularly want to speak to you” (P3). 
P2 suggested one reason why this may occur; “you learn not to blag or bluff their way 
through things, that is a very good way of losing a doctor’s respect”. In addition, P12 suggested 
that when HCPs “had a bad experience (with a different pharmacist), you would find it would 
carry over to you”. P14 also felt that some doctors had a sense of entitlement over 
pharmacists; “I don’t want to say entitlement but for example when doctors are doing their 
ward rounds they feel like they must have like the drug chart” (P14). These issues may be why 
participants suggested that some HCPs such as dieticians and nurses will interact with 
doctors rather than pharmacists; “a lot of the time the nurses speak to the doctors about 
medication” (P4), “they (dieticians) tend to speak to the doctors really if there is an issue” (P1).  
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It was also identified that a number of participants (n=7) had a limited understanding of the 
roles of other HCPs (including dieticians, physios SALT, OT, SW and community midwives) 
and were therefore unsure how they could work together to improve patient care; “so many 
clinical systems within hospitals don’t talk to each other, so we are not even aware of what our 
colleagues are doing for patients” (P5), “I don’t know in depth what they (OTs) do” (P11), “I 
thought dieticians and pharmacy were completely, you know, separate disciplines” (P2). P5 
suggested that this could be because “there isn’t a clear relationship or understanding of what 
one profession does or can do for another or why joint working is important”.  
2.4. When new in an interprofessional team  
Participants recognised that when either they themselves or another HCP was new to an 
interprofessional team this created challenges as they were not familiar with one another 
and hadn’t built a professional or personal relationship; “if I am covering a ward that I 
haven’t covered before it is more difficult because obviously they (HCPs) don’t know you and 
you don’t know them so erm you don’t know how much you can ask them to do” (P1), “it can 
depend on the familiarity of who is on the wards at that time and if it is a ward that I am on 
quite a lot so that the doctors know me and then they are more likely to come up to me” (P10), 
“we have kind of got new doctors so there are some barriers… that relationship is not the team 
that we last had then where they understood what was to be done” (P8). This can then cause 
barriers because “if they don’t feel they trust you then they will ask someone above you or 
someone separate to you” (P2). 
 
The impact that new interprofessional environments had on IPIs was particularly evident 
in the three participants who had most recently started working as hospital pharmacists. 
These newly qualified pharmacists reflected that they had a lack of confidence in interacting 
with other HCPs when they first began their professional roles, however this did improve 
somewhat over time; “I think sometimes we don’t see ourselves as high up as the doctors and 
that and we are badgering them… so that is difficult to begin with” (P14), “I’d only just 
qualified and you just thought of doubt yourself sometimes to begin with… I think it is just 
giving it that time and having good feedback that makes you realise you are doing well and 
that just gives me the confidence to say right I am going to bleep the doctor and get this sorted, 
speak to the nurse and not just keep putting things back” (P4). This lack of confidence in 
conducting IPIs was reinforced by P11 who often wrote notes rather than interacting face-
to-face with HCPs; “just sort of rely on sort of writing in notes”. This was a mechanism that 
P10 recognised they had initially used but had moved towards more face-to-face 
interactions as their confidence in interacting developed over time (also see theme 3.1); “I 
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think it does come with experience and confidence, so if you would have asked me that question 
10 years ago I would barely say boo to a ghost and I certainly wouldn’t really approach a 
doctor, I probably even take the route of writing in notes”. 
2.5. Pharmacist role creating barriers 
Participants felt that the role of the pharmacist could negatively impact interprofessional 
engagement, for example P2 stated that the ‘policing’ role of the pharmacist created barriers 
to interprofessional working; “often the time you are approaching a junior doctor is to say 
why haven’t you done this, why have you done this like this, which I view as wrong, gradually 
over time that is a negative, all of those little negative interactions can add up and it can get 
to the point where I think especially or junior doctors they will start avoiding you, erm because 
you are seen as the policeman of the ward perhaps… everyone is working in their own silos to 
cover themselves… making things less efficient”. P5 also felt the pharmacy profession as a 
whole is not as interprofessionally integrated as other HCPs; “I think we need to start 
recognising that we work in silos and you really need to professionally and geographically and 
clinically integrate into the frontline if you are going to make any difference… I think the 
barrier between pharmacy and the other healthcare professions is bigger than probably most 
others… pharmacy as a whole can learn an awful lot from the structure of nursing and medics 
in the fact that they are genuinely multidisciplinary”.  
6.3.2.3.3. Perceived facilitators to interprofessional interactions 
The facilitators to IPIs were separated into six subthemes: 
3.1. Building good relationships with HCPs over time 
3.2. Pharmacists and HCPs having good interpersonal skills  
3.3. Pharmacists and HCPs being easily accessible (co-location) 
3.4. Mutual understanding and appreciation of professional roles and 
responsibilities   
3.5. Taking part in interprofessional ward rounds and team meetings 
3.6. Development and incorporation of education methods including 
interprofessional education 
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3.1. Building good relationships with HCPs over time 
Having good professional and social relationships with HCPs was described by many 
participants as beneficial when engaging in IPIs as it helped make interactions less formal 
and resulted in the development of balanced  bipartisan interactions; “(we interact) within 
lunch hours, after working relationships you know, it is more than just formal relationships” 
(P5), “if you have got good interprofessional relationships with other people they tend to 
approach you more and you are more involved in the care of the patient” (P12), “I am quite 
happy to say I think I have made those really good connections and links with the teams so 
that they come and find me which is really rewarding way to practice really” (P10), “I suppose 
if someone is asking me for help I suppose I am more inclined to go and speak to them as well 
then” (P6). 
 
Relationships  were noted to develop over time; “obviously because I have been there for so 
long now I know the nurses really well, erm so it’s a lot easier in that sense” (P1), “the more 
time you spend working with people the greater the relationship develops so they will be more 
willing to come to you and it will be easier to ask for their assistance as well so just building 
that rapport really” (P13). In addition, as P4 suggested, once the relationships are built 
interactions become more open; “I have got to know them the last couple of weeks, especially 
the F1s they come up to me with queries so it’s sort of now that two-way rather than me just 
pestering the doctors with things”. P2 also felt that building these relationships is helps 
improve patient outcomes; “the better your relationship is you build it up over time, the more 
favourable outcomes you have, for yourself and the patient”. Participants also suggested 
approaches that could aid the development of relationships including regular time on the 
ward, having social ‘mixers’ and HCPs such as doctors having more regular times when they 
are on the ward and available to interact. 
3.2. Pharmacists and HCPs having good interpersonal skills 
Participants recognised the importance of good interpersonal skills both in themselves and 
in other HCPs. Being approachable was seen to improve the likelihood of a quality IPI; “I try 
to be quite open and I don’t mind them asking me questions, even if they feel it is a bit of a silly 
question I really don’t mind, so they tend to approach me” (P12), “your practice changes to 
make sure that your communication to them (nurses) is robust, that you understand their 
pressures and trust them to do things when it is safe and convenient to do so” (P5). One 
method pharmacists employed to do this was by introducing themselves and finding out the 
names of each HCP; “I would always like to introduce myself to the team and let them know I 
am around and available” (P10), “if it is a new ward that I am always introducing myself to 
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everyone of them, find out their names as well… I just think it is easier to talk to someone when 
they know your name… I think it just puts them at ease with me as well then doesn’t it, to think 
that I am friendly and easy to approach then life is easier” (P6), “I now go up to them and 
introduce myself to them, and now when I see them on wards I chat to them and say how are 
you, so its good because it makes it easier for you if you have problems, and it makes it easier 
for them as well if they have problems” (P14). A number of participants found that a range of 
professions were approachable and friendly which aided interactions; “the surgeons on my 
ward are great and the consultants are wonderful, even in terms of like actually speaking to 
me and don’t mind me asking them questions” (P1), “she (ward sister) is more than happy for 
me to knock and just pop in and have a quick chat about things” (P2), “they (dieticians) all 
seem very friendly… there’s no sort of intimidation with them” (P6). 
3.3. Pharmacists and HCPs being easily accessible (co-location) 
The accessibility of HCPs was seen to be a key factor when undertaking IPIs, with many 
participants suggesting that most HCPs were accessible if needed; “they (HCPs) are quite 
accessible if I need them” (P1), “if there is a need for any pharmacist input we are available 
and likewise if we need to get hold of a doctor or if there is any sort of concerns we know that 
there is always somebody that we can contact” (P13). Co-location on the ward was seen to 
be a key factor in having good accessibility to HCPs and was found to make IPIs with nurses 
and doctors (particularly junior doctors - see theme 4.2) easier due to their continuous 
presence on the ward; “as soon as you arrive on the ward you know that there is doctors there” 
(P15), “they (nurses) are the easiest to get a hold of, you know where they are, they are always 
on one ward” (P9), “they (doctors) are there on the ward all day” (P8). In addition, P1 
indicated physiotherapists had a regular ward presence and P8 indicated that dieticians 
regularly work alongside them on their ward. Of note, this was not a consistent feature of 
all interviews. HCPs having good access to pharmacists through co-location on the wards 
was also seen to benefit IPIs; “we do have quite a good presence on the ward so there is usually 
one of us around so they don’t have to go hunting for a pharmacy person to ask questions about 
because there is usually somebody there or easily accessible” (P13).  
 
P14 also expressed how co-location made IPIs much easier in comparison to the segregated 
community pharmacy environment; “that is one of the reasons why I interact better in 
hospital, it’s because they are close by, so the closer the healthcare professional is to you, when 
they are right in front of you it is much easier to interact than if they are far away, and that’s 
what tends to happen in community, you may have a pharmacist that is opposite the GP but it 
doesn’t mean they are interacting, I mean they may hardly talk to each other”. Other 
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participants expressed how interacting face-to-face aided the communication and helped 
get issues sorted more promptly; “if it can wait I will wait and see if I can see them face to 
face generally… you cannot properly get the full picture when communicating with someone 
over the telephone, you pick up on a lot of clues, body language, visual signs, expressions, eye 
contact, the way they act, you know lots of subconscious things that you probably get when 
you talk to someone, that you can’t appreciate if you speak to them over the telephone” (P2), 
“it is just easier to speak to them face-to-face as they are more likely to sort out the issues there 
and then” (P1). 
 
It was not just on the wards where participants found co-location helpful for conducting 
IPIs, P5 and P2 both shared office space with doctors and nurses which facilitated 
engagement between professionals; “I sit 5 yards away from a consultant nephrologist so 
geographically with where we are placed day to day there is just interaction… not only are we 
professionally integrated but we are geographically integrated as well” (P5). Other ways 
pharmacists were accessible to other HCPs when they were not present on the ward was 
through a bleep number and when pharmacists were tasked with answering phone calls 
from HCPs when based within the dispensary, medicines information department or when 
on-call. In addition, knowing how to contact HCPs when they are not present was seen to be 
important by participants; “cisco phone is the wireless mobile phone that some consultants or 
registrars will have, which means they are easily contactable on most phones” (P3) “sometimes 
they put their numbers in the notes” (P12). However, as some participants found that they 
did not know how to contact certain HCPs (see theme 2.2) it was suggested that having a 
central list of all contact numbers could be helpful and was indeed helpful in those hospitals 
where this system operated.  
3.4. Mutual understanding and appreciation of professional roles and responsibilities   
Understanding and appreciating the roles and responsibilities of other HCPs was seen to be 
an important aspect of being able to engage successfully with other professions; “you do 
have to have an element of respect and appreciation of their (HCPs) roles to know where your 
priorities lie in terms of with theirs… having an awareness of their duties will dictate when is 
good time and what is the best way to approach them to interact with them” (P2). It was also 
acknowledged that HCPs were more inclined to interact when they appreciated the role of 
the pharmacist; “they tend to come up to you as much as you go up to them because they 
understand your role as a pharmacist” (P3), “we work so closely with them (nurses) these days 
they fully appreciate the role of pharmacy, you know we never have any issues with nurses not 
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wanting to cooperate with us” (P9), “they (GPs) welcome pharmacy and what they bring to 
the table” (P15).  
 
It was also felt that the respect HCPs had for pharmacists had grown over time. One of the 
reasons for this was seen to be the advancement of pharmacy practice which has enabled 
pharmacists to become more embedded in the interprofessional team; “I have been a 
pharmacist 14 years now and I see things very different now to what they used to be, so now it 
is great, you know pharmacists are very much seen as part of the multidisciplinary team and 
you know our thoughts and opinions are valued and people will actually come to us now and 
say what do you think about this” (P9), “I think our profile is a lot lot higher now and people 
recognise far more than they did years ago the benefits of the pharmacists on the wards and 
in the hospital” (P10). One reason P5 believed their professional role had grown is through 
the backing of doctors within their hospital; “our medics have realised that pharmacists are 
capable… they have seen the limitations that pharmacy have that they don’t, they have worked 
to champion those professional boundaries so that we can become autonomous practitioners”.  
 
Two participants, P2 and P13, found that the respect and appreciation for pharmacists 
stemmed from the respect which had been earnt by their senior pharmacist(s); “it probably 
stems from my bosses relationship with the consultants, who is very highly respected which 
has stemmed down through his team, that has had an immense benefit for me personally 
because you have instantly got an amount of respect from the doctors because you are a 
pharmacist in the renal team” (P2), “I think our lead nephrology and transplant pharmacist is 
really well respected which kind of helps the rest of the team as well” (P13). P2 also felt that 
in providing high quality pharmacy services this positively influenced the frequency of 
interprofessional engagement that took place; “that whole respect for pharmacy that I think, 
that is why they stop and listen and that they value what you have got to say, the more you do 
for them and the more right choice you make the more they respect you the more they use you 
so they will get in touch with you”. The specific specialisms and extended role(s) of the 
pharmacist (such as delivering presentations and teaching, conducting audits and doing 
research) was also seen to have an positive impact on interactions. 
3.5. Taking part in interprofessional ward rounds and team meetings 
A significant number of participants found that having a set time and environment where 
pharmacists and HCPs were together actively encouraged IPIs and helped develop 
interprofessional relationships. One example of this described by a number of participants 
(n=6) was attending MDT meetings; “there may be a transplant patient review MDT, where 
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we discuss the clinics that have happened that week, so those are the day-to-day interactions 
so co-managing patients” (P5), “we have a weekly virology meeting where there is nurses, 
doctors and pharmacists that attend” (P13). Attending ward rounds was found to be a 
beneficial way of engaging in IPIs by a number of participants (n=8) and helped HCPs 
provide more efficient holistic care to patients; “I go on the consultant ward rounds twice a 
week, so I always consult with them (consultants) then so I am there at the point of 
prescribing… that improves your interaction and makes it much better because you are there, 
you don’t have to be hunting them down, you can understand why somebody had done 
something” (P8), “there is no formal referral systems that delay referral or interventions or 
treatments because the decision making including the diagnosis, supply of medications, the 
education, the follow up all happens at the patient’s bedside… you can create a holistic 
approach” (P5).  
 
A number of participants (n=7) intimated that attending (more) ward rounds with a larger 
range of HCPs would be beneficial; “having more frequent MDT meetings… I think that would 
be really helpful” (P3), “the ward rounds are a fantastic opportunity to meet people… I think 
it is really valuable so probably more so of that and more of us all being able to attend” (P10), 
“we don’t really get involved in consultant meetings… I know there are opportunities, 
pharmacy could input in those” (P15), “I think having a nurse a pharmacist and the team of 
doctors on the ward round would probably help, especially in terms of communicating 
discharges” (P7). 
 
Three participants also mentioned that ‘board rounds’ with other HCPs could facilitate 
interactions; “board rounds they have in the mornings on the ward, so kind of a huddle of 
different healthcare professionals, highlighting who is going to go home, who’s particularly 
high risk, who has got a social issues, who has got a dietician issue, you know that kind of thing, 
who has got a pharmacy issue, again joined up working” (P10). It was also felt that getting 
more HCPs involved in these would be beneficial; “if you had a sort of board round where 
you would involve all of those people and social workers, occ health and things, I think that 
would improve discharges because you could all communicate together so everyone knows 
what is going on” (P8).   
3.6. Development and incorporation of education methods including interprofessional 
education  
As discussed in section 6.3.2.2.6, many participants articulated a variety of benefits when 
undertaking IPE such as understanding other HCPs roles and responsibilities. However, a 
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number of participants commented that these sessions currently occur infrequently and 
therefore suggested earlier and more regular IPE was needed in undergraduate 
programmes. Participants felt these sessions were required due to the clear professional 
separation in healthcare education (especially pharmacy) i.e. programmes are developed 
and delivered in a uniprofessional manner making it challenging to establish and develop 
interprofessional relationships; “I’m not sure there is a mechanism in pharmacy that allows 
you to establish these relationships” (P5), “in university we are a bit separated aren’t we in our 
different areas, so when you start working yeah obviously you work together as a team but 
there is that initial barrier” (P10). 
 
Although all participants acknowledged the benefits of incorporating IPE as a regular 
feature of education and training, it was also felt that additional changes are needed to 
improve IPIs taking place in practice; “I don’t think there is any one amazing cure, one great 
thing that will solve it all, I think it’s one of those things that needs a really multifaceted 
approach” (P10). One suggestion which was articulated by a number of participants was the 
incorporation of more practice-based placements for pharmacy students, with many feeling 
there is a disparity with other healthcare courses (especially medicine) where students 
have significantly more workplace experience before reaching practice; “we don’t do much 
work experience and things so the doctors don’t see you when they are training” (P1), “the 
biggest thing with our undergraduate course at the moment without doubt is the lack of 
practical experience… we have to mimic the medical model as much as we can… we are missing 
a trick in that when these medical undergraduates are out at ward level with the teams we 
need to have our pharmacy undergraduates there at the same time doing that so really from 
an early, early stage they need to be part of that multidisciplinary team, patient facing, 
actually being able to apply the knowledge that they are learning in university” (P9). P9 did 
acknowledge that this would be challenging to achieve due to the increased funding medical 
programmes (“unfairly”) receive compared to pharmacy programmes, therefore they felt 
that pharmacy educators need to develop new innovative methods to achieve the desired 
interprofessional outcomes for students; “this is why we need to think outside of the box 
really … forget what we have done before, we really need to start thinking in a different way… 
rather than a student being employed by a pharmacy department actually getting employed 
by a health board and so then they could be attached to a consultant ward team”. One way 
that two participants indicated this may be achieved was through an integrated 5-year 
MPharm programme with co-terminus graduation and professional registration.  
Participants indicated this may allow for an expanded placements programme; the 5-year 
integrated programme is currently offered by a limited number of UK schools of pharmacy.  
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Other suggestions included undertaking more OSCEs with an interprofessional focus 
(iOSCEs), reflecting and getting feedback on previous interactions, expanding teaching 
outside of specific professions (i.e. pharmacists teaching medics and vice versa) and 
undertaking interprofessional research days. P10 believed that using a variety of methods 
in combination would be helpful in ensuring that barriers to IPIs are broken down as much 
as possible; “getting that experience under their belt from a very early stage as well as hand 
in hand with the OSCEs and the other things that are happening within the university, so I 
think those are supremely helpful in ensuring those barriers are broken down”. 
6.3.2.3.4. Impact of doctors’ seniority on interactions 
The impact that a doctor’s seniority had on IPIs was separated into four subthemes: 
4.1. Additional challenges when interacting with senior doctors compared to junior 
doctors 
4.2. Value of interacting with senior doctors 
4.3. Impact of pharmacists’ seniority on interactions with senior doctors 
4.4. Impact of doctors’ seniority on interactions with pharmacists 
4.1. Additional challenges when interacting with senior doctors compared to junior doctors 
P12 found that interacting with doctors was the most challenging of all HCPs; “they are the 
most challenging healthcare professional to interact with because they are very intelligent 
people and they have got a wealth of knowledge in specific fields”. Over half of the 
participants, indicated that senior doctors provided the greatest challenge in terms of IPIs 
as  they can be dismissive towards pharmacists and less inclined to interact; “it is much more 
difficult (interacting with senior doctors) because they are more sort of, they tend to try and 
rush you… or they don’t sort of take your suggestions or what you have to say on board, you 
know they don’t take what you say as the right thing to do” (P12), “the more senior doctors 
may think that they know better, erm and may dismiss your opinions” (P2), “as they get more 
experience they tend to move away having more of the interprofessional experiences as they 
feel it’s an experience they don’t need anymore” (P14), “so the higher grade the doctor is, 
potentially I feel there is more of a barrier… some consultants here are notoriously not keen 
on pharmacy questioning things, and they like to do what they know is best” (P15).  
 
Conversely junior doctors were found to be easier to interact with than their senior 
colleagues as they often had a greater appreciation for the role of the pharmacist, accepted 
advice more readily, were a similar age to some participants and had better personal 
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relationships; “I think that the junior doctors are fine, I think they accept us and appreciate 
the information that we give” (P15), “they tend to be the same age of me… you do get on well 
with them and you don’t mind approaching them and be like oh can you sort this out” (P12). 
Furthermore, junior doctors were generally seen to be more accessible than senior doctors 
as they spent more time on the ward presence and were said to be more readily contactable; 
“the junior doctors are usually based on the ward” (P2), “the junior doctors are there all the 
time and they are the ones I am interacting with a lot” (P12), “so you can’t really get hold of 
them (senior doctors) that easily, whereas like an F1 you literally bleep them and they pick up 
straight away” (P7), “the junior doctors are their constantly and those are the ones who we 
interact with” (P15). It was felt that interactions with senior doctors were, at times, limited 
to the occasions they visited the ward or were conducting ward rounds; “most times the 
consultants are only there is during their particular ward round” (P15). A number of 
participants commented how senior doctors had less time to interact and could become 
short with pharmacists (also see theme 2.1), with P2 commenting that this means they have 
to choose carefully their interactions with senior doctors; “some consultants, I don’t know if 
it’s stress, but they can get a bit short with you… I have to pick my queries a bit more carefully, 
does it warrant going to the consultant and using a minute and a half of his time”. 
4.2. Value of interacting with senior doctors 
Although IPIs were generally found to be less frequent with senior doctors, there were 
occasions where participants found it was important to contact senior doctors rather than 
junior doctors, even if this meant contacting them over the phone; “I do get a lot of 
interaction with the registrars as well because there are things that I feel that wouldn’t be fair 
for me to ask the junior doctor, from past experience I know that the junior doctor wouldn’t be 
happy answering… so it is quicker if I just contact the registrar, those things tend to be more 
via telephone, and the registrar will equally contact me a few times throughout the day” (P2).  
4.3. Impact of pharmacists’ seniority on interactions with senior doctors 
It was recognisable throughout the interviews that the more junior the pharmacist, the 
more challenging they found IPIs with senior doctors, with many finding interactions 
intimidating; “the more senior doctors it is intimidating to begin with” (P4), “the higher up 
they are, I think it is intimidating yeah, because consultants I would (be) less inclined to 
approach them than if it was an F1” (P6). Participants also commented how senior doctors 
could be less receptive to junior pharmacists; “I think perhaps sometimes erm the more 
senior registrars erm are a bit choosey on their receptiveness to sort of advice from 
pharmacists erm particularly those of a lower grade” (P13), “I think because they are way 
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more experience and they may see you as a new young person and think you can’t tell me (what 
to do)” (P14).  This was in contrast to more experienced pharmacist participants who stated 
they interacted with “consultants down to the F1s” (P8), with a number of senior 
pharmacists stating they had good relationships with senior doctors; “we do have a really 
good working relationship with the consultants” (P13), “I have got quite a close relationship 
with the consultants” (P15). The challenges junior pharmacists faced aligned with a number 
of the challenges described in theme 2.4, which outlined the barrier to interactions when 
HCPs/pharmacists are new to an interprofessional team. 
4.4. Impact of doctors’ seniority on interactions with pharmacists 
Similar to theme 4.3, and with reference to theme 2.4, participants also found that junior 
doctors often lacked confidence in engaging in IPIs with P6 feeling that they often led 
interactions with the junior doctors having little input. It was also felt by P2 that junior 
doctors “can be hit or miss… you can have exceptional juniors… (and) other juniors not so 
much…  you do start to just generally start avoiding them and start asking other people… if 
you don’t think you are going to get the result or appreciation of what you deserve”. This then 
led them to interact with other more senior doctors to ensure they achieved the required 
outcome; “if you don’t feel they are going to get the outcome you want then you will ask 
someone else” (P2).  
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6.5. Discussion 
The role of hospital based clinical pharmacists in the care of patients has significantly 
evolved. This has led to a rethinking within the NHS about how to take greater advantage of 
pharmacist’s unique skillset as experts in medicines. Whilst there has been a significant 
focus on further integrating pharmacists into interprofessional hospital teams (Dobson et 
al., 2006; Kaboli et al., 2006; Department of Health, 2013a; Carter, 2016) as there is a paucity 
of literature exploring hospital pharmacists’ interprofessional interactions it is challenging 
to understand the current state of pharmacists’ interprofessional roles.. This study 
therefore aimed to identify and explore hospital pharmacists’ interactions with HCPs in 
Wales using a mixed method approach. 
 
The questionnaire, which was disseminated via gatekeepers to approximately 520 
pharmacists across all 19 Welsh hospitals containing in-house pharmacy departments 
achieved an estimated response rate of 51.9%. The response was varied across the six NHS 
LHBs surveyed (standard deviation of 15.4%, range 24.3% - 68.8%); this may have been 
influenced by the gatekeeper role in dissemination. Analysis of returned questionnaires 
indicated that hospital pharmacists most frequently interact with doctors and nurses. Of 
note, pharmacists perceived that they interacted more frequently with professions that 
were similarly located within the hospital compared to other. Interactions with HCPs that 
were physically separated, for example HCPs based within primary care, were much less 
frequent. Following the questionnaire phase of the study, 15 semi-structured interviews 
were conducted with hospital pharmacists to further explore these interprofessional 
interactions.  
 
Given that a number of recent UK government enquires within secondary care have cited a 
breakdown in interprofessional team work as a key reason for the delivery of poor patient 
care in hospitals (Francis, 2013; Andrews and Butler, 2014; Kirkup, 2015) it may not be 
surprising that all interview participants suggested that working in interprofessional teams 
could improve patient care. In a review of interprofessional working in hospitals O'Leary et 
al. (2012) found that teamworking across professions was of critical importance in the 
provision of safe and effective hospital care and concluded that hospitals with high 
teamwork ratings experienced higher patient satisfaction, lower hospital costs and higher 
staff retention. In this current study, participants indicated that engaging with other HCPs 
improved information exchange and lead to better utilisation of the specialist skills and 
approaches of each HCP resulting in more efficient holistic patient-centred care. 
Participants also indicated that through IPIs, HCPs could learn from one another, recognise 
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roles and responsibilities and build social relationships which made the work environment 
more pleasurable. A number of reviews, summary papers and books related to 
interprofessional interactions and collaboration have noted similar benefits to practitioners 
(Freeth et al., 2008; O'Leary et al., 2012; Thistlethwaite, 2012; Carpenter and Dickinson, 
2014; Barr et al., 2017).  
 
In some cases, participants suggested improvements in service metrics were directly 
attributable to interprofessional interactions. For example, one participant stated that the 
implementation of regular pharmacist-dietician collaborative interventions in patients with 
renal disease had led to significantly improved CKD-MBD (chronic kidney disease - mineral 
bone density) markers in patients and the service has subsequently been recognised as one 
of the top performing in the UK. This is an interesting finding as, despite anecdotal evidence, 
a recent Cochrane review by Reeves et al. (2017) concluded that there is little high quality 
evidence which definitively correlates IPIs with improvements in patient care and patient 
outcomes. In addition, although a number of studies have concluded that pharmacists 
working in collaboration with other HCPs could improve specific patient outcomes in a 
range of disease states including CVD (Tsuyuki et al., 2016), CVD in type-2 diabetes (Al 
Hamarneh et al., 2017), heart failure (Koshman et al., 2008), blood pressure (Santschi et al., 
2014) and dyslipidemia (Charrois et al., 2012)(see chapter 2 for further details), they too 
provide a weak evidence base. In most cases these studies investigate the impact of the 
pharmacy service itself  rather than an interprofessional approach.   
 
In the seminal report conducted by Lord Carter into the operational productivity and 
performance of NHS acute hospitals, the two professional groups hospital pharmacists were  
said to need to engage with in order to enhance clinical outcomes related to medicines were 
doctors and nurses (Carter, 2016). In this current study nearly all questionnaire 
respondents indicated that they interact with these professionals on a weekly basis (doctors 
- 94.1% of respondents, nurses - 94.8% of respondents) and a significant majority of 
respondents indicated they did so on a daily basis (doctors – 77.4% of respondents, nurses 
– 87.0% of respondents). All 15 interviewees also indicated that they had daily interactions 
with doctors and nurses. The IPIs with doctors and nurses were predominantly described 
to be collaborative with everybody working together to achieve common goals.  
 
The interviews highlighted that pharmacists’ IPIs with hospital doctors and to some extent 
with nurses predominately concerned clinical issues related to the appropriateness of 
medicines and this was seen as an activity that spanned a patient’s stay in hospital from 
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admission to discharge. In a systematic review of pharmacists’ clinical interventions 
conducted by Kaboli et al. (2006) the pharmacists’ role in reconciling medicines and aiding 
the discharge process was found to improve patient outcomes (such as reduced medication 
errors, improved medication adherence and shortened length of hospital stay). However, 
the authors did not reference the interprofessional manner (if there was one) in which these 
tasks were conducted. In addition, in a study by Eggink et al. (2010) patients benefited from 
interprofessional collaboration between doctors, nurses and pharmacists as evidenced by 
a significant reduction in prescription errors on discharge when compared to those patients 
discharged by doctors and nurses alone (14.6% of those in the control group had at least 
one prescription error compared to 6.1% in the pharmacist collaborative intervention 
group). However, a number of limitations to the study were acknowledged including: the 
fairly small sample of prescriptions reviewed (n=86), the fact that interventions were 
conducted by one specific pharmacist in one hospital, and the nature of the pharmacists’ 
interprofessional engagement was not directly assessed.  
 
In a recent study conducted by Axon et al. (2018), 27 junior doctors (FY1s) across three UK 
hospitals were interviewed about their interactions with hospital pharmacists. The authors 
found that junior doctors perceived pharmacist-doctor interactions to be frequent and 
varied in nature, results which were corroborated by pharmacists in both the questionnaire 
and interview phases of this current study. In addition, Axon found that junior doctors felt 
they approached hospital pharmacists as much as the pharmacists approached them. This 
finding was in contrast to the findings here where the majority of interview participants felt 
they approached doctors on a more frequent basis. Interestingly this was less evident with 
nurses where on the whole participants indicated that the initiation of an IPI was fairly 
balanced between nurses and pharmacists.   
 
IPIs with nurses were often focused on the patient, providing information to pharmacists 
related to different aspects of the patient experience that impacted on their holistic care. 
Participants found they had in-depth discussions about the patients and their ongoing care, 
often turning to nurses to find out how the patient is coping and ascertaining other general 
information such as their weight and ability to take medications (both physically, i.e. 
patients’ swallowing ability, and with regards to their compliance). IPIs also included 
practical discussions surrounding how to administer particular medications (infusion rates 
etc.) in addition to other areas such as stock and supply of medications. It was generally 
found that IPIs with nurses had a more patient oriented, less clinical focus than with doctors. 
Similar findings were described by Snelgrove and Hughes (2000) who interviewed 20 
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doctors and 39 nurses across three hospitals in South Wales to determine their perspectives 
on interprofessional relations. The authors found that doctors perceived themselves as the 
key HCP in the management of the treatment process and this resulted in IPIs that were 
clinical in nature. Conversely, nurses felt they ‘knew’ the patient as a person and therefore 
could provide input in the interprofessional team about the patient’s social, emotional and 
daily needs.  
 
In a phenomenological study conducted by Makowsky et al. (2009b) that explored 
interprofessional experiences within an intensive care team (perhaps limiting 
generalisability), collaboration between pharmacists, doctors and nurses appeared to help 
facilitate positive patient outcomes, better team decision making about drug therapy, 
improved continuity of care and improved patient safety. These outcomes were all 
highlighted as benefits to IPIs within the interviews conducted in this current study. 
Furthermore, interviewees who felt they were embedded within the interprofessional team 
believed they developed trusting interprofessional relationships, made positive 
contributions to patient care and (like their HCP colleagues) developed an increased 
awareness of one another’s roles and had a greater recognition of the benefit of 
interprofessional team working; these benefits were similarly described by Makowsky et al. 
(2009b).  
 
Through the questionnaire phase of the study, dieticians were ranked third with respect to 
pharmacists’ frequency of IPIs, with the majority (n=14) of interviewees also stating they 
interacted with dieticians on a regular basis (four of which on a daily basis). IPIs with 
dieticians were said to be collaborative and primarily involved clinical discussions about 
total parenteral nutrition and management of patients’ electrolytes through diet and 
medication. Interactions involving information transfer between individuals of the two 
professional groups also occurred related to stock and supply of dietary items at the 
pharmacy. Other professions identified in both the questionnaire and interviews that 
hospital pharmacists interacted with included physiotherapists where interactions often 
focused on provision of medicines advice, occupational therapists and social workers who 
were found to be useful sources of information when arranging patient discharges, speech 
and language therapists where interactions aided the determination of appropriate 
medications for patients who may have difficulties swallowing, and midwives which were 
seen to engage in IPIs that were similar to nurse. Interestingly, although interactions in this 
study were found to be less frequent with ‘allied’ HCPs compared to doctors and nurses, 
Braithwaite et al. (2013) found that allied HCPs were the most supportive of the concept of 
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interprofessional collaborative working, with doctors the least supportive. The differences 
in attitudes towards interprofessional working have been measured elsewhere with Reid et 
al. (2006) similarly reporting that doctors had less positive attitudes towards 
interprofessional working in comparison to nurses, and Chang et al. (2009) also finding 
doctors were the least positive towards interprofessional working compared to nurses and 
other HCPs. 
 
One factor which was seen to impact interactions was the particular specialism(s) of the 
pharmacist. A number of interview participants suggested that specific specialisms meant 
that interactions with other HCPs were more likely or necessary. For example, when 
specialising in areas such as stroke or renal disease, interaction with dieticians was seen to 
be a real necessity in the role. This was evident for other professionals including 
physiotherapists, occupational therapists, speech and language therapists, social workers 
and midwives, which saw some participants having frequent interactions as a result of their 
own particular specialism. Although participants recognised that their specialisms did have 
some impact on their nature of their IPIs with doctors and nurses it did not particularly 
drive interactions due to both the generalist nature of their roles and the fact they are a 
consistent feature of the ward environment rather than present due to their specialism. 
Interestingly, this contradicted the views of junior doctors interviewed by Axon et al. (2018) 
who stated that when they worked in areas such as surgery this negatively impacted their 
perceived frequency of IPIs with hospital pharmacists, something which wasn’t generally 
evident in this study, even in interviews with pharmacists who specialised such areas (i.e. 
surgery).  
 
The diverse nature of hospital pharmacists’ roles was evident in the reported range of 
specialisms (43 across 270 respondents) by questionnaire respondents. One area of 
pharmacists’ activity that was undertaken by a sizeable proportion of questionnaire 
respondents (14.8%) was on the ‘supply chain’ side (either procurement or aseptics). 
Engagement in such activities is seen as a barrier to interprofessional interaction’s and 
inappropriate use of pharmacists’ expertise. For example, in the UK government paper by 
Carter (2016) a recommendation was made for pharmacists to move away from activities 
associated with medicines supply towards more interprofessionally integrated, clinically 
focused areas of practice. Whilst pharmacists did not directly highlight their roles in these 
more traditional areas as an issue, it was clear that pharmacists recognised a need to 
provide more collaborative clinically focused patient care.  
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When patients required the input of allied HCPs, interview participants recognised that in 
order to do this professionals from the relevant group often came directly to the ward, 
therefore allowing pharmacists the opportunity to interact with them directly. This 
coincided with data from the questionnaires which indicated that junior pharmacists (who 
had a greater ward presence than their senior pharmacist colleagues) reported that they 
interacted significantly more frequently with a range of HCPs who were similarly co-located 
on wards (as identified in interviews) including nurses, dieticians and speech and language 
therapists.  
 
The positive impact of co-location on frequency of IPIs was clear from the questionnaires 
and interviews. Indeed, there was a twenty-fold increase in respondents’ frequency of 
interaction with secondary care doctors and nurses compared to their primary care 
counterparts. Interview participants reinforced this, indicating that the consistent ward 
presence of doctors and nurses was beneficial to IPIs and when segregated from HCPs this 
made IPIs more challenging. Participants indicated that co-location afforded greater access 
to HCPs and facilitated face-to-face interactions which aided communication and improved 
the efficiency of problem resolution. This greater access enabled them to build both 
professional and social relationships over time which increased comfort and confidence. 
Indeed in a model for improving relationships between pharmacists and doctors developed 
by McDonough and Doucette (2001) the authors believed that having close proximity to one 
another, increased volume of interactions and could aid the development of collaborative 
relationships resulting in improvements in the delivery of patient care.    
 
Where HCPs were not regularly based on the wards due to factors such as limited numbers, 
staffing patterns and professional rotation to other specialisms, the process of developing 
relationships with individuals was hindered. Interviewees felt it was essential to have good 
interprofessional communication skills and used techniques such as introducing 
themselves to quickly build rapport. This technique has been shown to be welcomed by 
junior doctors who believed that knowing the names of pharmacists helped them get to 
know the pharmacist better, establishes a rapport and helps them to accept 
recommendations more readily (Axon et al., 2018). Participants’ recognition of the need to 
have strong communication skills, to be approachable and to take the time to undertake  
interactions were also factors recognised in the model for improving collaborative 
relationships between doctors and pharmacists developed by McDonough and Doucette 
(2001). In a Joint Commission Update that reviewed and summarised the need for 
teamworking and communication in the nursing profession, Nadzam (2009) expressed the 
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importance that interprofessional communication (including body language, attitude and 
tone) have in ensuring that patient safety is maintained. A number of recommendations 
were made for nurses which are also applicable to other HCPs including addressing each 
other by name, being professional (but not aggressive) and having good listening skills. 
 
Another area addressed by Nadzam (2009) was the need for nurses (and HCPs in general) 
to look for and resolve system problems and not ‘play the blame game’. This was touched 
upon within the interviews in this current study, with participants suggesting that the role 
of the pharmacist in raising and addressing issues, errors or omission made by other HCPs 
can lead to a negative image of pharmacy and result in HCPs at times avoiding interactions 
with pharmacists. This may be why Axon et al. (2018) found that some junior doctors felt 
that communication with pharmacists was frustrating, inconvenient and repetitive when 
resolving prescribing issues. These negative perceptions may explain why pharmacist 
interviewees here felt that approaching interactions in the right manner was vital in 
maintaining positive interprofessional relationships.  
 
When IPIs were deemed successful, participants indicated this helped build credibility and 
trust from HCPs and ultimately improved the interprofessional team dynamic. This 
corresponds with findings of Xyrichis and Lowton (2008) who undertook a review of the 
literature (43 papers included) to identify facilitators and barriers to interprofessional 
teamworking in primary care and found that a “climate of mutual respect and trust was 
fundamental for effective teamwork to exist” (pg. 149). Participants also found that 
professional credibility and respect could be developed and carried over from HCPs’ 
interactions with other pharmacists, leading a number of interviewees to express their 
gratitude towards their senior pharmacist who they felt had created an environment which 
drew the respect and appreciation of other HCPs. Conversely, some participants articulated 
that when HCPs had previously had poor encounters with other pharmacists this could be 
detrimental to their own IPIs, believing that HCPs projected the encounter onto the 
professional group rather than the individual and were subsequently less likely to approach 
or trust pharmacists.  In interviews (n=18) with doctors and nurses exploring perceptions 
of interprofessional roles and relationships Pullon (2008) detailed similar findings, with 
interviewees expressing that the development of mutual interprofessional respect and trust 
was related to demonstration of professional competence. 
 
In an ethnographic study of the interprofessional communication modes taking place in 
‘general internal medical wards’ in two teaching hospitals in Canada, Conn et al. (2009) 
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observed that HCPs communicated both synchronously (interactions happening at the 
same time, i.e. face-to-face communication) and asynchronously (interactions happening at 
different times, i.e. written notes). In this current study, although co-location of 
professionals resulted in IPIs being predominately face-to-face, interestingly junior 
pharmacists were found to prefer asynchronous interactions (via leaving notes) in 
comparison to senior pharmacists. This was generally seen as a negative mode of 
communication by participants as synchronous communication was said to result in more 
efficient delivery of care, helped develop relationships and enabled greater levels of 
interprofessional collaboration (rather than just information transfer). Junior pharmacists 
primarily cited lack of confidence as the reason they avoided synchronous engagement and 
therefore they often resulted left notes rather than engaging in face-to-face interactions. 
Whilst Conn et al. (2009) also observed that verbal interactions often substituted written 
communication they stressed that utilising both forms of communication is essential in 
order to comprehensively convey messages and highlighted that where individuals have 
recall issues following verbal communication, errors leading to patient safety issues could 
occur. 
 
Co-location of HCPs also extended beyond the ward, with a number of more senior 
pharmacists indicating they were co-located in offices alongside individuals from other 
professions such as senior doctors and nurses. This was as a result of their management or 
directorate related roles. For these senior pharmacists, the topics of interactions also varied 
and often involved ‘higher-level’ or strategic issues related to clinical governance and 
organisational management. This may help to explain why senior pharmacists were found 
to interact significantly more frequently with consultant doctors than junior pharmacists. 
Similarly, junior pharmacists were found to interact significantly more frequently with 
junior doctors than their senior colleagues, likely due to the co-location of the two junior 
HCPs on the wards together. This was reinforced by a number of interview participants who 
stated that junior doctors were primarily based on the ward allowing them to easily 
communicate, whereas the senior doctors were frequently physically separate from 
pharmacists leading to either communication by phone or email or by waiting until senior 
doctors come to the ward for patient consultations, ward rounds or when undertaking 
MDTs. Although participants found this far from ideal they recognised that senior doctors 
could still be contacted if necessary. For other HCPs, including dieticians, speech and 
language therapists, social workers and occupational therapists, contact was more 
challenging when not co-located as pharmacists were often unaware of how to contact them 
directly.  
Chapter 6 
 
 
259 
 
The time constraints experienced by consultants and other HCPs was one cited by some 
interview participants as one reason for their limited presence on the wards and they felt 
this limited the opportunities available to develop interprofessional team relations. A 
similar finding was identified in an ethnographic study of interprofessional relationships 
within acute care conducted by Allen (2002) who reported that doctors and nurses often 
experienced difficulties communicating as their roles required them to be located in 
different parts of a hospital throughout the day therefore limiting opportunities for face-to-
face discussions. In addition, as the resources and funding within the NHS become 
increasingly constrained, HCPs may be further limited in the time they can spend 
undertaking certain lower priority tasks. This was described by Snelgrove and Hughes 
(2000) who found in their study of doctor and nurse interprofessional relations in South 
Wales that work pressures negatively impacted interprofessional engagement and their 
effectiveness in working in interprofessional teams.  
 
Indeed Bogden et al. (1997), who conducted a RCT comparing the impact of patients’ (n=96) 
high cholesterol when receiving either an interprofessional pharmacist-doctor intervention 
or standard uniprofessional doctor care, found that although the collaborative pharmacist-
doctor care significantly reduced patients’ cholesterol levels the time required by the 
pharmacist to deliver this service diverted their time from other priority tasks. This raised 
concerns over the sustainability of the service and lead to the recommendation that further 
investment in HCP numbers was needed if this service were to continue. Greater investment 
in HCP staffing was raised in interviews in this study as it was believed this could improve 
access to HCPs which could in turn increase the frequency of IPIs. In addition, it was hoped 
that this would also reduce the stress on HCPs as it could help spread workload. Of note, 
Axon et al. (2018) found that junior doctors felt that having greater access to pharmacists 
would be helpful as pharmacists could be difficult to find, phone lines were often busy and 
pharmacy departments could be slow. They also felt that there was a lack of continuity of 
pharmacists on the wards which made conversations repetitive and time-consuming.  
 
One curious finding was that over half of the interviewees in this study felts that interactions 
with senior doctors provided an additional challenge as they could be dismissive and less 
inclined to interact with pharmacists. They believed that junior doctors had a greater 
appreciation for the role of the pharmacist, accepted advice and were more open to the 
development of social relationships. Furthermore, participants felt senior doctors’ time was 
more valuable and constrained which resulted in some participants being more selective 
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with their IPIs with senior doctors and ultimately engaging in less frequent interactions. 
Whilst it was not exclusively the case, junior pharmacists found IPIs with senior doctors the 
most challenging. Participants explained this was because they felt intimidated by senior 
doctors and believed that they were not receptive to their advice in comparison to more 
experienced pharmacists. Findings from the questionnaire element of the study reinforced 
this disparity with junior pharmacists seen to have significantly less frequent IPIs with 
consultant doctors than their senior pharmacist counterparts. In a study conducted by Paice 
et al. (2002b) which surveyed 1435 UK junior doctors to determine their feelings towards 
their consultant mentors they found that a small number of respondents believed their 
engagement was negative as the consultant gave unfair criticism, were disrespectful and/or 
were bullying. Indeed, Paice et al. (2002a) further summised that poor attitudes of some 
consultants towards the junior doctors resulted in them feeling confused, distressed and 
angry.  
 
Nugus et al. (2010) also recognised the impact that a doctor’s ‘power’ had on IPIs. They 
showed through 63 interviews, 68 focus groups and 209 hours of observation across HCPs 
within acute and non-acute health services that doctors were the dominant profession who 
were seen to assume responsibility for patient management and coordinating roles within 
the healthcare team. Although the study took place in Australia and therefore will feature 
some organisational differences compared to the UK, it is probably generalisable given the 
similarities in healthcare delivery and education between the UK and Australia. Similar 
findings were also highlighted by Baker et al. (2011) who identified through a series of 25 
interviews with a range of HCPs in Canada that doctors perceived themselves as the 
‘leaders’ and ‘decision makers’ in healthcare while pharmacists and other HCPs saw 
themselves as ‘team members’ who tend to adopt a holistic approach to care. Interestingly, 
Baker also found doctors had dominance in the decision-making process making it 
challenging for other HCP to assert their expertise, particularly if the doctor disagreed with 
their advice. This provides a challenge for pharmacists who have generally been seen to 
display a lack of confidence, a fear of new responsibility, a need for approval and are often 
risk averse (Rosenthal et al., 2010a).  
 
Through ethnographic observation Rice et al. (2010) found that interprofessional 
hierarchies had considerable negative effects on communication and collaboration between 
HCPs on a general internal medicine unit. The authors highlighted how doctors were often 
accustomed  to having their ‘orders’ carried out without discussion or negotiation. Similar 
issues were found by Jones (2006) who interviewed a range of HCPs and highlighted that 
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doctors used their position of power to critique their colleagues and ‘expose’ perceived 
faults in practice. This issue was also recognised by the interview participants in this 
current study as senior doctors were often said to display dominance and power within the 
interprofessional team, making it challenging for junior pharmacists to interact as they 
often felt intimidated by consultants and lacked confidence in undertaking these IPIs. This 
variation in ‘power’ seemed to decrease as pharmacists progressed in their careers and 
their professional and clinical knowledge grew, with senior pharmacists expressing their 
comfort in interacting with all levels of seniority. As senior pharmacists had significantly 
more frequent interactions with senior doctors than their junior colleagues this could also 
have been due to the greater level of trust and respect developed between the HCPs over 
time. Another reason, although not directly stated by senior pharmacists, was that junior 
pharmacists found interactions with junior doctors easier as they felt they were at a similar 
career level (and often age) which allowed for social relationships to develop which in turn 
enhanced the likelihood of each HCP approaching one another.  
 
Whilst there was some reluctance to interact with senior doctors by some participants, 
there were certain clinical issues that were said to require their input. This was often 
because junior doctors felt uncomfortable in resolving some tasks which they determined 
were outside of their competence.  In an online questionnaire completed by 20 UK junior 
doctors, Jubraj et al. (2015) found that junior doctors felt uncomfortable in altering 
medications without consulting a senior doctor first.  
 
In this current study, participants who were more junior stated they interacted with a more 
limited range of HCPs, perhaps due to their own limited experience or lack of understanding 
of professional roles and responsibilities. This was a common theme for all participants 
irrespective of experience when they were new to an interprofessional team. The initial 
interactions were more challenging as participants stated they did not know the individual 
HCPs or the team dynamic.  
 
This lack of understanding of one another’s professional roles was seen as perhaps the 
biggest barrier to IPIs. This is a common theme in the literature and has been cited by a 
number of authors in a range of domains showing that team members often do not 
acknowledge, do not understand, or do not respect each other’s roles and knowledge 
contributions (Hughes and McCann, 2003; Long et al., 2003; Barrett et al., 2005; Larkin and 
Callaghan, 2005; Kvarnström, 2008; Baker et al., 2011). Indeed, it is not only pharmacists 
who lack an understanding of other HCPs roles and responsibilities, there appears to be a 
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general lack of understanding of the pharmacist role. For example Makowsky et al. (2013) 
identifies through a survey of 26 doctors that they had a limited understanding of 
pharmacists’ roles. This was similarly highlighted as an issue during the interviews in this 
current study, with many participants believing that this lack of understanding could breed 
negative relationships with pharmacists.  
 
A recent study conducted in Australia by Wilson et al. (2016) explored the perspectives of 
recently graduated doctors, nurses and pharmacists (total n=68) related to their 
interprofessional collaborative practice. They found that the quality of collaboration was 
influenced by the extent to which each team member knew about and valued the particular 
skills and expertise of the other HCPs and respected each person’s unique contribution to 
the work of the team. This was especially evident for pharmacists who often felt 
undervalued due to the misconceptions surrounding their roles. Having a good 
understanding of roles was also been seen to be vital where there was potential for 
professional activities to overlap. This was seen to make HCPs feel defensive of their own 
position, something which was highlighted by an interviewee within this current study who 
believed that doctors felt threatened by the new advanced role of the pharmacist. This is 
not a new challenge, Jones (2006) for example interviewed a range of HCPs and identified 
that professions often work in silos in order to protect their professional boundaries.  
 
One method a number of interview participants felt could help improve understanding of 
roles and responsibilities was IPE. A positive perception of IPE was often dependent on the 
participant’s prior experience of IPE; this was more common for junior pharmacists.  These 
participants stated a number of benefits of IPE that directly aligned with the literature 
including the belief that it can improve interprofessional communication (Greiner and 
Knebel, 2003), develop interprofessional relationships (Barr et al., 2017) and improve 
attitudes towards other HCPs (Barrett et al., 2005; Freeth et al., 2008; Barr et al., 2017). 
These participants also indicated that early and repeated IPE would be beneficial in 
reducing barriers between HCPs during professional education; a number of authors have 
concluded the same including (Carpenter, 1995; Tunstall-Pedoe et al., 2003; Lindqvist et al., 
2005). This was not universally supported however, with some participants suggesting that 
IPE should be undertaken at postgraduate level once professionals have a greater 
awareness of their own professional identity.  
 
One theme that was fairly universal among participants was the identity of the HCPs who 
should be involved in IPE sessions with most participants indicating that IPE should be with 
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doctors and nurses. These professions were preferred as they were seen to be most relevant 
to practice.  This is seen as a key feature of successful IPE in the literature. Where IPE is 
irrelevant to practice some suggest that it does more harm than good as it may instill the 
belief that interprofessional engagement is not valuable (Barr et al., 2017; Steven et al., 
2017). Whilst the topics of proposed IPE sessions varied, nearly half of the participants 
suggested that IPE should be focused on understanding HCPs’ roles and responsibilities and 
a similar number suggested that IPE should incorporate the development of soft skills such 
as communication. This is supported by Suter et al. (2009) who found, through interviews 
with 60 HCPs in Canada, that understanding and appreciating professional roles and 
responsibilities and communicating effectively emerged as the two core competencies 
required for achieving patient-centred collaborative practice and therefore suggested that 
these topics should be central to any IPE activity. Furthermore, differences in the way HCPs 
communicate has been found to lead to professional frictions (Rodgers, 2007). For example, 
nurses are trained to be highly descriptive whereas doctors are trained to be succinct, and 
his results in a mismatch in the way they communicate with one another. Acknowledging 
these differences in early parts of training pathways has been suggested as one way to 
develop relationships and achieve more effective communication and collaboration (Dixon 
et al., 2006; Clark, 2014). This is something that could feasibly be achieved through the use 
of IPE.  
 
Although participants felt that IPE was valuable to practice they also recognised challenges 
in conducting IPE including logistical issues surrounding timetabling and accommodating 
large numbers of varying HCP students simultaneously. These are issues that are well 
developed in the literature (Levett-Jones et al., 2012; Lapkin et al., 2013; Carpenter and 
Dickinson, 2014). It was also suggested that sessions should be conducted in environments 
which facilitate interprofessional engagement such as workshop rooms or on wards as 
opposed to lecture theatres where interactions are challenging to achieve as has been 
shown by a number of authors including Taylor et al. (2012), Parsell and Bligh (1998), Barr 
(2000), Wilhelmsson et al. (2009) and Hammar (2000). As much as participants recognised 
the value of IPE it was also felt that this alone was not going to solve the current issues with 
interprofessional collaboration and suggested that alternative educational methods such as 
practice-based experience, integration of the MPharm programme with the pre-registration 
year and interprofessional OSCEs could all be of value.  
 
A number of interviewees spoke of the potential value of engaging in interprofessional 
(often consultant-led) ward rounds. They indicated that these could significantly improve 
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their IPIs with doctors and other HCPs also present and believed they helped provide more 
holistic care to patients and improve patient outcomes. In a systematic review of hospital 
pharmacists’ clinical interventions conducted by Kaboli et al. (2006), the authors 
summarised that including pharmacists in multidisciplinary ward rounds could improve 
patient outcomes, with a number of the studies included in the review showing statistically 
improved outcomes such as decreased adverse drug events and length of hospital stay. 
However, the generalisability and robustness of the studies included in this review were 
generally low as methodologies varied, sample sizes were often small, studies frequently 
focused on one institution and the extent of the interprofessional collaboration was rarely 
detailed.  
 
A more recent example of the benefits of involving pharmacists on ward rounds was 
identified by Miller et al. (2011b) who found that when pharmacists attended consultant-
led ward rounds they had significantly more interventions accepted by doctors than those 
made by pharmacists undertaking a ward visit alone (mean of 1.73 accepted interventions 
per patient compared to 0.89 when pharmacists did not attend ward rounds, p<0.001). This 
meant that there were a higher number of prescription errors rectified and treatment was 
better optimised. Furthermore, Miller et al. (2011a) stated that by involving pharmacists in 
these ward rounds it made pharmacists more aware of the priority patients and issues and 
provided greater opportunities for pharmacists to discuss drug therapies with senior 
doctors in which interventions could be made. A number of pharmacists expressed 
throughout the interviews in this current study how the ward rounds they attended helped 
facilitate IPIs with a range of HCPs (particularly consultants and other doctors). However, 
such ward rounds were often undertaken by more senior pharmacists and junior 
pharmacists who might see the most benefit often excluded. This co-location of senior 
pharmacists alongside consultants on ward rounds perhaps provides further explanation 
as to why they have significantly more frequent interactions with consultants than their 
junior colleagues.  
 
In a response to Miller et al. (2011b), Quantrill and Webbe (2011) discussed how including 
pharmacists in consultant led ward rounds could help not only the patients but also the 
education of junior doctors in areas such as prescribing. This finding is supported by 
interview participants who found that attending ward rounds and other MDT meetings 
provided an opportunity for learning. Interestingly, as senior pharmacists were more likely 
to attend ward rounds this resulted in disparity in educational opportunities, with the 
junior pharmacists who would arguably benefit most often excluded due to lack of 
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experience and expertise. This is unfortunate as interviewees expressed how IPIs with 
senior doctors generally provided the most educational benefits. 
 
As IPIs between secondary care HCPs are thought to be essential in the provision safe, 
effective care of hospital inpatients (Francis, 2013) and direct co-location of HCPs was seen 
to have a positive impact on IPIs (Jenkins et al., 2016) it may be no surprise that hospital 
pharmacists’ interactions with HCPs based within primary care were found to be 
significantly less frequent. It was also evident that when interactions did occur, for example 
with GPs or community nurses, this often concerned the transfer of information between 
sectors rather than collaboration on patient issues. In a publication by the Kings Fund 
entitled ‘Avoiding hospital admissions- Lessons learnt from evidence’ interactions across 
sectors were said to be vital in ensuring timely and accurate transfer of information and 
ultimately reducing hospital (re)admissions (Ham et al., 2010).   
 
In a review of services which aimed to prevent medication errors on admission to hospitals, 
Karnon et al. (2009) found that medicines reconciliation conducted by hospital pharmacists 
in collaboration with GPs provided a cost-effective way of preventing errors. They also 
found that this role was mainly conducted by junior pharmacists, possibly highlighting why 
this population was found to interact significantly more frequently with community nurses 
and GP receptionists in the questionnaire element of the study. In common with community 
pharmacists’ views (see chapter 5), GP receptionists were seen to play a ‘broker’ role (Burt, 
2005) in interactions with primary care HCPs which, in some cases, impeded interactions. 
This is a finding that has been reported elsewhere (Swinglehurst et al., 2011; Bradley, 
2012). These interactions with receptionists were generally unavoidable as IPIs with 
primary care HCPs were found to be exclusively the phone and therefore required 
pharmacists to contact the receptionist in the first instance in order to access the HCP. In 
addition, Eggink et al. (2010) found that hospital pharmacists’ role in optimising 
medications on discharge and subsequently informing HCPs within the primary care sector 
resulted in more accurate implementation of care. These cross sector interactions are 
therefore strongly encouraged within the NHS (Bienkowska-Gibbs et al., 2015). 
 
One area of pharmacy practice which has significantly expanded in recent years is the 
pharmacist role within GP practices, with Welsh Assembly Government (2015) believing 
pharmacists can provide valuable medicines related information, optimise medication 
regimens and ensure the safety of a patient’s medication use. Nearly two-thirds of hospital 
pharmacists interacted with GP practice pharmacist at least once a month and although the 
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reasons for these interactions were not identified within the interviews they are likely to 
relate to the transfer of information across sectors much like the other IPIs that hospital 
pharmacists had with primary care HCPs.  
 
Whilst the transfer of information on patient admission and discharge to/from hospital is a 
clear reason for hospital pharmacists’ interactions with primary care HCPs, the process with 
which hospital pharmacists can access this information has very recently changed. Much 
like their colleagues in NHS England who have access to  the Summary of Care Record (SCR) 
system (Pharmaceutical Services Negotiating Commitee, 2018), NHS Wales (2018c) have 
introduced a similar system entitled the ‘Welsh GP Record’ which enables hospital 
pharmacists (as well as hospital doctors, nurses and pharmacy technicians), to access an 
electronic summary of a patient’s key clinical information. The implementation of this 
system may therefore reduce direct interactions with primary care HCTMs (including GPs, 
nurses, pharmacists and GP receptionists) as pharmacists will have ready access to much of 
the information required for conducting tasks such as medicines reconciliations.  
 
Although co-location was seen to be a key facilitator to IPIs, interestingly two of the 270 
participants indicated they interacted more frequently with GPs than hospital doctors. 
Whilst the reasons for this are not fully clear, these participants shared common 
characteristics. They were both primarily office-based with a role in management, with one 
being the only band 9 respondent and the other a band 8 who also specialised in primary 
care.  
 
Much like community pharmacists (see chapter 5), hospital pharmacists frequently 
interacted with D/Ts and ACT, highlighting the roles these individuals have in supporting 
pharmacists in the safe provision of medications (Royal Pharmaceutical Society, 2017c). 
Pre-registration pharmacists were also seen to be an integral part of the hospital pharmacy 
team, with questionnaire respondents from 18 of the 19 hospitals interacting with this 
pharmacy based HCTM.  
6.4.1. Limitations 
Although a mixed method approached was utilised to reduce the limitations of undertaking 
a single methodological approach (Johnson and Onwuegbuzie, 2004) some limitations still 
remained. Whilst stage one (questionnaire) had a good estimated response rate of 51.9%, 
this was varied across health boards impacting on the generalisability of the data (Babbie, 
2015c). This variation was likely due to the gatekeeper dissemination process, therefore 
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ensuring gatekeepers were provided with an increased number of prompts and reminders 
may have been of value in aiding the dissemination and collection of questionnaires within 
their hospitals.  
 
Many of the limitations within this study overlapped with those within the community 
questionnaire and therefore have been briefly touched upon here (see chapter 5.4.1 – 
limitations for more details). These limitations include: the impact of recall bias on 
respondents self-reported (perceived) frequency of interactions; respondents 
understanding of the term ‘interaction’; respondents understanding of section A 
(demographic) questions (e.g. the definition of ‘current specialty’, which referred to all the 
specialty roles respondents were currently undertaking rather than the one they were 
doing on the day of the questionnaire); the use of visual comparisons within the chi-squared 
testing process; the impact of demand characteristics; and the fact that the study was solely 
centred around Wales.  
 
Much like the community pharmacist study, a limitation of stage two of the study (semi-
structured interviews) also related to participant recruitment. As ethical approval was not 
practicable in a timely manner from one LHB (Aneurin Bevan UHB) this limited the pool of 
potential participants. In addition, as the study progressed it became clear that recruiting 
participants from the Hywel Dda UHB was not possible due to a number of factors including 
distance, time and response to participation requests. Furthermore, no participants were 
recruited from Velindre specialist cancer hospital. Therefore, although the study achieved 
a strong repetition of themes (Malterud et al., 2015) participants from other demographic 
areas may have helped identified new themes. Additionally, as results were based on 
personal experiences it is impossible to state that recruitment of more participants in 
general would not have impacted the data and themes generated (Morse et al., 2002; Bowen, 
2008; Corbin and Strauss, 2008). 
 
Although interviews were conducted for convenience in the participant’s workplace, unlike 
with interviews conducted with community pharmacists (see chapter 5) the participants 
were not the sole responsible pharmacist therefore were able to freely engage in interviews 
with minimal distractions. Additionally, on all occasions interviews were conducted in a 
private, quiet room to further avoid distractions. There was only one occasion during the 
interviews where an interview was interrupted due to the participant receiving a bleep 
(phone call), however this was coincidentally from another HCP (nurse) which enabled 
further development of this topic within the interview. 
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6.5. Conclusion 
Following on from the community pharmacy study (see chapter 5), stage one 
(questionnaire) of this study identified the HCPs that hospital pharmacists interact with 
most frequently in practice, namely hospital-based doctors, nurses and dieticians. IPIs with 
primary care-based HCPs occurred significantly less frequently. Stage two (semi-structured 
interviews) determined the topics and mode of interactions with specific HCPs, highlighting 
that IPIs with secondary care HCPs primarily occurred face-to-face on wards and were often 
collaborative in nature. This differed significantly from IPIs with primary care HCPs which 
were primarily over the phone and generally involved the transfer of information. A number 
of benefits of IPIs were articulated by participants including improving information 
exchange, utilising professional skills, educating HCPs and building interprofessional 
relationships. These were all said to improve the delivery of patient care. Participants stated 
that IPIs increased through co-location alongside HCPs on the ward or on interprofessional 
ward rounds.  
 
A number of barriers to IPIs were identified including time constraints experienced by 
HCPs, the negative interprofessional role of the pharmacist (i.e. pointing out errors made 
by other HCPs) and challenges in interacting with senior doctors (especially when a junior 
pharmacist). Similarly, a lack of understanding of professional roles and responsibilities and 
poor communication during interactions resulted in sub-optimal interactions. Addressing 
these issues through IPE sessions was suggested as one possible facilitator. The time that 
IPE should be introduced was disputed by participants, with some advocates for early and 
regular undergraduate IPE and others believing it should be conducted once pharmacists 
developed a greater understanding of their own roles and responsibilities (i.e. at 
postgraduate level). One area which was not disputed was the need for IPE with both 
doctors and nurses, with participants suggesting that other HCPs could be added as long as 
relevance to practice is maintained.  
 
While the frequency and collaborative aspects of hospital pharmacists’ IPIs varied it was 
clear that interprofessional relationships can and do develop even when absent of external 
or internal facilitators. Therefore, by actively supporting the development of 
interprofessional collaborative relationships through a variety of measures including the 
incorporation of meaningful and relevant IPE this can help make highly functional 
interprofessional working become the norm across healthcare practice.  
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Chapter 7 - Summary 
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7.1. Personal reflections and implications for my professional pharmacy 
practice 
The results from this thesis have recognised that pharmacists believe interprofessional 
practice is a progressive field which can have benefits on professional practice and the 
delivery of patient care. As a researcher who was practicing within both the community and 
hospital pharmacy throughout the duration of this thesis I believe the insights I have gained 
from conducting these projects have also had a direct positive impact on my practice. I have 
therefore given a personal reflective account of my own interprofessional practice and how 
this has developed as a result of undertaking this project:  
 
Upon completion of an MPharm degree at Cardiff University I found myself both nervous 
and excited to continue my progression towards a professional career that I felt could have 
a genuine positive impact on the care of a patient. To do this I still needed to navigate 
through my pre-registration year, a role I undertook within the University Hospital of South 
Manchester. This role represented my first real experience within a hospital as, much like 
many UK MPharm degrees, I had limited practical work experience provided during 
university and I was therefore excited but apprehensive for the prospects ahead. Strangely 
the apprehension was not only from meeting new colleagues and integrating into a new 
professional environment, it was also because I had no real idea about what my role was 
and how I fit within the interprofessional team. This was something which became instantly 
apparent when I found myself asking seemingly ‘basic’ questions such as: ‘what is my 
professional role?’; ‘how do I fit within the interprofessional team?’; ‘why would I interact 
with each HCP?’; ‘why would they interact with me?!’. This represented a steep learning 
curve. I initially found myself exploring my professional role and how this could aid the 
interprofessional care of patients. I then began to explore other HCPs’ roles and 
responsibilities by approaching (often junior) staff for discussions, probing areas such as 
their specific skills and knowledge. Upon doing this I was surprised to find that they too had 
questions around the role of the pharmacist, something which was initially difficult to 
answer without generically stating ‘well we are the experts in medicines’. 
 
Through actively pursuing interactions with other HCPs and observing the 
interprofessional interactions pharmacist mentors undertook this started to pique my 
interest in the area, not least because the responses and interactions were so varied. Some 
HCPs had clear close interprofessional relationships and would actively and frequently 
interact with one another, whereas others would work very independently. I questioned 
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why this was the case and wondered if it could be altered. This drew me back to my single 
experience of IPE within university and my MPharm project in this area. Could this be a 
solution? Would more of this have helped better prepare me for starting my pre-reg and 
future professional practice? Once I completed my pre-reg I decided to embark on 
answering some of these questions by undertaking this PhD.  
 
The aim of this thesis was therefore to explore pharmacists’ interprofessional interactions 
in order to help inform the meaningful design of IPE for pharmacists and pharmacy 
students. A mixed method approach was conducted to explore the IPIs of pharmacists in the 
two current predominant sectors of UK pharmacy practice namely community and hospital 
(see chapter 5 and 6 respectively). Stage one of each study featured a questionnaire to 
identify the frequency of pharmacists’ interactions with a range of HCTMs in Wales 
(response rate: community pharmacies 443/716 (61.9%); hospital pharmacists 
270/approx. 520 (51.9%)). This was subsequently followed by semi-structured interviews 
with pharmacists from the two healthcare sectors. Participants were recruited until the 
samples represented a sufficient cross section of pharmacists in each sector, constant 
comparison indicated strong repetition of data and themes, and the study aims had been 
achieved (participation from: 14 community pharmacists; 15 hospital pharmacists)(Bowen, 
2008; King and Horrocks, 2010a; Malterud et al., 2015). Interestingly, as my research 
progressed so too did my professional career, with my PhD findings having a direct, positive 
impact on my interprofessional practice (which spanned across both community and 
hospital pharmacy) in a number of ways.  
 
Throughout the interviews pharmacists from both sectors of practice expressed the belief 
that interprofessional working led to the provision of safer and more effective patient-
oriented care. Those interviewed indicated that this was achieved through a number of 
mechanisms including (i) improvements in the exchange of knowledge and information; (ii) 
better utilisation of the specific skillset of each HCP; (iii) increased understanding of 
professional roles and responsibilities within the healthcare team; (iv) increased 
understanding of the patient and their condition through an interprofessional approach; (v) 
informal learning from one another and (vi) building professional and social relationships 
which enable HCPs to more readily approach and trust one another which in turn makes 
the work environment more pleasurable. In some cases, participants indicated that direct 
improvements in patient care through strategic interprofessional teamwork had been 
evidenced through patient metrics. For example, one hospital pharmacist stated that the 
implementation of regular pharmacist-dietician collaborative interventions resulted in 
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such significant improvement of patient disease markers and that as a consequence the 
service was recognised as one of the top performing services for this specialism in the UK, 
a finding which is rarely directly attributed to interprofessional collaboration (see chapter 
2). These findings strengthened my belief that interprofessional practice can improve 
patient care, whether that is directly through improved outcomes or indirectly through 
HCPs sharing knowledge and referring patients to the most appropriate profession.  
 
One finding that I have purposefully integrated into my practice is the benefit of making 
acquaintance with HCPs as early as possible and actively using first names as this helps 
build rapport. This initial interaction subsequently creates a platform for developing 
interprofessional relationships overtime. Developing social relationships through more 
frequent engagement was also found to be vital as this also opened more natural 
opportunities for professional interactions, as both HCPs were found to be happy to 
approach one another. I therefore now aim to develop social relationships as quickly as 
possible, often using my first introduction to HCPs to be more general and social rather than 
grilling them with a number of professional queries. This was found to be particularly 
important for pharmacists as study participants found that their interactions with other 
HCPs were perceived to be negative as they point out errors in others, therefore 
approaching this in a positive way is vital in order to ensure interactions are productive and 
not defensive. Participants also felt that individuals with friendly and personable 
communication skills were more approachable, facilitating positive interprofessional 
relationships that ultimately increases the frequency of interactions. The findings of this 
study also helped me better reflect on my own interpersonal skills to ensure they were open 
and engaging in order to make HCPs feel they can readily engage in IPIs.   
 
Within the interviews it was interesting to see that a number of community pharmacists felt 
that GPs and some other HCPs had a negative perception of their role believing that their 
primary driver was to make money and that the role was more akin to being a shopkeeper 
rather than a health professional. Whilst this was not a unique finding (Van et al., 2011; 
Bradley, 2012) it highlighted that there was still progression required in order to create a 
cohesive interprofessional team. A broader lack of understanding about HCPs’ roles and 
responsibilities was highlighted as a key challenge for successful IPIs by both community 
and hospital pharmacists. Participants perceived it to be a factor that led to the 
underutilisation of HCPs as quite simply if one lacks an understanding of the skillset of 
another HCP then they are unlikely to be called upon for their expertise. A number of 
hospital pharmacists also recognised how more senior doctors often had a reduced 
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appreciation for pharmacists, however found more junior doctors to be more willing and 
receptive to engagement. Whilst this may be due to a number of reasons, the recent 
incorporation of IPE into undergraduate HCP curriculum may have helped reduce barriers 
and improve the understanding of different HCPs (see section 7.2 for further discussion). 
However, as I had limited IPE within university (one session with medics) and had 
undertaken no IPE post-graduation I had to seek my own opportunities to engage. Initially 
this was a challenge as I had little confidence in approaching HCPs as I was unaware of the 
reasons why this may be of value. However, as stated across the interviews, my 
understanding of and relationships with other HCPs developed over time, having a positive 
impact on my delivery of interprofessional patient-centred care.  
 
One finding which was also evident within my own personal practice was the disparity 
between interprofessional engagement when in community pharmacy compared to 
hospital. The co-location of HCPs was hugely beneficial to my interprofessional practice 
when working in hospitals compared to being physically separated in dedicated community 
pharmacy buildings. This was reflected in my research, with hospital pharmacists’ 
engagement generally seen to be more regular than community pharmacists, evidenced by 
the frequency of interaction with a range of HCPs including doctors and nurses which were 
the two most frequently interacted with HCPs. In interviews, participants indicated that 
doctors and nurses were present almost continuously on wards which facilitated face-to-
face interactions. The ability to interact in a face-to-face manner was seen as a facilitator to 
interprofessional interactions and conversely lack of accessibility was seen as a barrier, a 
finding demonstrated elsewhere in the literature (McDonough and Doucette, 2001; Brock 
and Doucette, 2004; Snyder et al., 2010). By co-locating HCPs within hospitals this also 
benefited the ways interactions were initiated with hospital pharmacists feeling that 
interactions were very much two-way, with each profession regularly approaching one 
another enabling greater utilisation of specialist skills and knowledge. The data within this 
study helped me recognise that by physically co-locating myself on the wards as much as 
possible this could increase the likelihood of interactions and enable more face-to-face 
interactions which subsequently increased the ease with which they took place compared 
to phone and written communication.  
 
There were a number of suggestions within the research to aid relationship development 
through co-location, these included being based on the same 
wards/specialisms/community pharmacies regularly and engaging in interprofessional 
ward rounds/multidisciplinary meetings/GP practice meetings. As a locum pharmacist I 
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found these were missed opportunities for me personally as my irregular practice often saw 
me utilised in a variety of environments making it more challenging for me to maintain and 
build relationships and get involved in arranged interprofessional practice such as ward 
rounds. This resulted in frequent reintroduction to interprofessional teams, all of which 
take some time to integrate within. 
 
In contrast to hospital pharmacists, community pharmacists’ interactions with HCPs were 
primarily over the telephone. Whilst this mode enabled IPIs to take place, it is more difficult 
to build personal and professional rapport and this was seen to negatively impact IPIs. The 
benefits of being co-located within the community was evidence within this study with 
those community pharmacists who were located within GP practices reported significantly 
greater levels of interactions with HCPs similarly co-located in the practice. This 
represented the first study showing the positive impact on levels of interprofessional 
interactions when pharmacists are co-located with other HCPs (Jenkins et al., 2016). 
However interestingly, even when community pharmacists were based in GP practices 
interactions continued to be via the telephone perhaps due to the time pressures in the 
community pharmacy environment or perhaps because community pharmacists are more 
confident with this method. Furthermore, in contrast to hospital pharmacists, community 
pharmacists primarily identified themselves as the initiators of interactions and articulated 
that their IPIs were generally related to informing HCPs of issues rather undertaking two-
way collaborative practice. 
 
One of the key barriers to interacting with primary care HCPs which was perpetuated by 
the lack of co-location was the role of the GP practice receptionist. Receptionists were seen 
to act in a broker role (Burt, 2005) that often reduced and in some cases prevented 
pharmacists’ direct engagement with a HCP (often the GP or community nurse); other 
studies have demonstrated a similar finding (Swinglehurst et al., 2011; Bradley, 2012). 
Compounding this issue were restrictions pharmacists felt were in place that prevented 
access to patient information. This can have negatively impact on continuity of care given 
that timely and accurate information transfer has been shown to be vital in preventing 
hospital (re)admissions (Ham et al., 2010). Receptionists were seen to be a significant 
hindrance in this information transfer at the time of the study as (outside of directly 
contacting the HCPs, often via the receptionist) there was no other method of accessing GP 
records within Wales, a factor NHS Wales (2018c) have recognised and aimed to rectify 
through the introduction of the ‘Welsh GP Record’ scheme which enables HCPs direct access 
to patient care summaries. However, this is currently restricted to secondary care HCPs 
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(including hospital pharmacists) and therefore community pharmacists don’t yet have 
access. In order to combat this in my own practice I made a conscious effort to try to build 
a rapport with the receptionists, once again introducing myself and actively learning names. 
Unsurprisingly, and in line with community pharmacist interview data, once a professional 
understanding was built it was clear that the receptionist was an asset in aiding information 
transfer and solving certain non-clinical issues. 
 
These small but significant changes have helped me to advance my interprofessional 
practice and allowed me to flourish as a well-respected and integral part of the 
interprofessional team in primary and secondary care.  
7.1.1. Recommendations for pharmacy practice 
 Whilst the research positively influenced my own personal practice and enabled me to 
implement a number of changes to my day-to-day interprofessional practice as discussed 
above, there is plenty of room for further improvement. Although there a number of 
methods I can personally implement to improve this practice (see section 7.1) interview 
participants also believed that there are a number of other facilitators can be implemented 
at a large scale organisational level to improve aid the uptake of interprofessional practice 
throughout and across a range of care sectors. A series of recommendations have therefore 
been identified from the research which if implemented on a national and international 
level may help drive policy to achieve better interprofessional collaboration across 
healthcare (Department of Health, 2010; World Health Organisation, 2010). The four 
recommendations below do not include advice surrounding the incorporation of IPE in 
undergraduate/postgraduate education as this has been discussed in depth in section 7.2: 
 
1. Increase the frequency and ease with which interactions can be initiated through 
greater co-location of pharmacists alongside other HCPs (data supporting this in 
chapter 5 questionnaire and interviews (see 5.3.2.3.4) and chapter 6 interviews). 
This can be done in hospitals by encouraging pharmacists to be regularly based on 
the wards and to attend interprofessional ward rounds (see chapter 6.3.2.3.3) and 
done within primary care by creating more interprofessional health centres (see 
5.3.2.3.4) or through driving the development of alternative methods of interaction 
between primary care HCPs and other sectors. Alternative methods could include 
greater utilisation of technological advances such the Welsh GP Record scheme 
(extend to community pharmacists as well as hospital pharmacists) and direct email 
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or telephone numbers could enable greater access to HCPs (see 5.3.2.3.3 and 
6.3.2.3.3 for further details of these suggestions) 
2. Encourage pharmacists to engage in more clinically/patient focused 
interprofessional practice by ensuring pharmacists have more time in order to 
undertake this practice (see chapter 5.3.2.3.2) . This can be done through the 
continued transition of pharmacists away from technical roles (i.e. dispensing, 
manufacture) and by better utilising other pharmacy team members. Providing 
higher levels of funding for staffing (see 6.3.2.3.2) could also increase time for 
interprofessional collaboration outside of the regular workload and relieve stress, a 
factor which was recognised to negatively impact IPIs  
3. Provide formal opportunities for interprofessional interactions when pharmacists 
are new to interprofessional teams (see 6.3.2.3.3). This will help them to meet HCP 
collaborators, build relationships and embed within interprofessional teams 
smoothly. Whilst this could be encouraged through incentivised schemes (i.e. the 
Collaborative Working Scheme) it must be made clear that interprofessional 
collaboration is good practice and not just done for monetary purposes. 
Furthermore, if incentivised it should be ensured that explicit measures are 
implemented in order to monitor progress 
4. Encourage greater promotion of the unique roles and responsibilities of the 
pharmacist in order to inform other HCPs about how pharmacists fit within the 
interprofessional team and how they can aid other HCPs in the provision of patient 
care (see 5.3.2.3.2, 6.3.2.3.2 and 6.3.2.3.3). 
7.2. Implications for the design and delivery of interprofessional education 
As there was a paucity of literature surrounding the landscape of IPE in UK pharmacy a 
questionnaire was disseminated to academics involved in the design and delivery of IPE 
within each UK school of pharmacy to explore this area. Analysis of returned questionnaires 
(17/29 pharmacy schools participated) demonstrated a significant diversity in the breadth 
of IPE currently taking place, with variations seen in: (i) the number of sessions conducted 
by each school (ranging from 1 to 20); (ii) the MPharm year group undertaking sessions 
(relatively evenly spread across all four years); (iii) the range of student groups involved in 
each session (26 different student groups involved across the 88 sessions described); (iv) 
the number of student groups involved in each session (ranging from 1 to 11 student groups 
alongside pharmacy students in a single session); (v) the environment the sessions took 
place; (vi) the theme/topic of each session; (vii) the learning outcomes set; (viii) the method 
(if any) of assessing outcomes; (ix) the method (if any) of evaluation sessions. Whilst the 
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sessions were varied, there were some commonalities seen between sessions including: 
(i)sessions primarily being conducted with pharmacy students and just one other HCP 
student group (of which medical students were the most common); (ii) sessions generally 
being set in workshop rooms; (iii)  sessions frequently being centred on the development 
interprofessional teamworking and communication. Whilst IPE was embedded to a greater 
or lesser extent across schools, learning outcomes were rarely assessed and robust 
evaluation of sessions was not common (see chapter 3.3.3.5 and 3.3.3.6). This makes it 
challenging for pharmacy educators to recognise and ensure the value of IPE sessions for 
students.  
 
The diversity in IPE delivered is at least partly due to the autonomy that pharmacy 
educators have in developing programmes working against an outcomes framework rather 
than a prescriptive IPE programme from the regulator. IPE is often then developed to 
address local needs and mitigate against local constraints (O'Halloran et al., 2006; 
Carpenter and Dickinson, 2014; Neocleous, 2014). This can mean that educators create 
sessions out of convenience, i.e. with other student groups from programmes where there 
is a similar drive to actively pursue IPE or with those that are in close proximity.. Having 
been directly involved in the delivery and evaluation of IPE within Cardiff University School 
of Pharmacy there were a number of factors which were immediately apparent including 
the need for sessions to be reflective of current practice. This belief was shared with the 
interview participants as well as within the wider literature (Knowles, 1973; Parsell and 
Bligh, 1998; van Soeren et al., 2011; Barr et al., 2017). In my opinion, it is therefore essential 
that educators embed IPE with student groups and on topics which directly reflect current 
practice (for all professions involved). However, this provides a challenge for pharmacy 
educators as there is currently a paucity of literature related to pharmacists’ 
interprofessional roles in practice and was therefore explored using questionnaires and 
interviews with community and hospital pharmacists (see chapters 4,5 and 6). 
 
Within the interviews many participants indicated that a focus on understanding roles and 
responsibilities in such sessions isimportant as this could directly enhance understanding 
and prevent/mitigate negative or stereotypical perceptions. It was also felt that this topic 
would be applicable for all HCTMs involved in the care of patients (including GP 
receptionists and pharmacy staff) as it is vital for all HCTMs to recognise when and with 
whom interactions would be most beneficial and how each team member fits into the 
interprofessional team. By ensuring that the roles of responsibilities of HCTMs is an 
outcome of each IPE session it was felt that this could aid the relevance and therefore 
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increase the engagement of students. However, participants also stressed the importance 
of incorporating this topic into a specific practice-based scenario which is ability/specialism 
appropriate (i.e. develops through the years in line with the curriculum of each HCP) to aid 
students engagement in sessions.   
 
Another set of topics believed to be of relevance to a range of HCPs (and other team 
members) and thus would be appropriate for IPE was the development of soft skills such as 
communication, teamworking and bedside manner. Pharmacists from both hospital and 
community sectors recognised these skills are essential in improving interprofessional 
collaboration as they help to build professional and social relationships and enable HCPs to 
successfully articulate their care messages to the interprofessional team. The negative 
impact of poor communication was made clear when exploring junior pharmacists’ 
interactions with senior doctors. Junior pharmacists indicated that they found senior 
doctors to be stressed and time pressured. This they felt led them to be ‘short’ with junior 
pharmacists who then felt intimidated and lacked confidence in undertaking interactions 
with such colleagues. Therefore, by introducing early and repeated IPE at undergraduate as 
well as at postgraduate level this could help provide pharmacists and other HCPs with an 
opportunity to enhance their communication skills and so build their confidence.  
 
It was evident from both the questionnaire and interview phases of the studies that 
community and hospital pharmacists interact most frequently with doctors and nurses, 
therefore in order for IPE to reflect practice, conducting IPE with these professions would 
be of particular value. This was a finding reflected within the interviews with the majority 
of participants believing developing IPE with these HCPs should be prioritised. It was also 
felt that having sessions that feature pharmacy, medical and nursing students 
simultaneously would be beneficial, however this may be challenging particularly in terms 
of logistics.  
 
Whilst the frequency of interactions with individual HCPs varied across the two sectors, on 
the whole interactions with doctors were similar in terms of the themes of the interactions 
and therefore can help provide a valuable platform for the development of IPE sessions 
which are reflective of practice. Pharmacists’ IPIs with doctors were predominately focused 
on clinical issues such as determining or confirming medication appropriateness, 
particularly in areas such as dosing, interactions, formulation and indication. This said, 
tailoring IPE to each healthcare sector may help retain relevance and therefore it may be 
helpful to including patient care plans, discharge and admissions, blood results and clinical 
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governance issues for hospital-based pharmacists and doctors, and prescription writing 
and the delivery of joint services (such as DMRs and MURs) for primary care-based HCPs. 
 
IPIs with nurses often focused on the patient with respect to ongoing care and general 
wellbeing, as well as practical issues such as stock and supply of medication. Although IPIs 
were sometimes clinical in nature, compared to doctors this was far less frequent, therefore 
the findings from this study suggest that IPE surrounding the ongoing holistic care of 
patients would be of value with nurses. Beyond the common themes articulated above, it 
was interesting to see that the nature of interaction with nurses varied quite considerably 
between sectors. This was generally seen to be due to the differences in the nurse role. In 
primary care, nurses were often non-medical prescribers and therefore interactions with 
community pharmacists were more commonly related to prescription issues as well as 
vaccinations and dressings, and could thus be valuable IPE topics for community based 
practitioners. This was in contrast to secondary care where pharmacists often approached 
nurses for more in-depth patient information such as how the patient is coping, their weight 
and ability to take medications (patients’ swallowing ability and compliance). Also, as 
nurses were regularly administering medications within hospital, pharmacists frequently 
discussed issues such as administering medications in patients with swallowing difficulties 
and determining IV infusion rates. These all represent IPE topics that could be meaningful 
during hospital pharmacist-nurse IPE. 
 
When analysing the IPE sessions currently delivered in UK MPharm programmes significant 
diversity was apparent in the range of HCTMs participating in IPE sessions. Whilst a number 
of these sessions did feature nurses and doctors there were a number of schools of 
pharmacy that did not have IPE sessions with doctors or nurses. This perhaps represents a 
lost opportunity to engage with the two key professional groups with which pharmacists 
interact most frequently irrespective of sector of practice. Ensuring that IPE is relevant and 
meaningful is particularly important since IPE that lacks this approach can be 
counterproductive and cause students to have negative perceptions of interprofessional 
engagement (Parsell and Bligh, 1998; van Soeren et al., 2011; Barr et al., 2017). 
 
In addition to doctors and nurses, a significant proportion of hospital pharmacists 
interacted with a number of other HCPs also co-located in hospitals such as dieticians (third 
most frequent), physiotherapists, occupational therapists, midwives, social workers and 
speech and language therapists. As hospital pharmacists’ third most frequently interacted 
with HCP it would be useful to undertake IPE with dieticians related to hospital-based 
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scenarios such as managing patients who require TPN and/or have electrolyte imbalances 
to medication/diet. However, it must be noted that interactions with these HCPs (outside of 
doctors and nurses) were generally found to be dependent on the particular specialism of 
the pharmacist, with certain specialisms requiring more frequent input from a range of 
HCPs. The blend of HCPs that community pharmacists interacted with was both different 
and narrower compared to hospital pharmacists. Interactions were with dentists (third 
most frequent), health visitors, social workers, opticians, vets and midwives. This variation 
in the HCPs that pharmacists interact with probably highlights the differences in services 
provided and the types of patients seen in the two sectors. Of note, community pharmacists’ 
interactions with dentists included confirming the appropriateness of medicines 
(particularly in areas such as dosing, interactions, formulation, indication, allergies) and 
prescription writing and therefore may be appropriate scenarios for community-based IPE 
sessions.  
 
Throughout the study, interprofessional interactions were found to occur across sectors i.e. 
between primary and secondary care. These interactions often involved the transfer of 
information or clarification of a patient’s medicines. This was often due to the medicines 
reconciliation process undertaken when patients were admitted to hospital or when 
interacting around alterations to medicines when patients were discharged from hospital 
back into the community. Primarily this meant pharmacists were interacting with doctors 
and nurses as well as pharmacy colleagues from the opposite care sectors. These 
engagements could provide a further opportunity for IPE and could help express the 
importance of interprofessional interactions across care sectors. 
 
It was also suggested that engaging members of the wider health care team (GP receptionist, 
the pharmacy team etc) in IPE would be beneficial in reinforcing effective team working and 
developing positive relationships due to the frequent nature with which pharmacists from 
both sectors interact (although predominantly community pharmacists). It was suggested 
that IPE with receptionists may reduce barriers as the two would have a better 
understanding of one another’s roles which could possibly lead pharmacists having 
increased engagement with other HCPs owing to the receptionist’s gatekeeper role. 
 
Whilst a small number of participants felt that pharmacists should be more aware of their 
own roles before undertaking IPE and therefore believe IPE should be exclusively 
conducted at postgraduate level, the majority of participants were significantly in favour of 
early and frequent IPE at undergraduate level. This was generally desired as it enabled 
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students to develop their interprofessional practice overtime, build interprofessional 
relationships and prevent negative perceptions forming. 
 
A number of other factors have been identified within the literature which should be 
considered when developing sessions, this includes the belief that topics and learning 
outcomes should be disseminated to students prior to undertaking IPE to help them 
recognise the relevance of sessions and frame their learning. These learning outcomes 
should also be assessed to ensure they are being met during sessions. Additionally, when 
sessions are being designed educators should ensure that appropriate educational 
strategies are employed such as adult learning and authentic learning. This will help to 
ensure participants are engaged in sessions. The environment in which sessions are 
conducted can have an impact on ease of engagement and therefore selecting settings that 
facilitate interactions such as workshop rooms, placements or through simulation could 
enhance the effectiveness of such sessions. Utilising a range and blend of these sessions 
could also be of value in providing variation for students, with the introduction of virtual 
IPE sessions (online resources etc.) also a possibility when used alongside these methods. 
In order to make sure students’ perceptions of IPE and interprofessional engagement are 
positive it is important to evaluate each session, preferably using a mixed methods, 
longitudinal analysis. 
7.2.1. Recommendations for the design and delivery of interprofessional education 
Whilst a number of suggestions for general development of IPE that is relevant for 
pharmacy students based on the studies conducted have been discussed above, the research 
also identified a series of recommendations which would be of value if actioned at an 
organisational, national or international level. Therefore, listed below are five 
recommendations which may help improve the provision of both undergraduate and 
postgraduate IPE and ultimately improve the value of IPE for learners:  
1. The continued development of UK special interest groups such as CAIPE which 
represent a diversity of HCPs, regulatory bodies, IPE researchers, patients and other 
stakeholders is important in order to create more specific guidance for educators 
surrounding the provision of IPE. This guidance should help educators in 
recognising the professions, topics and settings which will ensure students 
undertake IPE that is relevant and meaningful for future practice 
2. IPE should be introduced early and repeatedly throughout undergraduate level, 
with many interviewees believing it should also be incorporated within 
postgraduate education (although further research would be needed into this level) 
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3. This will help students build on previous sessions and reinforce interprofessional 
collaboration as an essential skill rather than a ‘bolt on’. Having earlier sessions can 
also increase HCPs’ confidence in undertaking interactions, providing a strong 
foundation for interprofessional practice and reducing the potential for missed 
collaborative opportunities (see chapter 6.3.2.2.6) 
4. Given the provision of formal IPE at postgraduate level appears to be sporadic, 
introducing more robust mechanisms for the engagement and delivery of IPE would 
be beneficial in allowing HCPs to share their experiences, reinforce their roles and 
responsibilities and ultimately develop their interprofessional collaborative 
practice (see chapter 6.3.2.2.6). It would be preferable for these to occur before 
starting new rotations/specialisms, in order to develop specific interprofessional 
collaborative relationships within their relevant workplace. This could be 
implemented through a number of mechanisms including as a formal element of an 
NHS employee’s contract and development plan, and as an embedded component of 
postgraduate taught causes such as the clinical diploma or non-medical prescribing 
courses. Before implementing this, further research would be required into the 
provision of pharmacy postgraduate IPE as there is currently a paucity of literature 
in this area  
5. One key reason IPE is so varied is because of a paucity of published research that 
effectively demonstrates benefits to practice and patient care. By promoting and 
funding more research and encouraging educators to evaluate sessions and assess 
students on learning outcomes this could help develop an evidence base that would 
enable the development of relevant and meaningful IPE 
6. Continue to promote IPE across healthcare and at a government level encourage IPE 
as a required aspect in all healthcare qualifications thus widening the desire for HCP 
programmes to participate in IPE sessions with pharmacists (if relevant). 
7.3. Future research 
Whilst this study has helped to address a number of gaps within the literature related to 
interprofessional interactions and collaboration, it is clear that there is still some way to go 
to fully understand pharmacists’ interprofessional role within practice and ensure that any 
IPE that is developed to address this is relevant and helps improve interprofessional 
interactions.  
 
Although this study has explored pharmacist’s views on IPIs and IPE, by expanding this 
research to explore the opinions of other HCPs, particularly doctors and nurses, this could 
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help to provide further understanding of the pharmacists’ role (both real and perceived) 
within the interprofessional team, identify recommendations for improving collaborative 
practice and ensure that IPE sessions are meaningful and relevant for all HCPs. 
Furthermore, as the role of pharmacists within GP practices has expanded in recent years 
(Royal Pharmaceutical Society, 2017b) and particularly in Wales it would be valuable to 
open the study out to ‘primary care’ pharmacists in order to determine similarities and 
difference in interprofessional practice compared to community and hospital pharmacists. 
Another area of pharmacy that would be interesting to explore is the interprofessional role 
of the locum pharmacists as their role often sees them rotate around interprofessional 
teams. This would provide a challenge in embedding such individuals in interprofessional 
teams which may be compounded by evidence suggesting  that GPs can be reluctant in 
trusting locum pharmacists (Bradley et al., 2012). Locum pharmacists were 
underrepresented in this current study due to the requirement for pharmacists to work at 
least two days a week within their practice setting. 
 
Interviews were conducted until the sample represented a cross section of pharmacists, 
there was strong repetition of data and themes, and the study aims had been achieved, 
however it is difficult to state that new data or themes may not have been determined 
through conducting further interviews (Bowen, 2008; King and Horrocks, 2010a; Malterud 
et al., 2015). This limitation was accentuated by the lack of representation from pharmacists 
based in West or Central Wales, with the majority of participants generally working around 
the South Wales area due to time and geographical convenience, therefore undertaking 
interviews with pharmacists from these areas may add value. Furthermore, as pharmacists’ 
specialisms within hospitals were seen to be broad and had some impact on the HCPs that 
pharmacists interacted with, interviewing more pharmacists from a wider range of 
specialisms would be valuable. Another limitation to both stages of this study was that the 
study population centred solely on pharmacists from within Wales, and although the GPhC 
regulates pharmacists from across the UK and therefore there will be many similarities with 
other UK countries, as NHS healthcare is devolved into the four UK countries there may 
evidently be some differences in pharmacists interprofessional practice. Further work 
would be required in order to explore these similarities and differences.    
 
Although the mixed method approach was valuable in achieving the research aims, it would 
be useful to conduct observational studies to identify if there are any differences between 
pharmacists’ reported interactions and those actually undertaken.  
 
Chapter 7 
 
 
284 
One of the major limitations that policy makers face when striving for greater levels of 
interprofessional collaboration is demonstrating its explicit value. Whilst it is believed both 
nationally and internationally that it improves patient care (World Health Organisation, 
2010; Department of Health, 2013a) there is no robust evidence that this is the case, 
therefore studies should be designed and conducted to directly assess improvements in 
patient outcomes as a result of interprofessional care.  
 
As there is currently limited research assessing the long-term trends of interprofessional 
collaboration it would also be interesting to follow up this research in 10 to 15 years at 
which point it would be hoped that the national drivers combined with the incorporation of 
more extensive IPE into healthcare programmes will have resulted in more frequent and 
fruitful interprofessional teamworking. Furthermore, with the expansion of pharmacists’ 
roles leading to better utilisation of pharmacists’ clinical skills showing no signs of slowing 
down, this may have significant impact on their role within the interprofessional team. One 
area that has already seen development since the time of the community study in this thesis 
is that hospital pharmacists in certain areas of Wales now have access to patient’s summary 
of care records through the Welsh GP Records scheme (NHS Wales, 2018c), with the aim to 
get community pharmacists similar access (already common across NHS 
England)(Pharmaceutical Services Negotiating Commitee, 2018) therefore it would be 
interesting to determine if this has had any impact on the IPIs conducted.  
 
One specific finding from the hospital questionnaire that would also be interesting to 
explore is why the hospital size had significant impacts on hospital pharmacists’ IPIs. Here 
hospital pharmacists were found to interact significantly more frequently with some 
professions such as nurses, midwives and speech and language therapists in smaller 
hospitals but interacted with dieticians more frequently in larger hospitals. Observational 
studies would be useful in addressing this research question.   
 
Whilst the study clearly identified the significant volume of IPE delivered in undergraduate 
MPharm programmes, the extent of postgraduate IPE is still generally unknown (outside of 
the small number of experiences described by interview participants). It would therefore 
be valuable to determine and explore pharmacists’ opportunities and experiences of 
postgraduate IPE, possibly by surveying or interviewing postgraduate educators across a 
range of institutions.  
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A number of recommendations have been made towards embedding IPIs in practice and 
delivering IPE in a more strategic fashion. Conducting research to determine the impacts of 
these recommendations (where they are implemented) would be valuable. One way to do 
this is by developing IPE sessions based on recommendations and then evaluating these 
sessions through the use of mixed methods. Areas of particular interest and value would 
include measurement of student outcomes pre and post session, determination of students’ 
perceptions of these sessions (preferably through qualitative interviews) and observational 
review of sessions. Ideally this research would also include a longitudinal randomised 
control trial comparing student development of interprofessional skills. In utilising a 
number of different methods to determine the value of sessions this would help add to an 
area of which there is little robust data. 
7.4. Conclusion 
This mixed method study identified that whilst some pharmacists are embedded within the 
interprofessional team and regularly engage in interprofessional collaboration this is not 
currently a universal method of practice. A range of organisational and practical facilitators 
and barriers were cited as potential reasons for this, prompting a number of 
recommendations at both micro and macro level that aim to further expand and develop 
interprofessional collaboration and teamworking across the pharmacy profession. One 
method recognised to benefit interprofessional collaboration is IPE that is reflective of 
current practice. However, the provision of IPE across UK schools of pharmacy lacks a 
cohesive strategic design, likely due to limited guidance on IPE from the regulator, a limited 
evidence base and local constraints.  This may limit the value of such IPE sessions that are 
often opportunistic in their design and delivery. This study therefore provides a number of 
recommendations that can aid educators in the development of relevant and meaningful 
sessions to help improve interprofessional teamworking skills and ultimately enhance the 
provision of effective patient-oriented interprofessional care.  
Bibliography 
 
 
286 
 
 
 
 
 
Bibliography 
Bibliography 
 
 
287 
ABU-RISH, E., KIM, S., CHOE, L., VARPIO, L., MALIK, E., WHITE, A. A., CRADDICK, K., BLONDON, K., 
ROBINS, L., NAGASAWA, P., THIGPEN, A., CHEN, L. L., RICH, J. & ZIERLER, B. 2012. Current 
trends in interprofessional education of health sciences students: a literature review. J 
Interprof Care, 26, 444-51. 
AL HAMARNEH, Y. N., HEMMELGARN, B. R., HASSAN, I., JONES, C. A. & TSUYUKI, R. T. 2017. The 
Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult Patients with 
Type 2 Diabetes: The Multicentre Randomized Controlled RxEACH Trial. Canadian Journal of 
Diabetes, 41, 580-586. 
ALLEN, D. 2002. Time and space on the hospital ward: Shaping the scope of nursing practice. Nursing 
and the Division of Labour in Healthcare. Springer. 
ANDREWS, J. & BUTLER, M. 2014. Trusted to care. Stirling, Scotland: Dementia Services Development. 
AUDITOR GENERAL FOR WALES 2016. Managing medicines in primary and secondary care. Cardiff: 
Wales Audit Office. 
AUTA, A., STRICKLAND-HODGE, B. & MAZ, J. 2017. There is still a case for a generic qualitative 
approach in some pharmacy practice research. Research in Social and Administrative 
Pharmacy, 13, 266-268. 
AXON, D. R., LIM, R. H. M., LEWIS, P. J., SANDHER, S., THONDEE, J., EDWARDS, K. & HOWARD, R. L. 
2018. Junior doctors’ communication with hospital pharmacists about prescribing: findings 
from a qualitative interview study. European Journal of Hospital Pharmacy. 
BABBIE, E. 2015a. Analysing qualitative data. The practice of social research. Fourteenth ed. Canada: 
Wadsworth, Cengage Learning. 
BABBIE, E. 2015b. Inquiry, theory and paradigms. The practice of social research. Fourteenth ed. 
Canada: Wadsworth, Cengage Learning. 
BABBIE, E. 2015c. Sample logic. The practice of social research. Fourteenth ed. Canada: Wadsworth, 
Cengage Learning. 
BABBIE, E. 2015d. Surveys. The practice of social research. Fourteenth ed. Canada: Wadsworth, 
Cengage Learning. 
BAKER, L., EGAN-LEE, E., MARTIMIANAKIS, M. A. & REEVES, S. 2011. Relationships of power: 
Implications for interprofessional education. Journal of Interprofessional Care, 25, 98-104. 
BÄLTER, K. A., BÄLTER, O., FONDELL, E. & LAGERROS, Y. T. 2005. Web-Based and Mailed 
Questionnaires:" A Comparison of Response Rates and Compliance". Epidemiology, 577-579. 
BARBOUR, R. S. & BARBOUR, M. 2003. Evaluating and synthesizing qualitative research: the need to 
develop a distinctive approach. Journal of evaluation in clinical practice, 9, 179-186. 
BARDET, J.-D., VO, T.-H., BEDOUCH, P. & ALLENET, B. 2015. Physicians and community pharmacists 
collaboration in primary care: A review of specific models. Research in Social and 
Administrative Pharmacy, 11, 602-622. 
BARR, H. 2000. Working together to learn together: learning together to work together. Journal of 
Interprofessional Care, 14, 177-179. 
BARR, H. 2002a. Interprofessional education. Educational strategies, 187-192. 
BARR, H. 2002b. Interprofessional Education: Today, Yesterday and Tomorrow. The Learning and 
Teaching Support Network for Health Sciences & Practice and The UK Centre for the 
Advancement of Interprofessional Education. 
BARR, H., GRAY, R., HELME, M., LOW, H. & REEVES, S. 2017. Interprofessional education guidelines. 
London: CAIPE. 
BARR, H., HAMMICK, M., KOPPEL, I. & REEVES, S. 1999. Evaluating interprofessional education: two 
systematic reviews for health and social care. British Educational Research Journal, 25, 533-
544. 
BARR, H., HELME, M. & D’AVRAY, L. 2014. Review of interprofessional education in the United 
Kingdom 1997–2013. London: CAIPE. 
BARR, H., KOPPEL, I., REEVES, S., HAMMICK, M. & FREETH, D. 2005. Effective interprofessional 
education: Assumption, argument and evidence., Oxford, UK, Blackwell. 
BARRETT, G., SELLMAN, D. & THOMAS, J. 2005. Interprofessional working in health and social care: 
professional perspectives, Palgrave Macmillan. 
BAUER, H. & BRIGHI, E. 2002. Editorial note. Millennium: Journal of international studies, 31. 
BAXTER, S. K. & BRUMFITT, S. M. 2008. Benefits and losses: a qualitative study exploring healthcare 
staff perceptions of teamworking. Quality and Safety in Health Care, 17, 127-130. 
BIENKOWSKA-GIBBS, T., KING, S., SAUNDERS, C. & HENHAM, M.-L. 2015. New organisational models 
of primary care to meet the future needs of the NHS: a brief overview of recent reports, RAND. 
BLACK, D. A., TAGGART, J., JAYASINGHE, U. W., PROUDFOOT, J., CROOKES, P., BEILBY, J., POWELL-
DAVIS, G., WILSON, L. & HARRIS, M. F. 2013. The Teamwork Study: enhancing the role of 
Bibliography 
 
 
288 
non-GP staff in chronic disease management in general practice. Australian Journal of 
Primary Health, 19, 184-189. 
BLAND, J. M. & ALTMAN, D. G. 1997. Statistics notes: Cronbach's alpha. BMJ: British Medical Journal, 
314, 572. 
BOGDEN, P. E., KOONTZ, L. M., WILLIAMSON, P. & ABBOTT, R. D. 1997. The physician and pharmacist 
team: An effective approach to cholesterol reduction. Journal of General Internal Medicine, 
12, 158-164. 
BOWEN, G. A. 2008. Naturalistic inquiry and the saturation concept: a research note. Qualitative 
Research, 8, 137-152. 
BRADLEY, F. 2012. Exploring interactions between General Practitioners and Community Pharmacists: 
a novel application of social network analysis. University of Manchester. 
BRADLEY, F., ASHCROFT, D. M. & NOYCE, P. R. 2012. Integration and differentiation: a conceptual 
model of general practitioner and community pharmacist collaboration. Research in Social 
and Administrative Pharmacy, 8, 36-46. 
BRAITHWAITE, J., WESTBROOK, M., NUGUS, P., GREENFIELD, D., TRAVAGLIA, J., RUNCIMAN, W., 
FOXWELL, A. R., BOYCE, R. A., DEVINNEY, T. & WESTBROOK, J. 2012. A four-year, systems-
wide intervention promoting interprofessional collaboration. BMC Health Services Research, 
12, 99. 
BRAITHWAITE, J., WESTBROOK, M., NUGUS, P., GREENFIELD, D., TRAVAGLIA, J., RUNCIMAN, W., 
FOXWELL, A. R., BOYCE, R. A., DEVINNEY, T. & WESTBROOK, J. 2013. Continuing differences 
between health professions' attitudes: the saga of accomplishing systems-wide 
interprofessionalism. International Journal for Quality in Health Care, 25, 8-15. 
BRAUN, V. & CLARKE, V. 2006. Using thematic analysis in psychology. Qualitative research in 
psychology, 3, 77-101. 
BREWER, M. L. & STEWART-WYNNE, E. G. 2013. An Australian hospital-based student training ward 
delivering safe, client-centred care while developing students’ interprofessional practice 
capabilities. Journal of Interprofessional Care, 27, 482-488. 
BRITISH MEDICAL ASSOCIATION. 2014. Your GP cares [Online]. Available: 
https://www.bma.org.uk/news/2014/may/care-counts-your-gp-cares-campaign-
highlights-workload-pressures [Accessed 2018]. 
BROCK, K. A. & DOUCETTE, W. R. 2004. Collaborative working relationships between pharmacists 
and physicians: an exploratory study. Journal of the American Pharmacists Association, 44, 
358-365. 
BROWN, J. B., BOLES, M., MULLOOLY, J. P. & LEVINSON, W. 1999. Effect of clinician communication 
skills training on patient satisfaction: a randomized, controlled trial. Annals of Internal 
Medicine, 131, 822-829. 
BRYANT, L. J. M., COSTER, G., GAMBLE, G. D. & MCCORMICK, R. N. 2011. The General Practitioner–
Pharmacist Collaboration (GPPC) study: a randomised controlled trial of clinical medication 
reviews in community pharmacy. International Journal of Pharmacy Practice, 19, 94-105. 
BURING, S. M., BHUSHAN, A., BROESEKER, A., CONWAY, S., DUNCAN-HEWITT, W., HANSEN, L. & 
WESTBERG, S. 2009. Interprofessional Education: Definitions, Student Competencies, and 
Guidelines for Implementation. American Journal of Pharmaceutical Education, 73, 59. 
BURT, R. S. 2005. Brokerage and closure: An introduction to social capital, Oxford university press. 
CAELLI, K., RAY, L. & MILL, J. 2003. ‘Clear as mud’: toward greater clarity in generic qualitative 
research. International journal of qualitative methods, 2, 1-13. 
CALLAND, J. F., TURRENTINE, F. E., GUERLAIN, S., BOVBJERG, V., POOLE, G. R., LEBEAU, K., PEUGH, J. 
& ADAMS, R. B. 2011. The surgical safety checklist: lessons learned during implementation. 
The American surgeon, 77, 1131-1137. 
CAMPBELL, J. C., COBEN, J. H., MCLOUGHLIN, E., DEARWATER, S., NAH, G., GLASS, N., LEE, D. & 
DURBOROW, N. 2001. An evaluation of a system‐ change training model to improve 
emergency department response to battered women. Academic Emergency Medicine, 8, 131-
138. 
CARPENTER, J. 1995. Doctors and Nurses: Stereotypes and Stereotype Change in Interprofessional 
Education. Journal of Interprofessional Care, 9, 151-161. 
CARPENTER, J., BARNES, D., DICKINSON, C. & WOOFF, D. 2006. Outcomes of interprofessional 
education for Community Mental Health Services in England: The longitudinal evaluation of 
a postgraduate programme. Journal of Interprofessional Care, 20, 145-161. 
CARPENTER, J. & DICKINSON, H. 2014. Interprofessional education and training, Policy Press. 
Bibliography 
 
 
289 
CARTER, P. 2016. Operational productivity and performance in English NHS acute hospitals: 
Unwarranted variations. An independent report for the Department of Health by Lord Carter 
of Coles. London: Department of Health. 
CATCHPOLE, K. R., DE LEVAL, M. R., MCEWAN, A., PIGOTT, N., ELLIOTT, M. J., MCQUILLAN, A., 
MACDONALD, C. & GOLDMAN, A. J. 2007. Patient handover from surgery to intensive care: 
using Formula 1 pit‐stop and aviation models to improve safety and quality. Pediatric 
Anesthesia, 17, 470-478. 
CENTRE FOR WORKFORCE INTELLIGENCE 2014. In-depth Review of the General Practitioner 
Workforce: Final Report. 
CHANG, W. Y., MA, J. C., CHIU, H. T., LIN, K. C. & LEE, P. H. 2009. Job satisfaction and perceptions of 
quality of patient care, collaboration and teamwork in acute care hospitals. Journal of 
advanced nursing, 65, 1946-1955. 
CHARROIS, T. L., ZOLEZZI, M., KOSHMAN, S. L., PEARSON, G., MAKOWSKY, M., DUREC, T. & TSUYUKI, 
R. T. 2012. A Systematic Review of the Evidence for Pharmacist Care of Patients With 
Dyslipidemia. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 32, 
222-233. 
CHEATER, F. M., HEARNSHAW, H., BAKER, R. & KEANE, M. 2005. Can a facilitated programme 
promote effective multidisciplinary audit in secondary care teams? An exploratory trial. 
International Journal of Nursing Studies, 42, 779-791. 
CLARK, P. G. 2014. Narrative in interprofessional education and practice: implications for 
professional identity, provider–patient communication and teamwork. Journal of 
Interprofessional Care, 28, 34-39. 
CLEGG, F. 2001. Simple chi-squared. Simple statistics: A course book for the social sciences. Cambridge 
University Press. 
CLOUDER, D. L., GOODMAN, S., BLUTEAU, P., JACKSON, A., DAVIES, B. & MERRIMAN, L. 2011. An 
investigation of “agreement” in the context of interprofessional discussion online: A 
“netiquette” of interprofessional learning? Journal of Interprofessional Care, 25, 112-118. 
COMMUNITY PHARMACY WALES. 2015. Community Pharmacies in Wales [Online]. Available: 
http://www.cpwales.org.uk/CPW-s-work/About/Community-Pharmacies-in-Wales.aspx 
[Accessed 2018]. 
COMMUNITY PHARMACY WALES. 2017. Information on services provided by community pharmacies 
in Wales [Online]. Available: http://www.cpwales.org.uk/getattachment/Home/20121113-
information-on-services-Copy.pdf.aspx?lang=en-GB [Accessed 2018]. 
COMMUNITY PHARMACY WALES. 2018. 2018/19 Collaborative Working Scheme [Online]. Available: 
http://www.cpwales.org.uk/getattachment/Services-and-commissioning/Collaborative-
Working/20180413-Contracto-rNews-Collaborative-Working-Scheme-2018-
19.pdf.aspx?lang=en-GB [Accessed 2018]. 
CONN, L. G., LINGARD, L., REEVES, S., MILLER, K.-L., RUSSELL, A. & ZWARENSTEIN, M. 2009. 
Communication Channels in General Internal Medicine: A Description of Baseline Patterns 
for Improved Interprofessional Collaboration. Qualitative Health Research, 19, 943-953. 
COOPER, S. & ENDACOTT, R. 2007. Generic qualitative research: a design for qualitative research in 
emergency care? Emergency Medicine Journal, 24, 816-819. 
CORBIN, J. & STRAUSS, A. 2008. Practical considerations. Basics of qualitative research. Third ed. 
London: Sage Publications. 
COTTERILL, S. T. 2012. Introdution. Team psychology in sports: Theory and practice. Routledge. 
COUGHLIN, S. S. 1990. Recall bias in epidemiologic studies. Journal of clinical epidemiology, 43, 87-
91. 
COULMAN, S. A., JOHN, D. N., JENKINS, A., WILKINS, S. J., SWEETLAND, H., HAYES, J., COULSON, J. M., 
THOMPSON, J. P. & ROUTLEDGE, P. A. 2014. Therapeutics and Prescribing Interprofessional 
Education (IPE). Medical and Pharmacy Students Working and Learning Together. Research 
in Social and Administrative Pharmacy, 10, e56-e57. 
CRESWELL, J. W. & CRESWELL, J. D. 2017. Mixed Methods Procedures. Research design: Qualitative, 
quantitative, and mixed methods approaches. Sage publications. 
CRESWELL, J. W. & POTH, C. N. 2017. Five qualitative approaches to inquiry. Qualitative inquiry and 
research design: Choosing among five approaches. Sage publications. 
CURLEY, C., MCEACHERN, J. E. & SPEROFF, T. 1998. A firm trial of interdisciplinary rounds on the 
inpatient medical wards: an intervention designed using continuous quality improvement. 
Medical care, AS4-AS12. 
Bibliography 
 
 
290 
CURRAN, V., SARGEANT, J. & HOLLETT, A. 2007. Evaluation of an interprofessional continuing 
professional development initiative in primary health care. Journal of Continuing Education 
in the Health Professions, 27, 241-252. 
D'AMOUR, D., FERRADA-VIDELA, M., SAN MARTIN RODRIGUEZ, L. & BEAULIEU, M.-D. 2005. The 
conceptual basis for interprofessional collaboration: Core concepts and theoretical 
frameworks. Journal of Interprofessional Care, 19, 116-131. 
DAVIES, J. E., BARBER, N. & TAYLOR, D. 2014. What do community pharmacists do?: results from a 
work sampling study in London. International Journal of Pharmacy Practice, 22, 309-318. 
DENECKERE, S., EUWEMA, M., LODEWIJCKX, C., PANELLA, M., MUTSVARI, T., SERMEUS, W. & 
VANHAECHT, K. 2013. Better interprofessional teamwork, higher level of organized care, 
and lower risk of burnout in acute health care teams using care pathways: a cluster 
randomized controlled trial. Medical care, 51, 99-107. 
DENZIN, N. K. & LINCOLN, Y. S. 2008. Introduction: The discipline and practice of qualitative research. 
Strategies of qualitative inquiry. Sage Publications. 
DEPARTMENT OF HEALTH 2000. The NHS plan: A plan for investment, a plan for reform. London: 
Department of Health. 
DEPARTMENT OF HEALTH 2009. NHS Constitution. London. 
DEPARTMENT OF HEALTH 2010. Equity and Excellence: Liberating the NHS. London: Department of 
Health. 
DEPARTMENT OF HEALTH 2012. Health and Social Care Act 2012. London: Department of Health. 
DEPARTMENT OF HEALTH 2013a. Integrated Care and Support: Our Shared Commitment. London: 
Department of Health. 
DEPARTMENT OF HEALTH 2013b. The NHS outcomes framework 2014/15. London: Department of 
Health. 
DEPARTMENT OF HEALTH 2013c. Patients First and Foremost: The Initial Government Response to 
the Report of the Mid Staffordshire NHS Foundation Trust Public Inquiry. London: 
Department of Health. 
DEPARTMENT OF HEALTH 2015. Learning not blaming: The government response to Freedom to 
Speak Up, the Public Administration Select Committee report on clinical incidents, and the 
Morecambe Bay Investigation. London: Department of Health. 
DEPARTMENT OF HEALTH 2016. NHS Outcomes Framework: at-a-glance. London: Department of 
Health. 
DIACK, H., GIBSON, M., HEALEY, T., BOND, C. & MCKENZIE, H. 2008. The Aberdeen interprofessional 
health and social care education initiative: Final report. University of Aberdeen and The 
Robert Gordon University. 
DIXON, J. F., LARISON, K. & ZABARI, M. 2006. Skilled communication: making it real. AACN advanced 
critical care, 17, 376-382. 
DOBSON, R. T., HENRY, C. J., TAYLOR, J. G., ZELLO, G. A., LACHAINE, J., FORBES, D. A. & KEEGAN, D. L. 
2006. Interprofessional health care teams: attitudes and environmental factors associated 
with participation by community pharmacists. Journal of Interprofessional Care, 20, 119-132. 
DRINKA, T. J. K., MILLER, T. F. & GOODMAN, B. M. 1996. Characterizing motivational styles of 
professionals who work on interdisciplinary healthcare teams. Journal of Interprofessional 
Care, 10, 51-61. 
DRISCOLL, D. L., APPIAH-YEBOAH, A., SALIB, P. & RUPERT, D. J. 2007. Merging qualitative and 
quantitative data in mixed methods research: How to and why not. Ecological and 
Environmental Anthropology (University of Georgia), 18. 
EDWARDS, N. 2010. The triumph of hope over experience. NHS Confederation: London. 
EDWARDS, P., ROBERTS, I., CLARKE, M., DIGUISEPPI, C., PRATAP, S., WENTZ, R. & KWAN, I. 2009. 
Increasing response rates to postal questionnaires: systematic review. BMJ: British Medical 
Journal 324, 1183. 
EGGINK, R. N., LENDERINK, A. W., WIDDERSHOVEN, J. W. & VAN DEN BEMT, P. M. 2010. The effect of 
a clinical pharmacist discharge service on medication discrepancies in patients with heart 
failure. Pharmacy world & science, 32, 759-766. 
ELVEY, R., HASSELL, K. & HALL, J. 2013. Who do you think you are? Pharmacists' perceptions of their 
professional identity. International Journal of Pharmacy Practice, 21, 322-332. 
FALCK, H. S. 1977. Interdisciplinary education and implications for social work practice. Journal of 
Education for Social Work, 13, 30-37. 
FRANCIS, R. 2013. Report of the Mid Staffordshire NHS Foundation Trust Public Inquiry: Executive 
Summary. London: The Stationery Office. 
Bibliography 
 
 
291 
FRANCIS, R. 2015. Freedom to speak up: An independent review into creating an open and honest 
reporting culture in the NHS. London: The Stationery Office. 
FRANKEL PRATT, S. 2016. Pragmatism as ontology, not (just) epistemology: Exploring the full 
horizon of pragmatism as an approach to IR theory. International Studies Review, 18, 508-
527. 
FREETH, D., HAMMICK, M., KOPPEL, I., REEVES, S. & BARR, H. 2002. A critical review of evaluations 
of interprofessional education. In: LEARNING AND TEACHING SUPPORT NETWORK, C. F. H. 
S. A. P. (ed.). London. 
FREETH, D., REEVES, S., KOPPEL, I., HAMMICK, M. & BARR, H. 2005. Evaluating interprofessional 
education: A self-help guide. Higher Education Academy: Health Sciences and Practice. 
FREETH, D. S., HAMMICK, M., REEVES, S., KOPPEL, I. & BARR, H. 2008. Effective interprofessional 
education: development, delivery, and evaluation, John Wiley & Sons. 
FRENK, J., CHEN, L., BHUTTA, Z. A., COHEN, J., CRISP, N., EVANS, T., FINEBERG, H., GARCIA, P., KE, Y. 
& KELLEY, P. 2010. Health professionals for a new century: transforming education to 
strengthen health systems in an interdependent world. The lancet, 376, 1923-1958. 
FULOP, N., PROTOPSALTIS, G., KING, A., ALLEN, P., HUTCHINGS, A. & NORMAND, C. 2005. Changing 
organisations: a study of the context and processes of mergers of health care providers in 
England. Social Science & Medicine, 60, 119-130. 
GENERAL MEDICAL COUNCIL 2009. Tomorrows Doctors; Outcomes and standards for 
undergraduate medical education. London: General Medical Council. 
GENERAL PHARMACEUTICAL COUNCIL 2010. Accreditation of Master of Pharmacy Degrees. London. 
GENERAL PHARMACEUTICAL COUNCIL 2011. Future pharmacists: Standards for the initial 
education and training of pharmacists. London. 
GENERAL PHARMACEUTICAL COUNCIL 2017. Business plan 2017-20. London. 
GENERAL PHARMACEUTICAL COUNCIL. 2018a. Accredited MPharm degrees [Online]. Available: 
https://www.pharmacyregulation.org/education/pharmacist/accredited-mpharm-
degrees [Accessed 2018]. 
GENERAL PHARMACEUTICAL COUNCIL. 2018b. Hospital and Community setting [Online]. Available: 
https://www.pharmacyregulation.org/resources/registrant-survey-2013/key-survey-
findings/community-hospital-settings [Accessed 2018]. 
GENERAL PHARMACEUTICAL COUNCIL. 2018c. Pharmacist education and training [Online]. 
Available: https://www.pharmacyregulation.org/education/pharmacist-education 
[Accessed 2018]. 
GENERAL PHARMACEUTICAL COUNCIL. 2018d. What does a pharmacist do? [Online]. Available: 
https://www.pharmacyregulation.org/raising-concerns/raising-concerns-about-
pharmacy-professional/what-expect-your-pharmacy/what-does-0 [Accessed 2018]. 
GEURTS, M. M. E., TALSMA, J., BROUWERS, J. R. B. J. & DE GIER, J. J. 2012. Medication review and 
reconciliation with cooperation between pharmacist and general practitioner and the 
benefit for the patient: a systematic review. British Journal of Clinical Pharmacology, 74, 16-
33. 
GOLAFSHANI, N. 2003. Understanding reliability and validity in qualitative research. The qualitative 
report, 8, 597-606. 
GORDON, M., UPPAL, E., HOLT, K., LYTHGOE, J., MITCHELL, A. & HOLLINS-MARTIN, C. 2013. 
Application of the team objective structured clinical encounter (TOSCE) for continuing 
professional development amongst postgraduate health professionals. Journal of 
interprofessional care, 27, 191-193. 
GREEN, L., FRYER JR, G., YAWN, B., LANIER, D. & DOVEY, S. 2001. Ecology of medical care. New 
England Journal of Medicine, 344, 5. 
GREINER, A. C. & KNEBEL, E. 2003. The core competencies needed for health care professionals. 
Health Professions Education: A Bridge to Quality. Washington (DC): National Academies 
Press (US). 
GUEST, C., SMITH, L., BRADSHAW, M. & HARDCASTLE, W. 2002. Facilitating interprofessional 
learning for medical and nursing students in clinical practice. Learning in Health and Social 
Care, 1, 132-138. 
HALL, P. 2005. Interprofessional teamwork: Professional cultures as barriers. Journal of 
Interprofessional care, 19, 188-196. 
HALL, P. & WEAVER, L. 2001. Interdisciplinary education and teamwork: a long and winding road. 
Medical education, 35, 867-875. 
HAM, C., IMISON, C. & JENNINGS, M. 2010. Avoiding hospital admissions; Lessons from evidence and 
experience. The Kings Fund, 7-8. 
Bibliography 
 
 
292 
HAMMAR, M. B. F. M. 2000. Strategies and focus at an integrated, interprofessional training ward. 
Journal of Interprofessional Care, 14, 337-350. 
HAMMICK, M., FREETH, D., KOPPEL, I., REEVES, S. & BARR, H. 2007. A best evidence systematic 
review of interprofessional education: BEME Guide no. 9. Medical teacher, 29, 735-751. 
HARDEN, R. M. 2015. Interprofessional education: The magical mystery tour now less of a mystery. 
Anatomical sciences education, 8, 291-295. 
HARDEN, R. M. & GLEESON, F. A. 1979. Assessment of clinical competence using an objective 
structured clinical examination (OSCE). Medical Education, 13, 39-54. 
HARDEN, R. M. & STAMPER, N. 1999. What is a spiral curriculum? Medical teacher, 21, 141-143. 
HELMREICH, R. L., MERRITT, A. C. & WILHELM, J. A. 1999. The evolution of crew resource 
management training in commercial aviation. The international journal of aviation 
psychology, 9, 19-32. 
HENDERSON, C. D., BROESEKER, A. E., BERRY, C. G., FORT, D. N., THOMASON, A. R., CAHOON, T. M. & 
KARLET, M. C. 2013. Interprofessional education sessions involving doctor of pharmacy, 
bachelor of science in nursing, and nurse anesthetist students. Currents in Pharmacy 
Teaching and Learning, 5, 458-469. 
HINTON, P. R. 2014. Analysing frequency data - chi-square. Statistics explained. East Sussex, UK: 
Routledge. 
HODSON, K., BLENKINSOPP, A., COHEN, D., LONGLEY, M., ALAM, M., DAVIES, P., HUGHES, L., JAMES, 
D., O’BRIEN, C. & SMITH, M. 2014. Evaluation of the discharge medicines review service. 
Welsh Institute for Health and Social Care, University of South Wales. 
HOLLAND, R., LENAGHAN, E., HARVEY, I., SMITH, R., SHEPSTONE, L., LIPP, A., CHRISTOU, M., EVANS, 
D. & HAND, C. 2005. Does home based medication review keep older people out of hospital? 
The HOMER randomised controlled trial. BMJ: British Medical Journal, 330, 293. 
HUGHES, C. M. & MCCANN, S. 2003. Perceived interprofessional barriers between community 
pharmacists and general practitioners: a qualitative assessment. British Journal of General 
Practice, 53, 600-606. 
HUSBAND, A. K., TODD, A. & FULTON, J. 2014. Integrating Science and Practice in Pharmacy Curricula. 
American Journal of Pharmaceutical Education, 78, 63. 
HYLIN, U. 2010. Interprofessional education: Aspects on learning together on an interprofessional 
training ward. PhD Thesis, Department of Clinical Science and Education, Södersjukhuset, 
Karolinska Institutet, Stockholm, Sweden. 
HYLIN, U., NYHOLM, H., MATTIASSON, A.-C. & PONZER, S. 2007. Interprofessional training in clinical 
practice on a training ward for healthcare students: A two-year follow-up. Journal of 
Interprofessional Care, 21, 277-288. 
ILLINGWORTH, P. & CHELVANAYAGAM, S. 2017. The benefits of interprofessional education 10 
years on. British Journal of Nursing, 26, 813-818. 
IRVINE, A. 2011. Duration, dominance and depth in telephone and face-to-face interviews: A 
comparative exploration. International Journal of Qualitative Methods, 10, 202-220. 
ISSENBERG, B. S., MCGAGHIE, W. C., PETRUSA, E. R., LEE GORDON, D. & SCALESE, R. J. 2005. Features 
and uses of high-fidelity medical simulations that lead to effective learning: a BEME 
systematic review. Medical Teacher, 27, 10-28. 
ISSENBERG, S. B. & SCALESE, R. J. 2008. Simulation in health care education. Perspectives in biology 
and medicine, 51, 31-46. 
JACOBSEN, F., FINK, A. M., MARCUSSEN, V., LARSEN, K. & BÆK HANSEN, T. 2009. Interprofessional 
undergraduate clinical learning: Results from a three year project in a Danish 
Interprofessional Training Unit. Journal of Interprofessional Care, 23, 30-40. 
JELPHS, K., DICKINSON, H. & MILLER, R. 2016. What is teamworking and why does it matter? Working 
in teams. Bristol: Policy Press. 
JENKINS, A. 2013. An evaluation of Interprofessional Education (IPE) sessions conducted between 
Medicine and Pharmacy students at Cardiff University. In: PROJECT, M. R. (ed.). Cardiff 
School of Pharmacy and Pharmaceutical sciences. 
JENKINS, A. I., HUGHES, M. L., MANTZOURANI, E. & SMITH, M. W. 2016. Too far away to work with 
each other: Does location impact on pharmacists' perceptions of interprofessional 
interactions? Journal of Interprofessional Care, 30, 678-81. 
JOHNSON, R. B. & ONWUEGBUZIE, A. J. 2004. Mixed Methods Research: A Research Paradigm Whose 
Time Has Come. Educational Researcher, 33, 14-26. 
JONASSEN, D. H. 1999. Designing constructivist learning environments. Instructional design theories 
and models: A new paradigm of instructional theory, 2, 215-239. 
Bibliography 
 
 
293 
JONES, A. 2006. Multidisciplinary team working: Collaboration and conflict. International Journal of 
Mental Health Nursing, 15, 19-28. 
JONES, K. M., BLUMENTHAL, D. K., BURKE, J. M., CONDREN, M., HANSEN, R., HOLIDAY-GOODMAN, M. 
& PETERSON, C. D. 2012. Interprofessional education in introductory pharmacy practice 
experiences at US colleges and schools of pharmacy. American journal of pharmaceutical 
education, 76. 
JUBRAJ, B., MARVIN, V., POOTS, A. J., PATEL, S., BOVILL, I., BARNETT, N., ISSEN, L. & BELL, D. 2015. A 
pilot survey of junior doctors’ attitudes and awareness around medication review: time to 
change our educational approach? European Journal of Hospital Pharmacy, 22, 243-248. 
KABOLI, P. J., HOTH, A. B., MCCLIMON, B. J. & SCHNIPPER, J. L. 2006. Clinical pharmacists and 
inpatient medical care: a systematic review. Archives of internal medicine, 166, 955-964. 
KARNON, J., CAMPBELL, F. & CZOSKI‐MURRAY, C. 2009. Model‐based cost‐effectiveness analysis 
of interventions aimed at preventing medication error at hospital admission (medicines 
reconciliation). Journal of evaluation in clinical practice, 15, 299-306. 
KING, N. & HORROCKS, C. 2010a. Carrying out qualitative interviews Interviews in qualitative 
research. Sage Publications. 
KING, N. & HORROCKS, C. 2010b. An introduction to interview data analysis. Interviews in qualitative 
research. Sage Publications. 
KIRK, R. E. 1982. Experimental design, Wiley Online Library. 
KIRKUP, B. 2015. The report of the Morecambe Bay investigation. The Stationery Office, London. 
KNOWLES, M. 1973. Exploring the strange world of learning theory. The adult learner: a neglected 
species. Texas, USA: Gulf Publishing Company. 
KOSHMAN, S. L., CHARROIS, T. L., SIMPSON, S. H., MCALISTER, F. A. & TSUYUKI, R. T. 2008. Pharmacist 
care of patients with heart failure: a systematic review of randomized trials. Archives of 
Internal Medicine, 168, 687-694. 
KUMAR, R. 2014. Research Methodology: A step-by-step guide for beginners, Sage. 
KVALE, S. 2007. Planning an interview study. Doing interviews. London: Sage Publications. 
KVARNSTRÖM, S. 2008. Difficulties in collaboration: A critical incident study of interprofessional 
healthcare teamwork. Journal of Interprofessional Care, 22, 191-203. 
KWINT, H.-F., BERMINGHAM, L., FABER, A., GUSSEKLOO, J. & BOUVY, M. L. 2013. The relationship 
between the extent of collaboration of general practitioners and pharmacists and the 
implementation of recommendations arising from medication review. Drugs & aging, 30, 91-
102. 
LALONDE, L., HUDON, E., GOUDREAU, J., BÉLANGER, D., VILLENEUVE, J., PERREAULT, S., BLAIS, L. & 
LAMARRE, D. 2011. Physician-pharmacist collaborative care in dyslipidemia management: 
the perception of clinicians and patients. Research in Social and Administrative Pharmacy, 7, 
233-245. 
LAPKIN, S., LEVETT-JONES, T. & GILLIGAN, C. 2012. A cross-sectional survey examining the extent to 
which interprofessional education is used to teach nursing, pharmacy and medical students 
in Australian and New Zealand Universities. Journal of Interprofessional Care, 26, 390-396. 
LAPKIN, S., LEVETT-JONES, T. & GILLIGAN, C. 2013. A systematic review of the effectiveness of 
interprofessional education in health professional programs. Nurse Education Today, 33, 90-
102. 
LARKIN, C. & CALLAGHAN, P. 2005. Professionals' perceptions of interprofessional working in 
community mental health teams. Journal of Interprofessional Care, 19, 338-346. 
LATIF, A., BOARDMAN, H. F. & POLLOCK, K. 2013a. Understanding the patient perspective of the 
English community pharmacy Medicines Use Review (MUR). Research in Social and 
Administrative Pharmacy, 9, 949-957. 
LATIF, A., POLLOCK, K. & BOARDMAN, H. F. 2013b. Medicines use reviews: a potential resource or 
lost opportunity for general practice? BMC family practice, 14, 57. 
LEVETT-JONES, T., GILLIGAN, C., LAPKIN, S. & HOFFMAN, K. 2012. Interprofessional education for 
the quality use of medicines: designing authentic multimedia learning resources. Nurse 
education today, 32, 934-938. 
LINDQVIST, S., DUNCAN, A., SHEPSTONE, L., WATTS, F. & PEARCE, S. 2005. Case-based learning in 
cross-professional groups – the development of a pre-registration interprofessional learning 
programme. Journal of Interprofessional Care, 19, 509-520. 
LIU, Y., DOUCETTE, W. R. & FARRIS, K. B. 2010. Examining the development of pharmacist-physician 
collaboration over 3 months. Research in Social and Administrative Pharmacy, 6, 324-333. 
LOMBARDI, M. M. 2007. Authentic learning for the 21st century: An overview. Educause learning 
initiative, 1, 1-12. 
Bibliography 
 
 
294 
LONG, A. F., KNEAFSEY, R. & RYAN, J. 2003. Rehabilitation practice: challenges to effective team 
working. International Journal of Nursing Studies, 40, 663-673. 
MAHLER, C., BERGER, S. & REEVES, S. 2015. The Readiness for Interprofessional Learning Scale 
(RIPLS): A problematic evaluative scale for the interprofessional field. Journal of 
interprofessional care, 29, 289-291. 
MAKOWSKY, M. J., KOSHMAN, S. L., MIDODZI, W. K. & TSUYUKI, R. T. 2009a. Capturing outcomes of 
clinical activities performed by a rounding pharmacist practicing in a team environment: the 
COLLABORATE study [NCT00351676]. Medical care, 47, 642-650. 
MAKOWSKY, M. J., MADILL, H. M., SCHINDEL, T. J. & TSUYUKI, R. T. 2013. Physician perspectives on 
collaborative working relationships with team-based hospital pharmacists in the inpatient 
medicine setting. International Journal of Pharmacy Practice, 21, 123-127. 
MAKOWSKY, M. J., SCHINDEL, T. J., ROSENTHAL, M., CAMPBELL, K., TSUYUKI, R. T. & MADILL, H. M. 
2009b. Collaboration between pharmacists, physicians and nurse practitioners: A 
qualitative investigation of working relationships in the inpatient medical setting. Journal of 
Interprofessional Care, 23, 169-184. 
MALTERUD, K., SIERSMA, V. D. & GUASSORA, A. D. 2015. Sample size in qualitative interview studies: 
guided by information power. Qualitative health research, 26, 1753-1760. 
MANTZOURANI, E., WAY, C. M. & HODSON, K. L. 2017. Does an integrated information technology 
system provide support for community pharmacists undertaking Discharge Medicines 
Reviews? An exploratory study. Integrated Pharmacy Research & Practice, 6, 145-156. 
MAYS, N. & POPE, C. 2000. Assessing quality in qualitative research. BMJ : British Medical Journal, 320, 
50-52. 
MCDONOUGH, R. & DOUCETTE, W. 2001. Developing collaborative working relationships between 
pharmacists and physicians. Journal of the American Pharmaceutical Association, 41, 682-
692. 
MCFADYEN, A. K., WEBSTER, V. S., MACLAREN, W. M. & O'NEILL, M. A. 2010. Interprofessional 
attitudes and perceptions: Results from a longitudinal controlled trial of pre-registration 
health and social care students in Scotland. Journal of Interprofessional Care, 24, 549-564. 
MEADS, G. & ASHCROFT, J. 2005. Policy into practice. The Case for Interprofessional Collaboration: In 
Health and Social Care. Oxford: Blackwell Publishing. 
MERRIAM, S. B. 1998. Qualitative Research and Case Study Applications in Education. Revised and 
Expanded from" Case Study Research in Education.", ERIC. 
MERRY, A. F., WELLER, J. & MITCHELL, S. J. 2014. Teamwork, Communication, Formula-One Racing 
and the Outcomes of Cardiac Surgery. The Journal of Extra-corporeal Technology, 46, 7-14. 
MILLER, G., FRANKLIN, B. & JACKLIN, A. 2011a. Including pharmacists on consultant-led ward 
rounds - Response. Clinical Medicine, 11, 627-628. 
MILLER, G., FRANKLIN, B. D. & JACKLIN, A. 2011b. Including pharmacists on consultant-led ward 
rounds: a prospective non-randomised controlled trial. Clinical Medicine, 11, 312-316. 
MILLER, G. E. 1990. The assessment of clinical skills/competence/performance. Academic medicine, 
65, S63-7. 
MOREY, J. C., SIMON, R., JAY, G. D., WEARS, R. L., SALISBURY, M., DUKES, K. A. & BERNS, S. D. 2002. 
Error reduction and performance improvement in the emergency department through 
formal teamwork training: evaluation results of the MedTeams project. Health services 
research, 37, 1553-1581. 
MORISON, S. L. & STEWART, M. C. 2005. Developing interprofessional assessment. Learning in Health 
and Social Care, 4, 192-202. 
MORSE, J. M. 2015. Data were saturated. Sage Publications Sage CA: Los Angeles, CA. 
MORSE, J. M., BARRETT, M., MAYAN, M., OLSON, K. & SPIERS, J. 2002. Verification strategies for 
establishing reliability and validity in qualitative research. International journal of 
qualitative methods, 1, 13-22. 
MOSSIALOS, E., COURTIN, E., NACI, H., BENRIMOJ, S., BOUVY, M., FARRIS, K., NOYCE, P. & SKETRIS, I. 
2015. From retailers to health care providers: Transforming the role of community 
pharmacists in chronic disease management. Health Policy, 119, 628-639. 
MYERS VIRTUE, S., ROTZ, M. E., BOYD, M., LYKON, J. L., WALDRON, E. M. & THEODOROU, J. 2017. 
Impact of a novel interprofessional dental and pharmacy student tobacco cessation 
education programme on dental patient outcomes. Journal of Interprofessional Care, 1-11. 
NADZAM, D. M. 2009. Nurses' role in communication and patient safety. Journal of Nursing Care 
Quality, 24, 184-188. 
NAIK, G. 2006. A hospital races to learn lessons of Ferrari pit stop. Wall Street Journal, 14. 
Bibliography 
 
 
295 
NATIONAL ASSEMBLY FOR WALES 2018. Medicines management. Cardiff: National Assembly for 
Wales. 
NEOCLEOUS, A. 2014. Interprofessional education: How can it enhance learning? Whitireia Nursing 
& Health Journal, 23. 
NHS ENGLAND 2013. Improving Health and Patient Care Through Community Pharmacy—A Call to 
Action. London: NHS England. 
NHS ENGLAND 2014a. Community pharmacy—helping provide better quality and resilient urgent 
care. 2014. London: NHS England. 
NHS ENGLAND 2014b. Five Year Forward View. London: NHS England. 
NHS FUTURE FORUM 2011a. Choice and competition. London. 
NHS FUTURE FORUM 2011b. Integration. London. 
NHS HEALTH EDUCATION ENGLAND. 2015. Health Careers within the NHS [Online]. Health Careers. 
Available: https://www.healthcareers.nhs.uk/explore-roles [Accessed 2018]. 
NHS HEALTH EDUCATION ENGLAND. 2016. Pharmacists in emergency departments [Online]. 
Available: https://www.healthcareers.nhs.uk/explore-roles/allied-health-
professionals/roles-allied-health-professions/dietitian [Accessed 2018]. 
NHS HEALTH EDUCATION ENGLAND. 2018. Explore roles - Pharmacist [Online]. Health careers. 
Available: https://www.healthcareers.nhs.uk/explore-roles/pharmacy/pharmacist 
[Accessed 2018]. 
NHS WALES. 2016. Health in Wales - Hospitals [Online]. Available: 
http://www.wales.nhs.uk/ourservices/directory/hospitals [Accessed 2018]. 
NHS WALES. 2018a. Day in the life of a Hospital Pharmacist [Online]. Abertawe Bro Morgannwg 
University Health Board. Available: 
http://www.wales.nhs.uk/sitesplus/documents/863/Day%20in%20the%20life%20of%2
0a%20Pharmacist.pdf [Accessed 2018]. 
NHS WALES. 2018b. Health in Wales - Structure [Online]. Available: 
http://www.wales.nhs.uk/nhswalesaboutus/structure [Accessed 2018]. 
NHS WALES. 2018c. Welsh GP Record [Online]. Available: http://www.gprecord.wales.nhs.uk/home 
[Accessed 2018]. 
NKANSAH, N., MOSTOVETSKY, O., YU, C., CHHENG, T., BENEY, J., BOND, C. M. & BERO, L. 2010. Effect 
of outpatient pharmacists' non‐dispensing roles on patient outcomes and prescribing 
patterns. The Cochrane Library. 
NORTON, D., TEED, A., GRENFELL, R., MACKAY, C., MACDONALD, C. & MEASDAY, J. 2003. GP-
pharmacist liaison: a rural case study. Australian family physician, 32, 191. 
NOYCE, P. R. 2007. Providing Patient Care Through Community Pharmacies in the UK: Policy, 
Practice, and Research. Annals of Pharmacotherapy, 41, 861-868. 
NUFFIELD TRUST. 2017. Facts on staffing and staff shortages in England [Online]. Available: 
www.nuffieldtrust.org.uk/resource/the-nhs-workforce-in-numbers [Accessed 2018]. 
NUGUS, P., GREENFIELD, D., TRAVAGLIA, J., WESTBROOK, J. & BRAITHWAITE, J. 2010. How and 
where clinicians exercise power: Interprofessional relations in health care. Social Science & 
Medicine, 71, 898-909. 
O'HALLORAN, C., HEAN, S., HUMPHRIS, D. & MACLEOD-CLARK, J. 2006. Developing common 
learning: the new generation project undergraduate curriculum model. Journal of 
Interprofessional Care, 20, 12-28. 
O'LEARY, K. J., SEHGAL, N. L., TERRELL, G. & WILLIAMS, M. V. 2012. Interdisciplinary teamwork in 
hospitals: A review and practical recommendations for improvement. Journal of Hospital 
Medicine, 7, 48-54. 
O’REILLY, M. & PARKER, N. 2013. ‘Unsatisfactory Saturation’: a critical exploration of the notion of 
saturated sample sizes in qualitative research. Qualitative research, 13, 190-197. 
ORNE, M. T. 1962. On the social psychology of the psychological experiment: With particular 
reference to demand characteristics and their implications. American psychologist, 17, 776. 
PAICE, E., HEARD, S. & MOSS, F. 2002a. How important are role models in making good doctors? BMJ 
: British Medical Journal, 325, 707-710. 
PAICE, E., MOSS, F., HEARD, S., WINDER, B. & MCMANUS, I. 2002b. The relationship between pre‐
registration house officers and their consultants. Medical education, 36, 26-34. 
PARSELL, G. & BLIGH, J. 1998. Interprofessional learning. Postgraduate Medical Journal, 74, 89-95. 
PARSELL, G. & BLIGH, J. 1999. The development of a questionnaire to assess the readiness of health 
care students for interprofessional learning (RIPLS). Medical education, 33, 95-100. 
PATTON, M. Q. 1990. Qualitative evaluation and research methods, Sage Publications. 
Bibliography 
 
 
296 
PAWSON, R., GREENHALGH, T., HARVEY, G. & WALSHE, K. 2005. Realist review-a new method of 
systematic review designed for complex policy interventions. Journal of health services 
research & policy, 10, 21-34. 
PHARMACEUTICAL SERVICES NEGOTIATING COMMITEE. 2018. Summary Care Record (SCR) 
[Online]. Available: https://psnc.org.uk/contract-it/pharmacy-it/electronic-health-
records/summary-care-record-scr-home/ [Accessed 2018]. 
POLLARD, K. C. & MIERS, M. E. 2008. From students to professionals: Results of a longitudinal study 
of attitudes to pre-qualifying collaborative learning and working in health and social care in 
the United Kingdom. Journal of Interprofessional Care, 22, 399-416. 
POLLARD, K. C., MIERS, M. E. & RICKABY, C. 2012. “Oh why didn't I take more notice?” Professionals' 
views and perceptions of pre-qualifying preparation for interprofessional working in 
practice. Journal of Interprofessional Care, 26, 355-361. 
POPE, C., ZIEBLAND, S. & MAYS, N. 2000. Qualitative research in health care: analysing qualitative 
data. BMJ: British Medical Journal, 320, 114. 
PRIMARY CARE WORKFORCE COMMISSION 2015. The future of primary care: creating teams for 
tomorrow. London. 
PULLON, S. 2008. Competence, respect and trust: Key features of successful interprofessional nurse-
doctor relationships. Journal of Interprofessional Care, 22, 133-147. 
QUANTRILL, S. & WEBBE, D. 2011. Including pharmacists on consultant-led ward rounds. Clinical 
Medicine, 11, 627-628. 
RAY, M. D. 1998. Shared borders: achieving the goals of interdisciplinary patient care. American 
Journal of Health-System Pharmacy, 55, 1369-1374. 
REESE, D. J. & SONTAG, M.-A. 2001. Successful interprofessional collaboration on the hospice team. 
Health & Social Work, 26, 167-175. 
REEVES, S. 2012. The rise and rise of interprofessional competence. Journal of Interprofessional Care, 
26, 253-255. 
REEVES, S. & BARR, H. 2016. Twelve steps to evaluating interprofessional education. Journal of 
Taibah University Medical Sciences, 11, 601-605. 
REEVES, S., FLETCHER, S., BARR, H., BIRCH, I., BOET, S., DAVIES, N., MCFADYEN, A., RIVERA, J. & 
KITTO, S. 2016. A BEME systematic review of the effects of interprofessional education: 
BEME Guide No. 39. Medical teacher, 38, 656-668. 
REEVES, S. & FREETH, D. 2002. The London training ward: an innovative interprofessional learning 
initiative. Journal of Interprofessional Care, 16, 41-52. 
REEVES, S., FREETH, D., MCCRORIE, P. & PERRY, D. 2002. It teaches you what to expect in future…': 
interprofessional learning on a training ward for medical, nursing, occupational therapy and 
physiotherapy students. Medical Education, 36, 337-344. 
REEVES, S. & HEAN, S. 2013. Editorial: Why we need theory to help us better understand the nature 
of interprofessional education, practice and care. Journal of Interprofessional Care, 1-3. 
REEVES, S., LEWIN, S., ESPIN, S. & ZWARENSTEIN, M. 2010a. Glossary. Interprofessional teamwork 
for health and social care. London, UK: Blackwell-Wiley. 
REEVES, S., LEWIN, S., ESPIN, S. & ZWARENSTEIN, M. 2010b. Interprofessional Teamwork: Key 
Concepts and Issues. Interprofessional Teamwork for Health and Social Care. London, UK: 
Blackwell-Wiley. 
REEVES, S., PELONE, F., HARRISON, R., GOLDMAN, J. & ZWARENSTEIN, M. 2017. Interprofessional 
collaboration to improve professional practice and healthcare outcomes. Cochrane Database 
of Systematic Reviews. 
REEVES, S., PERRIER, L., GOLDMAN, J., FREETH, D. & ZWARENSTEIN, M. 2013. Interprofessional 
education: effects on professional practice and healthcare outcomes (update). Cochrane 
Database of Systematic Reviews, 3. 
REEVES, S., TASSONE, M., PARKER, K., WAGNER, S. J. & SIMMONS, B. 2012. Interprofessional 
education: An overview of key developments in the past three decades. Work: A Journal of 
Prevention, Assessment and Rehabilitation, 41, 233-245. 
REEVES, S. & VAN SCHAIK, S. 2012. Simulation: A Panacea for interprofessional learning? Journal of 
Interprofessional Care, 26, 167-169. 
REEVES, S., ZWARENSTEIN, M., GOLDMAN, J., BARR, H., FREETH, D., KOPPEL, I. & HAMMICK, M. 
2010c. The effectiveness of interprofessional education: Key findings from a new systematic 
review. Journal of Interprofessional Care, 24, 230-241. 
REID, R., BRUCE, D., ALLSTAFF, K. & MCLERNON, D. 2006. Validating the Readiness for 
Interprofessional Learning Scale (RIPLS) in the postgraduate context: are health care 
professionals ready for IPL? Medical education, 40, 415-422. 
Bibliography 
 
 
297 
RICE, K., ZWARENSTEIN, M., CONN, L. G., KENASZCHUK, C., RUSSELL, A. & REEVES, S. 2010. An 
intervention to improve interprofessional collaboration and communications: A 
comparative qualitative study. Journal of Interprofessional Care, 24, 350-361. 
RICHMOND, S., MORTON, V., CROSS, B., WONG, I. C. K., RUSSELL, I., PHILIPS, Z., MILES, J., HILTON, A., 
HILL, G. & FARRIN, A. 2010. Effectiveness of shared pharmaceutical care for older patients: 
RESPECT trial findings. British Journal of General Practice, 60, e10-e19. 
RIESEN, E., MORLEY, M., CLENDINNENG, D., OGILVIE, S. & ANN MURRAY, M. 2012. Improving 
interprofessional competence in undergraduate students using a novel blended learning 
approach. Journal of Interprofessional Care, 26, 312-318. 
RIFFENBURGH, R. 2012. Statistics in Medicine, Elsevier. 
RISSER, D. T., RICE, M. M., SALISBURY, M. L., SIMON, R., JAY, G. D. & BERNS, S. D. 1999. The potential 
for improved teamwork to reduce medical errors in the emergency department. Annals of 
emergency medicine, 34, 373-383. 
ROBERTSON, J. & BANDALI, K. 2008. Bridging the gap: Enhancing interprofessional education using 
simulation. Journal of Interprofessional Care, 22, 499-508. 
RODGER, S. & HOFFMAN, S. 2010. Where in the world is interprofessional education? A global 
environmental scan. Journal of Interprofessional Care, 24, 479-491. 
RODGERS, K. L. 2007. Using the SBAR communication technique to improve nurse-physician phone 
communication: a pilot study. AAACN Viewpoint, 29, 7. 
ROSENFIELD, D., OANDASAN, I. & REEVES, S. 2011. Perceptions versus reality: a qualitative study of 
students’ expectations and experiences of interprofessional education. Medical education, 
45, 471-477. 
ROSENTHAL, M., AUSTIN, Z. & TSUYUKI, R. T. 2010a. Are pharmacists the ultimate barrier to 
pharmacy practice change? Canadian Pharmacists Journal/Revue des Pharmaciens du 
Canada, 143, 37-42. 
ROSENTHAL, M., MAKOWSKY, M. J., TSUYUKI, R. T. & MADILL, H. M. 2010b. Patient’s perspectives on 
team-based care by a clinical pharmacist: case report. The Canadian journal of hospital 
pharmacy, 63, 38. 
ROTZ, M. E., DUEÑAS, G. G., GROVER, A. B., HEADLY, A. & PARVANTA, C. F. 2015. Exploring first-year 
pharmacy and medical students’ experiences during a longitudinal interprofessional 
education program. Currents in Pharmacy Teaching and Learning, 7, 302-311. 
ROUGHEAD, E. E., BARRATT, J. D., RAMSAY, E., PRATT, N., RYAN, P., PECK, R., KILLER, G. & GILBERT, 
A. L. 2009. The Effectiveness of Collaborative Medicine Reviews in Delaying Time to Next 
Hospitalization for Patients With Heart Failure in the Practice SettingCLINICAL 
PERSPECTIVE: Results of a Cohort Study. Circulation: Heart Failure, 2, 424-428. 
ROUGHEAD, E. E., BARRATT, J. D., RAMSAY, E., PRATT, N., RYAN, P., PECK, R., KILLER, G. & GILBERT, 
A. L. 2011. Collaborative home medicines review delays time to next hospitalization for 
warfarin associated bleeding in Australian war veterans. Journal of clinical pharmacy and 
therapeutics, 36, 27-32. 
ROYAL COLLEGE OF GENERAL PRACTITIONERS 2014. An inquiry into patient centred care in the 
21st Century. London: Royal College of General Pratitioners. 
ROYAL PHARMACEUTICAL SOCIETY 2015. Transforming the Pharmacy Workforce in Great Britain: 
The RPS Vision. London: Royal Pharmaceutical Society. 
ROYAL PHARMACEUTICAL SOCIETY 2016. The Right Medicine: Improving Care in Care Homes. 
London: Royal Pharmaceutical Society. 
ROYAL PHARMACEUTICAL SOCIETY 2017a. Medicines, Ethics and Practice, London, Pharmaceutical 
Press. 
ROYAL PHARMACEUTICAL SOCIETY 2017b. Pharmacy Workforce Summit Report: right place, right 
time, right number – positioning the workforce for patients. London: Royal Pharmaceutical 
Society. 
ROYAL PHARMACEUTICAL SOCIETY 2017c. Professional standards for hospital pharmacy services: 
an updated draft for consultation July 2017. London: Royal Pharmaceutical Society. 
ROYAL PHARMACEUTICAL SOCIETY AND ROYAL COLLEGE OF GENERAL PRACTITIONERS 2011. 
Joint Statement - Breaking down the barriers – how community pharmacists and GPs can 
work together to improve patient care London: Royal Pharmaceutical Society and Royal 
College of General Practitioners. 
ROYAL PHARMACEUTICAL SOCIETY WALES 2015. Models of Care for Pharmacy within Primary Care 
Clusters. Cardiff: Royal Pharmaceutical Society. 
Bibliography 
 
 
298 
SALAS, E., DIAZGRANADOS, D., KLEIN, C., BURKE, C. S., STAGL, K. C., GOODWIN, G. F. & HALPIN, S. M. 
2008. Does team training improve team performance? A meta-analysis. Human factors, 50, 
903-933. 
SANTSCHI, V., CHIOLERO, A., COLOSIMO, A. L., PLATT, R. W., TAFFÉ, P., BURNIER, M., BURNAND, B. & 
PARADIS, G. 2014. Improving blood pressure control through pharmacist interventions: a 
meta-analysis of randomized controlled trials. Journal of the American Heart Association, 3, 
e000718. 
SCHINDEL, T. J., YUKSEL, N., BREAULT, R., DANIELS, J., VARNHAGEN, S. & HUGHES, C. A. 2017. 
Perceptions of pharmacists' roles in the era of expanding scopes of practice. Research in 
Social and Administrative Pharmacy, 13, 148-161. 
SCHMIDT, I., B. CLAESSON, C., WESTERHOLM, B., NILSSON, L. G. & SVARSTAD, B. L. 1998. The impact 
of regular multidisciplinary team interventions on psychotropic prescribing in Swedish 
nursing homes. Journal of the American Geriatrics Society, 46, 77-82. 
SELLORS, J., KACZOROWSKI, J., SELLORS, C., DOLOVICH, L., WOODWARD, C., WILLAN, A., GOEREE, R., 
COSBY, R., TRIM, K. & SEBALDT, R. 2003. A randomized controlled trial of a pharmacist 
consultation program for family physicians and their elderly patients. Canadian Medical 
Association Journal, 169, 17-22. 
SEXTON, J. B., THOMAS, E. J. & HELMREICH, R. L. 2000. Error, stress, and teamwork in medicine and 
aviation: cross sectional surveys. BMJ: British Medical Journal, 320, 745-749. 
SHOJANIA, K. G., DUNCAN, B. W., MCDONALD, K. M., WACHTER, R. M. & MARKOWITZ, A. 2001. Making 
health care safer: a critical analysis of patient safety practices. Evid Rep Technol Assess 
(Summ), 43, 668. 
SIMMONS, B., EGAN-LEE, E., WAGNER, S. J., ESDAILE, M., BAKER, L. & REEVES, S. 2011. Assessment 
of interprofessional learning: the design of an interprofessional objective structured clinical 
examination (iOSCE) approach. Journal of interprofessional care, 25, 73-74. 
SIMMONS, B. & WAGNER, S. 2009. Assessment of continuing interprofessional education: Lessons 
learned. Journal of Continuing Education in the Health Professions, 29, 168-171. 
SMITH, F. 1998. Health services research methods in pharmacy: Qualitative interviews. International 
Journal of Pharmacy Practice, 6, 97-108. 
SMITH, J., PICTON, C. & DAYAN, M. 2013. Now or Never: Shaping Pharmacy for the Future. The Report 
of the Commission on future models of care delivered through pharmacy. Royal 
Pharmaceutical Society, London. 
SNELGROVE, S. & HUGHES, D. 2000. Interprofessional relations between doctors and nurses: 
perspectives from South Wales. Journal of Advanced Nursing, 31, 661-667. 
SNYDER, M. E., ZILLICH, A. J., PRIMACK, B. A., RICE, K. R., MCGIVNEY, M. A. S., PRINGLE, J. L. & SMITH, 
R. B. 2010. Exploring successful community pharmacist-physician collaborative working 
relationships using mixed methods. Research in social and administrative pharmacy, 6, 307-
323. 
STEVEN, K., HOWDEN, S., MIRES, G., ROWE, I., LAFFERTY, N., ARNOLD, A. & STRATH, A. 2017. Toward 
interprofessional learning and education: Mapping common outcomes for prequalifying 
healthcare professional programs in the United Kingdom. Medical Teacher, 39, 720-744. 
STEVENS, S. S. 1946. On the theory of scales of measurement. 
STRASSER, D. C., FALCONER, J. A., STEVENS, A. B., UOMOTO, J. M., HERRIN, J., BOWEN, S. E. & 
BURRIDGE, A. B. 2008. Team training and stroke rehabilitation outcomes: a cluster 
randomized trial. Archives of physical medicine and rehabilitation, 89, 10-15. 
SUTER, E., ARNDT, J., ARTHUR, N., PARBOOSINGH, J., TAYLOR, E. & DEUTSCHLANDER, S. 2009. Role 
understanding and effective communication as core competencies for collaborative practice. 
Journal of Interprofessional Care, 23, 41-51. 
SWINGLEHURST, D., GREENHALGH, T., RUSSELL, J. & MYALL, M. 2011. Receptionist input to quality 
and safety in repeat prescribing in UK general practice: ethnographic case study. BMJ: British 
Medical Journal, 343. 
TASHAKKORI, A. & TEDDLIE, C. 2010. Overview of contemporary issues in mixed methods research. 
Sage handbook of mixed methods in social & behavioral research. USA: Sage Publications. 
TAVAKOL, M. & DENNICK, R. 2011. Making sense of Cronbach's alpha. International Journal of Medical 
Education, 2, 53-55. 
TAYLOR, D., YUEN, S., HUNT, L. & EMOND, A. 2012. An interprofessional pediatric prescribing 
workshop. American journal of pharmaceutical education, 76. 
TEDDLIE, C. & YU, F. 2007. Mixed methods sampling: A typology with examples. Journal of mixed 
methods research, 1, 77-100. 
Bibliography 
 
 
299 
THISTLETHWAITE, J. 2012. Interprofessional education: a review of context, learning and the 
research agenda. Medical Education, 46, 58-70. 
THISTLETHWAITE, J. & MORAN, M. 2010. Learning outcomes for interprofessional education (IPE): 
Literature review and synthesis. Journal of interprofessional care, 24, 503-513. 
THOMPSON, C., KINMONTH, A., STEVENS, L., PEVELE, R., STEVENS, A., OSTLER, K., PICKERING, R., 
BAKER, N., HENSON, A. & PREECE, J. 2000a. Effects of a clinical-practice guideline and 
practice-based education on detection and outcome of depression in primary care: 
Hampshire Depression Project randomised controlled trial. The Lancet, 355, 185-191. 
THOMPSON, R. S., RIVARA, F. P., THOMPSON, D. C., BARLOW, W. E., SUGG, N. K., MAIURO, R. D. & 
RUBANOWICE, D. M. 2000b. Identification and management of domestic violence: A 
randomized trial1. American journal of preventive medicine, 19, 253-263. 
TODD, A., COPELAND, A., HUSBAND, A., KASIM, A. & BAMBRA, C. 2015. Access all areas? An area-level 
analysis of accessibility to general practice and community pharmacy services in England by 
urbanity and social deprivation. BMJ: British Medical Journal Open, 5. 
TSUYUKI, R. T., AL HAMARNEH, Y. N., JONES, C. A. & HEMMELGARN, B. R. 2016. The Effectiveness of 
Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled 
RxEACH Trial. Journal of the American College of Cardiology, 67, 2846-2854. 
TSUYUKI, R. T., JOHNSON, J. A., TEO, K. K., SIMPSON, S. H., ACKMAN, M. L., BIGGS, R. S., CAVE, A., 
CHANG, W.-C., DZAVIK, V. & FARRIS, K. B. 2002. A randomized trial of the effect of community 
pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk 
Intervention by Pharmacists (SCRIP). Archives of internal medicine, 162, 1149-1155. 
TUNSTALL-PEDOE, S., RINK, E. & HILTON, S. 2003. Student attitudes to undergraduate 
interprofessional education. Journal of Interprofessional Care, 17, 162-172. 
TURNER III, D. W. 2010. Qualitative interview design: A practical guide for novice investigators. The 
qualitative report, 15, 754. 
VAN, C., MITCHELL, B. & KRASS, I. 2011. General practitioner–pharmacist interactions in professional 
pharmacy services. Journal of Interprofessional Care, 25, 366-372. 
VAN SOEREN, M., DEVLIN-COP, S., MACMILLAN, K., BAKER, L., EGAN-LEE, E. & REEVES, S. 2011. 
Simulated interprofessional education: An analysis of teaching and learning processes. 
Journal of interprofessional care, 25, 434-440. 
VINCENT, C., BATALDEN, P. & DAVIDOFF, F. 2011. Multidisciplinary centres for safety and quality 
improvement: learning from climate change science. BMJ Quality & Safety, 20, i73-i78. 
VOGLER, C., ARNOLDI, J., MOOSE, H. & HINGLE, S. T. 2017. Interprofessional education involving 
medical and pharmacy students during transitions of care. Journal of Interprofessional Care, 
31, 404-406. 
VYGOTSKY, L. 1978. Interaction between learning and development. Readings on the development of 
children, 23, 34-41. 
WAKEFIELD, A., COOKE, S. & BOGGIS, C. 2003. Learning together: use of simulated patients with 
nursing and medical students for breaking bad news. International journal of palliative 
nursing, 9, 32-38. 
WALSHE, K. 2003. Foundation hospitals: a new direction for NHS reform? Journal of the Royal Society 
of Medicine, 96, 106-110. 
WELSH ASSEMBLY GOVERNMENT 2011a. Sustainable social services for Wales: A framework for 
action Cardiff: Welsh Assembly Government. 
WELSH ASSEMBLY GOVERNMENT 2011b. Together for Health: A Five Year Vision for the NHS in 
Wales. Cardiff: Welsh Assembly Government. 
WELSH ASSEMBLY GOVERNMENT 2015. A Planned Primary Care Workforce for Wales; Approach 
and development actions to be taken in support of the plan for a primary care service in 
Wales up to 2018. Cardiff: Welsh Assembly Government. 
WELSH ASSEMBLY GOVERNMENT 2017a. Community pharmacy services in Wales, 2016-17. Cardiff: 
Welsh Assembly Government. 
WELSH ASSEMBLY GOVERNMENT 2017b. GPs in Wales, 2006 - 2016. Cardiff: Welsh Assembly 
Government. 
WHILE, A., SHAH, R. & NATHAN, A. 2005. Interdisciplinary working between community pharmacists 
and community nurses: the views of community pharmacists. Journal of Interprofessional 
Care, 19, 164-170. 
WILD, D., NAWAZ, H., CHAN, W. & KATZ, D. L. 2004. Effects of interdisciplinary rounds on length of 
stay in a telemetry unit. Journal of Public Health Management and Practice, 10, 63-69. 
Bibliography 
 
 
300 
WILES, R., CROW, G., HEATH, S. & CHARLES, V. 2008. The management of confidentiality and 
anonymity in social research. International Journal of Social Research Methodology, 11, 417-
428. 
WILHELMSSON, M., PELLING, S., LUDVIGSSON, J., HAMMAR, M., DAHLGREN, L.-O. & FARESJÖ, T. 
2009. Twenty years experiences of interprofessional education in Linköping – ground-
breaking and sustainable. Journal of Interprofessional Care, 23, 121-133. 
WILSON, A. J., PALMER, L., LEVETT-JONES, T., GILLIGAN, C. & OUTRAM, S. 2016. Interprofessional 
collaborative practice for medication safety: Nursing, pharmacy, and medical graduates’ 
experiences and perspectives. Journal of Interprofessional Care, 30, 649-654. 
WILSON, H. & BARBER, N. 2013. Review of NHS pharmaceutical care of patients in the community in 
Scotland. Scottish Government Edinburgh. 
WILSON, S., MARKS, R., COLLINS, N., WARNER, B. & FRICK, L. 2004. Benefits of multidisciplinary case 
conferencing using audiovisual compared with telephone communication: a randomized 
controlled trial. Journal of telemedicine and telecare, 10, 351-354. 
WOOLLARD, M. 2006. The role of the paramedic practitioner in the UK. Australasian Journal of 
Paramedicine, 4. 
WORLD HEALTH ORGANISATION 2010. Framework for action on interprofessional education and 
collaborative practice. Geneva: World Health Organisation. 
WORLD HEALTH ORGANISATION 2013. Transforming and scaling up health professionals' education 
and training. Geneva: World Health Organisation. 
XYRICHIS, A. & LOWTON, K. 2008. What fosters or prevents interprofessional teamworking in 
primary and community care? A literature review. International journal of nursing studies, 
45, 140-153. 
YOUNG, A. S., CHINMAN, M., FORQUER, S. L., KNIGHT, E. L., VOGEL, H., MILLER, A., ROWE, M. & MINTZ, 
J. 2005. Use of a consumer-led intervention to improve provider competencies. Psychiatric 
Services, 56, 967-975. 
ZWARENSTEIN, M., ATKINS, J., BARR, H., HAMMICK, M., KOPPEL, I. & REEVES, S. 1999. A systematic 
review of interprofessional education. Journal of Interprofessional Care, 13, 417-424. 
ZWARENSTEIN, M., REEVES, S. & PERRIER, L. 2005. Effectiveness of pre-licensure interprofessional 
education and post-licensure collaborative interventions. Journal of Interprofessional Care, 
19, 148-165. 
 
  
Appendices 
 
 
301 
 
 
 
 
 
 
Appendices 
 
Appendices 
 
 
302 
Appendix A – Methods for literature searching 
The aims of literature searching throughout this thesis were to identify and describe 
existing literature concerning collaboration and interprofessional working relationships 
between pharmacists and other healthcare professionals to identify themes in the current 
literature and areas which are under addressed. In addition, further evaluation was done to 
determine methods used which aim to improve interprofessional working, with a particular 
focus on interprofessional education. 
 
A systematic approach was taken to searching and identifying the literature, however, due 
to the heterogeneity of the literature in the area, this approach also needed to be iterative 
and flexible. The approach taken draws on some of the principles of ‘realist review’ (Pawson 
et al., 2005) which include:  
1. Being flexible and iterative in approach and strategy, with refinement throughout 
the process   
2. The use of snowballing to identify further literature – pursuing references of 
references – as well as conventional database searches with keywords   
3. Appraising the quality of the studies, but with recognition that this cannot be 
standardised due to the disparate nature of the literature. Instead each study is 
assessed for ‘fitness for purpose’, relevance and rigour (Barbour and Barbour, 
2003) 
4. Data extraction takes the form of information assimilation through note-taking 
rather than the use of a standardised data extraction form  
 
A list of keywords was produced based on prior knowledge of and reading in the subject 
area. The thesaurus function in OVID was also utilised across the various databases to 
identify any further keyword terms. When determining the interprofessional working 
between pharmacists and HCPs and the interprofessional education used the following 
keywords were entered: interprofessional OR multiprofessional OR multidisciplinary OR 
interdisciplinary OR inter-professional OR multi-professional. These were combined with 
pharmac$ and then also collaborat$ OR cooperat$ OR teamwork$ OR integrat$ OR 
partnership$ OR relationship$ OR network$ OR interaction, when determining 
pharmacists’ interprofessional relationships, and combined with education OR learning 
when exploring educational methods.  
 
All keywords were searched in the abstract, title, keyword and subject heading search fields. 
The following databases were searched: EMBASE, MEDLINE, Scopus, Science Direct, 
International Pharmaceutical Abstracts, British Nursing Index and PyschINFO and Health 
Management Information Consortium (HMIC). These searches were limited to the English 
language only.  
 
The following inclusion criteria were applied when exploring pharmacist-HCP 
interprofessional working in practice and thus papers not covering at least one of these 
areas were excluded from the review:  
• Pharmacist or HCP views on collaboration or working relations   
• The nature or type of collaboration or interaction between the two professions  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• The extent or measure of collaboration or interaction between the two professions 
  
• The process of pharmacist-HCP collaboration (including barriers, facilitators and 
strategies)   
• The outcomes of pharmacist-HCP collaboration 
 
Although the PhD did not aim to measure clinical outcomes of collaboration, it was felt that 
the literature in the area should also be included to provide background and a more 
complete picture of the overall collaboration process. 
 
In addition, the following inclusion criteria were applied when exploring pharmacist based 
interprofessional education and thus papers not covering at least one of these areas were 
excluded from the review:  
• Pharmacist or HCP (including student) views on interprofessional education 
sessions 
• The nature or type of interprofessional education session between pharmacists 
and other HCPs, including descriptive terms around the session 
• Analysis of the IPE sessions or the outcomes achieved/aimed to be achieved 
• The benefits, facilitators and barriers to conducting IPE 
 
Data extraction was conducted inductively and took the form of information assimilation 
through note-taking. Following the ‘realist review’ approach, which enables flexibility in 
approach and strategy, the researcher drew on existing knowledge and experience of the 
literature area, in order to verify the search strategy and the results produced. A 
standardised data extraction form was not employed, due to heterogeneity of the studies. 
 
This method was augmented with manual searching of references in the reviewed articles 
and additional searching on government, department of health and professional governing 
body websites to determine key policy documents in the area.  
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Appendix B – Ethical approval 
Ethical approval for chapter 3 – The landscape of IPE across schools of pharmacy 
This approval allowed an online questionnaire to explore this area.  
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Ethical approval for chapters 4, 5 and 6 – Who do pharmacists within Wales work 
with? 
This approval allowed a mixed methods approach (both questionnaires and interviews) to 
be used explore this area. 
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Appendix C – Landscape of IPE information sheet 
 
What is the current landscape of interprofessional education within schools of pharmacy? 
Participant Information Sheet 
As an academic member of staff within a UK school of pharmacy you have been invited to take part 
in a short online questionnaire surrounding the topic of interprofessional education (IPE). Before 
taking part please read the following information about the study. 
What is the purpose of the study? 
The purpose of this study is to identify the current landscape of IPE across schools of pharmacy in 
the UK that, to our knowledge, is not currently available within the literature. 
Why have I been contacted for this study? 
You have been contacted, alongside academic colleagues from schools of pharmacy across the UK, as 
you have been identified by myself or my supervisors as someone who has an interest in IPE, or are 
involved in the development or delivery of IPE sessions.If there is another colleague within your 
University who would be more suitable to take part in this study please could you provide me with 
his/her contact details and I will contact them directly regarding their participation. 
Who are the researchers? 
The questionnaire has been produced by myself, Andy Jenkins, a second year PhD student, under the 
supervision of Dr Mat Smith, Dr Louise Hughes and Dr Efi Mantzourani. This study has been approved 
by the Cardiff School of Pharmacy and Pharmaceutical Sciences Research Ethics Committee. 
How will the research take place? 
If you consent you will be transferred to the questionnaire that should take no longer than 15 minutes 
of your time. Questions will be asked regarding the current practice of IPE within your school of 
pharmacy. All responses are confidential and anonymous. Participation in this study is entirely 
optional and you do not have to answer all questions if you do not wish.  
You can participate by following the link below: http://tinyurl.com/IPE-PharmSchoolQuestionnaire 
What are the potential benefits? 
The results gained from each participating school will be collated and disseminated at the request of 
participants. This will provide each participant with valuable information about the landscape of IPE 
across the UK and Australia. 
Do I have to take part? 
Participation in this study is entirely optional and you do not have to answer all questions if you do not 
wish. Any additional information you provide is welcome. 
Who can I contact for more information? 
For more information please contact myself Andy at JenkinsAI1@cardiff.ac.uk. If further information is 
required the project supervisors can also be contacted; Dr Mat Smith (SmtihMW1@cardiff.ac.uk), Dr 
Louise Hughes (HughesML@cardiff.ac.uk), Dr Efi Mantzourani (MantzouraniE1@cardiff.ac.uk). Please 
note that contacting the investigator does not commit you to participating. 
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Appendix D - Landscape of IPE questionnaire 
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Appendix E – Community questionnaire 
The aim of the study is to investigate the day-to-day interaction between pharmacists and members 
of the healthcare team.  By completing the questionnaire you will be helping teaching staff in the 
School of Pharmacy and Pharmaceutical Sciences at Cardiff University to gain valuable information.  
This will help to inform the School’s future undergraduate and postgraduate education provision. 
The questions relate to your individual experiences in this pharmacy specifically. We are trying to 
capture what is happening on a regular basis in the pharmacy environment; therefore, if you work 
within this pharmacy less than 2 days a week, we would be grateful if you could pass this 
questionnaire to the regular pharmacist to complete. 
This questionnaire should take no longer than 5 minutes to complete.Please remember that all 
replies are completely confidential and a freepost envelope is provided to return your 
questionnaire.    
Section A –About you and this pharmacy 
We would like to obtain some background information that will assist us in contextualising your 
answers. For this section, please answer related to the pharmacy you are working at today (referred 
to as “this” pharmacy in the questions).Please tick one answer for each of the following questions 
(unless stated otherwise): 
 
A1) Which health board is this pharmacy associated with?  
Abertawe Bro Morgannwg  ☐      Aneurin Bevan ☐   Betsi Cadwaladr ☐    
Cardiff & Vale ☐   Cwm Taf ☐          Hywel Dda ☐      Powys ☐ 
 
A2) How would you describe the location of this pharmacy? 
City/Town high street ☐    City/Town residential suburbs ☐     
Out-of-town supermarket ☐ Out-of-town retail park ☐     
Rural/Village ☐    Other ☐ (Please state) ___________________________________ 
 
A3) How would you describe your position in this pharmacy? 
Locum ☐    Manager ☐     Regular pharmacist ☐    Owner ☐    
Relief pharmacist ☐  Other ☐ (Please state) __________________________________________                                                                                                      
 
A4) How many branches does this pharmacy business have? 
1 ☐  2-3 ☐  4-6 ☐        7-9 ☐    More than 10 ☐ 
 
A5) Is this pharmacy directly attached to the following healthcare providers? (Please tick more 
than one if necessary) 
GP surgery ☐     Opticians ☐     Dentists ☐ 
           Other ☐ (Please State) _________________________________________ 
 
A6) How many GP surgeries does this pharmacy regularly work with in a typical week? 
1 ☐           2-5 ☐    6-8 ☐    More than 8 ☐ 
 
A7) How many staff work within this pharmacy’s dispensary daily (excluding yourself):         
0 ☐   1 ☐   2 ☐  3 ☐  4 ☐   5 ☐      
More than 5 ☐ 
 
A8) Which of the following services do you typically provide when working in this pharmacy? 
(Please tick more than one if necessary) 
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Medicines Use Review (MUR) ☐ Discharge Medicines Review (DMR) ☐  
Common Ailment Scheme ☐ 
Other advanced/enhanced services ☐ (please state) 
________________________________________________ 
Section B –Members of the healthcare team 
 
In this section we are collecting information about members of the healthcare team with whom you 
could be interacting, as part of your professional life. Please tick a box for each line of the table, 
which best describes the amount of direct personal interaction (either face to face, by phone or by 
email) you have with that healthcare team member.  
 
If a healthcare team member is not listed here, please fill in the ‘other’ section and state the 
frequency of the interaction. 
 
Member of healthcare 
team 
At least 
once a 
DAY 
At least 
once a 
WEEK 
At least 
once a 
MONTH 
At least 
once a 
YEAR 
Less 
frequently 
Never 
Accredited checking 
technician (ACT) 
      
Care home staff       
Dentist       
Dietician        
Dispenser/Technician       
Doctor - Hospital       
General practitioner 
(GP) 
      
GP receptionist       
GP practice manager       
Health visitor       
Medicines counter/ 
Healthcare assistant 
      
Midwife        
Nurse - Community       
Nurse - Hospital       
Occupational therapist       
Optician       
Paramedic       
Pharmacist - Hospital       
Pharmacist - Primary 
care 
      
Physiotherapist       
Podiatrist       
Pre-registration 
Pharmacist 
      
Radiographer       
Social worker       
Speech and language 
therapist 
      
Vet       
Other (please list below) 
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If you have any additional comments you would like to make relating to which healthcare 
colleagues you work with please fill in the box below. 
 
 
Thank you very much for your time in completing this questionnaire. 
 
 
Please use the freepost envelope provided to submit your response to Andy Jenkins at: 
 
Pharmacy Education and Practice, Cardiff School of Pharmacy and Pharmaceutical Sciences, Redwood 
Building, King Edward VII Avenue, Cardiff, CF10 3NB 
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Appendix F – Community questionnaire cover letter 
Who do pharmacists work with? 
Dear Pharmacist, 
 
I would like to invite you to take part in a study that aims to investigate the day-to-day interaction 
between pharmacists and members of the healthcare team.   
Pharmacists working in all community pharmacies throughout Wales are being invited to take part 
and instructions on completing the study are detailed within the questionnaire. 
 
The questionnaire is voluntary, however, I would greatly appreciate it if you could take no longer 
than 5 minutes out of your time to share your views with me.  
 
The questions relate to your individual experiences in this pharmacy specifically.  If you work within 
this pharmacy less than 2 days a week, please pass onto another pharmacist to complete. 
By completing the questionnaire you will be helping teaching staff in the School of Pharmacy and 
Pharmaceutical Sciences at Cardiff University to gain valuable information.  This will help to inform 
the School’s future undergraduate and postgraduate education provision. 
 
Your responses will be completely confidential. The code number specified on each questionnaire 
is to allow me to send reminders to those pharmacies who have not responded. Information 
identifying the respondent will not be disclosed under any circumstances.   
 
If you have any questions or comments about this study, feel free to contact myself, or my 
supervisors, using the contact details provided. 
 
Your responses will be of great importance to my research and I very much look forward to receiving 
your completed questionnaire, which can be returned using the freepost envelope enclosed by 20th 
February. 
 
Thank you very much for your time in completing the questionnaire. 
 
Yours Sincerely, 
 
     
 
 
 
 
 
 
  
Dr Louise Hughes 
Tel: 02920876432 
HughesML@cardiff.ac.uk 
Dr Efi Mantzourani 
Tel: 02920870452 
MantzouraniE1@cardiff.ac.uk 
Dr Mat Smith 
Tel: 02920879286 
SmithMW1@cardiff.ac.uk 
Andy Jenkins 
Tel: 02920870516 
JenkinsAI1@cardiff.ac.uk 
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Appendix G – Community interviews cover letter 
Who do pharmacists work with? 
 
Dear Pharmacist, 
 
As a practicing pharmacist in Wales you have been invited to take part in a study surrounding the 
interactions of pharmacists and other healthcare professionals in practice.  
 
Attached is a further information leaflet; please take the time to read through the information before 
deciding whether or not you wish to participate.  
 
This study is a follow up of a recent project sent to pharmacists across Wales that aimed to determine 
the frequency of interactions between pharmacists and healthcare professionals. In this study would 
now like to understand the nature of these interactions. 
 
If you wish to take part please contact Lauren, Andy or one of the research team below and we will 
arrange a mutually convenient time and location to conduct a one-on-one audio-recorded interview. 
Your responses will be completely confidential.  
 
By completing the questionnaire you will be helping teaching staff in the School of Pharmacy and 
Pharmaceutical Sciences at Cardiff University to gain valuable information.  This will help to inform 
the School’s future undergraduate and postgraduate education provision. 
 
If you have any questions or comments about this study, feel free to contact myself, or my 
supervisors, using the contact details provided. 
 
Your participation will be of great importance to my research and I very much look forward to 
receiving your response, which can be done through contacting any of the research team below. 
 
Thank you very much for your time, hope to hear from you soon. 
 
Yours Sincerely, 
 
     
  
Lauren Akers 
AkersL@cardiff.ac.uk 
Dr Mat Smith 
Tel: 029208 79286 
SmithMW1@cardiff.ac.uk 
Andy Jenkins 
Tel: 029225 10138 
JenkinsAI1@cardiff.ac.uk 
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Appendix H - Community interviews information sheet 
Who do Pharmacists work with? Participant Information Sheet 
 
As a practicing pharmacist in Wales you have been invited to take part in a study surrounding the 
interactions of pharmacists and other healthcare professionals in practice. Please take the time to 
read through the information before deciding whether or not you wish to participate.  
 
What is the purpose of the study? 
This study is a follow up of a recent survey sent to pharmacists across Wales that aimed to determine 
the frequency of interactions between pharmacists and healthcare professionals. In this study would 
now like to understand the nature of these interactions. 
 
Who are the researchers? 
This study is to be undertaken by a final year MPharm student Lauren Akers under the supervision 
of Andy Jenkins, a final year PhD student. This study has been approved by the Cardiff School of 
Pharmacy and Pharmaceutical Sciences Research Ethics Committee. 
Why have I been invited to participate in this study? 
You have been invited to take part because you are a practicing pharmacist in Wales and are 
therefore knowledgeable on the interprofessional interactions that take place in practice 
 
How will the research take place? 
If you consent, you will be invited to take part in a one-to-one interview which will be audio-recorded.   
The interview will be conducted in private and will start by clarifying some initial demographic 
details, ie the health board you work in and your role within the pharmacy. The interview will then 
progress to determine your interactions with other healthcare professionals and the reasons behind 
these interactions. Please be aware that this interview is about your experiences in general and you 
will not be asked to divulge any patient/healthcare member specific information. The interview 
should last approximately … minutes.  
 
Do I have to take part? 
The decision to consent lies entirely with you. If you wish to take part we will arrange a mutually 
convenient time and location. Please sign the two enclosed copies of the consent form and bring them 
along to the arranged interview. One copy of the form is for you to keep. The research team will retain 
the other copy. You are free to withdraw from the study at any time without giving a reason.  
 
How will the information collected be used? 
Confidentiality will be ensured at all stages of the research process. The transcripts will be 
anonymised and consent forms, transcripts, questionnaires and tapes will be kept securely in the 
School of Pharmacy & Pharmaceutical Sciences. Any information retained on university computers 
will contain a reference number in place of your personal data. Any personal details that are collected 
during the study will only be seen by the research team and will not be kept for any longer than is 
needed to complete this study. It is anticipated that this will be no longer than 12 months. 
 
This research could help the School in understanding the relationships pharmacists have in practice 
which could help inform the undergraduate and postgraduate pharmacy programmes in the future. 
 
Who to contact to participate or for more information? 
If you are happy to take part in the study or would like further information please contact Lauren, 
Andy or any member of the research team via the details given below. Please note that contacting the 
investigator does not commit you to participating. 
 
Research Student: Lauren Akers (AkersL@cardiff.ac.uk) 
Cardiff University project supervisors: Andy Jenkins (JenkinsAI1@cardiff.ac.uk), Dr Mat Smith 
(SmtihMW1@cardiff.ac.uk), Dr Louise Hughes (HughesML@cardiff.ac.uk), Dr Efi Mantzourani 
(MantzouraniE1@cardiff.ac.uk)  
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Appendix I - Community interviews consent forms 
 
Consent Form  
 
Please read the following statements and initial the boxes next to the statements for which 
you give consent.  
Please also sign and date the form below. 
 
1. I confirm that I have read and understood the participant information sheet 
and have had the opportunity to ask any questions.  
 
2. I understand that my participation is voluntary and I have the right to 
withdraw at anytime.  
 
3. I understand that by signing the form I agree to give consent to participate 
within the study. 
 
4. I give my consent for the interview to be audio-recorded.  
 
5. I agree to be contacted by the researchers if clarification is needed regarding 
any points discussed during the interview. 
 
6. I understand that verbatim quotes may be used in reports and if so, they will be 
anonymised.  
 
 
Participant details 
Name (please print): 
Telephone Number:    Email: 
Signature:      Date: 
 
Name of Researcher: 
Signature of Researcher:                      Date: 
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Appendix J - Community interview schedule  
Aim: To explore the reasons behind interprofessional interactions that take place between 
pharmacists and healthcare professionals they frequently interact with. 
 
Main topics  
These are the main topics that the questions below are focused around, from these use prompts to 
gain further expanded information 
Perception of interprofessional education and interactions 
Who do they interact with and how often? 
What are the interactions about, what was their purpose?  
How were the interactions undertaken? 
Barriers and facilitators to interactions 
Perceived benefits of IP interaction 
 
Intro  
ENSURE TWO COPIES OF CONSENT FORMS ARE SIGNED – Make sure they are happy to be recorded 
from the consent form. Confirmation of anonymity and confidentiality. 
Personal introduction and explanation of the study. Explanation about interview. 
 
“I am going to start with some general questions relating to your career as a pharmacist then I will 
follow on with a  card-sorting activity focusing on interprofessional interactions and  finish with some 
short questions relating to your personal experiences with other healthcare professionals in THIS 
pharmacy. Please remember that these are your opinions, there are no right or wrong answers. The 
interview should take approximately 20 minutes in total, I may make some notes throughout but these 
are for my own benefit and please feel free to ask any questions if you need to. If you need to stop at 
any time to talk to a customer that is also fine I will pause and restart afterwards.”  
 
General questions 
Could you first of all tell me a bit about your background as a pharmacist?  
a) Which university did you study at?  
b) When did you qualify?  
c) How long have you worked in this branch?  
d) Do you work in any other pharmacies? (Reiterate that answers should be related to                             
this pharmacy   
e) Have you always worked in community pharmacy? 
 
Opening questions 
Could you explain what the term interprofessional interaction means to you?  
What do you perceive as the benefits of interprofessional interactions to yourself and the patient? 
 
Reflective card activity 
‘Could you now sort in order those who you interact with the most frequently to the least? These 
healthcare professionals have been chosen from the previous study of which pharmacists interact with 
based on experiences in THIS pharmacy’ 
Is it okay for me to take a photo of this order for my data collection?  
‘Hopefully that has started you to think about the various interactions which can occur within 
pharmacy. I’d like to look at a few of these in more detail.’  
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Questions related to card activity 
GP 
I have noted that you have put GP as number ….. on your list; could you tell me a bit about a typical 
interaction with a GP? 
 
What would you say are the main reasons for interactions with GPs? 
How did this occur? 
How frequently would you interact with a GP? 
Any barriers? 
Anything which could make these interactions easier? 
Do these typical interactions benefit your learning?   
Is there a particular example of a GP interaction that you can think of?  
Could you elaborate on that? When/How etc.   
Have you had any other interactions with any other types of doctors other than GPs? 
Are these similar to the interactions you have already discussed?’  
 
COMMUNITY NURSE 
Another one of your interactions I would like to explore is with Community Nurses, could you tell 
me a bit about a typical interaction with this professional? 
What would you say are the main reasons for interactions with a community nurse? 
How did this happen? 
How frequently would you interact with a community nurse? 
Was there anything which makes these interactions more difficult? 
Anything which could make these interactions easier? 
Do these typical interactions benefit your learning?  
Is there a particular example of a community nurse interaction that you can think of?  
Could you elaborate on that?  
Have you had any other interactions with any other types of nurses? 
Are these similar to the interactions you have already discussed?’  
Use similar prompts as questions above to find out more 
 
DENTIST 
The final healthcare professional I would like to ask about is a Dentist, could you tell me a bit about 
a typical interaction with this professional? 
What would you say are the main reasons for interactions with a dentist? 
How did this occur? 
Are interactions with dentists a frequent? 
Any barriers? 
Anything which could make these interactions easier? 
Do these typically benefit your learning?  
Is there a particular example of a dentist interaction that you can think of?  
Could you elaborate on that?  
 
If the participant ranks another healthcare professional in the card-sorting activing within 
their top three, explore this more using the same questions and prompts as above.  
 
Final questions 
Do you have anything you want to add about any other healthcare professionals on this list that you 
may feel are important? 
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 Have you had any previous training for interprofessional work? This could be at undergraduate 
level or from courses you have taken  
 
 What do you think would be a useful IPE session to add into the undergraduate course?  
They may not have done IPE before, so just say ‘from what you know about IPE what do you think 
would be useful?  
 
When was the last time you learnt something new from another HCP?  
a) What was it?  
b) Was it by chance or organised?  
c) How have you applied this learning?  
 
 In terms of quantity of your interactions with our professions, do you feel this is too much, too little 
or just right? – Can you explain why you think this?  
a) Would this increased interaction benefit you?  
b) Is there anything specific at the moment that you would like to learn from another?  
 
 If you could add in one IPE session into the undergraduate curriculum, what would it be? 
Could you explain why this is your choice? 
 
GENERAL PROMPTS 
Can you give me another example of this?  
Could you elaborate on that?  
Is there anything else you would like to add onto this?  
Could you expand a bit more on that?  
Is that everything you would like to comment on this subject?  
Could you explain that a bit further?   
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Appendix K – Community questionnaire free text comments 
Section C of the questionnaire comprised a free text comments box for respondents to add any 
further information they thought appropriate to the study. A total of 25 of the 443 respondents made 
comments which were transcribed and inductively analysed producing six main themes and 
associated subthemes as shown in Table Appendix K.1. 
 
Table Appendix K.1. Themes/subthemes produced from free text qualitative responses through 
inductive, thematic analysis 
Theme Subtheme 
1. Respondent’s relationship 
with healthcare professionals 
1.1. Respondent has a close relationship with HCP 
1.2. Respondent doesn’t have a close relationship with HCP 
2. Perceived benefits to 
interprofessional interactions 
2.1. Benefits to the patient 
2.2. Benefits to the pharmacist and other HCPs 
3. Perceived barriers to 
interprofessional interactions 
3.1. HCPs have a lack of understanding of pharmacy role 
3.2. There is a lack of respect for the pharmacy team 
3.3. Time constraints 
3.4. Approachability of HCPs  
3.5. Not being within close proximity to HCPs 
3.6. GP practices worry about having a close relationship with 
one pharmacy 
3.7. Pharmacists don’t network with other HCPs 
3.8. Difficult to know which healthcare professional to contact 
4. Perceived facilitators to 
interprofessional interactions 
4.1. Being within close proximity to other HCPs 
4.2. Utilising private consultation room for other HCPs 
4.3. Providing collaborative service 
4.4. Developing relationships in other pharmacy roles 
5. Methods of improving 
interprofessional interactions 
5.1. Participating in group meeting with GP practices 
5.2. Having a way of emailing prescribers 
6. Reasons for, and frequency 
of, respondents interactions 
with specific HCPs 
See Appendix 5.2 for more detail 
 
1. Participants relationships with HCPs 
1.1. Participant has a close relationship with HCP 
A number of participants commented on how they had a close relationship with other HCPs (n=5), 
‘we have a very close and co-operative relationship with the community nursing teams’ (P644), ‘The 
cooperation is very satisfactory, I find them very helpful and open-minded.’ 126. ‘We work in a rural 
community and as part of an integrated healthcare team.’ 267 
1.2. Participant doesn’t have a close relationship with HCP 
However, P224 believed that their interprofessional relationship with GPs has broken down 
somewhat, saying there is ‘now less contact with new GPs, used to be a far closer relationship’ and 
participant 178 made a general comment about their lack of interactions, ‘hardly ever anyone else 
unless there are specific queries with Rx (eg vet and dentists)’. 
 
2. Perceived benefits to interprofessional interactions 
2.1. Benefits to the patient 
Some participants (n=3) commented on the benefits of interprofessional interactions, P679 believed 
that by offering ‘a more holistic healthcare service’ this ‘improves patient outcomes’, whereas P67 
found that these relationships benefit everyone; ‘I think (and find) that better relationships benefit 
everyone’. This was reiterated by P199 who stated that a ‘very close working relationship with local 
surgery is essential for optimal healthcare provision and safety of patients’.  
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2.2. Benefits to the pharmacist and other HCPs 
P85 summarised these points, stating that ‘when professionals work together it’s amazing how much 
you can learn and benefit from each other so ultimately the customer/patient benefits which is surely 
what we aim for.’  
 
3. Perceived barriers to interprofessional interactions 
Eight different barriers to interprofessional interactions emerged from the comments left by 
participants. These have been listed below: 
3.1. HCPs have a lack of understanding of pharmacy role 
This was summed up by P169; ‘There is a lack of understanding within the wider primary healthcare 
team and hospital pharmacy of the role of community pharmacy and the legalities within which we 
operate. We are still viewed by many as a ‘shopkeeper’, and our use as an information resource is 
underutilised’. 
3.2. There is a lack of respect for the pharmacy team 
P375 stated; ‘it still amazes me the lack of respect for pharmacy team, from the GP surgery staff, 
especially when we have had to chase lost prescriptions and errors which they are responsible for’. P26 
also felt that there was a lack of respect and doctors didn’t take the pharmacists advice seriously; 
‘GPs don’t value pharmacists’ opinion!! I raised an overdose with a GP last week and it was dismissed by 
him as came from specialist and on further investigation it was an overdose and 5 times as much as 
recommended.’  
3.3. Time constraints  
It was felt by P67 that time constraints were the greatest barrier to interprofessional interactions; ‘I 
would love to build stronger relationships with the GPs in the local surgeries, time constraints are the 
greatest barrier’. In addition, P375 also stated how having poor interprofessional interactions can 
lead to wasted time ‘as we have had to chase lost prescriptions and errors which they are responsible 
for. This usually takes many phone calls on our behalf and many man power hours ’ P375. 
3.4. Approachability of HCPs  
Here P174 stated that ‘some other healthcare professionals more approachable than others’. 
3.5. Not being within close proximity to HCP 
The proximity to HCPs was seen to impact pharmacists’ interprofessional relationships, with 
participants commenting how not being located alongside HCPs can have a detrimental impact on 
their interprofessional interactions. This has also been touched upon as a facilitator as those co-
located alongside HCPs, i.e. within GP practices, recognised the positive influence this had on their 
HCP interactions. ‘This type of pharmacy (ie within a health centre) allows us to interact very well with 
the GPs and surgery staff. It is noticeable that we do not have as good a relationship with other practices 
in the area’ P146. ‘We are in a fortunate position in same building as GP surgery so have many 
interactions with healthcare professionals and a good working relationship but have worked in other 
places that are more isolated in this regard’ P478. 
3.6. GP practices worry about having a close relationship with one pharmacy 
This barrier was stated by one participant, P67, believing that ‘surgeries (GPs) worry about having an 
inappropriately close relationship with one contractor’.  
3.7. Pharmacists don’t network with other HCPs 
Participant 679 believes that ‘unfortunately the majority of community pharmacists are not willing to 
invest in their business and use free time to network with their professional colleagues’. 
3.8. Difficult to know which healthcare professional to contact 
When participants interact with other HCPs it is important to know who is best to contact, something 
that P264 found challenging stating that it’s ‘difficult to identify hospital prescribers from the 
information on the prescription form’. 
 
4. Perceived facilitators to interprofessional interactions 
Within this theme four facilitators to interprofessional interactions were described by participants: 
4.1. Being in close proximity to other HCPs  
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This was previously touched upon in section 3.4.3.5 as this was seen by participants as a facilitator 
but also a barrier for pharmacists if they are far away from other HCPs.  In addition to that mentioned 
in section 3.4.4.3.5, P644 believes that when they move into a new healthcare centre they will engage 
more with other HCPs; ‘In the next 12 months the pharmacy will be moving to a new site within a newly 
built medical centre. I plan to take on a pre-reg pharmacist and an Accredited Checking Technician and 
I plan to work closely with the practice manager’. 
4.2. Utilising private consultation room for other healthcare professionals  
Participant 679 believes that by utilising pharmacy space for other HCPs this can also help provide 
more holistic patient care; ‘we have a private consultation room and lease it to – a podiatrist, an 
osteopath, a holistic therapist. Luckily we have the space, but at a cost and investment. Hopefully we are 
able to offer a more holistic healthcare service that improves patient outcomes’. 
4.3. Providing collaborative services 
By providing certain services this can lead to interactions with other specific healthcare 
professionals. P371 has frequent interactions with hospital staff due to their services; ‘we provide all 
medication for a private hospital so this is why we have such frequent contact with hospital staff’. P178 
also has interactions with ‘drug workers because we supervised clients’. 
4.4. Developing relationships in other pharmacy roles 
One participant, P61, has been able to develop their relationships with the local GP surgery as they 
work within it as a primary care pharmacist; ‘I work as a primary care pharmacist one day a week in 
the surgery next door and have a good relationship with all the staff -  receptionists, nurses, GPs, 
pharmacy techs’ P61. This once again links to both sections 3.4.4.3.5 and 3.4.4.4.1, as being with the 
health centre in close proximity to other HCPs has enabled the participant to develop relationships 
over being just within the community pharmacy.  
 
5. Methods of improving interprofessional interactions 
Within this theme two different methods of improving interprofessional interactions were 
recognised by participants: 
5.1. Participating in group meeting with GP practices 
Participant 67 said that group meetings with GP practices could help build relationships and 
potentially stop close GPs thinking they have an inappropriately close relationship with one 
pharmacy; ‘maybe a group meeting with all local contractors needs to be the answer?’. 
5.2. Having a way of emailing prescribers 
Another method to help ease interprofesional communication is having a method in which you the 
pharmacist can email prescribers; ‘could do with a secure email system (NHS Wales email is not 
encrypted) to communicate more easily with prescribers for non-urgent matters’ P265. 
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6. Reasons for, and frequency of, participants interactions with specific HCPs 
In addition, a number of participants made specific comments around their interactions with 
individual professions and have been shown in Table Appendix K.2. 
 
Table Appendix K.2. Reasons for, and frequency of, participants interactions with specific HCPs  
Profession ID Comment 
Pre-reg 
student 
338 ‘We have a pre-reg pharmacist starting in July so from then it will be daily 
contact’ 
473 ‘Usually have a pre-registration student, don’t have one this year, have 
community placements for pre-reg hospital students’ 
(Plus ACT) 644 ‘Will employ ACT and prereg when in new medical centre’ 
GPs and 
surgery staff 
 
 
(Plus hospital 
pharmacists) 
375 ‘we have had to chase lost prescriptions and errors which they are 
responsible for’ 
253 ‘In close communication with surgery staff daily due to stock shortages!’ 
178 ‘Majority we have contact with are the receptionists at GP surgeries if we 
have queries with Rx’ 
398 ‘Need to contact GPs/hospital pharmacists regularly to retrieve missing 
information when patients discharged from hospital to community and 
rely on MDS’ 
 
Hospital staff 
371 ‘We provide all medication for a private hospital so this is why we have 
such frequent contact with hospital staff’ 
 
(Plus Opticians 
and Dentists) 
503 ‘The majority of instances where I speak to hospital prescribers, 
opticians, dentists, it’s because their prescriptions are illegible or 
missing information’ 
Drug and 
alcohol tem 
178 ‘Drug workers because we supervised clients’ 
Primary care 
pharmacists 
178 ‘Occasional communication with PCT pharmacists’ 
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Appendix L – Publication within the Journal of Interprofessional Care (abstract) 
As the abstract to this publication has open access this has been reproduced below. The full 
publication can be accessed through the Journal of Interprofessional Care:  
 
JENKINS, A. I., HUGHES, M. L., MANTZOURANI, E. & SMITH, M. W. 2016. Too far away to work 
with each other: Does location impact on pharmacists' perceptions of interprofessional 
interactions? Journal of Interprofessional Care, 30, 678-81. 
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Appendix M – Hospital questionnaire 
Who do pharmacists work with? 
 
The aim of this study is to find out which members of the healthcare team do pharmacists, like you, 
work with on a day-to-day basis.   
 
By completing the questionnaire you will be helping teaching staff in the School of Pharmacy and 
Pharmaceutical Sciences at Cardiff University to gain valuable information on the interprofessional 
interactions that take place when delivering pharmacy services. 
 
The questions relate to your individual experiences in this hospital specifically. We are trying to 
capture the frequency of interprofessional interaction between pharmacists and healthcare 
professionals on a regular basis; therefore, if you work within this hospital less than 2 days a week, 
we would be grateful if you could pass this questionnaire to another pharmacist to complete.  
 
This questionnaire should take no longer than 5 minutes to complete. Please remember that all 
replies are completely confidential and to return your questionnaire to the ‘project champion’ ie. 
the pharmacist responsible for the questionnaire within your hospital, or to a designated location 
specified by the ‘project champion’. 
 
Section A – About you and this hospital  
We would like to obtain some background information that will assist us in contextualising your 
answers. For this section, please answer related to the hospital you are working at today (referred to 
as “this” hospital in the questions). 
Please tick one answer for each of the following questions unless stated otherwise: 
A1) With which health board is this hospital associated?  
Abertawe Bro Morgannwg  ☐       Aneurin Bevan ☐     Betsi Cadwaladr ☐     Cardiff & Vale ☐
  Cwm Taf ☐           Hywel Dda ☐              Powys ☐              Velindre ☐ 
 
A2) How many beds are in this hospital? 
Fewer than 100 ☐        100 to 299 ☐           300 to 499 ☐       500 to 700 ☐          More than 700 ☐ 
 
A3) How would you describe your position within the hospital? 
Band 6 ☐   Band 7 ☐     Band 8A-D ☐     Band 9 ☐     
Other ☐ (Please state)  _______________________________________                                                                                                               
 
A4a) In which specialties do you currently work in? (Please tick all that apply) 
Aseptic ☐  Burns and Plastics ☐  Cardiology ☐   Care of the elderly ☐ 
Complex Health ☐ Gastroenterology ☐  Intensive care ☐ Maternity ☐ Medicines 
information ☐ Medicines specialties ☐   Mental health ☐  Paediatrics ☐     Primary Care 
☐Respiratory ☐  Stroke ☐   Surgery ☐  Women’s Health ☐    
Other ☐ (Please state) ___________________________           No specialty ☐                                                        
A4b) If you have ticked more than one, however you have a particular primary specialty please state 
what this is: ____________________________________________   
 
A5a) In which parts of the hospital do you regularly work in? (Please tick all that apply) 
Ward ☐         Dispensary ☐ Aseptics department ☐ Office based ☐  Primary Care  ☐          Other ☐ 
(Please state) __________________________________                                                                    
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A5b) If you ticked more than one area please state the area in which you spend most of your 
working week:  _______________________________________ 
Section B –Members of the healthcare team 
In this section we are collecting information about members of the healthcare team with whom you 
interact with, as part of your job. Please tick a box for each line of the table which best describes the 
frequency of direct personal interaction (either face to face, by phone or by email) you have with that 
healthcare team member. If a healthcare team member is not listed here, please fill in the ‘other’ 
section and state the frequency of the interaction. 
Member of healthcare 
team 
At least 
once a 
DAY 
At least 
once a 
WEEK 
At least 
once a 
MONTH 
At least 
once a 
YEAR 
Less 
frequently 
Never 
Accredited checking 
technician (ACT) 
      
Care home staff       
Dentist       
Dietician        
Dispenser/Technician       
Doctor - Consultant       
Doctor - Junior 
(FY1/FY2)  
      
Doctor - Registrar (ST1 
- 3) 
      
Drug and alcohol team       
General practitioner 
(GP) 
      
GP receptionist       
GP practice manager       
Health visitor       
Medicines counter/ 
Healthcare assistant 
      
Midwife        
Nurse - Community       
Nurse - Hospital       
Occupational therapist       
Opticians       
Paramedic       
Pharmacist - 
Community 
      
Pharmacist – Primary 
care 
      
Physiotherapist       
Podiatrist       
Pre-registration 
Pharmacist 
      
Radiographer       
Social worker       
Speech and language 
therapist 
      
Vet       
Other (please state profession and frequency in the ‘additional comments’ box on the next 
page) 
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If you have any additional comments you would like to make relating to which healthcare 
colleagues you work with please fill in the box below. 
 
Thank you very much for your time in completing this questionnaire. 
 
Please return your questionnaire to the ‘project champion’ ie. the pharmacist responsible for the 
questionnaire within your hospital, or to a designated location specified by the ‘champion’. Or 
alternatively please mail your response to Andy Jenkins at: 
 
Pharmacy Education and Practice, Cardiff School of Pharmacy and Pharmaceutical Sciences, Redwood 
Building, King Edward VII Avenue, Cardiff, CF10 3NB  
Appendices 
 
 
330 
Appendix N – Hospital questionnaire cover letter 
Who do pharmacists work with? 
 
Dear Pharmacist, 
 
I would like to invite you to take part in a study that aims to investigate the day-to-day interactions 
between pharmacists and members of the extended healthcare team.   
 
Pharmacists working in all hospital pharmacy departments throughout Wales are being invited to 
take part and instructions on completing the study are detailed within the questionnaire. 
 
The questionnaire is voluntary, however, I would greatly appreciate it if you could take no longer 
than 5 minutes out of your time to share your views with me.  
 
The questions relate to your individual experiences in this hospital specifically.  If you work within 
this hospital less than 2 days a week, please pass onto another pharmacist to complete. 
 
By completing the questionnaire you will be helping teaching staff in the School of Pharmacy and 
Pharmaceutical Sciences at Cardiff University to gain valuable information on the interprofessional 
interactions that take place when delivering services. 
 
Your responses will be completely confidential. Any information identifying the respondent will not 
be disclosed under any circumstances.   
 
If you have any questions or comments about this study, feel free to contact myself, or my 
supervisors, using the contact details provided. 
 
Your responses will be of great importance to my research and I very much look forward to receiving 
your completed questionnaire. The questionnaire should be returned to the ‘project champion’, ie. 
the pharmacist responsible for the questionnaire within your hospital, or to a designated location 
specified by the ‘project champion’. 
 
Thank you very much for your time in completing the questionnaire. 
 
Yours Sincerely, 
 
     
 
 
 
 
 
  
Dr Louise Hughes 
Tel: 02920876432 
HughesML@cardiff.ac.uk 
Dr Efi Mantzourani 
Tel: 02920870452 
MantzouraniE1@cardiff.ac.uk 
Dr Mat Smith 
Tel: 02920879286 
SmithMW1@cardiff.ac.uk 
Andy Jenkins 
Tel: 02920870516 
JenkinsAI1@cardiff.ac.uk 
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Appendix O – Template email for gatekeeper to aid hospital questionnaire 
dissemination 
Initial email 
Dear Pharmacist, 
 
A project conducted by Cardiff School of Pharmacy aims to investigate the day-to-day interactions 
between pharmacists and members of the extended healthcare team within the secondary care 
environment. 
 
You have been invited to take part in a short confidential questionnaire that should take no longer 
than 5 minutes of your time.   
 
A paper copy of this questionnaire is available from myself at (insert location). More information 
regarding the study has been attached in the form of a cover letter. 
 
I would encourage you to take a short period of your time to complete the questionnaire, as this 
information will be valuable in understanding the interactions that take place between the modern day 
pharmacist and the wider healthcare team. 
 
Once you have completed the questionnaire please return directly to myself or to (insert location). If 
you would like further information regarding the study please contact myself, or the principle supervisor 
Andy Jenkins (JenkinsAI1@cardiff.ac.uk) directly. 
 
Kind regards, 
(Insert name) 
 
Reminder email 
Dear Pharmacist, 
 
I emailed recently regarding a project conducted by Cardiff School of Pharmacy that aims to investigate 
the day-to-day interactions between pharmacists and members of the extended healthcare team within 
the secondary care environment. 
 
Thank you so much to those that have already taken the time to complete the questionnaire, however if 
you have not yet had chance I would encourage you to take part by completing a short confidential 
questionnaire that should take no longer than 5 minutes of your time.   
 
A paper copy of this questionnaire is available from myself at (insert location). More information 
regarding the study has been attached in the form of a cover letter. 
 
The information gathered from the questionnaire will be valuable in understanding the interactions 
that take place between the modern day pharmacist and the wider healthcare team. 
 
Once you have completed the questionnaire please return directly to myself or to (insert location). If 
you would like further information regarding the study please contact myself, or the principle supervisor 
Andy Jenkins (JenkinsAI1@cardiff.ac.uk) directly. 
 
Kind regards, 
(Insert name) 
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Appendix P – Hospital interview cover letter 
Who do pharmacists work with? 
 
 
Dear Pharmacist, 
 
 
As a practicing pharmacist in Wales you have been invited to take part in a service evaluation 
surrounding the interactions of pharmacists and other healthcare professionals in practice.  
 
Attached is a further information leaflet; please take the time to read through the information before 
deciding whether or not you wish to participate.  
 
This evaluation is a follow up of a recent project sent to pharmacists across Wales that aimed to 
determine the frequency of interactions between pharmacists and healthcare professionals. In this 
evaluation we would now like to understand the nature of these interactions. 
 
If you wish to take part please contact myself, Andy Jenkins (PhD student) or the principal 
investigator, Dr Mat Smith, through the contact details below and we will arrange a mutually 
convenient time and location to conduct a one-on-one audio-recorded interview. Your responses will 
be completely confidential.  
 
By taking part in the interview you will be helping teaching staff in the School of Pharmacy and 
Pharmaceutical Sciences at Cardiff University to gain valuable information.  This will help to inform 
the School’s future undergraduate and postgraduate education provision. 
 
If you have any questions or comments about this project, feel free to contact myself, or my 
supervisors, using the contact details provided. 
 
Your participation will be of great importance to this project and I very much look forward to 
receiving your response, which can be done through contacting any of the evaluation team below. 
 
Thank you very much for your time, hope to hear from you soon. 
 
Yours Sincerely, 
 
     
 
 
 
 
  
Dr Mat Smith 
Tel: 029208 79286 
SmithMW1@cardiff.ac.uk 
Andy Jenkins 
Tel: 029225 10138 
JenkinsAI1@cardiff.ac.uk 
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Appendix Q – Hospital interview information sheet 
As a practicing pharmacist in Wales you have been invited to take part in a service evaluation 
surrounding the interactions of pharmacists and other healthcare professionals in practice. Please 
take the time to read through the information before deciding whether or not you wish to participate.  
 
What is the purpose of the service evaluation? 
This service evaluation is a follow up of a recent survey sent to pharmacists across Wales that aimed 
to determine the frequency of interactions between pharmacists and healthcare professionals. We 
would now like to understand the nature of these interactions in practice. 
 
Who are the evaluators? 
This evaluation is to be undertaken by Andy Jenkins, a final year PhD student, and Dr Mat Smith, the 
principal investigator. This evaluation has been approved by the Cardiff School of Pharmacy and 
Pharmaceutical Sciences Research Ethics Committee. 
Why have I been invited to participate in this evaluation? 
You have been invited to take part because you are a practicing pharmacist in Wales and are 
therefore knowledgeable on the interprofessional interactions that take place in practice. 
 
How will the evaluation take place? 
If you consent, you will be invited to take part in a one-to-one interview which will be audio-recorded.   
The interview will be conducted in private and will start by clarifying some initial demographic 
details, ie the health board you work in and your role within the pharmacy. The interview will then 
progress to determine your interactions with other healthcare professionals and the reasons behind 
these interactions. Please be aware that this interview is about your experiences in general and you 
will not be asked to divulge any patient/healthcare member specific information. The interview 
should last approximately 20 minutes.  
 
Do I have to take part? 
The decision to consent lies entirely with you. If you wish to take part a mutually convenient time 
and location will be arranged through contacting one of the evaluation team through the contact 
details below. Consent forms will be provided and filled in at the interview to give you chance to 
clarify any points within this. One copy of the form will also be provided in advance for reference. 
The evaluation team will retain the other copy. You are free to withdraw from the study at any time 
without giving a reason.  
 
How will the information collected be used? 
Confidentiality will be ensured at all stages of the research process. The transcripts will be 
anonymised and consent forms, transcripts, questionnaires and tapes will be kept securely in the 
School of Pharmacy & Pharmaceutical Sciences. Any information retained on university computers 
will contain a reference number in place of your personal data. Any personal details that are collected 
during the project will only be seen by the evaluation team and will not be kept for any longer than 
is needed to complete this project. It is anticipated that this will be no longer than 12 months. This 
evaluation could help the school in understanding the relationships pharmacists have in practice 
which could help inform the undergraduate and postgraduate pharmacy programmes in the future. 
 
Who to contact to participate or for more information? 
If you are happy to take part or would like further information please contact Andy or alternatively 
Mat via the details given below. Please note that contacting the investigator does not commit you to 
participating. 
PhD Student: Andy Jenkins (Email: JenkinsAI1@cardiff.ac.uk Tel: 029225 10138)  
Principal Investigator: Dr Mat Smith (Email: SmtihMW1@cardiff.ac.uk Tel: 029208 79286)  
Appendices 
 
 
334 
Appendix R – Hospital interview consent form 
Consent Form  
 
Please read the following statements and initial the boxes next to the statements for which 
you give consent.  
Please also sign and date the form below. 
 
1. I confirm that I have read and understood the participant information sheet 
and have had the opportunity to ask any questions.  
 
2. I understand that my participation is voluntary and I have the right to 
withdraw at anytime.  
 
3. I understand that by signing the form I agree to give consent to participate 
within the evaluation. 
 
4. I give my consent for the interview to be audio-recorded.  
 
5. I agree to be contacted by the evaluators if clarification is needed regarding 
any points discussed during the interview. 
 
6. I understand that verbatim quotes may be used in reports and if so, they will be 
anonymised.  
 
 
Participant details 
Name (please print): 
Telephone Number:    Email: 
Signature:      Date: 
 
Name of Researcher: 
Signature of Researcher:                      Date: 
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Appendix S – Hospital interview schedule 
Aim: To explore the interprofessional interactions taking place between pharmacists and 
other healthcare professionals. 
 
Main topics  
Perception of interprofessional education (IPE) and interactions 
Who do they interact with and how often? 
What are the interactions about, what was their purpose?  
How were the interactions undertaken? 
Barriers and facilitators 
Perceived benefits of interprofessional interactions 
 
Intro  
Ensure consent forms have been signed and understood. 
Explain focus of the project – To explore pharmacists interactions with other healthcare 
professionals  
Confirm participant is happy to be recorded and stress that all data will be anonymised and is 
confidential 
Explanation about interview: “I am going to start with some general questions relating to your career 
as a pharmacist then I will follow on with a card-sorting activity focusing on interprofessional 
interactions and finish with some short questions relating to your personal experiences with other 
healthcare professionals in THIS hospital/primary care environment. Please remember that these are 
your opinions, there are no right or wrong answers. The interview should take approximately 20 
minutes in total, I may make some notes throughout but these are for my own benefit and please feel 
free to ask any questions if you need to. If you need to stop at any time to talk to a customer that is also 
fine I will pause and restart afterwards.”  
 
General questions 
Could you first of all tell me a bit about your background as a pharmacist?  
a) Which university did you study at?  
b) When did you qualify?  
c) How long have you worked within this hospital/GP surgery (interchangeable depending on 
participant)? 
d) What other positions have you had during your career as a hospital pharmacist?   
e) Have you done any other work outside of hospital pharmacy? 
 
Opening questions 
Could you explain what the term interprofessional interaction means to you?  
What do you perceive as the benefits of interprofessional interactions to yourself? 
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What do you perceive as the benefits of interprofessional interactions to the patient? 
 
Reflective card activity 
Cards showing the top 15 professions hospital pharmacists work with (from data gathered in the 
previous questionnaire study) will be presented to the participant where they will be asked to 
arrange based on their experiences within the hospital/primary care environment the 
predominantly work within. Prompt: “Could you now sort in order those who you interact with the 
most frequently to the least? These healthcare professionals have been chosen from the previous study 
of which pharmacists interact with based on your experiences in THIS hospital environment” 
“Hopefully that has started you to think about the various interactions which can occur within 
pharmacy. I’d like to look at a few of these in more detail.” 
 
Questions related to card activity 
Questions will then be directed to the participant surrounding the top three healthcare 
professionals put during the card sorting activity. The same structure for each healthcare 
professional will be used and is shown below.  Additionally if any other ‘obscure’ professions (when 
compared with the overall frequency data found in the previous project) they will also be explored.  
 
I have noted that you have put … as number ….. on your list; could you tell me a bit about a typical 
interaction with this profession? 
What would you say are the main reasons for interactions with …? 
How did this occur? 
How frequently would you interact with a …? 
Are there any barriers to these interactions? 
Is there anything that could make these interactions easier? 
Do these typical interactions benefit your learning?  
Have you applied this learning since? 
Is there a particular example of an interaction that you can think of?  
Could you elaborate on that? When/How etc.   
Have you had any other interactions with other types of …? (this question for professions where 
there is different areas, hospital vs primary care doctors/nurses) 
Are these similar to the interactions you have already discussed?’  
 
Final questions 
Do you have anything you would like to add about any other healthcare professionals? 
Have you had any previous training in working with other healthcare professional? This could be at 
undergraduate level or from courses you have taken? 
Is there anything specific at the moment that you would like to learn from another?  
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One method used to help improve interprofessional working is IPE, if you could design an IPE 
session that would help improve your practice what would this look like? Who would this be with, 
what topics would this be on? 
 In terms of quantity of your interactions with our professions, do you feel this is too much, too little 
or just right? – Can you explain why you think this?   
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Appendix T - Hospital questionnaire free text comments 
Table Appendix S.1. Additional comments made by respondents (represented by their individuate ID 
code) in Section C of the hospital questionnaire (n=20) 
ID  Comment 
21 Regulatory liaise with consultant microbiologists, infection control nurses and other 
antimicrobial pharmacists within the health board 
54 Outpatients receptionists, charitable organisation employees, medical secretaries  
122 My core work is in medicines polices and procedures and PGD hence the need to 
counsel multidisciplinary teams 
126 Constantly work with mental health nurses working in community mental health team, 
drug and alcohol team, home treatment teams. Also nurse managers and matrons 
153 I work within a mental health specialist team 
154 Multidisciplinary working is essential for pre-operative clinic – work closely with 
haematology consultants, anesthetists, pre-operative assessment nurses. 
Communicate medication changes to surgical consultants and GPs where necessary 
156 Difficult to quantify how frequently I interact with some professions, depends on 
rotational role, admissions ward, sessions covered 
174 Nurse practitioners, dermatology specialist nurse, ward clerk – clerical staff 
184 Working as part of a multidisciplinary team is very important and patient care 
198 Aim to attend consultant or registrar ward rounds 2-3 times per week (part time work 
3 days) in current role. Direct contact/interaction with medical teams everyday on 
wards. Currently undertaking IP course also so increase contact with consultant DSMP 
and Registrar 
211 We have a nurse practitioner based in the pharmacy department working alongside us 
in anticoagulation. The clinical lead for anticoagulation is a consultant haematologist. 
We take referrals from consultants on a daily basis. 
231 In the clinical trials role I speak to clinical research associates, R+D officers 
244 Also have contact with Directorate managers, executive directors, welsh government, 
RPS, GPhC, GP and other royal colleagues, public health wales, academic colleagues. 
263 Any healthcare colleague can contact medicines information but the regularity with 
which we interact with them in uncertain as the service is reactive to queries 
267 I work mostly with the ward staff; junior doctors (FY1) and SMOs, nurses and charge 
sisters. I also work with another pharmacist (diploma tutor). I work with a medication 
management technician, however they cover the surgical ward when I’m not in – only 
work indirectly with them 
288 In my role as cancer services lead pharmacist I regularly work with the following staff 
groups within the NHS: Finance/accounting, administrative staff, assistant technical 
offices, IM+T staff, estates staff, cleaners, managers, Macmillan staff, voluntary staff, 
cancer network team, pathology/biochemistry, human resources, procurement staff, 
patient representatives, porters 
412 I am based of site of the main hospital in aseptic/manufacturing unit, my role is 
majority non-clinical 
413 Can have significant contact with a range of healthcare professionals regarding use of 
our unlicensed products. This could range from advice on current formulation to 
excipient and allergy advice, to stock review and lead times on products. Also questions 
regarding new products. Aseptics queries are usually from secondary care consultants 
or nurses requiring information on stability and shelf lives for different temperatures 
of storage. 
418 Work as a MDT – Dietician, nurses, consultant and registrar, biochemist 
419 Microbiologist, ward sister 
 
